UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
(Mark One)
x |
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the fiscal year ended December 31, 2014
OR
¨ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number: 001-34680
Primerica, Inc.
(Exact name of registrant as specified in its charter)
Delaware |
|
27-1204330 |
(State or other jurisdiction of incorporation or organization) |
|
(I.R.S. Employer Identification No.) |
|
|
|
1 Primerica Parkway Duluth, Georgia |
|
30099 |
(Address of principal executive offices) |
|
(ZIP Code) |
Registrant’s telephone number, including area code: (770) 381-1000
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Name of each exchange on which registered |
Common Stock, $0.01 Par Value |
|
New York Stock Exchange |
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. x Yes ¨ No
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. ¨ Yes x No
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. x Yes ¨ No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). x Yes ¨ No
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of the registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. x
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
|
x |
|
Accelerated filer |
|
¨ |
|
|
|
|
|||
Non-accelerated filer |
|
¨ (Do not check if a smaller reporting company) |
|
Smaller reporting company |
|
¨ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ¨ Yes x No
The aggregate market value of the voting stock held by non-affiliates of the registrant as of June 30, 2014, was $2,552,645,945. The number of shares of the registrant’s Common Stock outstanding at January 31, 2015, with $0.01 par value, was 52,240,149.
Documents Incorporated By Reference
Certain information contained in the Proxy Statement for the Company’s Annual Meeting of Stockholders to be held on May 20, 2015 is incorporated by reference into Part III hereof.
TABLE OF CONTENTS
|
|
|
|
Page |
|
|
|
1 |
|
Item 1. |
|
|
1 |
|
Item 1A. |
|
|
18 |
|
Item 1B. |
|
|
30 |
|
Item 2. |
|
|
30 |
|
Item 3. |
|
|
30 |
|
Item 4. |
|
|
31 |
|
Item X. |
|
|
31 |
|
|
|
|
||
|
|
|
33 |
|
Item 5. |
|
|
33 |
|
Item 6. |
|
|
35 |
|
Item 7. |
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
|
37 |
Item 7A. |
|
|
55 |
|
Item 8. |
|
|
57 |
|
Item 9. |
|
Changes in and Disagreements With Accountants on Accounting and Financial Disclosure |
|
91 |
Item 9A. |
|
|
91 |
|
Item 9B. |
|
|
94 |
|
|
|
|
||
|
|
|
95 |
|
Item 10. |
|
|
95 |
|
Item 11. |
|
|
95 |
|
Item 12. |
|
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters |
|
95 |
Item 13. |
|
Certain Relationships and Related Transactions, and Director Independence |
|
96 |
Item 14. |
|
|
96 |
|
|
|
|
||
|
|
|
97 |
|
Item 15. |
|
|
97 |
|
|
|
|
111 |
i
CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS
Investors are cautioned that certain statements contained in this report as well as some statements in periodic press releases and some oral statements made by our officials during our presentations are “forward-looking” statements. Forward-looking statements include, without limitation, any statement that may project, indicate or imply future results, events, performance or achievements, and may contain the words “expect”, “intend”, “plan”, “anticipate”, “estimate”, “believe”, “will be”, “will continue”, “will likely result”, and similar expressions, or future conditional verbs such as “may”, “will”, “should”, “would”, and “could.” In addition, any statement concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects, and possible actions taken by us or our subsidiaries are also forward-looking statements. These forward-looking statements involve external risks and uncertainties, including, but not limited to, those described under the section entitled “Risk Factors” included herein.
Forward-looking statements are based on current expectations and projections about future events and are inherently subject to a variety of risks and uncertainties, many of which are beyond the control of our management team. All forward-looking statements in this report and subsequent written and oral forward-looking statements attributable to us, or to persons acting on our behalf, are expressly qualified in their entirety by these risks and uncertainties. These risks and uncertainties include, among others:
· |
our failure to continue to attract and license new recruits, retain sales representatives, or license or maintain the licensing of our sales representatives; |
· |
changes to the independent contractor status of our sales representatives; |
· |
our or our sales representatives’ violation of, or non-compliance, with laws and regulations; |
· |
our or our sales representatives’ failure to protect the confidentiality of client information; |
· |
differences between our actual experience and our expectations regarding mortality, persistency, expenses and interest rates as reflected in the pricing for our insurance policies; |
· |
the occurrence of a catastrophic event that causes a large number of premature deaths of our insureds; |
· |
changes in federal and state legislation and regulation, including other legislation or regulation that affects our insurance and investment product businesses; |
· |
our failure to meet risk-based capital standards or other minimum capital or surplus requirements; |
· |
a downgrade or potential downgrade in our insurance subsidiaries’ financial strength ratings or in the investment grade credit ratings for our senior unsecured debt; |
· |
the effects of credit deterioration and interest rate fluctuations on our invested asset portfolio; |
· |
incorrectly valuing our investments; |
· |
inadequate or unaffordable reinsurance or the failure of our reinsurers to perform their obligations; |
· |
the failure of, or legal challenges to, the support tools we provide to our sales force; |
· |
heightened standards of conduct or more stringent licensing requirements for our sales representatives; |
· |
inadequate policies and procedures regarding suitability review of client transactions; |
· |
the inability of the investment and savings products we distribute to remain competitive with other investment options or key providers could change the investment and savings products they offer in a way that is not beneficial to our business; |
· |
fluctuations in the performance of client assets under management in our investment savings products segment |
· |
the inability of our subsidiaries to pay dividends or make distributions; |
· |
our ability to generate and maintain a sufficient amount of working capital; |
· |
our non-compliance with the covenants of our senior unsecured debt; |
· |
legal and regulatory investigations and actions concerning us or our sales representatives; |
· |
the loss of key personnel; |
· |
the failure of our information technology systems, breach of our information security or failure of our business continuity plan; and |
· |
fluctuations in Canadian currency exchange rates. |
Developments in any of these areas could cause actual results to differ materially from those anticipated or projected or cause a significant reduction in the market price of our common stock.
The foregoing list of risks and uncertainties may not contain all of the risks and uncertainties that could affect us. In addition, in light of these risks and uncertainties, the matters referred to in the forward-looking statements contained in this report may not in fact occur. Accordingly, undue reliance should not be placed on these statements. We undertake no obligation to publicly update or revise any forward-looking statements as a result of new information, future events or otherwise, except as otherwise required by law.
ii
Primerica, Inc. (“Primerica”, “we”, “us” or the “Parent Company”) is a leading distributor of financial products to middle income households in the United States and Canada with approximately 98,000 licensed sales representatives at December 31, 2014. We assist our clients in meeting their needs for term life insurance, which we underwrite, and mutual funds, annuities and other financial products, which we distribute primarily on behalf of third parties. We insured more than 4.3 million lives and maintained approximately two million investment accounts on behalf of our clients at December 31, 2014. Our distribution model uniquely positions us to reach underserved middle income consumers in a cost effective manner and has proven itself in both favorable and challenging economic environments.
Our mission is to serve middle income families by helping them make informed financial decisions and providing them with a strategy and means to gain financial independence. Our distribution model is designed to:
· |
Address our clients’ financial needs. Our sales representatives primarily use our proprietary financial needs analysis tool (“FNA”) and an educational approach to demonstrate how our products can assist clients to provide financial protection for their families, save for their retirement and other needs, and manage their debt. Typically, our clients are the friends, family members and personal acquaintances of our sales representatives. Meetings are generally held in informal, face-to-face settings, usually in the clients’ homes. |
· |
Provide a business opportunity. We provide an entrepreneurial business opportunity for individuals to distribute our financial products. Low entry costs and the ability to begin part-time allow our sales representatives to supplement their income by starting their own independent businesses without incurring significant start-up costs or leaving their current jobs. Our unique compensation structure, technology, training and back-office processing are designed to enable our sales representatives to successfully grow their independent businesses. |
Corporate Structure
We conduct our core business activities in the United States through three principal entities, all of which are direct or indirect wholly owned subsidiaries of the Parent Company:
· |
Primerica Financial Services, Inc. (“PFS”), our general agency and marketing company; |
· |
Primerica Life Insurance Company (“Primerica Life”), our principal life insurance underwriting company; and |
· |
PFS Investments Inc. (“PFS Investments”), our investment and savings products company, broker-dealer and registered investment advisor. |
Primerica Life is domiciled in Massachusetts, and its wholly owned subsidiary, National Benefit Life Insurance Company (“NBLIC”), is a New York life insurance underwriting company.
We conduct our core business activities in Canada through three principal entities, all of which are indirect wholly owned subsidiaries of the Parent Company:
· |
Primerica Life Insurance Company of Canada (“Primerica Life Canada”), our Canadian life insurance underwriting company; |
· |
PFSL Investments Canada Ltd. (“PFSL Investments Canada”), our Canadian licensed mutual fund dealer; and |
· |
PFSL Fund Management Ltd. (“PFSL Fund Management”), our Canadian investment funds manager. |
Primerica was incorporated in the United States as a Delaware corporation in October 2009 to serve as a holding company for the Primerica businesses (collectively, the “Company”). Our businesses, which prior to April 1, 2010 were wholly owned indirect subsidiaries of Citigroup Inc. (“Citigroup”), were transferred to us by Citigroup on April 1, 2010 in a reorganization pursuant to which we completed an initial public offering in April 2010 (the “IPO”). On March 31, 2010, we entered into certain reinsurance transactions with affiliates of Citigroup (the “Citigroup reinsurers”) and ceded between 80% and 90% of the risks and rewards of our term life insurance policies that were in force at year-end 2009.
Our Clients
Our clients are generally middle income consumers, which we define as households with $30,000 to $100,000 of annual income. According to the 2013 U.S. Census Bureau Current Population Survey, the latest period for which data is available, approximately 50% of U.S. households fall in this range. We believe that we understand the financial needs of the middle income segment which include:
· |
They have inadequate or no life insurance coverage. Individual life insurance sales in the United States declined from 12.5 million policy sales in 1975 to 6.0 million policy sales in 2013, the latest period for which data is available, according to the Life Insurance Marketing and Research Association International, Inc. (“LIMRA”), a worldwide association of insurance and financial services companies. We believe that term life insurance, which we have provided to middle income clients for many years, is generally the best option for them to meet their life insurance needs. |
1
· |
They need help saving for retirement and other personal goals. Middle income families continually find it challenging to save for retirement and other goals. By developing personalized savings programs for our clients using our proprietary FNA and offering a wide range of mutual funds, annuities, managed investments and segregated fund products sponsored and managed by reputable firms, our sales representatives are well equipped to help clients develop long-term savings plans to address their financial needs. |
· |
They need to reduce their consumer debt. Many middle income families have numerous debt obligations from credit cards, auto loans, and home mortgages. We help our clients address these financial burdens by providing personalized client-driven debt resolution techniques and third party referrals that can help them reduce and ultimately pay off their debts. |
· |
They prefer to meet face-to-face when considering financial products. Historically, middle income consumers have indicated a preference to meet face-to-face when considering financial products or services. As such, we have designed our business model to address this preference in a cost-effective manner. |
Our Distribution Model
Our distribution model, which is based on a traditional insurance agency model and borrows aspects from franchising and direct sales, is designed to reach and serve middle income consumers efficiently through direct selling to customers by our sales representatives. Key characteristics of our unique distribution model include:
· |
Independent entrepreneurs: Our sales representatives are independent contractors building and operating their own businesses. This business-within-a-business approach means that our sales representatives are entrepreneurs who take responsibility for selling products, recruiting sales representatives, setting their own schedules and managing and paying the expenses associated with their sales activities, including office rent and administrative overhead. |
· |
Part-time opportunity: By offering a flexible part-time opportunity, we are able to attract a significant number of recruits who desire to earn supplemental income and generally concentrate on smaller-sized transactions typical of middle income consumers. Our sales representatives are able to join our sales force at minimal expense, and they receive technological support, pre-licensing training and licensing examination preparation programs. Our sales representatives distribute our products directly to consumers, and therefore our business opportunity does not require recruits to purchase and resell our products. Virtually all of our sales representatives begin selling our products on a part-time basis, which enables them to hold jobs while exploring an opportunity with us. |
· |
Incentive to build distribution: When a sale is made, the selling representative receives a commission, as does the licensed representative who recruited and supervises him or her, which we refer to as override compensation. Override compensation is paid through several levels of the selling representative’s recruitment and supervisory organization. This structure motivates existing sales representatives to grow our sales force and provides them with commission income from the sales completed by representatives in their downline sales organization. |
· |
Sales force leadership: A sales representative who has built a successful organization and has obtained his or her life insurance and securities licenses can achieve the sales designation of Regional Vice President (“RVP”), which entitles him or her to earn higher compensation and bonuses. RVPs are independent contractors who open and operate offices for their sales organizations and devote their full attention to their Primerica businesses. RVPs also support and monitor the sales representatives on whose sales they earn override commissions in compliance with applicable regulatory requirements. RVPs’ efforts to expand their businesses are a primary driver of our success. |
· |
Innovative compensation system: We have developed an innovative system for compensating our independent sales force that is contingent upon product sales. We advance to our sales representatives a significant portion of their insurance commissions upon their submission of an insurance application and the first month’s premium payment. In addition to being a source of motivation, this upfront payment provides our sales representatives with immediate cash flow to offset costs associated with originating the business. In addition, monthly production bonuses are paid to RVPs whose downline sales organizations meet certain sales levels. With compensation tied to sales activity, our compensation approach accommodates varying degrees of individual productivity, which allows us to effectively use a large group of part-time sales representatives while providing a variable cost structure. In addition, we incentivize our RVPs with equity compensation on a quarterly basis, which aligns their interests with those of our stockholders. |
· |
Large, dynamic sales force: Members of our sales force primarily serve their friends, family members and personal acquaintances through individually driven networking activities. We believe that this warm market approach is an effective way to distribute our products because it facilitates face-to-face interaction initiated by a trusted acquaintance of the prospective client, which is difficult to replicate using other distribution approaches. Due to the large size of our sales force and our active recruiting of new sales representatives, our sales force is able to continually access an expanding base of prospective clients without engaging costly media channels. |
· |
Motivational culture: In addition to the motivation for our sales representatives to achieve financial success, we seek to create a culture that inspires and rewards our sales representatives for their personal successes and those of their sales organizations through sales force recognition events and contests. We also use Internet-streamed broadcasts and local, regional and national meetings to inform and teach our sales representatives, as well as facilitate camaraderie and the exchange of ideas across the sales force organization. These initiatives encourage and empower our sales representatives to develop their own successful sales organizations. |
2
· |
Inclusive culture: Building and maintaining an ethnically and demographically diverse sales force is important to us, as we believe our sales force does reflect the middle market communities we serve. As the communities we serve become more diverse, the diversity of our salesforce also improves. |
Structure and Scalability of Our Sales Force
New sales representatives are recruited by existing sales representatives. When these new recruits join our sales force, they are assigned an upline relationship with the sales representative who recruited them and with the recruiting sales representative’s respective upline RVP organization. As new sales representatives are successful in recruiting other sales representatives, they begin to build their own organization of sales representatives who become their downline sales representatives. We encourage our sales representatives to bring in new recruits to build their own sales organizations, enabling them to earn override commissions on sales made by members of their downline organization.
RVPs establish and maintain their own offices, which we refer to as field offices. Additionally, they are responsible for funding the costs of their administrative staff, marketing materials, travel and training and certain exclusive recognition events for the sales representatives in their respective downline organizations. Field offices provide a location for conducting recruiting meetings, training events and sales-related meetings, disseminating our Internet-streamed broadcasts, conducting compliance functions, and housing field office business records. Some business locations contain more than one onsite field office. At December 31, 2014, approximately 4,500 field offices in approximately 2,700 locations were managed by sales representatives that served as full-time RVPs.
Our sales-related expenses are largely variable costs that fluctuate with product sales volume. Sales-related expenses consist primarily of sales commissions and incentive programs for our sales representatives, as well as costs associated with information technology, compliance, administrative activities, sales management, and training.
With support provided by our home office staff, RVPs play a major role in training, motivating and monitoring their sales representatives. Because the sales representative’s compensation grows with the productivity of his or her downline organization, our distribution model provides financial rewards to sales representatives who successfully develop, support and monitor productive sales representatives. Furthermore, we have developed proprietary tools and technology to enable our RVPs to reduce the time spent on administrative responsibilities associated with their sales organizations so they can devote more time to the sales and recruiting activities that drive our growth. We believe that our tools and technology, coupled with our bonus and equity incentive award programs, further incentivize our sales representatives to become RVPs.
To encourage our most successful RVPs to build large downline sales organizations that generate strong sales volumes, we established the Primerica Ownership Program. This program provides qualifying RVPs a contractual right, upon meeting certain criteria, to transfer their Primerica businesses to another RVP or transfer it to a qualifying family member.
Both the structure of our sales force and the capacity of our support capabilities provide us with a high degree of scalability as we grow our business. Our support systems and technology are capable of supporting a large sales force and a high volume of transactions. In addition, by sharing training and compliance activities with our RVPs, we are able to grow without incurring proportionate overhead expenses.
Recruitment of Sales Representatives
The recruitment of sales representatives is undertaken by our existing sales representatives, who identify prospects and share with them the benefits of associating with our organization. Our sales representatives showcase our organization as dynamic and capable of improving lives by demonstrating the success achieved by the members of our sales force and the value of the solutions that we provide.
After the initial contact, prospective recruits typically are invited to an opportunity meeting, which is conducted by an RVP. The objective of an opportunity meeting is to inform prospective recruits about our mission and their opportunity to join our sales force. At the conclusion of each opportunity meeting, prospective recruits are asked to complete an application and pay us a nominal fee to commence their pre-licensing training and licensing examination preparation programs and, depending on the state or province, to cover their licensing exam registration costs, which are provided by the Company generally at no additional charge. Recruits are not obligated to purchase any of our products in order to become sales representatives, though they may elect to make such purchases.
Our sales force is our sole distribution channel for our term life insurance and investment and savings products, and our success depends on the ongoing recruitment, training and licensing of new sales representatives. Recruits may become our clients or provide us with access to their friends, family members and personal acquaintances. As a result, we continually work to improve our systematic approach to recruiting and training new sales representatives.
Similar to other distribution systems that rely upon part-time sales representatives and typical of the life insurance industry in general, we experience wide disparities in the productivity of individual sales representatives. Many new recruits do not get licensed, mainly due to the time commitment required to obtain licenses and various regulatory hurdles. Many of our licensed sales representatives are only marginally active in our business. As a result, we plan for this disparate level of productivity and view a continuous recruiting cycle as a key component of our distribution model. Our distribution model is designed to address the varying productivity associated
3
with part-time sales representatives by paying production-based compensation, emphasizing recruiting, and developing initiatives to address barriers to licensing new recruits. By providing override commissions to sales representatives on the sales generated by their downline sales organization, our compensation structure aligns the interests of our sales representatives with our interests in recruiting new representatives and creating sustainable sales production.
The following table provides information on new recruits and insurance-licensed sales representatives:
|
|
Year ended December 31, |
|
|||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|||
Number of new recruits |
|
|
190,439 |
|
|
|
186,251 |
|
|
|
191,752 |
|
Number of newly insurance-licensed sales representatives |
|
|
33,832 |
|
|
|
34,155 |
|
|
|
34,425 |
|
Number of insurance-licensed sales representatives, at period end |
|
|
98,358 |
|
|
|
95,566 |
|
|
|
92,373 |
|
Average number of insurance-licensed sales representatives during period |
|
|
96,780 |
|
|
|
93,086 |
|
|
|
90,981 |
|
We define new recruits as individuals who have submitted an application to join our sales force, together with payment of the nominal fee to commence their pre-licensing training. We may not approve certain new recruits to join our sales force, and others elect to withdraw from our sales force prior to becoming active in our business.
On average, it requires approximately three months for our sales representatives to complete the necessary applications and pre-licensing coursework and to pass the applicable state or provincial examinations to obtain a license to sell our term life insurance products. As a result, individuals recruited to join our sales force within a given fiscal period may not become licensed sales representatives until a subsequent period.
Sales Force Motivation, Training and Communication
Motivating, training and communicating with our sales force are critical to our success and that of our sales force.
Motivation. Through our proven system of sales force recognition events, contests, and communications, we provide incentives that drive our results. Motivation is driven in part by our sales representatives’ belief that they can achieve higher levels of financial success by building their own businesses as Primerica sales representatives. The opportunity to help underserved middle income households address financial challenges is also a significant source of motivation for many of our sales representatives, as well as for our management and home office employees.
We motivate our sales representatives to succeed in our business by:
· |
compensating our sales representatives for product sales by them and their downline organizations; |
· |
helping our sales representatives learn financial fundamentals so they can confidently and effectively assist our clients; |
· |
reducing the administrative burden on our sales force, which allows them to devote more of their time to building a downline organization and selling products; and |
· |
creating a culture in which sales representatives are encouraged to achieve goals through the recognition of their sales and recruiting achievements, as well as those of their sales organizations. |
To help our sales representatives understand that they are part of a larger enterprise than their field office, we conduct numerous local, regional and national meetings. These meetings inform and motivate our sales force. In July 2015, we are scheduled to hold our biennial international convention at the Georgia Dome in Atlanta, at which tens of thousands of our sales representatives have assembled in previous years. Also, in previous years, many of our new recruits and sales representatives attended our biennial international convention and other meetings at their own expense, which we believe further demonstrates their commitment to our organization and mission.
Training. Our sales representatives must hold licenses to sell most of our products. Our in-house insurance licensing program offers a significant number of classroom, online and self-study insurance pre-licensing courses to meet applicable state and provincial licensing requirements and prepare recruits to pass applicable licensing exams. For those representatives who wish to sell our investment and savings products, we contract with third-party training firms to conduct exam preparation and also offer supplemental training tools.
We provide courses, tools and incentives to help new recruits become licensed sales representatives. For example, we offer, generally at no cost to our sales force, a personalized study plan, a variety of review classes, and life insurance study and exam review videos and audios. With a subscription to our secure Internet website, new recruits in the U.S. gain access to an online exam simulator, a tool that uses a student’s prior performance to provide simulated exams that focus on individual study needs. In Canada, new recruits procure and utilize exam simulators that are not included as part of our secure Internet website. We also provide an online interactive tool that provides new recruits with a step-by-step guide to building their Primerica sales businesses.
Other internal training program opportunities include training modules and videos covering sales, management skills, business ownership, products and compliance. Additionally, many RVPs conduct sales training either on nights or weekends, providing new recruits a convenient opportunity to attend training outside of weekday jobs or family commitments.
4
Communication. We communicate with our sales force through multiple channels, including:
· |
Primerica Online (“POL”), which is our secure Internet website designed to be a support system for our sales force. POL provides sales representatives with access to their Primerica e-mail, bulletins and alerts, business tracking tools and real-time updates on their pending life insurance applications and new recruits. We also use POL to provide real-time recognition of sales representatives’ successes and scoreboards for sales force production, contests and trips. In addition, POL is a gateway to our product providers and product support. A substantial majority of our sales representatives subscribe to POL. Subscribers generally pay a $25 monthly fee to subscribe to POL, which helps cover the cost of maintaining this support system. |
· |
our in-house broadcasts, which are delivered by Internet-streaming video. We create original broadcasts and videos that enable senior management to update our sales force and provide training and motivational presentations. We broadcast a live weekly program hosted by home office management and selected RVPs that focuses on new developments and provides motivational messages to our sales force. We also broadcast a training-oriented program to our sales force on a weekly basis and profile successful sales representatives, allowing these individuals to educate and train our other sales representatives by sharing their secrets for success. |
· |
our publications department, which produces materials to support, motivate, and inform our sales force. We sell recruiting materials, sales brochures, business cards and stationery and provide total communications services, including web design, print presentations, graphic design and script writing. We also produce a weekly mailing that includes materials promoting our current incentives, as well as the latest news about our product offerings. |
Sales Force Support and Tools
Our information systems and technology are designed to support a sales and distribution model that relies on a large group of predominantly part-time sales representatives and assist them in building their own businesses. We provide our sales representatives with sales tools that allow both new and experienced sales representatives to offer financial information and products to their clients. The most significant of these tools are:
· |
Our Financial Needs Analysis: Our FNA is a proprietary, needs-based analysis tool. The FNA gives our sales representatives the ability to collect and synthesize client financial data and develop a financial analysis for the client that is easily understood. The FNA, while not a financial plan, provides our clients with a personalized explanation of how our products work and introduces prudent financial concepts, such as regular saving and accelerating the repayment of high cost credit card debt to help them reach their financial goals. The FNA provides clients with a snapshot of their current financial position and identifies their life insurance, savings and debt resolution needs. |
· |
Our Point-of-Sale Application Tool: Our point-of-sale software, TurboApps, is an internally developed system that streamlines the application process for our insurance products. This application populates client information from the FNA to eliminate redundant data collection and provides real-time feedback to eliminate incomplete and illegible applications. Integrated with our paperless field office management system described below and with our home office systems, TurboApps allows our RVPs and us to realize the efficiencies of straight-through-processing of application data and other information collected on our sales representatives’ mobile devices, which results in expedited processing of our life insurance product sales. We also leverage the TurboApps concept with our investment partners to process U.S. mutual fund and annuity product sales. |
· |
Virtual Base Shop: In an effort to ease the administrative burden on RVPs and simplify sales force operations, we make available to RVPs a secure Internet-based paperless field office management system as part of the POL subscription. This virtual office is designed to automate the RVP’s administrative responsibilities and can be accessed by all sales representatives in an RVP’s immediate downline sales organization, which we refer to as his or her base shop. |
· |
Other Tools: We utilize proprietary and third-party products for more efficient application processing, client support, and sales force administration, among other uses. For example, our Primerica App for Android and iOS are broadly used by our sales force for managing contacts, generating client proposals, and receiving and sending communications. In addition to our Primerica App, we continue to develop mobile applications as the use of mobile devices by our sales representatives increases. |
We also make available other technology to support our sales force in managing their businesses and in serving our clients, including:
· |
a toll-free sales support call center to address questions and assist with paperwork, underwriting and licensing; |
· |
a tele-underwriting process that allows clients to provide needed medical information without disclosing it to our sales representatives; and |
· |
POL for tracking the status of pending life insurance applications and the progress of their new recruits in their training and licensing efforts. |
Performance-Based Compensation Structure
Our compensation system is rooted in our origin as an insurance agency. Our sales representatives can earn compensation in multiple ways, including:
· |
sales commissions and fees based on their personal sales and client assets under management; |
· |
override commissions based on sales by sales representatives and fees based on client assets under management in their downline organizations; |
5
· |
bonuses and other compensation, including equity-based compensation, based on their own sales performance, the aggregate sales performance of their downline organizations and other criteria; and |
· |
participation in our contests and other incentive programs. |
Our compensation system pays a commission to the representative who sells the product and override commissions to several levels of the selling representative’s upline organization. With respect to term life insurance sales, commissions are calculated based on the total first-year premium (excluding policy fee) for all policies and riders up to a maximum premium. To motivate our sales force, we compensate sales representatives for term life insurance product sales as quickly as possible. We advance a majority of the insurance commission upon the submission of a completed application and the first month’s premium payment. As the client makes his or her premium payments, the commission is earned by the sales representative and the commission advance is recovered by the Company. If premium payments are not made by the client and the policy terminates, any outstanding advance commission is charged back to the sales representative. The chargeback would equal that portion of the advance that was made, but not earned, by the sales representative because the client did not pay the full premium for the period of time for which the advance was made to the sales representative. Chargebacks, which occur in the normal course of business, may be recovered by reducing any cash amounts otherwise payable to the sales representative.
Sales representatives and their upline organizations are contractually obligated to repay us any commission advances that are ultimately not earned due to the underlying policy lapsing prior to the full commission being earned. Additionally, we hold back a portion of the commissions earned by our sales representatives as a reserve out of which we may recover chargebacks. The amounts held back are referred to as deferred compensation account commissions (“DCA commissions”). DCA commissions are available to reduce amounts owed to the Company by sales representatives. DCA commissions also provide an upline sales representative with a cushion against the chargeback obligations of their downline sales representatives. DCA commissions, unless applied to amounts owed, are ultimately released to sales representatives.
We pay most term life insurance commissions during the first policy year. One of our term riders provides for coverage increases after the first year. For such riders, we pay first year and renewal commissions only for premium increases related to the increased coverage. Additionally, we pay renewal commissions on some older in-force policies. At the end of the policy durations, we pay compensation on policy continuations and exchanges.
We also pay compensation to our sales force for the sale of mutual funds, annuities, prepaid legal services, the referral of customers seeking auto and home insurance, segregated funds, and other financial products. For most mutual funds (non-managed investments) and annuity products, commissions are paid both on the sale and on the value of assets under management and are calculated based on the dealer reallowance and trail compensation actually paid to us. For managed investment mutual fund products, fees earned are primarily based on the total of assets under management and represent the annual fee we receive as compensation for as long as we retain the account. Prepaid legal services commissions are paid in fixed amounts on the sale of the respective product. For auto and homeowners’ insurance products, fees are paid for referrals that result in completed applications. We pay our sales representatives in Canada a sales commission on segregated fund sales and a quarterly fee based on clients’ asset values. We also pay commissions to our sales force related to certain other financial products, which are calculated based on the type of product sold or referred.
We pay bonuses and other incentive compensation for the sale of certain products. Bonuses are paid to the RVPs or to selected override levels, or both, for achieving specified supervising production levels for the sale of term life insurance, investment and savings products and other distributed products.
In addition to these methods of compensation, we use a quarterly compensation program under which RVPs can earn equity awards based on various supervising production criteria. Effective deployment of these programs allows us to align the interests of our sales force with those of our stockholders.
Sales Force Licensing
The states, provinces and territories in which our sales representatives operate generally require our sales representatives to obtain and maintain licenses to sell our insurance and securities products, requiring our sales representatives to pass applicable examinations. Our sales representatives may also be required to maintain licenses to sell certain of our other financial products. To encourage new recruits to obtain their life insurance licenses, we either pay directly or reimburse the sales representative for certain licensing-related fees and expenses once he or she passes the applicable exam and obtains the applicable life insurance license.
To sell insurance products, our sales representatives must be licensed by their resident state, province or territory and by any other state, province or territory in which they do business. In most states, our sales representatives must be appointed by our applicable insurance subsidiary.
To sell mutual funds and variable annuity products, our U.S. sales representatives must be registered with the Financial Industry Regulatory Authority (“FINRA”) and hold the appropriate license(s) designated by each state in which they sell securities products, as well as be appointed by the annuity underwriter in the states in which they market annuity products. Our representatives must meet all state and regulatory requirements and be designated as an investment advisor representative in order to sell our managed investment products.
6
Our Canadian sales representatives selling mutual fund products are required to be licensed by the securities regulators in the provinces and territories in which they sell mutual fund products. Our Canadian sales representatives who are licensed to sell our insurance products do not need any further licensing to sell our segregated funds products. For sales of our supplemental health and accidental death & disability insurance products, appropriate provincial licensing is required. In Canada, sales representatives who refer clients to a mortgage lender do not have to be licensed as a mortgage broker.
Supervision and Compliance
To ensure compliance with various federal, state, provincial and territorial legal requirements, we and our RVPs share responsibility for maintaining an overall compliance program that involves compliance training and supporting and monitoring the activities of our sales representatives. We work with our RVPs to develop appropriate compliance procedures and systems.
Generally, all RVPs must obtain a principal license (FINRA Series 26 in the United States and Branch Manager license in Canada), and, as a result, they assume supervisory responsibility over the activities of their downline sales organizations. Additional supervision is provided by approximately 450 Offices of Supervisory Jurisdiction (“OSJs”), which are run by select RVPs who receive additional compensation for assuming additional responsibility for supervision and compliance monitoring across all product lines. OSJs are required to periodically inspect our field offices and report to us any compliance issues they observe. Our Field Supervision Department regularly assists the OSJs and communicates compliance requirements to them to ensure they properly discharge their supervisory responsibilities. In addition, our Compliance Department regularly runs surveillance reports designed to monitor the activity of our sales force and investigates any unusual or suspicious activity identified during these reviews or during periodic inspections of our RVP offices.
All of our sales representatives are required to participate in our annual compliance meeting, a program administered by our senior management and our legal and compliance staff at which we provide a compliance training overview across all product lines and require the completion of compliance checklists by each of our licensed sales representatives for each product he or she offers. Additionally, our sales representatives receive periodic compliance newsletters regarding new compliance developments and issues of special significance. Furthermore, the OSJs are required to complete an annual training program that focuses on securities compliance and field supervision.
Our Field Audit Department regularly conducts audits of all sales representative offices, including scheduled and no-notice audits. Our policy is to conduct approximately 50% of the field office audits on a no-notice basis. The Field Audit Department reviews all regulatory-required records that are not maintained at our home office. Any compliance deficiencies noted in the audit must be corrected, and we carefully monitor all corrective action. Field offices that fail an audit are subject to a follow-up audit in 150 days. Audit deficiencies are addressed through a progressive disciplinary structure that includes fines, reprimands, probations and terminations.
Our Products
Reflecting our philosophy of helping middle income clients with their financial product needs and ensuring compatibility with our distribution model, our products generally meet the following criteria:
· |
Consistent with sound individual finance principles: Products must be consistent with good personal finance principles for middle income consumers, such as financial protection, minimizing expenses, encouraging long-term savings and reducing debt. |
· |
Designed to support multiple client goals: Products are designed to address and support a broad range of financial goals rather than compete with or cannibalize each other. For example, term life insurance does not compete with mutual funds because term life has no cash value or investment element. |
· |
Ongoing needs based: Products are designed to meet the ongoing financial needs of many middle income consumers. This long-term approach bolsters our relationship with our clients by allowing us to continue to serve them as their financial needs evolve. |
· |
Easily understood and sold: Products must be appropriate for distribution by our sales force, which requires that the application and approval process must be simple to understand and explain, and the likelihood of approval must be sufficiently high to justify the investment of time by our sales representatives. |
We use three operating segments to organize, evaluate and manage our business: Term Life Insurance, Investment and Savings Products, and Corporate and Other Distributed Products. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Results of Operations” and Note 3 (Segment and Geographical Information) to our consolidated financial statements included elsewhere in this report for certain financial information regarding our operating segments and the geographic areas in which we operate.
7
The following table provides information on our principal products and the principal sources thereof by operating segment as of December 31, 2014.
Operating Segment |
|
Principal Products |
|
Principal Sources of Products (Applicable Geographic Territory) |
Term Life Insurance |
|
Term Life Insurance |
|
Primerica Life (U.S. (except New York), the District of Columbia and certain territories) |
|
|
|
|
NBLIC (New York) |
|
|
|
|
Primerica Life Canada (Canada) |
|
|
|
|
|
Investment and Savings Products |
|
Mutual Funds and Certain Retirement Plans |
|
American Century Investments (U.S.) |
|
|
|
|
American Funds (U.S.) |
|
|
|
|
AXA Distributors, LLC (U.S.) |
|
|
|
|
Franklin Templeton (U.S.) |
|
|
|
|
VOYA Financial, Inc. (U.S.) |
|
|
|
|
Invesco (U.S.) |
|
|
|
|
Legg Mason Global Asset Management (U.S.) |
|
|
|
|
Pioneer Investments (U.S.) |
|
|
|
|
AGF Funds (Canada) |
|
|
|
|
Primerica Concert™ Funds (Canada) |
|
|
|
|
Mackenzie Investments (Canada) |
|
|
Managed Investments |
|
Lockwood Advisors and PFS Investments (U.S.) |
|
|
Variable Annuities |
|
AXA Distributors, LLC (U.S.) |
|
|
|
|
Lincoln National Life Insurance Company and its affiliates (U.S.) |
|
|
|
|
MetLife Investors and its affiliates (U.S.) |
|
|
Fixed Indexed Annuities |
|
American General Life Insurance Company and its affiliates (U.S.) |
|
|
|
|
Lincoln National Life Insurance Company and its affiliates (U.S.) |
|
|
Fixed Annuities |
|
MetLife Investors USA Life Insurance Company and its affiliates (U.S.) |
|
|
|
|
Universal Life Insurance Company (Puerto Rico) |
|
|
Segregated Funds |
|
Primerica Life Canada (Canada) |
|
|
|
|
|
Corporate and Other Distributed Products |
|
Credit Information Services |
|
Equifax Consumer Services LLC (U.S. and Canada) |
|
|
Long-Term Care Insurance |
|
Genworth Life Insurance Company and its affiliates (U.S.) |
|
|
|
|
John Hancock Life Insurance Company and its affiliates (U.S.) |
|
|
|
|
Various insurance companies, as offered through LTCI Partners (U.S.) |
|
|
Prepaid Legal Services |
|
Pre-paid Legal Services, Inc. (U.S. and Canada) |
|
|
Supplemental Health and Accidental Death & Disability Insurance |
|
The Edge Benefits Inc. (Canada) |
|
|
Auto and Homeowners' Insurance(1) |
|
Various insurance companies, as offered through Answer Financial, Inc. (U.S.) |
|
|
Debt Resolution Products(1) |
|
Freedom Financial Network, LLC (U.S.) |
|
|
Mortgage Loan Referrals(1) |
|
B2B Bank (Canada) |
(1) |
Referrals only. |
Term Life Insurance Products
Through our three life insurance subsidiaries – Primerica Life, NBLIC and Primerica Life Canada – we offer term life insurance to clients in the United States, its territories, the District of Columbia and Canada. In 2013, the latest period for which data is available, we were the largest provider of individual term life insurance in the United States based on the amount of in-force premiums collected, according to LIMRA.
We believe that term life insurance is a better alternative for middle income clients than cash value life insurance. Term life insurance provides a guaranteed death benefit if the insured dies during the fixed coverage period of an in-force policy, thereby providing financial protection for his or her named beneficiaries in return for the periodic payment of premiums. Term insurance products, which are sometimes referred to as pure protection products, have no savings or investment features. By buying term life insurance rather than cash value life insurance, a policyholder initially pays a lower premium and, as a result, would have funds available to invest for retirement and other needs. We also believe that a person’s need for life insurance is inversely proportional to that person’s
8
need for retirement savings, a concept we refer to as the theory of decreasing responsibility. Young adults with children, new mortgages and other obligations need to buy higher amounts of insurance to protect their family from the loss of future income resulting from the death of a primary bread winner. With its lower initial premium, term life insurance lets young families buy more coverage for their premium dollar when their needs are greatest and still have the ability to have funds for their retirement and other savings goals.
We design our term life insurance products to be easily understood by, and meet the needs of, our clients. Clients purchasing our term life insurance products generally seek stable, longer-term income protection products for themselves and their families. In response to this demand, we offer term life insurance products with level premium coverage periods that range from 10 to 35 years and a wide range of coverage face amounts. Additionally, certain term life insurance policies may be customized through the addition of riders to provide coverage for specific protection needs, such as mortgage and college expense protection. Policies remain in force until the expiration of the coverage period or until the policyholder ceases to make premium payments and terminates the policy. Premiums are guaranteed for policies issued in the United States for the initial term period, up to a maximum of 20 years. After 20 years, we have the right to raise the premium, subject to limits provided for in the applicable policy. In Canada, the amount of the premium is guaranteed for the entire term of the policy.
One of the innovative term life insurance products that we offer is TermNow, which is our rapid issue term life product that provides for face amounts of $250,000 ($300,000 in Canada) and below. TermNow allows a sales representative to take an online application and, with the client’s permission, allows the Company to access databases, including Medical Information Bureau (“MIB”) data in the United States and Canada and prescription drug and motor vehicle records in the United States, as part of the underwriting process. The Company uses this data and the client’s responses to application questions to determine any additional underwriting requirements. Results of these processes are reported in real time to our underwriting system, which then decides whether or not to rapidly issue a policy.
The average face amount of our in-force policies issued in 2014 was approximately $244,600. The following table sets forth selected information regarding our term life insurance product portfolio:
|
|
Year ended December 31, |
|
|||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|||
Life insurance issued: |
|
|
|
|
|
|
|
|
|
|
|
|
Number of policies issued |
|
|
220,984 |
|
|
|
214,617 |
|
|
|
222,558 |
|
Face amount issued (in millions) |
|
$ |
69,574 |
|
|
$ |
67,783 |
|
|
$ |
68,053 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
|||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|||
Life insurance in force: |
|
|
|
|
|
|
|
|
|
|
|
|
Number of policies in force |
|
|
2,341,670 |
|
|
|
2,320,824 |
|
|
|
2,317,679 |
|
Face amount in force (in millions) |
|
$ |
681,927 |
|
|
$ |
674,868 |
|
|
$ |
670,412 |
|
Pricing and Underwriting. We believe that effective pricing and underwriting are significant drivers of the profitability of our life insurance business and we have established our pricing assumptions to be consistent with our underwriting practices. We set pricing assumptions for expected claims, lapses, investment returns and expenses based on our experience and other factors. These other factors include:
· |
expected changes from relevant experience due to changes in circumstances, such as (i) revised underwriting procedures affecting future mortality and reinsurance rates, (ii) new product features, and (iii) revised administrative programs affecting sales levels, expenses, and client continuation or termination of policies; and |
· |
observed trends in experience that we expect to continue, such as general mortality improvement in the general population and better or worse policy persistency (the period over which a policy remains in force) due to changing economic conditions. |
Under our current underwriting guidelines, we individually assess each insurable adult applicant and place each applicant into a risk classification based on current health, medical history and other factors. Each classification (generally preferred plus, preferred, non-tobacco and tobacco) has specific health criteria. We may decline an applicant’s request for coverage if his or her health or activities create unacceptable risks for us.
Our sales representatives ask applicants a series of yes or no questions regarding the applicant’s medical history. We may also consider information about the applicant from third-party sources, such as MIB, prescription drug databases, motor vehicle bureaus and physician statements. If we believe that follow up regarding an applicant’s medical history is warranted, we use a third-party provider and its trained personnel to contact the applicant by telephone to obtain a more detailed medical history. The report resulting from this tele-underwriting process is electronically transmitted to us and is evaluated in our underwriting process.
To accommodate the significant volume of insurance business that we process, we and our sales force use technology to make our operations more efficient. We provide an electronic life insurance application that supports TermNow and other term life insurance products. Approximately 89% of the life insurance applications we received in 2014 were submitted electronically. Our electronic life insurance application ensures that the application is submitted error-free, collects the applicant’s electronic signatures and populates the RVP’s sales log. For paper applications, we use our proprietary review and screening system to automatically screen that an
9
application meets regulatory and other requirements, as well as alert our application processing staff to any deficiencies with the application. If any deficiencies are noted, our application processing staff contacts the sales representative to obtain the necessary information. Once an application is complete, the pertinent application data is uploaded to our life insurance administrative systems, which manage the underwriting process by electronically analyzing data, recommending underwriting decisions, and communicating with the sales representative and third-party providers.
Claims Management. Our insurance subsidiaries processed over 14,000 life insurance benefit claims in 2014 on policies underwritten by us and sold by our sales representatives. These claims fall into three categories: death, waiver of premium (applicable to disabled policyholders who purchased a rider pursuant to which Primerica agrees to waive remaining life insurance premiums during a qualifying disability), or terminal illness. The claim may be reported by our sales representative, a beneficiary or, in the case of terminal illness, the policyholder. Following are the benefits paid by us for each category of claim:
|
|
Year ended December 31, |
|
|||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|||
|
|
(In thousands) |
|
|||||||||
Death |
|
$ |
1,186,523 |
|
|
$ |
1,104,123 |
|
|
$ |
1,040,507 |
|
Waiver of premium |
|
|
36,346 |
|
|
|
31,786 |
|
|
|
28,665 |
|
Terminal illness(1) |
|
|
14,297 |
|
|
|
11,765 |
|
|
|
7,819 |
|
(1) |
We consider claims paid for terminal illness to be loans made to the beneficiary that are repaid to us upon death of the beneficiary from the death benefit. |
In the United States, after coverage has been in force for two years, we may not contest the policy for misrepresentations in the application or the suicide of the insured. In Canada, we have a similar two-year contestability period, but we are permitted to contest insurance fraud at any time. As a matter of policy, we do not contest any coverage issued by us to replace the face amount of another insurance company’s individual coverage to the extent the replaced coverage would not be contestable by the replaced company. We believe this approach helps our sales representatives sell replacement policies, as it reassures clients that claims made under their replacement policies are not more likely to be contested as to the face amount replaced. Through our claims administration system, we record, process and pay the appropriate benefit for any reported claim. Our claims system is used by our home office investigators to order medical and investigative reports from third-party providers, calculate amounts due to the beneficiary (including interest), and report payments to the appropriate reinsurance companies.
Primerica Life, a Massachusetts domestic insurer, regularly consults the Social Security Administration’s Death Master File (“Death Master File”) in accordance with all states’ requirements and, since 2011, consistent with Massachusetts Division of Insurance (“Massachusetts DOI”) best practices. NBLIC, a New York domestic insurer, has regularly consulted the Death Master File in accordance with New York State insurance requirements, to identify potential deceased policyholders for whom claims have not been presented in the normal course of business. If unreported deaths are identified, Primerica Life and NBLIC attempt to determine if a valid claim exists, to locate beneficiaries, and to pay benefits accordingly. Prior to 2011, the Company did not use the Death Master File in any aspect of its business.
Reinsurance. We use reinsurance primarily to reduce the volatility risk with respect to mortality. Since 1994, we have reinsured death benefits in the United States on a first dollar quota share yearly renewable term (“YRT”) basis. We pay premiums to each reinsurer based on rates in the applicable agreement.
We generally reinsure 90% of all U.S. insurance policies that we underwrite, excluding coverage under certain riders, and, for all risks in excess of $4.0 million per life of coverage, we reinsure on a case-by-case basis. With respect to our Canadian insurance policies, we previously utilized reinsurance arrangements pursuant to which we reinsured only face amounts above $500,000 per life on an excess loss YRT basis, and, for all risk in excess of $2.0 million per life, we reinsured on a case-by-case basis. In 2012, we began a YRT reinsurance arrangement in Canada similar to our U.S. program that reinsures 80% of the face amount for every policy sold. We also reinsure substandard cases on a facultative basis to capitalize on the extensive experience some of our reinsurers have with substandard cases. A substandard case has a level of risk that is acceptable to us, but at higher premium rates than a standard case because of the health, habits or occupation of the applicant.
While our reinsurance agreements have indefinite terms, both we and our reinsurers are entitled to discontinue any reinsurance agreement as to future policies by giving advance notice of 90 days to the other. Each reinsurer’s ability to terminate coverage for existing policies is limited to circumstances such as a material breach of contract or nonpayment of premiums by us. Each reinsurer has the right to increase rates with certain restrictions. If a reinsurer increases rates, we have the right to immediately recapture the business. Either party may offset any balance due from the other party. For additional information on our reinsurance, see Note 1 (Description of Business, Basis of Presentation, and Summary of Significant Accounting Policies) and Note 6 (Reinsurance) to our consolidated financial statements included elsewhere in this report.
Financial Strength Ratings. Ratings with respect to financial strength are an important factor in establishing our competitive position and maintaining public confidence in us and our ability to market our products. Ratings organizations review the financial performance and condition of most insurers and provide opinions regarding financial strength, operating performance and ability to meet obligations to policyholders. For additional information, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Liquidity and Capital Resources – Financial Ratings.”
10
Investment and Savings Products
We believe that middle income families have significant unmet retirement and other savings needs. Using our FNA tool, our sales representatives help our clients understand their current financial situation and how they can use time-tested financial principles, such as prioritizing personal savings, to reach their savings goals. Our products comprise basic saving and investment vehicles that seek to meet the needs of clients in all stages of life.
Through PFS, PFS Investments, Primerica Life Canada, PFSL Investments Canada, and our licensed sales representatives, we distribute and sell to our clients mutual funds, managed investments, variable and fixed annuities, fixed indexed annuities and segregated funds. As of December 31, 2014, approximately 22,600 of our sales representatives were licensed to distribute mutual funds in the United States and Canada. As of December 31, 2014, approximately 13,000 of our sales representatives were licensed and appointed to distribute annuities in the United States and approximately 9,400 of our sales representatives were licensed to sell segregated funds in Canada.
Mutual Funds. In the United States, our licensed sales representatives primarily distribute mutual funds from the following select asset management firms: American Century Investments, American Funds, Franklin Templeton, Invesco, Legg Mason and Pioneer. We have selling agreements with each of these fund companies and a number of other fund companies. These firms have diversified product offerings, including domestic and international equity, fixed income and money market funds. Each firm has individual funds with long track records and each continually evaluates its fund offerings and adds new funds on a regular basis. Additionally, their product offerings reflect diversified asset classes and varied investment styles. We believe these asset management firms provide funds that meet the investment needs of our clients.
During 2014, four of these fund families (Legg Mason, Invesco, American Funds and Franklin Templeton) accounted for approximately 94% of our mutual fund sales in the United States. Legg Mason and Invesco each have large wholesaling teams that support our sales force in distributing their mutual fund products. Our selling agreements with these firms all have indefinite terms and provide for termination at will. Each of these agreements authorizes us to receive purchase orders for shares of mutual funds or similar investments underwritten by the fund company and to sell and distribute the shares on behalf of the fund company. All purchase orders are subject to acceptance or rejection by the relevant fund company in its sole discretion. Purchase orders received by the fund company from us are accepted only at the then-applicable public offering price for the shares ordered (the net asset value of the shares plus any applicable sales charge).
In Canada, our sales representatives offer Primerica-branded Concert™ Series funds, which accounted for approximately 34% of our Canadian mutual fund product sales in 2014. Our Concert™ Series of funds consist of six different asset allocation funds with varying investment objectives ranging from fixed income to aggressive growth. Each Concert™ Series fund is a fund of funds that allocates fund assets among equity and income mutual funds of AGF Funds, a major asset management firm in Canada. The asset allocation within each Concert™ Series fund is determined on a contract basis by Morneau Shepell Asset and Risk Management Ltd. The principal non-proprietary funds that we offer our clients in Canada are funds of AGF Funds and Mackenzie Investments. Sales of these non-proprietary funds accounted for approximately 45% of mutual fund product sales in Canada in 2014. Like our U.S. fund family list, the asset management partners we have chosen in Canada have a diversified offering of stock, bond and money market funds, including domestic and international funds with a variety of investment styles.
A key part of our investment philosophy for our clients is the long-term benefits of dollar cost averaging through systematic investing. To accomplish this, we assist our clients by facilitating monthly contributions to their investment account by bank draft against their checking accounts. As of December 31, 2014, qualified retirement plans accounted for 74% of client account assets in the United States (58% of total client account assets) and 76% of client account assets in Canada (13% of total client account assets). Our qualified retirement plans in Canada are considered registered retirement savings plans (“RRSP”). An RRSP is similar to an individual retirement account, or IRA, in the United States in that contributions are made to the RRSP on a pre-tax basis and income is earned on a tax-deferred basis. Our high concentration of retirement plan accounts and our systematic savings philosophy are beneficial to us as these accounts tend to have lower redemption rates than the industry and, therefore, generate more recurring asset-based revenues.
Managed Investments. PFS Investments is a registered investment advisor in the United States, and it offers a managed investments program under a contract with Lockwood Advisors, a registered investment advisor and unit of Bank of New York Mellon. The offering consists of a mutual fund advisory program with a $25,000 minimum initial investment. As part of our contract, Lockwood Advisors participates in the design and assists in the ongoing administration of the program, including the investment of client assets on a discretionary basis into one or more asset allocation portfolios. In contrast to our existing mutual fund and annuity business, in an advisory fee program, clients do not pay an upfront commission; rather, they pay an annual fee based on the value of the assets in their account.
Variable Annuities. Our U.S. licensed sales representatives also distribute variable annuities underwritten and provided by Lincoln National Life Insurance Company and its affiliates (“Lincoln National”), AXA Distributors, LLC (“AXA”), and MetLife Investors and its affiliates. Variable annuities are insurance products that enable our clients to invest in accounts with attributes similar to mutual funds, but also have benefits not found in mutual funds, including death benefits that protect beneficiaries from losses due to a market downturn and income benefits that guarantee future income payments for the life of the policyholder(s). These companies bear the insurance risk on the variable annuities that we distribute.
11
In 2014, we added an additional variable annuity product issued by AXA. The Retirement Cornerstone® product has unique features that complement our existing offerings and give our clients and representatives additional opportunities for tax deferred growth and guaranteed retirement income.
Segregated Funds. In Canada, we offer segregated fund products, which are branded as our Common Sense FundsTM, that have some of the characteristics of our variable annuity products distributed in the United States. Our Common Sense FundsTM are underwritten by Primerica Life Canada and offer our clients the ability to participate in a diversified managed investments program that can be opened for as little as C$25. While the assets and corresponding liability (reserves) are recognized on our consolidated balance sheets, the assets are held in trust for the benefit of the segregated fund contract owners and are not commingled with the general assets of the Company.
The investment objective of segregated funds is long-term capital appreciation combined with some guarantee of principal. Unlike mutual funds, our segregated fund product guarantees clients at least 75% of their net contributions (net of withdrawals) at the earlier of the date of their death or at the segregated fund’s maturity date, which is selected by the client. The portfolio consists of both equities and bonds with the equity component consisting of a pool of large cap Canadian equities and the bond component consisting of Canadian federal government zero coupon treasuries and government-backed floating rate notes. The portion of the segregated fund portfolio allocated to zero coupon treasuries are held in sufficient quantity to satisfy the guarantees payable at the maturity date of the segregated fund. As a result, our potential loss exposure is very low as it comes from the guarantees payable upon the death of the client prior to the maturity date. With the guarantee level at 75% and in light of the time until the scheduled maturity of our segregated funds contracts, we currently do not believe it is necessary to allocate any corporate capital as reserves for segregated fund contract benefits.
Many of our Canadian clients invest in segregated funds through a RRSP. Our Common Sense Funds™ are managed by AGF Funds, one of Canada’s leading investment management firms, and a leading provider of our mutual fund products.
Fixed Indexed Annuities. We offer fixed indexed annuity products through Lincoln National and American General Life Insurance Company and its affiliates (“AIG”). These products combine safety of principal and guaranteed rates of return with additional investment options tied to the S&P 500 Index that allow for returns that move based on the performance of an index. In 2013, we launched a proprietary fixed indexed annuity product underwritten by Lincoln National that includes an integrated income rider, which is tailored for income-oriented clients due to periodic increases in the income base. During 2014, we added another new strategic partner with the introduction of the Power AdvantageSM Fixed Index Annuity products issued by AIG. We believe these and other fixed annuity products give both our life and securities representatives more ways to assist our clients with their retirement planning needs.
Fixed Annuities. We sell fixed annuities underwritten by MetLife Investors USA Insurance Company and its affiliates in the U.S. Our current offering includes a fixed premium deferred annuity and a single premium immediate annuity. The fixed premium deferred annuity allows our clients to accumulate savings on a tax deferred basis with safety of principal and a guaranteed rate of return. The single premium immediate annuity provides clients with an immediate income alternative. In Puerto Rico, we currently offer two annuity products: a fixed annuity and a fixed bonus annuity underwritten by Universal Life Insurance Company (“Universal Life”). These products provide guarantees against loss with several income options.
Investment and Savings Products Revenue. In the United States, we earn revenue from our investment and savings products business in three ways: commissions earned on the sale of such products; fees earned based upon client asset values; and account-based revenue. On the sale of mutual funds (not including managed investments) and annuities, we earn a dealer reallowance or commission on new purchases as well as trail commissions on the assets held in our clients’ accounts. We also receive marketing and support fees from most of our fund providers. These payments are typically a percentage of sales or a percentage of the clients’ total asset values, or a combination of both. For managed investments, we receive an asset-based fee as compensation for asset management services, recordkeeping services, and marketing and support services.
We perform custodial services and receive fees on a per-account basis for serving as a non-bank custodian for certain of our clients’ retirement plan accounts for certain of the funds offered in the United States. We also perform recordkeeping services for some of our select U.S. fund companies and receive compensation on a per-account basis for these services. Because the total amount of these fees fluctuates with the number of such accounts, the opening or closing of accounts has a direct impact on our revenues. From time to time, the fund companies for whom we provide these services request that accounts with small balances be closed.
In Canada, we earn revenue from the sales of our investment and savings products in two ways: commissions (or dealer reallowance) on mutual fund sales and fees paid based upon clients’ asset values (mutual fund trail commissions and asset management fees from segregated funds and Concert™ Series funds). On the sale of segregated funds, we earn a fee based on client asset values.
Other Distributed Products
We offer other products, including prepaid legal services, auto and homeowners’ insurance referrals, credit information products, long-term care insurance, and debt resolution referrals. In Canada, we also offer mortgage loan referrals and insurance offerings for small businesses. While many of these products are Primerica-branded, all of them are underwritten or otherwise provided by a third party.
12
We offer our U.S. and Canadian clients a Primerica-branded prepaid legal services program on a subscription basis that is underwritten and provided by Pre-paid Legal Services, Inc. The prepaid legal services program offers a network of attorneys in each state, province or territory to assist subscribers with legal matters such as drafting wills, living wills and powers of attorney, trial defense and motor vehicle-related matters. We receive a commission based on our sales of these subscriptions.
We have an arrangement with Answer Financial, Inc. (“Answer Financial”), an independent insurance agency, whereby our U.S. sales representatives refer clients to Answer Financial to receive multiple, competitive auto and homeowners’ insurance quotes. Answer Financial’s comparative quote process allows clients to easily identify the underwriter that is most competitively priced for their type of risk. We receive commissions based on completed auto and homeowners’ insurance applications and pay our sales representatives a flat referral fee for each completed application.
We offer credit information products in the United States and Canada. Credit information products allow clients to access their credit score and other personal credit information. Clients also have the capability of creating a simple-to-understand plan for paying off their debts with information from their credit file. Our credit information products are co-branded with and supported by a subsidiary of Equifax Inc.
We have an arrangement with LTCI Partners, LLC (“LTCI Partners”), an independent brokerage general agency specializing in long-term care insurance, whereby our U.S. sales representatives refer clients to LTCI Partners to receive a long-term care insurance quote. Many of these policies are underwritten and provided by Genworth Life Insurance Company and its affiliates and some by various other insurance providers. We receive commissions based on the annualized premium of placed and taken policies.
We have an arrangement with Freedom Financial Network, LLC, an independent limited liability company and its affiliates (collectively, “FFN”), whereby our U.S. sales representatives refer clients to FFN to receive solutions for resolving unmanageable debt. FFN’s debt solutions include a debt resolution program, whereby FFN acts as the credit advocate for its clients by negotiating discounts to resolve unsecured debts and a federal income tax debt resolution program. We receive fees from FFN based on referred clients’ enrollments in FFN’s debt and tax resolution programs, and we pay our sales representatives a scheduled fee with respect to qualified enrollments.
In Canada, we have a referral program for mortgage loan products offered by a third party lender, B2B Bank. Due to regulatory requirements, our sales representatives in Canada only refer clients to the lender and are not involved in the loan application and closing process.
In Canada, we offer insurance products, including supplemental medical and dental, accidental death, and disability, to small businesses. These insurance products are underwritten and provided by The Edge Benefits Inc. and its affiliates. We receive a commission based on our sales of these policies and any subsequent renewals.
Prior to December 31, 2014, we offered student life and short-term disability benefit insurance, which were underwritten through our New York insurance subsidiary, NBLIC. These products were distributed solely by outside third parties. In 2014, NBLIC sold its short-term disability benefit business to AmTrust North America, Inc., and ceased the marketing and underwriting of new student life insurance policies. NBLIC will continue to administer the existing block of student life business.
Regulation
Our operations are subject to extensive laws and governmental regulations, including administrative determinations, court decisions and similar constraints. The purpose of the laws and regulations affecting our operations is primarily to protect our clients and other consumers. Many of the laws and regulations to which we are subject are regularly re-examined, and existing or future laws and regulations may become more restrictive or otherwise adversely affect our operations.
Insurance and securities regulatory authorities periodically make inquiries regarding compliance by us and our subsidiaries with insurance, securities and other laws and regulations regarding the conduct of our insurance and securities businesses. At any given time, a number of financial or market conduct examinations of our subsidiaries may be ongoing. We cooperate with such inquiries and take corrective action when warranted.
Regulation of Our Insurance Business. Primerica Life, as a Massachusetts domestic insurer, is regulated by the Massachusetts DOI and is licensed to transact business in the United States (except New York), the District of Columbia and certain U.S. territories. NBLIC, as a New York domestic insurer and a wholly owned subsidiary of Primerica Life, is regulated by the New York State Department of Financial Services (“NYSDFS”) and is licensed to transact business in all 50 U.S. states, the District of Columbia and the U.S. Virgin Islands. Peach Re, Inc. (“Peach Re”) and Vidalia Re, Inc. (“Vidalia Re”), as special purpose financial captive insurance companies domiciled in Vermont and wholly owned subsidiaries of Primerica Life, are regulated by the Vermont Department of Financial Regulation (“Vermont DOI”).
State insurance laws and regulations regulate all aspects of our U.S. insurance business. Such regulation is vested in state agencies having broad administrative and, in some instances, discretionary power dealing with many aspects of our business, which may include, among other things, premium rates and increases thereto, reserve requirements, marketing practices, advertising, privacy, policy forms, reinsurance reserve requirements, acquisitions, mergers, and capital adequacy.
13
Our U.S. insurance subsidiaries are required to file certain annual, quarterly and periodic reports with the supervisory agencies in the jurisdictions in which they do business, and their business and accounts are subject to examination by such agencies at any time. These examinations generally are conducted under National Association of Insurance Commissioners (“NAIC”) guidelines. Under the rules of these jurisdictions, insurance companies are examined periodically (generally every three to five years) by one or more of the supervisory agencies on behalf of the states in which they do business. Our most recent insurance department examinations have not produced any significant adverse findings regarding any of our insurance subsidiaries.
Primerica Life Canada is federally incorporated and provincially licensed. It transacts business in all Canadian provinces and territories. Primerica Life Canada is regulated federally by the Office of the Superintendent of Financial Institutions Canada (“OSFI”) and provincially by the Superintendents of Insurance for each province and territory. Federal and provincial insurance laws regulate all aspects of our Canadian insurance business. OSFI regulates insurers’ corporate governance, financial and prudential oversight, and regulatory compliance, while provincial and territorial regulators oversee insurers’ market conduct practices and related compliance.
Our Canadian insurance subsidiary files quarterly and annual financial statements prepared in accordance with International Financial Reporting Standards (“IFRS”) and other locally accepted standards with OSFI in compliance with legal and regulatory requirements. OSFI conducts periodic detailed examinations of insurers’ business and financial practices, including the control environment, internal and external auditing and minimum capital adequacy, surpluses and related testing, legislative compliance and appointed actuary requirements. These examinations also address regulatory compliance with anti-money laundering practices, outsourcing, related-party transactions, privacy and corporate governance. Provincial regulators conduct periodic market conduct examinations of insurers doing business in their jurisdiction.
In addition to federal and provincial oversight, Primerica Life Canada is also subject to the guidelines set out by the Canadian Life and Health Insurance Association (“CLHIA”). CLHIA is an industry association that works closely with federal and provincial regulators to establish market conduct guidelines and sound business and financial practices addressing matters such as sales representative suitability and screening, insurance illustrations and partially guaranteed savings products.
The laws and regulations governing our U.S. and Canadian insurance businesses include numerous provisions governing the marketplace activities of insurers, including policy filings, payment of insurance commissions, disclosures, advertising, product replacement, sales and underwriting practices and complaints and claims handling. The state insurance regulatory authorities in the United States and the federal and provincial regulators in Canada generally enforce these provisions through periodic market conduct examinations.
In addition, most U.S. states and Canadian provinces and territories, as well as the Canadian federal government, have laws and regulations governing the financial condition of insurers, including standards of solvency, types and concentration of investments, establishment and maintenance of reserves, reinsurance and requirements of capital adequacy, and the business conduct of insurers, including sales and marketing practices, claim procedures and practices, and policy form content. As discussed previously, U.S. state insurance law and Canadian provincial insurance law also require certain licensing of insurers and their agents.
Insurance Holding Company Regulation; Limitations on Dividends. The states in which our U.S. insurance subsidiaries are domiciled have enacted legislation and adopted regulations regarding insurance holding company systems. These laws require registration of, and periodic reporting by, insurance companies domiciled within the jurisdiction that control, or are controlled by, other corporations or persons so as to constitute an insurance holding company system. These laws also affect the acquisition of control of insurance companies as well as transactions between insurance companies and companies controlling them.
The Parent Company is a holding company that has no significant operations. Our primary asset is the capital stock of our subsidiaries, and our primary liability is $375.0 million in principal amount of senior unsecured notes (the “Senior Notes”). As a result, we depend on dividends or other distributions from our insurance and other subsidiaries as the principal source of cash to meet our obligations, including the payment of interest on, and repayment of, principal of any debt obligations.
The states in which our U.S. insurance subsidiaries are domiciled impose certain restrictions on our insurance subsidiaries’ ability to pay dividends to us. In Canada, dividends can be paid subject to the paying insurance company’s continuing compliance with regulatory requirements and upon notice to OSFI. We determine the dividend capacity of our insurance subsidiaries using statutory accounting principles (“SAP”) in the United States and IFRS in Canada.
The following table sets forth the statutory value of cash and securities dividends paid or payable by our insurance subsidiaries:
|
|
Year ended December 31, |
|
|||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|||
|
|
(In thousands) |
|
|||||||||
Primerica Life |
|
$ |
235,000 |
|
|
$ |
150,000 |
|
|
$ |
150,000 |
|
Primerica Life Canada |
|
|
13,434 |
|
|
|
14,387 |
|
|
|
15,100 |
|
For additional information on dividend capacity and restrictions, see Note 15 (Statutory Accounting and Dividend Restrictions) to our consolidated financial statements included elsewhere in this report.
Policy and Contract Reserve Sufficiency Analysis. Under the laws and regulations of their jurisdictions of domicile, our U.S. insurance subsidiaries are required to conduct annual analyses of the sufficiency of their life insurance statutory reserves. In addition, other U.S.
14
jurisdictions in which our U.S. subsidiaries are licensed may have certain reserve requirements that differ from those of their domiciliary jurisdictions. In each case, a qualified actuary must submit an opinion that states that the aggregate statutory reserves, when considered in light of the assets held with respect to such reserves, make good and sufficient provision for the associated contractual obligations and related expenses of the insurer. If such an opinion cannot be provided, the affected insurer must set up additional reserves by moving funds from surplus. Our U.S. insurance subsidiaries most recently submitted these opinions without qualification as of December 31, 2014 to applicable insurance regulatory authorities.
Our Canadian insurance subsidiary also is required to conduct regular analyses of the sufficiency of its life insurance statutory reserves. Life insurance reserving and reporting requirements are completed by our Canadian insurance subsidiary’s appointed actuary. Materials provided by the appointed actuary are filed with OSFI as part of our annual filing and are subject to OSFI’s review. Based upon this review, OSFI may institute remedial action against our Canadian insurance subsidiary as OSFI deems necessary. Our Canadian insurance subsidiary has not been subject to any such remediation or enforcement by OSFI.
Surplus and Capital Requirements. U.S. insurance regulators have the discretionary authority, in connection with the ongoing licensing of our U.S. insurance subsidiaries, to limit or prohibit the ability of an insurer to issue new policies if, in the regulators’ judgment, the insurer is not maintaining a minimum amount of surplus or is in hazardous financial condition. Insurance regulators may also limit the ability of an insurer to issue new life insurance policies and annuity contracts above an amount based upon the face amount and premiums of policies of a similar type issued in the prior year. We do not believe that the current or anticipated levels of statutory surplus of our U.S. insurance subsidiaries present a material risk that any such regulator would limit the amount of new policies that our U.S. insurance subsidiaries may issue.
The NAIC has established risk-based capital (“RBC”) standards for U.S. life insurance companies, as well as a model act to be applied at the state level. The model act provides that life insurance companies must submit an annual RBC report to state regulators reporting their RBC based upon four categories of risk: asset risk, insurance risk, interest rate risk and business risk. For each category, the capital requirement is determined by applying factors to various asset, premium and reserve items, with the factor being higher for those items with greater underlying risk and lower for less risky items. The formula is intended to be used by insurance regulators as an early warning tool to identify possible weakly capitalized companies for purposes of initiating further regulatory action. If an insurer’s RBC falls below specified levels, the insurer would be subject to different degrees of regulatory action depending upon the level. These actions range from requiring the insurer to propose actions to correct the capital deficiency to placing the insurer under regulatory control. As of December 31, 2014, Primerica Life had statutory capital and surplus in excess of the applicable regulatory thresholds.
In Canada, OSFI has authority to request an insurer to enter into a prudential agreement implementing measures to maintain or improve the insurer’s safety and soundness. OSFI also may issue orders to an insurer directing it to refrain from unsafe or unsound practices or to take action to remedy financial concerns. OSFI has neither requested that our Canadian insurance subsidiary enter into any prudential agreement nor has OSFI issued any order against our Canadian insurance subsidiary.
In Canada, OSFI oversees an insurer’s minimum capital requirement and determines the sum of capital requirements for five categories of risk: asset default risk, mortality/morbidity/lapse risks, changes in interest rate environment risk, segregated funds risk and foreign exchange risk. As of December 31, 2014, Primerica Life Canada had statutory capital in excess of the applicable regulatory thresholds.
NAIC Pronouncements and Reviews. The NAIC promulgates model insurance laws and regulations for adoption by the states in order to standardize insurance industry accounting and reporting guidance. Although many state regulations emanate from NAIC model statutes and pronouncements, statutory accounting principles continue to be established by individual state laws, regulations and permitted practices. Certain changes to NAIC model statutes and pronouncements, particularly as they affect accounting issues, may take effect automatically without affirmative action by a given state. With respect to some financial regulations and guidelines, non-domiciliary states sometimes defer to the interpretation of the insurance department of the state of domicile. However, neither the action of the domiciliary state nor the action of the NAIC is binding on a non-domiciliary state. Accordingly, a non-domiciliary state could choose to follow a different interpretation.
The NAIC has established guidelines to assess the financial strength of insurance companies for U.S. state regulatory purposes. The NAIC conducts annual reviews of the financial data of insurance companies primarily through the application of 12 financial ratios prepared on a statutory basis. The annual statements are submitted to state insurance departments to assist them in monitoring insurance companies in their state.
Statutory Accounting Principles. SAP is a basis of accounting developed by U.S. insurance regulators to monitor and regulate the solvency of insurance companies. In developing SAP, insurance regulators were primarily concerned with evaluating an insurer’s ability to pay all of its current and future obligations to policyholders. As a result, statutory accounting focuses on conservatively valuing the assets and liabilities of insurers, generally in accordance with standards specified by the insurer’s domiciliary jurisdiction. Uniform statutory accounting practices are established by the NAIC and generally adopted by regulators in the various U.S. jurisdictions. These accounting principles and related regulations determine, among other things, the amounts our insurance subsidiaries may pay to us as dividends, and they differ somewhat from U.S generally accepted accounting principles (“U.S. GAAP”), which are designed to measure a business on a going-concern basis. Under U.S. GAAP, certain expenses are capitalized when
15
incurred and then amortized over the life of the associated policies. The valuation of assets and liabilities under U.S. GAAP is based in part upon best estimate assumptions made by the insurer. U.S. GAAP-basis stockholders’ equity represents the ownership interest in the U.S. GAAP-basis net assets held by stockholders. As a result, the values for assets, liabilities and equity reflected in financial statements prepared in accordance with U.S. GAAP may be different from those reflected in financial statements prepared under SAP.
State Insurance Guaranty Funds Laws. Under most state insurance guaranty fund laws, insurance companies doing business therein can be assessed up to prescribed limits for policyholder losses incurred by insolvent companies. Most insurance guaranty fund laws currently provide that an assessment may be excused or deferred if it would threaten an insurer’s own financial strength. In addition, assessments may be partially offset by credits against future state premium taxes.
Additional Oversight in Canada. The Minister of Finance (Canada) under the Insurance Companies Act (Canada) approved our indirect acquisition of Primerica Life Canada in April 2010. The Minister expects that a person controlling a federal insurance company will provide ongoing financial, managerial or operational support to its subsidiary should such support prove necessary. The Minister required us to sign a support principle letter, which provides, without limiting the scope of the support principle letter, that this ongoing support may take the form of additional capital, the provision of managerial expertise or the provision of support in such areas as risk management, internal control systems and training. The provision of the support principle letter is intended to ensure that the person controlling the federal insurance company is aware of the importance and relevance of the support principle in the consideration of the application. However, the letter does not create a legal obligation on our part to provide the support.
Our Canadian insurance subsidiary is currently in compliance with the terms of the support principle letter.
Various jurisdictions regulate state or provincial licensing examination processes that our sales representatives must complete to obtain their life insurance licenses. Recently, the insurance regulators in the Canadian provinces and territories entered into a Memorandum of Understanding and related agreements to implement a new life insurance licensing examination program across Canada in early 2016. If this new licensing program is implemented under the terms set forth in the agreements, we believe it would significantly decrease the ability of applicants to obtain their life insurance licenses in Canada. At this time, we cannot quantify the impact of the new licensing program on us. However, we believe the program could result in a significant decline in the number of our new life-licensed representatives in Canada and ultimately the size of our life-licensed sales force. This could lower new life insurance sales and over time lower the size of our in-force life insurance premium and materially adversely affect our Canadian Term Life insurance business. For more information, see “Risk Factors.”
Regulation of Our Investment and Savings Products Business. PFS Investments is registered with, and regulated by, FINRA and the Securities and Exchange Commission (“SEC”). It is subject to regulation by the Municipal Securities Rulemaking Board (the “MSRB”) with respect to 529 plans, by the Department of Labor (“DOL”) with respect to certain retirement plans, and by state securities agencies. PFS Investments operates as an introducing broker-dealer and is registered in all 50 U.S. states and certain territories and with the SEC. As such, it performs the suitability review of investment recommendations in accordance with FINRA requirements, but it does not hold client accounts. U.S. client funds are held by the mutual fund in which such client funds are invested or by the annuity underwriters in the case of variable annuities.
The SEC rules and regulations that currently apply to PFS Investments and our registered representatives generally require that we make suitable investment recommendations to our customers and disclose conflicts of interest that might affect the recommendations or advice we provide. The Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the “Dodd-Frank Act”) gave the SEC the power to impose on broker-dealers a heightened standard of conduct (fiduciary duty) that is currently applicable only to investment advisors. As required by the Dodd-Frank Act, the SEC staff submitted a report to Congress in 2010 in which it recommended that the SEC adopt a uniform fiduciary standard of conduct. The timing of any future rulemaking is unclear.
In October 2010, the DOL published a proposed rule (the “DOL Proposed Rule”) that would more broadly define the circumstances under which a person or entity may be considered a fiduciary for purposes of the prohibited transaction rules of Internal Revenue Code Section 4975 (“IRC Section 4975”). Under IRC Section 4975, certain types of compensation paid by third parties with respect to transactions involving assets in qualified accounts, including IRAs, may be prohibited. In September 2011, the DOL withdrew the DOL Proposed Rule, but has indicated that it will re-propose a similar fiduciary rule in 2015. The DOL has submitted its re-proposed rule to the Office of Management and Budget for review but has not released it to the public, consistent with customary administrative processes. The re-proposed rule is expected to be released in the coming months and the DOL has indicated that it intends to hold public hearings following a statutory comment period. If PFS Investments and its securities-licensed representatives are deemed to be fiduciaries under the new rule, our ability to receive and retain certain types of compensation paid by third parties with respect to both new and existing assets in qualified accounts could be significantly limited. Due to the uncertainty of present facts and circumstances, we currently are unable to determine the impact, if any, on our business, financial position or results of operations. For more information, see “Risk Factors.”
PFS Investments is also approved as a non-bank custodian under Internal Revenue Service (“IRS”) regulations and, in that capacity, may act as a custodian or trustee for certain retirement accounts. Our sales representatives who sell securities products through PFS Investments (including, in certain jurisdictions, variable annuities) are required to be registered representatives of PFS Investments. All aspects of PFS Investments’ business are regulated, including sales methods and charges, trade practices, the use and safeguarding of customer securities, capital structure, recordkeeping, conduct and supervision of its employees.
16
PFS Investments is an SEC-registered investment advisor and, under the name Primerica Advisors, offers a managed investments, or mutual fund advisory, program. In most states, our representatives are required to obtain an additional license to offer this program.
Primerica Shareholder Services, Inc. (“PSS”) is registered with the SEC as a transfer agent and, accordingly, is subject to SEC rules and examinations. Acting in this capacity, PSS and third party vendors employed by PSS are responsible for certain client investment account shareholder services.
PFSL Investments Canada is a mutual fund dealer registered with and regulated by the Mutual Fund Dealers Association of Canada (the “MFDA”), the national self-regulatory organization for the distribution side for the Canadian mutual fund industry. It is also registered with provincial and territorial securities commissions throughout Canada. As a registered mutual fund dealer, PFSL Investments Canada performs the suitability review of mutual fund investment recommendations, and like our U.S. broker-dealer, it does not hold client accounts.
PFSL Investments Canada sales representatives are required to be registered in the provinces and territories in which they do business, including regulation by the Autorité des marchés financiers in Quebec, and are also subject to regulation by the MFDA. These regulators have broad administrative powers, including the power to limit or restrict the conduct of our business and impose censures or fines for failure to comply with the law or regulations.
PFSL Fund Management in Canada is registered as an Investment Fund Manager in connection with our Concert™ Series mutual funds and is regulated by provincial securities commissions.
Other Laws and Regulations. The USA Patriot Act of 2001 (the “Patriot Act”) contains anti-money laundering and financial transparency laws and mandates the implementation of various regulations applicable to broker-dealers and other financial services companies, including insurance companies. The Patriot Act seeks to promote cooperation among financial institutions, regulators and law enforcement entities in identifying parties that may be involved in terrorism or money laundering.
U.S. federal and state laws and regulations require financial institutions, including insurance companies, to protect the security and confidentiality of consumer financial information and to notify consumers about their policies and practices relating to their collection and disclosure of consumer information and their policies relating to protecting the security and confidentiality of that information. Similarly, federal and state laws and regulations also govern the disclosure and security of consumer health information. In particular, regulations promulgated by the U.S. Department of Health and Human Services regulate the disclosure and use of protected health information by health insurers and others (including certain life insurers), the physical and procedural safeguards employed to protect the security of that information and the electronic storage and transmission of such information. Congress and state legislatures are expected to consider additional legislation relating to privacy and other aspects of consumer information.
The Financial Consumer Agency of Canada (“FCAC”), a Canadian federal regulatory body, is responsible for ensuring that federally regulated financial institutions, which include Primerica Life Canada and PFSL Investments Canada, comply with federal consumer protection laws and regulations, voluntary codes of conduct and their own public commitments. The Financial Transactions and Reports Analysis Centre of Canada (“FINTRAC”) is Canada’s financial intelligence unit. Its mandate includes ensuring that entities subject to the Proceeds of Crime (Money Laundering) and Terrorist Financing Act comply with reporting, recordkeeping and other obligations under that act. We are also subject to privacy laws under the jurisdiction of federal and provincial privacy commissioners, anti-money laundering laws enforced by FINTRAC and OSFI, and the consumer complaints provisions of federal insurance laws under the mandate of the FCAC, which requires insurers to belong to a complaints ombud-service and file a copy of their complaints handling policy with the FCAC.
Segment Financial and Geographic Disclosures
We have two primary operating segments — Term Life Insurance and Investment and Savings Products. The Term Life Insurance segment includes underwriting profits on our in-force book of term life insurance policies, net of reinsurance, which are underwritten by our life insurance company subsidiaries. The Investment and Savings Products segment includes mutual funds, managed investments and annuities distributed through licensed broker-dealer subsidiaries and includes segregated funds, an individual annuity savings product that we underwrite in Canada through Primerica Life Canada. We also have a Corporate and Other Distributed Products segment, which consists primarily of revenues and expenses related to the distribution of non-core products.
See “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Results of Operations” and Note 3 (Segment and Geographical Information) to our consolidated financial statements for more information concerning our domestic and international operations and our operating segments.
For information on risks relating to our Canadian operations, see “Risk Factors” and “Quantitative and Qualitative Information About Market Risks – Canadian Currency Risk.”
Competition
We operate in a highly competitive environment with respect to the sale of financial products and, to a lesser extent, for retaining our more productive sales representatives. Because we offer several different financial products, we compete directly with a variety of
17
financial institutions, such as insurance companies and brokers, banks, finance companies, credit unions, broker-dealers, mutual fund companies and other financial products and services companies.
Competitors with respect to our term life insurance products consist both of stock and mutual insurance companies, as well as other financial intermediaries. Competitive factors affecting the sale of life insurance products include the level of premium rates, benefit features, risk selection practices, compensation of sales representatives and financial strength ratings from ratings agencies such as A.M. Best.
In offering our securities products, our sales representatives compete with a range of other advisors, broker-dealers and direct channels, including wirehouses, regional broker-dealers, independent broker-dealers, insurers, banks, asset managers, registered investment advisors, mutual fund companies and other direct distributors. The mutual funds that we offer face competition from other mutual fund families and alternative investment products, such as exchange-traded funds. Our annuity products compete with products from numerous other companies. Competitive factors affecting the sale of annuity products include price, product features, investment performance, commission structure, perceived financial strength, claims-paying ratings, service, and distribution capabilities.
Information Technology
We built a sophisticated information technology platform to support our clients, operations and sales force. Located at our main campus in Duluth, Georgia, our data center houses an enterprise-class IBM mainframe that serves as the repository for all client and sales force data and operates as a database server for our distributed environment. Our business applications, many of which are proprietary, are supported by application developers and data center staff at our main campus. Our information security team provides services that include project consulting, threat management, application and infrastructure assessments, secure configuration management, and information security administration. This infrastructure also supports a combination of local and remote recovery solutions for business resumption in the event of a disaster.
Employees
As of December 31, 2014, we had 1,725 full-time employees in the United States and 228 full-time employees in Canada. In addition, as of December 31, 2014, we had 554 on-call employees in the United States and 72 on-call employees in Canada who provided services on an as-needed hourly basis. None of our employees is a member of any labor union, and we have never experienced any business interruption as a result of any labor disputes.
Available Information
We make available free of charge on our website (www.primerica.com) our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as soon as reasonably practicable upon filing such information with, or furnishing it to, the SEC. Information included on our website is not incorporated by reference into this annual report on Form 10-K. The Company’s reports are also available at the SEC’s Public Reference Room at 100 F. Street, NE, Washington, DC 20549, on their website at www.sec.gov, or by calling the SEC at 1-800-SEC-0330.
Risks Related to Our Distribution Structure
Our failure to continue to attract new recruits, retain sales representatives or license or maintain the licensing of our sales representatives would materially adversely affect our business, financial condition and results of operations.
New sales representatives provide us with access to new clients, enable us to increase sales and provide the next generation of successful sales representatives. As is typical with distribution businesses, we experience a high rate of turnover among our part-time sales representatives, which requires us to attract, retain and motivate a large number of sales representatives. Recruiting is performed by our current sales representatives, and the effectiveness of our recruiting is generally dependent upon our reputation as a provider of a rewarding and potentially lucrative income opportunity, as well as the general competitive and economic environment. Whether recruits are motivated to complete their training and licensing requirements and to commit to selling our products is largely dependent upon the effectiveness of our compensation and promotional programs and the competitiveness of such programs compared with other companies, including other part-time business opportunities.
If our new business opportunities and products do not generate sufficient interest to attract new recruits, motivate them to become licensed sales representatives and maintain their licenses and incentivize them to sell our products and recruit other new sales representatives, our business would be materially adversely affected.
Certain of our key RVPs have large sales organizations that include thousands of downline sales representatives. These key RVPs are responsible for attracting, motivating, supporting and assisting the sales representatives in their sales organizations. The loss of one or more key RVPs together with a substantial number of their sales representatives for any reason could materially adversely affect our financial results and could impair our ability to attract new sales representatives.
18
Furthermore, if we or any other businesses with a similar distribution structure engage in practices resulting in increased negative public attention for our business model, the resulting reputational challenges could adversely affect our ability to attract new recruits. Companies such as ours that use independent agents to sell directly to customers can be the subject of negative commentary on website postings, social media and other non-traditional media. This negative commentary can spread inaccurate or incomplete information about distribution companies in general or our company in particular, which can make our recruiting more difficult.
From time to time, various jurisdictions make changes to the state or provincial licensing examination process that may make it more difficult for our sales representatives to obtain their life insurance licenses. The insurance regulators in the Canadian provinces and territories entered into a Memorandum of Understanding and related agreements to implement a new life insurance licensing examination program across Canada in early 2016. If this new licensing program is implemented under the terms set forth in the agreements, we believe it would significantly decrease the ability of applicants to obtain their life insurance licenses in Canada. At this time, we cannot quantify the impact of the new licensing program on us. However, we believe the program could result in a significant decline in the number of our new life-licensed representatives in Canada and ultimately the size of our life-licensed sales force. New life-licensed representatives in our Canadian business were approximately 7% of our Company’s total new life-licensed representatives in 2014. The new licensing program in Canada could lower new life insurance sales and over time lower the size of our life insurance in-force and materially adversely affect our Canadian Term Life insurance business. Between July 4, 2014 and July 7, 2014, we issued Applications in the Ontario Superior Court of Justice naming as the Respondents the Financial Services Commission of Ontario and the government of Ontario. On July 24, 2014, we issued an Application in the Court of Queen's Bench for Saskatchewan naming as Respondents the Insurance Councils of Saskatchewan and Life Insurance Council of Saskatchewan. The Applications seek a declaration that the Memorandum of Understanding and related agreements are null and void and of no force and effect.
There are a number of laws and regulations that could apply to our distribution model, which subject us to the risk that we may have to modify our distribution structure.
In the past, certain distribution models that use independent agents to sell directly to customers have been subject to challenge under various laws, including laws relating to business opportunities, franchising and unfair or deceptive trade practices.
In general, state business opportunity and franchise laws in the United States prohibit sales of business opportunities or franchises unless the seller provides potential purchasers with a pre-sale disclosure document that has first been filed with a designated state agency and grants purchasers certain legal recourse against sellers of business opportunities and franchises. Certain Canadian provinces have enacted legislation dealing with franchising, which typically requires mandatory disclosure to prospective franchisees.
We have not been, and are not currently, subject to business opportunity laws because the amounts paid by our new representatives to us: (i) are less than the minimum thresholds set by many state statutes and (ii) are not fees paid for the right to participate in a business, but rather are for bona fide expenses such as state-required insurance examinations and pre-licensing training. We have not been, and are not currently, subject to franchise laws for similar reasons. However, there is a risk that a governmental agency or court could disagree with our assessment or that these laws and regulations could change. In addition, although we do not believe that the Federal Trade Commission ("FTC")'s Business Opportunity Rule applies to our company, it could be interpreted in a manner inconsistent with our interpretation. Becoming subject to business opportunity or franchise laws or regulations could require us to provide certain disclosures and regulate the manner in which we recruit our sales representatives that may increase the expense of, or adversely impact our success in, recruiting new sales representatives and make it more difficult for us to successfully attract and recruit new sales representatives.
There are various laws and regulations that prohibit fraudulent or deceptive schemes known as pyramid schemes. In general, a pyramid scheme is defined as an arrangement in which new participants are required to pay a fee to participate in the organization and then receive compensation primarily for recruiting other persons to participate, either directly or through sales of goods or services that are merely disguised payments for recruiting others. The application of these laws and regulations to a given set of business practices is inherently fact-based and, therefore, is subject to interpretation by applicable enforcement authorities. Our sales representatives are paid commissions based on sales of our products and services to bona fide purchasers, and for this and other reasons we do not believe that we are subject to laws regulating pyramid schemes. Moreover, our sales representatives are not required to purchase any of the products marketed by us. However, even though we believe that our distribution practices are currently in compliance with, or exempt from, these laws and regulations, there is a risk that a governmental agency or court could disagree with our assessment or that these laws and regulations could change, which could require us to cease our operations in certain jurisdictions or result in other costs or fines.
There are also federal, state and provincial laws of general application, such as the FTC Act, and state or provincial unfair and deceptive trade practices laws that could potentially be invoked to challenge aspects of our recruiting of sales representatives and compensation practices. In particular, our recruiting efforts include promotional materials for recruits that describe the potential opportunity available to them if they join our sales force. These materials, as well as our other recruiting efforts and those of our sales representatives, are subject to scrutiny by the FTC and state and provincial enforcement authorities with respect to misleading statements, including misleading earnings claims made to convince potential new recruits to join our sales force. If claims made by us or by our sales representatives are deemed to be misleading, it could result in violations of the FTC Act or comparable state and provincial statutes prohibiting unfair or deceptive trade practices or result in reputational harm.
19
Being subject to, or out of compliance with, the aforementioned laws and regulations could require us to change our distribution structure, which could materially adversely affect our business, financial condition and results of operations.
There may be adverse tax, legal or financial consequences if the independent contractor status of our sales representatives is overturned.
Our sales representatives are independent contractors who operate their own businesses. In the past, we have been successful in defending our company in various contexts before courts and governmental agencies against claims that our sales representatives should be treated like employees. Although we believe that we have properly classified our representatives as independent contractors, there is nevertheless a risk that the IRS, a court or other authority will take a different view. Furthermore, the tests governing the determination of whether an individual is considered to be an independent contractor or an employee are typically fact-sensitive and vary from jurisdiction to jurisdiction. Laws and regulations that govern the status and misclassification of independent sales representatives are subject to change or interpretation.
The classification of workers as independent contractors has been the subject of federal and state legislative and regulatory interest over the last several years, with proposals being made that call for greater scrutiny of independent contractor classifications and greater penalties for companies who wrongly classify workers as independent contractors instead of employees. We cannot predict the outcome of these legislative and regulatory efforts, but we expect the topic of independent contractor classification to remain active.
If there is a change in the manner in which employees and independent contractors are classified or an adverse determination with respect to some or all of our independent contractors by a court, government or agency, we could incur significant costs in complying with such laws and regulations, including in respect of tax withholding, social security payments and recordkeeping, or we may be required to modify our business model, any of which could have a material adverse effect on our business, financial condition and results of operations. In addition, there is the risk that we may be subject to significant monetary liabilities arising from fines or judgments as a result of any such actual or alleged non-compliance with federal, state, or provincial laws.
The Company or its independent sales representatives' violation of, or non-compliance with, laws and regulations and the related claims and proceedings could expose us to material liabilities.
Extensive federal, state, provincial and territorial laws regulate our products and our relationships with our clients, imposing certain requirements that our sales representatives must follow. At any given time, we may have pending state, federal or provincial examinations or inquiries of our investment and savings products and insurance businesses. In addition to imposing requirements that sales representatives must follow in their dealings with clients, these laws and regulations generally require us to maintain a system of supervision to attempt to ensure that our sales representatives comply with the requirements to which they are subject. We have developed policies and procedures to comply with these laws and regulations. However, despite these compliance and supervisory efforts, the breadth of our operations and the broad regulatory requirements could result in oversight failures and instances of non-compliance or misconduct on the part of our sales representatives.
From time to time, we are subject to private litigation as a result of alleged misconduct by our sales representatives. Examples include claims that a sales representative's failure to disclose underwriting-related information regarding the insured on an insurance application resulted in the denial of a life insurance policy claim, and with respect to investment and savings products sales, errors or omissions that a sales representative made in connection with an account. In addition to the potential for non-compliance with laws or misconduct applicable to our existing product offerings, we could experience similar regulatory issues or litigation with respect to new products. Non-compliance or misconduct by our sales representatives could result in adverse findings in either examinations or litigation and could subject us to sanctions, monetary liabilities, restrictions on or the loss of the operation of our business, claims against us or reputational harm, any of which could have a material adverse effect on our business, financial condition and results of operations.
Any failure to protect the confidentiality of client information could adversely affect our reputation and have a material adverse effect on our business, financial condition and results of operations.
Pursuant to federal laws, various federal agencies have established rules protecting the privacy and security of personal information. In addition, most states and some provinces have enacted laws, which vary significantly from jurisdiction to jurisdiction, to safeguard the privacy and security of personal information. Many of our sales representatives and employees have access to, and routinely process, personal information of clients through a variety of media, including the Internet and software applications. We rely on various internal processes and controls to protect the confidentiality of client information that is accessible to, or in the possession of, our company, our employees and our sales representatives. It is possible that a sales representative or employee could, intentionally or unintentionally, disclose or misappropriate confidential client information or our data could be the subject of a cybersecurity attack. If we fail to maintain adequate internal controls or if our sales representatives or employees fail to comply with our policies and procedures, misappropriation or intentional or unintentional inappropriate disclosure or misuse of client information could occur. Such internal control inadequacies or non-compliance could materially damage our reputation or lead to civil or criminal penalties, which, in turn, could have a material adverse effect on our business, financial condition and results of operations.
20
Risks Related to Our Insurance Business and Reinsurance
We may face significant losses if our actual experience differs from our expectations regarding mortality or persistency.
We set prices for life insurance policies based upon expected claim payment patterns derived from assumptions we make about the mortality rates, or likelihood of death, of our policyholders in any given year. The long-term profitability of these products depends upon how our actual mortality rates compare to our pricing assumptions. For example, if mortality rates are higher than those assumed in our pricing assumptions, we could be required to make more death benefit payments under our life insurance policies or to make such payments sooner than we had projected, which may decrease the profitability of our term life insurance products and result in an increase in the cost of our subsequent reinsurance transactions.
The prices and expected future profitability of our life insurance products are also based, in part, upon assumptions related to persistency. Actual persistency that is lower than our persistency assumptions could have an adverse effect on profitability, especially in the early years of a policy, primarily because we would be required to accelerate the amortization of expenses we deferred in connection with the acquisition of the policy. Actual persistency that is higher than our persistency assumptions could have an adverse effect on profitability in the later years of a block of policies because the anticipated claims experience is higher in these later years. If actual persistency is significantly different from that assumed in our pricing assumptions, our reserves for future policy benefits may prove to be inadequate. We are precluded from adjusting premiums on our in-force business during the initial term of the policies, and our ability to adjust premiums on in-force business after the initial policy term is limited to the maximum premium rates in the policy.
Our assumptions and estimates regarding mortality and persistency require us to make numerous judgments and, therefore, are inherently uncertain. We cannot determine with precision the actual persistency or ultimate amounts that we will pay for actual claim payments on a block of policies, the timing of those payments, or whether the assets supporting these contingent future payment obligations will increase to the levels we estimate before payment of claims. If we conclude that our future policy benefit reserves, together with future premiums, are insufficient to cover actual or expected claims payments and the scheduled amortization of our deferred policy acquisition costs ("DAC") assets, we would be required to first accelerate our amortization of the DAC assets and then increase our future policy benefit reserves and incur income statement charges for the period in which we make the determination, which could materially adversely affect our business, financial condition and results of operations.
The occurrence of a catastrophic event could materially adversely affect our business, financial condition and results of operations.
Our insurance operations are exposed to the risk of catastrophic events, which could cause a large number of premature deaths of our insureds. A catastrophic event could also cause significant volatility in global financial markets and disrupt the economy. Although we have ceded a significant majority of our mortality risk to reinsurers, a catastrophic event could cause a material adverse effect on our business, financial condition and results of operations. Claims resulting from a catastrophic event could cause substantial volatility in our financial results for any quarter or year and could also materially harm the financial condition of our reinsurers, which would increase the probability of default on reinsurance recoveries. Our ability to write new business could also be adversely affected.
In addition, most of the jurisdictions in which our insurance subsidiaries are admitted to transact business require life insurers doing business within the jurisdiction to participate in guaranty associations, which raise funds to pay contractual benefits owed pursuant to insurance policies issued by impaired, insolvent or failed issuers. It is possible that a catastrophic event could require extraordinary assessments on our insurance companies, which could have a material adverse effect on our business, financial condition and results of operations.
Our insurance business is highly regulated, and statutory and regulatory changes may materially adversely affect our business, financial condition and results of operations.
Life insurance statutes and regulations are generally designed to protect the interests of the public and policyholders. Those interests may conflict with the interests of our stockholders. Currently, in the United States, the power to regulate insurance resides almost exclusively with the states. The laws of the various U.S. jurisdictions grant state insurance regulators broad powers to regulate almost all aspects of our insurance business. Much of this state regulation follows model statutes or regulations developed or amended by the NAIC, which is composed of the insurance commissioners of each U.S. jurisdiction. The NAIC re-examines and amends existing model laws and regulations (including holding company regulations) in addition to determining whether new ones are needed.
The U.S. Congress continues to examine the current condition of U.S. state-based insurance regulation to determine whether to impose federal regulation and to allow optional federal insurance company incorporation. The Dodd-Frank Act created the Federal Insurance Office and authorized it to, among other things, study methods to modernize and improve insurance regulation, including uniformity and the feasibility of federal regulation. We cannot predict with certainty whether, or in what form, reforms will be enacted and, if so, whether the enacted reforms will materially affect our business. Changes in federal statutes, including the Gramm-Leach-Bliley Act and the McCarran-Ferguson Act, financial services regulation and federal taxation, in addition to changes to state statutes and regulations, may be more restrictive than current requirements or may result in higher costs, and could materially adversely affect our business, financial condition and results of operations.
21
We are currently undergoing targeted multi-state treasurer audits with respect to unclaimed property laws, and Primerica Life and NBLIC are engaged in targeted multi-state market conduct examinations with respect to their claims-paying practices. The Treasurer of the State of West Virginia brought a suit against Primerica Life and other insurance companies alleging violations of the West Virginia unclaimed property act. The suit was dismissed, and the Treasurer has appealed. Other jurisdictions may pursue similar audits, examinations and litigation. The potential outcome of such actions is difficult to predict but could subject us to adverse consequences, including, but not limited to, settlement payments, additional payments to beneficiaries and additional escheatment of funds deemed abandoned under state laws. We cannot predict with certainty the effect these proceedings may have on the conduct of our business, financial condition and results of operations.
Provincial and federal insurance laws regulate all aspects of our Canadian insurance business. Changes to provincial or federal statutes and regulations may be more restrictive than current requirements or may result in higher costs, which could materially adversely affect our business, financial condition and results of operations. If OSFI determines that our corporate actions do not comply with applicable Canadian law, Primerica Life Canada could face sanctions or fines, and Primerica Life Canada could be subject to increased capital requirements or other requirements deemed appropriate by OSFI.
We received approval from the Minister of Finance (Canada) under the Insurance Companies Act (Canada) in connection with our indirect acquisition of Primerica Life Canada. The Minister expects that a person controlling a federal insurance company will provide ongoing financial, managerial or operational support to its subsidiary should such support prove necessary, and has required us to sign a support principle letter to that effect. This ongoing support may take the form of additional capital, the provision of managerial expertise or the provision of support in such areas as risk management, internal control systems and training. However, the letter does not create a legal obligation on the part of the person to provide the support. In the event that OSFI determines Primerica Life Canada is not receiving adequate support from the Parent under applicable Canadian law, Primerica Life Canada may be subject to increased capital requirements or other requirements deemed appropriate by OSFI.
If there were to be extraordinary changes to statutory or regulatory requirements in the United States or Canada, we may be unable to fully comply with or maintain all required insurance licenses and approvals. Regulatory authorities have relatively broad discretion to grant, renew and revoke licenses and approvals. If we do not have all requisite licenses and approvals, or do not comply with applicable statutory and regulatory requirements, the regulatory authorities could preclude or temporarily suspend us from carrying on some or all of our insurance activities or impose fines or penalties on us, which could materially adversely affect our business, financial condition and results of operations. We cannot predict with certainty the effect any proposed or future legislation or regulatory initiatives may have on the conduct of our business.
A decline in the regulatory capital ratios of our insurance subsidiaries could result in increased scrutiny by insurance regulators and ratings agencies and have a material adverse effect on our business, financial condition and results of operations.
Each of our U.S. insurance subsidiaries is subject to RBC standards (imposed under the laws of its respective jurisdiction of domicile). The RBC formula for U.S. life insurance companies generally establishes capital requirements relating to insurance, business, asset and interest rate risks. Our U.S. insurance subsidiaries are required to report their results of RBC calculations annually to the applicable state department of insurance and the NAIC. Our Canadian life insurance subsidiary is subject to minimum continuing capital and surplus requirements (“MCCSR”), and Tier 1 capital ratio requirements, and is required to provide its MCCSR and Tier 1 capital ratio calculations to the Canadian regulators. The capitalization of our insurance subsidiaries is maintained at levels in excess of the effective minimum requirements of the NAIC in the United States and OSFI in Canada. In any particular year, statutory capital and surplus amounts and RBC and MCCSR ratios may increase or decrease depending on a variety of factors, including the amount of statutory income or losses generated by our insurance subsidiaries (which is sensitive to equity and credit market conditions), the amount of additional capital our insurance subsidiaries must hold to support business growth, changes in their reserve requirements, the value of certain fixed-income and equity securities in their investment portfolios, the credit ratings of investments held in their portfolios, changes in interest rates, credit market volatility, changes in consumer behavior, as well as changes to the NAIC's RBC formula or the MCCSR calculation of OSFI. Many of these factors are outside of our control.
Our financial strength and credit ratings are significantly influenced by the statutory surplus amounts and RBC and MCCSR ratios of our insurance company subsidiaries. Ratings agencies may change their internal models, effectively increasing or decreasing the amount of statutory capital our insurance subsidiaries must hold to maintain their current ratings. In addition, ratings agencies may downgrade the invested assets held in our portfolio, which could result in a reduction of their capital and surplus. Changes in statutory accounting principles could also adversely impact our insurance subsidiaries' ability to meet minimum RBC, MCCSR and statutory capital and surplus requirements. There is no assurance that our insurance subsidiaries will not need additional capital or, if needed, that we will be able to provide it to maintain the targeted RBC and MCCSR levels to support their business operations.
The failure of any of our insurance subsidiaries to meet its applicable RBC and MCCSR requirements or minimum capital and surplus requirements could subject it to further examination or corrective action imposed by insurance regulators, including limitations on its ability to write additional business, supervision by regulators or seizure or liquidation. Any corrective action imposed could have a material adverse effect on our business, financial condition and results of operations. A decline in RBC or MCCSR also limits the ability of our insurance subsidiaries to pay dividends or make distributions and could be a factor in causing ratings agencies to downgrade the financial strength ratings of all our insurance subsidiaries. Such downgrades would have an adverse effect on our
22
ability to write new insurance business and, therefore, could have a material adverse effect on our business, financial condition and results of operations.
A significant ratings downgrade by a ratings organization could materially adversely affect our business, financial condition and results of operations.
Each of our insurance subsidiaries, with the exception of Peach Re and Vidalia Re, has been assigned a financial strength rating by A.M. Best. Primerica Life currently also has an insurer financial strength rating from Standard & Poor's and Moody's. NBLIC, Primerica Life Canada, Peach Re and Vidalia Re are not rated by Standard & Poor's and Moody's.
The financial strength ratings of our insurance subsidiaries are subject to periodic review using, among other things, the ratings agencies' proprietary capital adequacy models, and are subject to revision or withdrawal at any time. Insurance financial strength ratings are directed toward the concerns of policyholders and are not intended for the protection of stockholders or as a recommendation to buy, hold or sell securities. Our financial strength ratings will affect our competitive position relative to other insurance companies. If the financial strength ratings of our insurance subsidiaries fall below certain levels, some of our policyholders may move their business to our competitors. In addition, the models used by ratings agencies to determine financial strength are different from the capital requirements set by insurance regulators.
Ratings organizations review the financial performance and financial conditions of insurance companies, and provide opinions regarding financial strength, operating performance and ability to meet obligations to policyholders. A significant downgrade in the financial strength ratings of any of our insurance subsidiaries, or the announced potential for a downgrade, could have a material adverse effect on our business, financial condition and results of operations by, among other things:
• |
reducing sales of insurance products; |
• |
adversely affecting our relationships with our sales representatives; |
• |
materially increasing the amount of policy cancellations by our policyholders; |
• |
requiring us to reduce prices to remain competitive; and |
• |
adversely affecting our ability to obtain reinsurance at reasonable prices or at all. |
If the rating agencies or regulators change their approach to financial strength ratings and statutory capital requirements, we may need to take action to maintain current ratings and capital adequacy ratios, which could have a material adverse effect on our business, financial condition and results of operations.
In addition to financial strength ratings of our insurance subsidiaries, the Parent Company currently has investment grade credit ratings from Standard & Poor's, Moody's, and A.M. Best for its senior unsecured debt. These ratings are indicators of a debt issuer's ability to meet the terms of debt obligations and are important factors in its ability to access liquidity in the debt markets. A rating downgrade by a rating agency can occur at any time if the rating agency perceives an adverse change in our financial condition, results of operations or ability to service debt. If such a downgrade occurs, it could have a material adverse effect on our financial condition and results of operations in many ways, including adversely limiting our access to capital in the unsecured debt market and potentially increasing the cost of such debt.
Credit deterioration in, and the effects of interest rate fluctuations on, our invested asset portfolio could materially adversely affect our business, financial condition and results of operations.
A large percentage of our invested asset portfolio is invested in fixed-income securities. As a result, credit deterioration and interest rate fluctuations could materially affect the value and earnings of our invested asset portfolio. Fixed-income securities decline in value if there is no active trading market for the securities or the market's impression of, or the ratings agencies' views on, the credit quality of an issuer worsens. During periods of declining market interest rates, any interest income we receive on variable interest rate investments would decrease, and we would be forced to invest the cash we receive as interest, return of principal on our investments and cash from operations in lower-yielding, high-grade instruments or in lower-credit instruments to maintain comparable returns. Issuers of fixed-income securities could also decide to prepay their obligations to borrow at lower market rates, which would increase our reinvestment risk. If interest rates generally increase, the market value of our fixed rate income portfolio decreases. Additionally, if the market value of any security in our invested asset portfolio decreases, we may realize losses if we deem the value of the security to be other-than-temporarily impaired. To the extent that any fluctuations in fair value or interest rates are significant or we recognize impairments that are material, it could have a material adverse effect on our business, financial condition and results of operations.
Valuation of our investments and the determination of whether a decline in the fair value of our invested assets is other-than-temporary are based on estimates that may prove to be incorrect.
U.S. GAAP requires that when the fair value of any of our invested assets declines and such decline is deemed to be other-than-temporary, we recognize a loss in either other comprehensive income or in our statement of income based on certain criteria in the period that such determination is made. The determination of the fair value of certain invested assets, particularly those that do not trade on a regular basis, requires an assessment of available data and the use of assumptions and estimates. Once it is determined that the fair value of an asset is below its carrying value, we must determine whether the decline in fair value is other-than-temporary, which is based on subjective factors and involves a variety of assumptions and estimates.
23
There are certain risks and uncertainties associated with determining whether declines in market value are other-than-temporary. These include significant changes in general economic conditions and business markets, trends in certain industry segments, interest rate fluctuations, rating agency actions, changes in significant accounting estimates and assumptions and legislative actions. In the case of mortgage- and asset-backed securities, there is added uncertainty as to the performance of the underlying collateral assets. To the extent that we are incorrect in our determination of the fair value of our investment securities or our determination that a decline in their value is other-than-temporary, we may realize losses that never actually materialize or may fail to recognize losses within the appropriate reporting period.
The failure by any of our reinsurers to perform its obligations to us could have a material adverse effect on our business, financial condition and results of operations.
We extensively use reinsurance in the United States to diversify our risk and to manage our loss exposure to mortality risk. Reinsurance does not relieve us of our direct liability to our policyholders, even when the reinsurer is liable to us. We, as the insurer, are required to pay the full amount of death benefits even in circumstances where we are entitled to receive payments from the reinsurer. Due to factors such as insolvency, adverse underwriting results or inadequate investment returns, our reinsurers may not be able to pay the amounts they owe us on a timely basis or at all. Further, reinsurers might refuse or fail to pay losses that we cede to them or might delay payment. Since death benefit claims may be paid long after a policy is issued, we bear credit risk with respect to our reinsurers. The creditworthiness of our reinsurers may change before we can recover amounts to which we are entitled. Any such failure to pay by our reinsurers could have a material adverse effect on our business, financial condition and results of operations.
The failure by the parties to the Citigroup reinsurance transactions to perform their obligations to us under our coinsurance agreements could have a material adverse effect on our business, financial condition and results of operations.
Immediately prior to the IPO, we entered into four coinsurance agreements with three reinsurer affiliates of Citigroup pursuant to which we ceded between 80% and 90% of the risks and rewards of our term life insurance policies that were in force at year-end 2009. Under this arrangement, our current third-party reinsurance agreements remain in place. The largest of these transactions involved two coinsurance agreements between Primerica Life and Prime Reinsurance Company, Inc. ("Prime Re"), then a wholly owned subsidiary of Primerica Life. Pursuant to these reinsurance agreements, we distributed to Citigroup all of the issued and outstanding common stock of Prime Re. Prime Re was formed solely for the purpose of entering into these reinsurance transactions, had no operating history at the time the coinsurance agreements were executed and does not possess a financial strength rating from any rating agency. The other transactions were between (i) Primerica Life Canada and Financial Reassurance Company 2010 Ltd., a wholly owned subsidiary of Citigroup formed to operate solely for the purpose of reinsuring Citigroup-related risks and (ii) NBLIC and American Health and Life Insurance Company (“AHL”), a wholly owned insurance subsidiary of Citigroup that is rated by A.M. Best. Each of the three reinsurers entered into trust agreements with our respective insurance subsidiaries and a trustee pursuant to which the reinsurer placed assets (primarily treasury and fixed-income securities) in trust for such subsidiary's benefit to secure the reinsurer's obligations to such subsidiary. Each such coinsurance agreement requires each reinsurer to maintain assets in trust sufficient to give the subsidiary full credit for regulatory purposes for the insurance, which amount will not be less than the amount of the reserves for the reinsured liabilities. In addition, in the case of the reinsurance transactions between Prime Re and Primerica Life, Citigroup has agreed in a capital maintenance agreement to maintain Prime Re's RBC above a specified minimum level, subject to a maximum amount being contributed by Citigroup. In the case of the reinsurance transaction between NBLIC and AHL, Citigroup has agreed to over-collateralize the assets in the trust for NBLIC for the life of the coinsurance agreement between NBLIC and AHL. Furthermore, our insurance subsidiaries have the right to recapture the business upon the occurrence of an event of default under their respective coinsurance agreement with the Citigroup affiliates subject to any applicable cure periods. While any such recapture would be at no cost to us, such recapture would result in a substantial increase in our insurance exposure and require us to be fully responsible for the management of the assets set aside to support statutory reserves. The type of assets we might obtain as a result of a recapture may not be as liquid as our current invested asset portfolio and could result in an unfavorable impact on our risk profile.
There is no assurance that the relevant Citigroup reinsurer will pay the reinsurance obligations owed to us now or in the future or that it will pay these obligations on a timely basis. Notwithstanding the capital maintenance agreement between Prime Re and Citigroup and the initial over-collateralization of assets in trust for the benefit of our insurance companies, if any of the Citigroup reinsurers becomes insolvent, the amount in the trust account to support the obligations of such reinsurer is insufficient to pay such reinsurer's obligations to us and we fail to enforce our right to recapture the business, it could have a material adverse effect on our business, financial condition and results of operations.
Risks Related to Our Investments and Savings Products Business
Our investment and savings products segment is heavily dependent on mutual fund and annuity products offered by a relatively small number of companies, and, if these products fail to remain competitive with other investment options or we lose our relationship with one or more of these fund companies or with the source of our annuity products, our business, financial condition and results of operations may be materially adversely affected.
We earn a significant portion of our earnings through our relationships with a small group of mutual fund and annuity companies. A decision by one or more of these companies to alter or discontinue their current arrangements with us could materially adversely affect our business, financial condition and results of operations. In addition, if any of our investment and savings products fail to achieve
24
satisfactory investment performance, our clients may seek higher yielding alternative investment products, and we could experience higher redemption rates.
In recent years there has been an increase in the popularity of alternative investments, which we do not currently offer, principally index funds and exchange traded funds. These investment options typically have low fee structures and provide some of the attributes of mutual funds, such as risk diversification. If these products continue to gain traction among our client base as viable alternatives to mutual fund investments, our investment and savings products revenues could decline.
In addition to sales commissions and asset-based compensation, a portion of our earnings from investment and savings products comes from recordkeeping services that we provide to third parties and from fees earned for custodial services that we provide to clients with retirement plan accounts in the funds of these mutual fund companies. We also receive revenue sharing payments from each of these mutual fund companies. A decision by one or more of these fund companies to alter or discontinue their current arrangements with us would materially adversely affect our business, financial condition and results of operations.
The Company or its securities-licensed sales representatives' violations of, or non-compliance with, laws and regulations could expose us to material liabilities.
Our subsidiary broker-dealer and registered investment advisor, PFS Investments, is subject to federal and state regulation of its securities business. These regulations cover sales practices, trade suitability, supervision of registered representatives, recordkeeping, the conduct and qualification of officers and employees, the rules and regulations of the MSRB and state blue sky regulation. Investment advisory representatives are generally held to a higher standard of conduct than registered representatives. Our subsidiary, PSS, is a registered transfer agent engaged in the recordkeeping business and is subject to SEC regulation. Violations of laws or regulations applicable to the activities of PFS Investments or PSS, or violations by a third party with which PFS Investments or PSS contracts which improperly performs its task, could subject us to disciplinary actions and could result in the imposition of cease and desist orders, fines or censures, restitution to clients, suspension or revocation of SEC registration, suspension or expulsion from FINRA, and reputational damage, any of which could materially adversely affect our business, financial condition and results of operations.
Our Canadian dealer subsidiary, PFSL Investments Canada and its sales representatives are subject to the securities laws of the provinces and territories of Canada in which we sell our mutual fund products and those of third parties and to the rules of the MFDA, the self-regulatory organization governing mutual fund dealers. PFSL Investments Canada is subject to periodic review by both the MFDA and the provincial and territorial securities commissions to assess its compliance with, among other things, applicable capital requirements and sales practices and procedures. These regulators have broad administrative powers, including the power to limit or restrict the conduct of our business for failure to comply with applicable laws or regulations. Possible sanctions that could be imposed include the suspension of individual sales representatives, limitations on the activities in which the dealer may engage, suspension or revocation of the dealer registration, censure or fines, any of which could materially adversely affect our business, financial condition and results of operations.
If heightened standards of conduct or more stringent licensing requirements, such as those proposed by the SEC and proposed and withdrawn by the DOL, are imposed on us or our sales representatives or selling compensation is reduced as a result of new legislation or regulations, it could have a material adverse effect on our business, financial condition and results of operations.
Our U.S. sales representatives are subject to federal and state regulation as well as state licensing requirements. PFS Investments, which is regulated as a broker-dealer, and our U.S. sales representatives are currently subject to general anti-fraud limitations under the Exchange Act and SEC rules and regulations, as well as other conduct standards prescribed by FINRA. These standards generally require that broker-dealers and their sales representatives disclose conflicts of interest that might affect the advice or recommendations they provide and require them to make suitable investment recommendations to their customers. In January 2011 under the authority of the Dodd-Frank Act, which gives the SEC the power to impose on broker-dealers a heightened standard of conduct that is currently applicable only to investment advisers, the SEC staff submitted a report to Congress in which it recommended that the SEC adopt a fiduciary standard of conduct for broker-dealers that is uniform with that of investment advisors. The SEC has slated the rule on its regulatory agenda for “long-term action” without a specific timetable.
In October 2010, the DOL published the DOL Proposed Rule, which would more broadly define the circumstances under which a person or entity may be considered a fiduciary for purposes of the prohibited transaction rules of IRC Section 4975. IRC Section 4975 prohibits certain types of compensation paid by third parties with respect to transactions involving assets in qualified accounts, including IRAs. In September 2011, the DOL withdrew the DOL Proposed Rule. The DOL has indicated that it will re-propose a similar fiduciary rule in 2015. The DOL has submitted its re-proposed rule to the Office of Management and Budget for review but has not released it to the public, consistent with customary administrative processes. The re-proposed rule is expected to be released in the coming months and the DOL has indicated that it intends to hold public hearings following a statutory comment period. If PFS Investments and its securities-licensed representatives are deemed to be fiduciaries under the new rule, our ability to receive and retain certain types of compensation paid by third parties with respect to both new and existing assets in qualified accounts could be significantly limited.
25
IRAs and other qualified accounts are a core component of the Investment and Savings Products segment of our business and accounted for a significant portion of the total revenue of this segment for the year ended December 31, 2014. Thus, if a fiduciary rule similar to the DOL Proposed Rule published in October 2010 is adopted, we would expect to substantially restructure our current business model for qualified accounts. Such restructuring could make it significantly more difficult for us and our sales representatives to profitably serve the middle-income market and could result in a significant reduction in the number of IRAs and qualified accounts that we serve, which could materially adversely affect the amount of revenue that we generate from this line of business and ultimately could result in a decline in the number of our securities-licensed sales representatives. Furthermore, our licensed representatives could be required to obtain additional securities licenses, which they may not be willing or able to obtain.
The form, substance and timing of any re-proposed or final rule are unknown at this time. It is possible that a rule could be adopted in a form that does not materially adversely affect us. If re-proposed and adopted in the form initially proposed, however, the DOL Proposed Rule could have a materially adverse effect on our business, financial condition and results of operations.
Heightened standards of conduct as a result of either of the above proposals or another similar proposed rule or regulation could also increase the compliance and regulatory burdens on our representatives, and could lead to increased litigation and regulatory risks, changes to our business model, a decrease in the number of our securities-licensed representatives and a reduction in the products we offer to our clients, any of which could have a material adverse effect on our business, financial condition and results of operations.
If our suitability policies and procedures were deemed inadequate, it could have a material adverse effect on our business, financial condition and results of operations.
We review the account applications that we receive for our investment and savings products for suitability. While we believe that the policies and procedures we implemented to help our sales representatives assist clients in making appropriate and suitable investment choices are reasonably designed to achieve compliance with applicable securities laws and regulations, it is possible that the SEC, FINRA or MFDA may not agree. Further, we could be subject to regulatory actions or private litigation, which could materially adversely affect our business, financial condition and results of operations.
Our sales force support tools may fail to appropriately identify suitable investment products.
Our support tools are designed to educate clients, help identify their financial needs, and introduce the potential benefits of our products. The assumptions and methods of analyses embedded in our support tools could be challenged and subject us to regulatory action or private litigation, which could materially adversely affect our business, financial condition and results of operations.
Non-compliance with applicable regulations could lead to revocation of our subsidiary's status as a non-bank custodian.
PFS Investments is a non-bank custodian of retirement accounts, as permitted under Treasury Regulation 1.408-2. A non-bank custodian is an entity that is not a bank and that is permitted by the IRS to act as a custodian for retirement plan account assets of our clients. The IRS retains authority to revoke or suspend that status if it finds that PFS Investments is unwilling or unable to administer retirement accounts in a manner consistent with the requirements of the applicable regulations. Revocation of PFS Investments' non-bank custodian status would affect its ability to earn revenue for providing such services and, consequently, could materially adversely affect our business, financial condition and results of operations.
As our securities sales increase we become more sensitive to performance of the equity markets.
A significant portion of our investment sales and assets under management are in North American equity-based products. The multi-year growth in equity valuations has increased proportionally the Company’s revenue and product income derived from the sale of these products. A significant correction in the North American equity markets that decreases the company’s assets under management, or a protracted long-term downturn in equity market performance that has a negative effect on the Company’s sales of securities products, could have an adverse effect on our business, financial condition and results of operations.
Other Risks Related to Our Business
Changes in accounting standards can be difficult to predict and could adversely impact how we record and report our financial condition and results of operations.
Our accounting policies and methods are fundamental to how we record and report our financial condition and results of operations. U.S. GAAP continues to evolve and, as a result, may change the financial accounting and reporting standards that govern the preparation of our financial statements. These changes can be hard to anticipate and implement and can materially impact how we record and report our financial condition and results of operations. For example, the Financial Accounting Standards Board's ("FASB") current insurance contracts accounting project could, among other things, significantly change the way we measure future policy benefits on our consolidated balance sheets and the timing of when we recognize earnings from insurance contracts on our statement of income. This project, in addition to other projects such as the FASB’s financial instruments accounting project, could adversely impact both our financial condition and results of operations as reported on a U.S. GAAP basis as well as our statutory capital calculations.
26
The effects of economic down cycles in the United States and Canada could materially adversely affect our business, financial condition and results of operations.
Our business, financial condition and results of operations have been materially adversely affected by economic downturns in the United States and Canada. Economic downturns, which are often characterized by higher unemployment, lower family income, lower valuation of retirement savings accounts, lower corporate earnings, lower business investment and lower consumer spending, have adversely affected the demand for the term life insurance, investment and other financial products that we sell. Future economic down cycles could severely adversely affect new sales and cause clients to liquidate mutual funds and other investments sold by our sales representatives. This could cause a decrease in the asset value of client accounts, reduce our trailing commission revenues and result in other-than-temporary-impairments in our invested asset portfolio. In addition, we may experience an elevated incidence of lapses or surrenders of insurance policies, and some of our policyholders may choose to defer paying insurance premiums or stop paying insurance premiums altogether. Further, volatility in equity markets or downturns could discourage purchases of the investment products that we distribute and could have a materially adverse effect on our business, including our ability to recruit and retain sales representatives.
We are subject to various federal laws and regulations in the United States and Canada, changes in which or violations of which may require us to alter our business practices and could materially adversely affect our business, financial condition and results of operations.
In the United States, we are subject to many regulations, including the Gramm-Leach-Bliley Act and its implementing regulations, including Regulation S-P, the Fair Credit Reporting Act, the Right to Financial Privacy Act, the Foreign Corrupt Practices Act, the Sarbanes-Oxley Act, the Telemarketing and Consumer Fraud and Abuse Prevention Act, the Telephone Consumer Protection Act, the FTC Act, the Health Insurance Portability and Accountability Act (HIPAA) and the Electronic Funds Transfer Act. We are also subject to anti-money laundering laws and regulations, including the Bank Secrecy Act, as amended by the Patriot Act, which requires us to develop and implement customer identification and risk-based anti-money laundering programs, report suspicious activity and maintain certain records. Further, we are required to follow certain economic and trade sanctions programs that are administered by the Office of Foreign Asset Control that prohibit or restrict transactions with suspected countries, their governments, and in certain circumstances, their nationals.
In Canada, we are subject to provincial and territorial regulations, including consumer protection legislation that pertains to unfair and misleading business practices, provincial and territorial credit reporting legislation that provides requirements in respect of obtaining credit bureau reports and providing notices of decline, the Personal Information Protection and Electronic Documents Act, the Competition Act, the Corruption of Foreign Public Officials Act, the Telecommunications Act and certain Canadian Radio-television and Telecommunications Commission Telecom Decisions in respect of unsolicited telecommunications. We are also subject to the Proceeds of Crime (Money Laundering) and Terrorist Financing Act and its accompanying regulations, which require us to develop and implement money laundering policies and procedures relating to customer indemnification, reporting and recordkeeping, develop and maintain ongoing training programs for employees, perform a risk assessment on our business and clients and institute and document a review of our anti-money laundering program at least once every two years. We are also required to follow certain economic and trade sanctions and legislation that prohibit us from, among other things, engaging in transactions with, and providing services to, persons on lists created under various federal statutes and regulations and blocked persons and foreign countries and territories subject to Canadian sanctions administered by Foreign Affairs and International Trade Canada and the Department of Public Safety Canada.
Changes in, or violations of, any of these laws or regulations may require additional compliance procedures, or result in enforcement proceedings, sanctions or penalties, which could have a material adverse effect on our business, financial condition and results of operations.
Litigation and regulatory investigations and actions may result in financial losses and harm our reputation.
We face a risk of litigation and regulatory investigations and actions in the ordinary course of operating our businesses. From time to time, we are subject to private litigation and regulatory investigations as a result of sales representative misconduct or failure of the Company to follow applicable insurance or securities laws or regulations. For example, we may become subject to lawsuits alleging, among other things, issues relating to sales or underwriting practices, payment of improper sales commissions, claims issues, product design and disclosure, additional premium charges for premiums paid on a periodic basis, denial or delay of benefits, pricing and sales practices issues. If we become subject to any such litigation, any judgment or settlement of the claims could have a material adverse effect on our business, financial condition and results of operations.
In addition, we are subject to litigation arising out of our general business activities. For example, we have a large sales force, and we could face claims by some of our sales representatives arising out of their relationship with us. We are also subject to various regulatory inquiries, such as information requests, subpoenas and books and record examinations, from state, provincial and federal regulators and other authorities. A substantial legal liability or a significant regulatory action against us could have a material adverse effect on our business, financial condition and results of operations.
27
Moreover, even if we ultimately prevail in any litigation, regulatory action or investigation, we could suffer significant reputational harm and we could incur significant legal expenses, either of which could have a material adverse effect on our business, financial condition and results of operations. In addition, increased regulatory scrutiny and any resulting investigations or proceedings could result in new legal precedents and industry-wide regulations or practices that could materially adversely affect our business, financial condition and results of operations.
The current legislative and regulatory climate with regard to financial services may adversely affect our business, financial condition, and results of operations.
The volume of legislative and regulatory activity relating to financial services has increased substantially in recent years, and we expect that the level of enforcement actions and investigations by federal regulators will increase correspondingly. The same factors that have contributed to legislative, regulatory and enforcement activity at the federal level are likely to contribute to heightened activity at the state and provincial level. If we or our sales representatives become subject to new requirements or regulations, it could result in increased litigation, regulatory risks, changes to our business model, a decrease in the number of our securities-licensed representatives or a reduction in the products we offer to our clients or the profits we earn, which could have a material adverse effect on our business, financial condition and results of operations.
Regulators could adopt laws or interpret existing laws in a way that would require retroactive changes to our business, accounting practices, or redundant reserve financing structure. Any such retroactive changes could have a material adverse effect on our business, financial condition and results of operations.
The inability of our subsidiaries to pay dividends or make distributions or other payments to us in sufficient amounts would impede our ability to meet our obligations and return capital to our stockholders.
We are a holding company, and we have no significant operations. Our primary asset is the capital stock of our subsidiaries and our primary liability is our senior unsecured notes. We rely primarily on dividends and other payments from our subsidiaries to meet our operating costs, other corporate expenses, senior unsecured notes obligations, as well as to return capital to our stockholders. The ability of our subsidiaries to pay dividends to us depends on their earnings, covenants contained in existing and future financing or other agreements and on regulatory restrictions. The ability of our insurance subsidiaries to pay dividends will further depend on their statutory income and surplus. If the cash we receive from our subsidiaries pursuant to dividend payments and tax sharing arrangements is insufficient for us to fund our obligations or if a subsidiary is unable to pay dividends to us, we may be required to raise cash through the incurrence of debt, the issuance of equity or the sale of assets. However, given the historic volatility in the capital markets, there is no assurance that we would be able to raise cash by these means.
The jurisdictions in which our insurance subsidiaries are domiciled impose certain restrictions on their ability to pay dividends to us. In the United States, these restrictions are based, in part, on the prior year's statutory income and surplus. In general, dividends up to specified levels are considered ordinary and may be paid without prior approval. Dividends in larger amounts are subject to approval by the insurance commissioner of the state of domicile. In Canada, dividends can be paid, subject to the paying insurance company continuing to meet the regulatory requirements for capital adequacy and liquidity and upon 15 days' minimum notice to OSFI. No assurance is given that more stringent restrictions will not be adopted from time to time by jurisdictions in which our insurance subsidiaries are domiciled, and such restrictions could have the effect, under certain circumstances, of significantly reducing dividends or other amounts payable to us by our subsidiaries without prior approval by regulatory authorities. In addition, in the future, we may become subject to debt covenants or other agreements that limit our ability to return capital to our stockholders. The ability of our insurance subsidiaries to pay dividends to us is also limited by our need to maintain the financial strength ratings assigned to us by the ratings agencies.
If any of our subsidiaries were to become insolvent, liquidate or otherwise reorganize, we, as sole stockholder, will have no right to proceed against the assets of that subsidiary. Furthermore, with respect to our insurance subsidiaries, we, as sole stockholder, will have no right to cause the liquidation, bankruptcy or winding-up of the subsidiary under the applicable liquidation, bankruptcy or winding-up laws, although, in Canada, we could apply for permission to cause liquidation. The applicable insurance laws of the jurisdictions in which each of our insurance subsidiaries is domiciled would govern any proceedings relating to that subsidiary. The insurance authority of that jurisdiction would act as a liquidator or rehabilitator for the subsidiary. Both creditors of the subsidiary and policyholders (if an insurance subsidiary) would be entitled to payment in full from the subsidiary's assets before we, as the sole stockholder, would be entitled to receive any distribution from the subsidiary.
If the ability of our insurance or non-insurance subsidiaries to pay dividends or make other distributions or payments to us is materially restricted by regulatory requirements, bankruptcy or insolvency, or our need to maintain our financial strength ratings, or is limited due to operating results or other factors, it could materially adversely affect our ability to fund our obligations and return capital to our stockholders.
A significant change in the competitive environment in which we operate could negatively affect our ability to maintain or increase our market share and profitability.
We face competition in all of our business lines. Our competitors include financial services companies, mutual fund companies, banks, investment management firms, broker-dealers, insurance companies and direct sales companies. In many of our product lines, we face
28
competition from competitors that have greater market share or breadth of distribution, offer a broader range of products, services or features, assume a greater level of risk, have lower profitability expectations or have higher financial strength ratings than we do. A significant change in this competitive environment could materially adversely affect our ability to maintain or increase our market share and profitability.
The loss of key employees and sales force leaders could negatively affect our financial results and impair our ability to implement our business strategy.
Our success substantially depends on our ability to attract and retain key members of our senior management team. The efforts, personality and leadership of our senior management team have been, and will continue to be, critical to our success. The loss of service of our senior management team due to disability, death, retirement or some other cause could reduce our ability to successfully motivate our sales representatives and implement our business plan and have a material adverse effect on our business, financial condition and results of operations. Although our senior executive officers have entered into employment agreements with us, there is no assurance that they will complete the term of their employment agreements or that they or the Company will renew them upon expiration.
In addition, the loss of key RVPs for any reason could negatively affect our financial results, impair our ability to attract new sales representatives and hinder future growth.
If one of our significant information technology systems fails, if its security is compromised or if the Internet becomes disabled or unavailable, our business, financial condition and results of operations may be materially adversely affected.
Our business is highly dependent upon the effective operation of our information technology systems and third party technology systems, networks and clouds to record, process, transmit and store information, including sensitive customer and proprietary information. We rely on these systems throughout our business for a variety of functions including to conduct many of our business activities and transactions with our customers, representatives, vendors and other third parties, to process components of our financial statements and to communicate with our Board of Directors. Our information technology systems run a variety of third-party and proprietary software, including POL (our website portal to our sales force), our insurance administration system, Virtual Base Shop (our paperless office for RVPs), TurboApps (our point-of-sale data collection tool for product/ recruiting applications), our licensing decision and support system and our compensation system. Our business also relies on the use of electronic mobile devices by employees, representatives and other third parties such as laptops and smartphones, which are particularly vulnerable to loss and theft.
Maintaining the integrity of these systems and networks is critical to the success of our business operations, including the retention of our representatives and customers, and to the protection of our proprietary information and our customers’ confidential and personal information. We could experience a failure of one or more of these systems or could fail to complete all necessary data reconciliation or other conversion controls when implementing new software systems. In addition, despite the implementation of security and back-up measures, our information technology systems may be vulnerable to physical or electronic intrusions, viruses or other attacks, programming errors and similar disruptions.
We are subject to international, federal and state regulations, and in some cases contractual obligations, that require us to establish and maintain policies and procedures designed to protect sensitive customer, employee, representative and third-party information. We have implemented and maintain security measures, including industry standard commercial technology, designed to protect against breaches of security and other interference with our systems and networks resulting from attacks by third parties, including hackers, and from employee or representative error or malfeasance. We continually assess our ability to monitor and respond to such threats. We also require third-party vendors, who in the provision of services to us are provided with or process information pertaining to our business or our customers, to meet certain information security standards. Despite the measures we have taken and may in the future take to address and mitigate cybersecurity and technology risks, we cannot assure that our systems and networks will not be subject to breaches or interference. Any such breaches or interference by third parties or by our representatives or employees that may occur in the future including the failure of any one of these systems for any reason, could cause significant interruptions to our operations, which could have a material adverse effect on our business, financial condition and results of operations.
Anyone who is able to circumvent our security measures and penetrate our information technology systems could access, view, misappropriate, alter, or delete information in the systems, including personally identifiable client information and proprietary business information. In addition, an increasing number of jurisdictions require that clients be notified if a security breach results in the disclosure of personally identifiable client information, which could exacerbate the harm to our business, financial condition or results of operations. We cannot be certain that advances in criminal capabilities, discovery of new vulnerabilities, attempts to exploit vulnerabilities in our systems, data thefts, physical system or network break-ins or inappropriate access, or other developments will not compromise or breach the technology or other security measures protecting the networks and systems used in connection with our business.
Operating system failures, ineffective system implementation, loss of the Internet or the compromise of security with respect to internal, external or third-party operating systems or portable electronic devices could subject us to significant civil and criminal liability, harm our reputation, interrupt our business operations, deter people from purchasing our products, require us to incur
29
significant technical, legal and other expenses, and adversely affect our internal control over financial reporting, business, financial condition, or results of operations.
In the event of a disaster, our business continuity plan may not be sufficient, which could have a material adverse effect on our business, financial condition and results of operations.
Our infrastructure supports a combination of local and remote recovery solutions for business resumption in the event of a disaster. In the event of either a campus-wide destruction or the inability to access our main campus in Duluth, Georgia, our business recovery plan provides for a limited number of our employees to perform their work functions via a dedicated business recovery site located 25 miles from our main campus or by remote access from an employee's home. However, in the event of campus-wide destruction, our business recovery plan may be inadequate, and our employees and sales representatives may be unable to carry out their work, which could have a material adverse effect on our business, financial condition and results of operations.
We may be materially adversely affected by currency fluctuations in the United States dollar versus the Canadian dollar.
A weaker Canadian dollar relative to the U.S. dollar would result in lower levels of reported revenues, net income, assets, liabilities and accumulated other comprehensive income in our U.S. dollar reporting currency financial statements. Significant exchange rate fluctuations between the U.S. dollar and Canadian dollar could have a material adverse effect on our financial condition and results of operations.
Not applicable.
We lease all of our office, warehouse, printing, and distribution properties. Our executive and home office operations for substantially all of our domestic U.S. operations (except New York) are located in Duluth, Georgia, in a build-to-suit facility completed in 2013. The initial lease term for the facility is 15 years.
We also lease continuation of business, print/distribution, and warehouse space in or around Duluth, Georgia, under leases expiring in January 2018, June 2018 and June 2023, respectively.
NBLIC subleases general office space in Long Island City, New York, from a subsidiary of Citigroup under a sublease expiring in March 2020.
In Canada, we lease general office space in Mississauga, Ontario, under a lease expiring in April 2018 and warehouse and printing operation space in Mississauga, Ontario, under a lease also expiring in April 2018.
Each of these leased properties is used by each of our operating segments, with the exception of our NBLIC office space, which is not used by our Investment and Savings Products segment.
We believe that our existing facilities in the U.S. and Canada are adequate for our current requirements and for our operations in the foreseeable future.
For additional details on our operating leases, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Liquidity and Capital Resources – Contractual Obligations.”
We are involved from time to time in legal disputes, regulatory inquiries and arbitration proceedings in the normal course of business. Additional information regarding certain legal proceedings to which we are a party is described under “Contingent Liabilities” in Note 16 (Commitments and Contingent Liabilities) to our consolidated financial statements included elsewhere in this report, and such information is incorporated herein by reference. As of the date of this report, other than as discussed in the paragraph below, we do not believe any pending legal proceeding to which Primerica or any of its subsidiaries is a party is required to be disclosed pursuant to this item.
The insurance regulators in the Canadian provinces and territories entered into a Memorandum of Understanding and related agreements to implement a new life insurance licensing examination program across Canada in early 2016. If this new licensing program is implemented under the terms set forth in the agreements, we believe it would significantly decrease the ability of applicants to obtain their life insurance licenses in Canada. In the third quarter of 2014, we issued Applications in the Ontario Superior Court of Justice naming as the Respondents the Financial Services Commission of Ontario and the government of Ontario. We also issued an Application in the Court of Queen’s Bench for Saskatchewan naming as Respondents the Insurance Councils of Saskatchewan and Life Insurance Council of Saskatchewan. The Applications seek a declaration that the Memorandum of Understanding and related agreements are null and void and of no force and effect. See “Item 1A. Risk Factors. – Risks Related to our Distribution Structure” for more information.
30
Not applicable.
Our executive officers are elected or appointed by our Board of Directors. On April 1, 2015, Mr. G. Williams will become Chief Executive Officer and Director, and Mr. P. Schneider will become President. In addition, Mr. R. Williams will become non-executive Chairman of the Board, and Mr. J. Addison will become non-executive Chairman of Primerica Distribution and Director.
The name, age at February 26, 2015, and position of each of our executive officers are presented below.
Name |
|
Age |
|
Position |
D. Richard Williams |
|
58 |
|
Chairman of the Board and Co-Chief Executive Officer |
John A. Addison, Jr. |
|
57 |
|
Chairman of Primerica Distribution, Co-Chief Executive Officer and Director |
Glenn J. Williams |
|
55 |
|
President |
Michael C. Adams |
|
58 |
|
Executive Vice President and Chief Business Technology Officer |
Chess E. Britt |
|
58 |
|
Executive Vice President and Chief Marketing Officer |
Jeffrey S. Fendler |
|
58 |
|
Executive Vice President and Chief Compliance and Risk Officer |
Gregory C. Pitts |
|
52 |
|
Executive Vice President and Chief Operating Officer |
Alison S. Rand |
|
47 |
|
Executive Vice President and Chief Financial Officer |
Peter W. Schneider |
|
58 |
|
Executive Vice President, General Counsel and Chief Administrative Officer |
William A. Kelly |
|
59 |
|
President of PFS Investments |
Set forth below is biographical information concerning our executive officers.
D. Richard Williams was elected to our Board of Directors and began serving as Chairman in October 2009. He has served as our Co-Chief Executive Officer since 1999 and has served our company in various capacities since 1989. Mr. Williams earned both his B.S. degree in 1978 and his M.B.A. in 1979 from the Wharton School of the University of Pennsylvania. Mr. Williams serves on the Board of Directors of the Anti-Defamation League Southeast Region, the Atlanta Area Council of the Boy Scouts of America and the Carter Center Board of Councilors.
John A. Addison, Jr. was elected to our Board of Directors in October 2009. He is the Chairman of Primerica Distribution, has served as our Co-Chief Executive Officer since 1999 and has served our company in various capacities since 1982. Mr. Addison earned his B.A. in economics from the University of Georgia in 1979 and his M.B.A. from Georgia State University in 1988.
Glenn J. Williams has served as President since 2005, as Executive Vice President from 2000 to 2005 and in various capacities at our company since 1981. Mr. Williams earned his B.S. in education from Baptist University of America in 1981. He serves on the board of the Georgia Baptist Foundation.
Michael C. Adams has served as Chief Business Technology Officer since April 2010, as Executive Vice President responsible for business technology since 1998 and in various capacities at our company since 1980. Mr. Adams earned his B.A. in business and economics from Hendrix College in 1978.
Chess E. Britt has served as Chief Marketing Officer since April 2010, as Executive Vice President responsible for marketing administration and field communication since 1995 and in various capacities at our company since 1982. Mr. Britt earned his B.A. in business administration from the University of Georgia in 1978. He serves on the board of directors of the Gwinnett Chamber of Commerce.
Jeffrey S. Fendler has served as Executive Vice President and Chief Compliance and Risk Officer of our company since February 2014. He served as President of Primerica Life, a subsidiary of Primerica, from 2005 through January 2014 and in various capacities at our company since 1980. Mr. Fendler received a B.A. in economics from Tulane University. He is the Co-Chair of Operation Hope’s Southeastern Region Board.
Gregory C. Pitts has served as Executive Vice President and Chief Operating Officer since December 2009, as Executive Vice President since 1995 with responsibilities within the Term Life Insurance and Investment and Savings Products segments and information technology division and in various capacities at our company since 1985. Mr. Pitts earned his B.S.B.A. in general business from the University of Arkansas in 1985.
Alison S. Rand has served as Executive Vice President and Chief Financial Officer since 2000 and in various capacities at our company since 1995. Prior to 1995, Ms. Rand worked in the audit department of KPMG LLP. Ms. Rand earned her B.S. in accounting from the University of Florida in 1990 and is a certified public accountant. She is a board member of the Atlanta Children’s Shelter, the Partnership Against Domestic Violence and Junior Achievement of Georgia. She also serves on the Terry College of Business Executive Education CFO Roundtable Advisory Board.
31
Peter W. Schneider has served as Executive Vice President, General Counsel, Chief Administrative Officer since 2000. He served as Corporate Secretary from 2000 through January 2014. He worked at the law firm of Rogers & Hardin LLP as a partner from 1988 to 2000. Mr. Schneider earned both his B.S. in political science and industrial relations in 1978 and J.D. in 1981 from the University of North Carolina at Chapel Hill. He serves on the Boards of Directors of the Georgia Chamber of Commerce, the Northwest YMCA and the Carolina Center for Jewish Studies.
William A. Kelly has overseen Primerica Life Insurance Company of Canada, a subsidiary of Primerica, since 2009, has served as President of PFS Investments, a subsidiary of Primerica, since 2005 and has served our company in various capacities since 1985. Mr. Kelly graduated from the University of Georgia in 1979 with a B.B.A. in accounting.
32
MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES. |
Quarterly Common Stock Prices and Dividends
The common stock of Primerica, Inc. (“Primerica”, “we”, “us” or the “Parent Company”) is listed for trading on the New York Stock Exchange (“NYSE”) under the symbol “PRI”. The quarterly high and low sales prices for our common stock as reported on the NYSE and the dividends paid per quarter for the periods indicated were as follows:
|
|
High |
|
|
Low |
|
|
Dividend |
|
|||
2014 |
|
|
|
|
|
|
|
|
|
|
|
|
4th quarter |
|
$ |
55.77 |
|
|
$ |
45.29 |
|
|
$ |
0.12 |
|
3rd quarter |
|
|
51.54 |
|
|
|
45.46 |
|
|
|
0.12 |
|
2nd quarter |
|
|
48.09 |
|
|
|
42.74 |
|
|
|
0.12 |
|
1st quarter |
|
|
49.59 |
|
|
|
39.12 |
|
|
|
0.12 |
|
2013 |
|
|
|
|
|
|
|
|
|
|
|
|
4th quarter |
|
$ |
44.22 |
|
|
$ |
38.74 |
|
|
$ |
0.11 |
|
3rd quarter |
|
|
42.37 |
|
|
|
36.42 |
|
|
|
0.11 |
|
2nd quarter |
|
|
37.93 |
|
|
|
31.13 |
|
|
|
0.11 |
|
1st quarter |
|
|
34.35 |
|
|
|
30.38 |
|
|
|
0.11 |
|
Dividends
We have paid quarterly dividends to our stockholders totaling approximately $26.5 million and $25.1 million in 2014 and 2013, respectively.
As of January 31, 2015, we had 67 holders of record of our common stock. In the first quarter of 2015, we declared a quarterly dividend to shareholders of $0.16 per share. We currently expect to continue to pay quarterly cash dividends to holders of our common stock. Our payment of cash dividends is at the discretion of our Board of Directors in accordance with applicable law after taking into account various factors, including our financial condition, operating results, current and anticipated cash needs and plans for growth. Under Delaware law, we can only pay dividends either out of surplus or out of the current or the immediately preceding year’s earnings. Therefore, no assurance is given that we will continue to pay any dividends to our common stockholders, or as to the amount of any such dividends.
We are a holding company and have no operations. Our primary asset is the capital stock of our operating subsidiaries. The states in which our U.S. insurance company subsidiaries are domiciled impose certain restrictions on our insurance subsidiaries’ ability to pay dividends to us. Our Canadian subsidiary can pay dividends subject to meeting regulatory requirements for capital adequacy and liquidity with appropriate minimum notice to the Office of the Superintendent of Financial Institutions Canada (“OSFI”). In addition, in the future, we may become subject to agreements that limit our ability to pay dividends. See Note 15 (Statutory Accounting and Dividend Restrictions) to our consolidated financial statements included elsewhere in this report.
Issuer Purchases of Equity Securities
Depending on market conditions, shares may be repurchased from time to time at prevailing market prices through open market or privately negotiated transactions. In November 2014, our Board of Directors authorized a share repurchase program under which we expect to repurchase up to $150 million of our outstanding common stock in 2015. The Parent Company has no obligation to repurchase any shares. Subject to applicable corporate securities laws, repurchases may be made at such times and in such amounts as management deems appropriate. Repurchases under a publicly announced program can be discontinued at any time management believes additional repurchases are not warranted.
During the quarter ended December 31, 2014, we repurchased shares of our common stock as follows:
Period |
|
Total number of shares purchased (1) |
|
|
Average price paid per share (1) |
|
|
Total number of shares purchased as part of publicly announced plans or programs |
|
|
Approximate dollar value of shares that may yet be purchased under the plans or programs |
|
||||
October 1-31, 2014 |
|
|
660,870 |
|
|
$ |
47.34 |
|
|
|
660,645 |
|
|
$ |
53,170,152 |
|
November 1-30, 2014 |
|
|
464,852 |
|
|
|
51.77 |
|
|
|
463,470 |
|
|
|
179,173,298 |
|
December 1-31, 2014 |
|
|
508,975 |
|
|
|
53.20 |
|
|
|
508,598 |
|
|
|
152,116,567 |
|
Total |
|
|
1,634,697 |
|
|
$ |
50.43 |
|
|
|
1,632,713 |
|
|
$ |
152,116,567 |
|
(1) |
Consists of (a) repurchases of 1,984 shares at an average price of $51.85 arising from share-based compensation tax withholdings and (b) open market repurchases of shares under the share repurchase program approved by our Board of Directors. |
For more information on our share repurchases, see Note 12 (Stockholders’ Equity) to our consolidated financial statements included elsewhere in this report.
33
Securities Authorized for Issuance under Equity Compensation Plans
We have two compensation plans under which our equity securities are authorized for issuance. The Primerica, Inc. Amended and Restated 2010 Omnibus Incentive Plan was approved by our stockholders in May 2011. The Primerica, Inc. Stock Purchase Plan for Agents and Employees was approved by our sole stockholder in March 2010. The following table sets forth certain information relating to these equity compensation plans at December 31, 2014.
|
Number of securities to be issued upon exercise of outstanding options, warrants and rights |
|
|
Weighted average exercise price of outstanding options, warrants and rights |
|
|
Number of securities remaining available for future issuance |
|
|
|||
Equity compensation plans approved by stockholders: |
|
|
|
|
|
|
|
|
|
|
|
|
Primerica, Inc. Amended and Restated 2010 Omnibus Incentive Plan |
|
1,403,760 |
|
(1) |
$ |
36.67 |
|
(2) |
|
2,078,974 |
|
(3) |
Primerica, Inc. Stock Purchase Plan for Agents and Employees |
|
- |
|
|
|
- |
|
|
|
2,109,973 |
|
(4) |
Total |
|
1,403,760 |
|
|
$ |
36.67 |
|
|
|
4,188,947 |
|
|
Equity compensation plans not approved by stockholders |
n/a |
|
|
n/a |
|
|
n/a |
|
|
(1) |
Consists of 1,157,889 and 245,871 shares of our common stock to be issued in connection with outstanding restricted stock units (“RSUs”) and options, respectively. |
(2) |
Represents the weighted average exercise price of stock options outstanding. |
(3) |
The number of shares of our common stock available for future issuance is 10,800,000 less the cumulative number of awards granted under the plan plus the cumulative number of awards canceled under the plan. |
(4) |
Represents shares of our common stock, which have already been issued and are outstanding, available to be purchased by employees and agents under the plan. The number of outstanding shares available to be purchased is 2,500,000 less the cumulative number of outstanding shares purchased to date under the plan. |
Stock Performance Table
The following graph compares the performance of our common stock since the initial public offering (“IPO”) to the Standard & Poor’s (“S&P”) MidCap 400 Index and the S&P 500 Insurance Index by assuming $100 was invested in each investment option as of April 1, 2010, the date of the IPO. The S&P MidCap 400 Index measures the performance of the United States middle market capitalization (“mid-cap”) equities sector. The S&P 500 Insurance Index is a capitalization-weighted index of domestic equities of insurance companies traded on the NYSE and NASDAQ. Our common stock is included in the S&P MidCap 400 index.
|
|
Period Ended |
|
||||||||||||||||
Index |
|
4/1/2010 |
|
12/31/2010 |
|
12/31/2011 |
|
12/31/2012 |
|
12/31/2013 |
|
12/31/2014 |
|
||||||
Primerica, Inc. |
|
$ |
100.00 |
|
$ |
161.82 |
|
$ |
155.80 |
|
$ |
202.98 |
|
$ |
293.78 |
|
$ |
375.31 |
|
S&P 500 Insurance |
|
|
100.00 |
|
|
102.59 |
|
|
94.09 |
|
|
112.05 |
|
|
164.39 |
|
|
178.01 |
|
S&P MidCap 400 |
|
|
100.00 |
|
|
115.00 |
|
|
113.01 |
|
|
133.22 |
|
|
177.84 |
|
|
195.22 |
|
34
The selected financial data should be read in conjunction with the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and the consolidated financial statements and accompanying notes included elsewhere in this report.
Prior to April 1, 2010, we were wholly owned by Citigroup Inc. (“Citigroup”). In April 2010, we completed a series of transactions (the “corporate reorganization”) that included an initial public offering of our common stock by Citigroup pursuant to the Securities Act of 1933, as amended (the “Securities Act”). The selected historical income statement data for the year ended December 31, 2010 may not be indicative of the revenues and expenses that would have existed or resulted if we had operated independently of Citigroup during that year. The selected historical financial data are not necessarily indicative of the financial position or results of operations as of any future date or for any future period.
35
|
|
Year ended December 31, |
|
|
|||||||||||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|
2011 |
|
|
2010 |
|
|
|||||
|
|
(In thousands, except per-share amounts) |
|
|
|||||||||||||||||
Statements of income data |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct premiums |
|
$ |
2,301,332 |
|
|
$ |
2,265,191 |
|
|
$ |
2,231,032 |
|
|
$ |
2,189,002 |
|
|
$ |
2,142,077 |
|
|
Ceded premiums |
|
|
(1,616,817 |
) |
|
|
(1,644,158 |
) |
|
|
(1,663,753 |
) |
|
|
(1,703,075 |
) |
|
|
(1,450,367 |
) |
|
Net premiums |
|
|
684,515 |
|
|
|
621,033 |
|
|
|
567,279 |
|
|
|
485,927 |
|
|
|
691,710 |
|
|
Commissions and fees |
|
|
527,166 |
|
|
|
471,808 |
|
|
|
429,044 |
|
|
|
414,471 |
|
|
|
383,984 |
|
|
Net investment income |
|
|
86,473 |
|
|
|
88,752 |
|
|
|
100,804 |
|
|
|
108,601 |
|
|
|
165,111 |
|
|
Realized investment gains (losses), including other-than- temporary impairment losses |
|
|
(261 |
) |
|
|
6,246 |
|
|
|
11,382 |
|
|
|
6,440 |
|
|
|
34,145 |
|
|
Other, net |
|
|
42,137 |
|
|
|
42,731 |
|
|
|
45,263 |
|
|
|
47,189 |
|
|
|
47,916 |
|
|
Total revenues |
|
|
1,340,030 |
|
|
|
1,230,570 |
|
|
|
1,153,772 |
|
|
|
1,062,628 |
|
|
|
1,322,866 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits and expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits and claims |
|
|
311,417 |
|
|
|
279,931 |
|
|
|
254,048 |
|
|
|
212,526 |
|
|
|
292,298 |
|
|
Amortization of deferred policy acquisition costs |
|
|
144,378 |
|
|
|
129,183 |
|
|
|
118,598 |
|
|
|
104,034 |
|
|
|
147,841 |
|
|
Sales commissions |
|
|
268,775 |
|
|
|
232,237 |
|
|
|
204,569 |
|
|
|
191,722 |
|
|
|
180,054 |
|
|
Insurance expenses |
|
|
115,452 |
|
|
|
105,457 |
|
|
|
90,894 |
|
|
|
84,093 |
|
|
|
100,220 |
|
|
Insurance commissions |
|
|
15,353 |
|
|
|
16,530 |
|
|
|
21,724 |
|
|
|
32,214 |
|
|
|
41,882 |
|
|
Interest expense |
|
|
34,570 |
|
|
|
35,018 |
|
|
|
33,101 |
|
|
|
27,968 |
|
|
|
20,872 |
|
|
Other operating expenses |
|
|
174,363 |
|
|
|
187,208 |
|
|
|
164,716 |
|
|
|
164,954 |
|
|
|
180,610 |
|
|
Total benefits and expenses |
|
|
1,064,308 |
|
|
|
985,564 |
|
|
|
887,650 |
|
|
|
817,511 |
|
|
|
963,777 |
|
|
Income from continuing operations before income taxes |
|
|
275,722 |
|
|
|
245,006 |
|
|
|
266,122 |
|
|
|
245,117 |
|
|
|
359,089 |
|
|
Income taxes |
|
|
95,888 |
|
|
|
86,305 |
|
|
|
92,813 |
|
|
|
87,143 |
|
|
|
128,175 |
|
|
Income from continuing operations |
|
|
179,834 |
|
|
|
158,701 |
|
|
|
173,309 |
|
|
|
157,974 |
|
|
|
230,914 |
|
|
Income (loss) from discontinued operations, net of income taxes (2) |
|
|
1,578 |
|
|
|
4,024 |
|
|
|
497 |
|
|
|
(783 |
) |
|
|
1,542 |
|
|
Net income |
|
$ |
181,412 |
|
|
$ |
162,725 |
|
|
$ |
173,806 |
|
|
$ |
157,191 |
|
|
$ |
232,456 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
3.26 |
|
|
$ |
2.80 |
|
|
$ |
2.76 |
|
|
$ |
2.12 |
|
|
$ |
3.07 |
|
(1) |
Discontinued operations |
|
|
0.03 |
|
|
|
0.07 |
|
|
|
0.01 |
|
|
|
(0.01 |
) |
|
|
0.02 |
|
(1) |
Basic earnings per share |
|
$ |
3.29 |
|
|
$ |
2.87 |
|
|
$ |
2.77 |
|
|
$ |
2.11 |
|
|
$ |
3.09 |
|
(1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
3.26 |
|
|
$ |
2.76 |
|
|
$ |
2.70 |
|
|
$ |
2.09 |
|
|
$ |
3.04 |
|
(1) |
Discontinued operations |
|
|
0.03 |
|
|
|
0.07 |
|
|
|
0.01 |
|
|
|
(0.01 |
) |
|
|
0.02 |
|
(1) |
Diluted earnings per share |
|
$ |
3.29 |
|
|
$ |
2.83 |
|
|
$ |
2.71 |
|
|
$ |
2.08 |
|
|
$ |
3.06 |
|
(1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends declared per share |
|
$ |
0.48 |
|
|
$ |
0.44 |
|
|
$ |
0.24 |
|
|
$ |
0.10 |
|
|
$ |
0.02 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
|
|||||||||||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|
2011 |
|
|
2010 |
|
|
|||||
|
|
(In thousands) |
|
|
|||||||||||||||||
Balance sheet data |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments |
|
$ |
2,068,316 |
|
|
$ |
1,835,403 |
|
|
$ |
1,956,536 |
|
|
$ |
2,021,504 |
|
|
$ |
2,153,584 |
|
|
Cash and cash equivalents |
|
|
192,516 |
|
|
|
149,189 |
|
|
|
112,216 |
|
|
|
136,078 |
|
|
|
126,038 |
|
|
Due from reinsurers |
|
|
4,115,533 |
|
|
|
4,055,054 |
|
|
|
4,005,194 |
|
|
|
3,855,318 |
|
|
|
3,731,002 |
|
|
Deferred policy acquisition costs, net |
|
|
1,351,180 |
|
|
|
1,208,466 |
|
|
|
1,066,422 |
|
|
|
904,485 |
|
|
|
738,946 |
|
|
Total assets |
|
|
10,738,114 |
|
|
|
10,329,950 |
|
|
|
10,337,877 |
|
|
|
9,851,820 |
|
|
|
9,769,409 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Future policy benefits |
|
|
5,264,608 |
|
|
|
5,063,103 |
|
|
|
4,850,488 |
|
|
|
4,614,860 |
|
|
|
4,409,183 |
|
|
Notes payable |
|
|
374,532 |
|
|
|
374,481 |
|
|
|
374,433 |
|
|
|
300,000 |
|
|
|
300,000 |
|
|
Total liabilities |
|
|
9,492,988 |
|
|
|
9,107,923 |
|
|
|
9,062,461 |
|
|
|
8,525,170 |
|
|
|
8,412,881 |
|
|
Stockholders' equity |
|
|
1,245,126 |
|
|
|
1,222,027 |
|
|
|
1,275,416 |
|
|
|
1,326,650 |
|
|
|
1,356,528 |
|
|
(1) |
Calculated on a pro forma basis using weighted-average shares, including the shares issued or issuable upon lapse of restrictions following our April 1, 2010 corporate reorganization as though they had been issued and outstanding on January 1, 2010. |
(2) |
In January 2014, we sold the assets and liabilities of our short-term statutory disability benefit insurance business (“DBL”) and the results of operations for DBL have been reported in discontinued operations for all periods presented in the statements of income data. For more information see Note 2 (Discontinued Operations) to our consolidated financial statements included elsewhere in this report. |
36
Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is intended to inform the reader about matters affecting the financial condition and results of operations of Primerica, Inc. (the “Parent Company”) and its subsidiaries (collectively, “we”, “us” or the “Company”) for the three-year period ended December 31, 2014. As a result, the following discussion should be read in conjunction with the consolidated financial statements and accompanying notes that are included herein. This discussion contains forward-looking statements that constitute our plans, estimates and beliefs. These forward-looking statements involve numerous risks and uncertainties, including, but not limited to, those discussed in “Risk Factors”. Actual results may differ materially from those contained in any forward-looking statements.
This MD&A is divided into the following sections:
· |
Business Trends and Conditions |
· |
Factors Affecting Our Results |
· |
Critical Accounting Estimates |
· |
Results of Operations |
· |
Financial Condition |
· |
Liquidity and Capital Resources |
Business Trends and Conditions
The relative strength and stability of financial markets and economies in the United States and Canada affect our growth and profitability. Our business is, and we expect will continue to be, influenced by a number of industry-wide and product-specific trends and conditions.
Economic conditions, including unemployment levels and consumer confidence, influence investment and spending decisions by middle income consumers, who are generally our primary clients. Consumer spending and borrowing levels affect how consumers evaluate their savings and debt management plans. In addition, interest rates and equity market returns impact consumer demand for the savings and investment products we distribute. These conditions and factors also impact prospective recruits’ perceptions of the business opportunity that becoming a Primerica sales representative offers, which can drive or dampen recruiting. The effects of these trends and conditions are discussed in the Results of Operations section below.
Recruiting and Sales Representatives. Our ability to increase the size of our sales force is largely based on the success of our recruiting efforts, our ability to train and motivate recruits to get licensed to sell life insurance, and retention of licensed sales representatives. We believe that recruitment and licensing levels are important to sales force trends and growth in recruiting and licensing is usually indicative of future growth in the overall size of the sales force. Recruiting results do not always result in commensurate changes in the size of our licensed sales force because new recruits may obtain the requisite licenses at rates above or below historical levels.
New recruits increased in 2014 to 190,439 from 186,251 in 2013. The size of our life-licensed sales force increased to 98,358 sales representatives at December 31, 2014 from 95,566 sales representatives at December 31, 2013, primarily due to a lower rate of non-renewals and terminations in relation to the size of our sales force in 2014.
Regulatory changes can also impact the size of our independent sales force. The insurance regulators in the Canadian provinces and territories entered into a Memorandum of Understanding and related agreements to implement a new life insurance licensing examination program across Canada in early 2016. If this new licensing program is implemented under the terms set forth in the agreements, we believe it would significantly decrease the ability of applicants to obtain their life insurance licenses in Canada. At this time, we cannot quantify the impact of the new licensing program might have on our Canadian sales force. However, we believe the program could result in a significant decline in the number of our new life-licensed representatives in Canada and ultimately the size of our life-licensed sales force. This could lower new life insurance sales and, over time, lower the size of our life insurance in force and materially adversely affect our Canadian Term Life insurance business. For more information, see “Part I — Item 3. Legal Proceedings.” included elsewhere within this report.
Term Life Insurance Product Sales and Face Amount In Force. We issued 220,984 new life insurance policies in 2014 compared with 214,617 new policies in 2013. Issued term life insurance policies grew during 2014 consistent with the size of our life-licensed sales force.
37
The average number of life-licensed sales representatives and the number of term life insurance policies issued, as well as the average monthly rate of new policies issued per life-licensed sales representative (historically between 0.18x and 0.22x), were as follows:
|
|
Year ended December 31, |
|
|||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|||
Average number of life-licensed sales representatives |
|
|
96,780 |
|
|
|
93,086 |
|
|
|
90,981 |
|
Number of new policies issued |
|
|
220,984 |
|
|
|
214,617 |
|
|
|
222,558 |
|
Average monthly rate of new policies issued per life- licensed sales representative |
|
0.19x |
|
|
0.19x |
|
|
0.20x |
|
During 2014, the average monthly rate of new policies issued per life-licensed sales representative remained relatively consistent with the prior year and historical experience.
Our average issued face amount of approximately $244,600 in 2014 was relatively consistent compared with approximately $246,800 in 2013.
Investment and Savings Product Sales and Asset Values. Investment and savings products sales were higher in 2014, totaling approximately $5.7 billion compared with approximately $5.2 billion in 2013. New product introductions and the impact of favorable market performance were the main contributors to the strong product sales in 2014.
The assets in our clients’ accounts are invested in diversified funds comprised mainly of U.S. and Canadian equity and fixed-income securities. The average value of assets in client accounts increased to approximately $46.9 billion in 2014 from approximately $41.0 billion in 2013, while the period-end asset value increased to approximately $48.7 billion at December 31, 2014 compared with approximately $45.0 billion a year ago. The increases both in period-end asset values and average client asset values during 2014 were attributable to higher product sales and positive returns on client assets.
Factors Affecting Our Results
Term Life Insurance Segment. Our Term Life Insurance segment results are primarily driven by sales volumes and retention of those issued policies, the accuracy of our pricing assumptions, terms and use of reinsurance, investment income and expenses.
Sales and policies in force. Sales of term policies and the size and characteristics of our in-force book of policies are vital to our results over the long term. Premium revenue is recognized as it is earned over the term of the policy and eligible acquisition expenses are deferred and amortized ratably with the level premiums of the underlying policies. However, because we incur significant cash outflows at or about the time policies are issued, including the payment of sales commissions and underwriting costs, changes in life insurance sales volume will have a more immediate effect on our cash flows.
Historically, we have found that while sales volume of term life insurance products between fiscal periods may vary based on a variety of factors, the productivity of our individual sales representatives remains within a relatively narrow range (i.e., an average monthly rate of new policies issued per life-licensed sales representative between 0.18x and 0.22x), and, consequently, our sales volume over the longer term generally correlates to the size of our sales force.
Pricing assumptions. Our pricing methodology is intended to provide us with appropriate profit margins for the risks we assume. We determine pricing classifications based on the coverage sought, such as the size and term of the policy, and certain policyholder attributes, such as age and health. In addition, we generally utilize unisex rates for our term life insurance policies. The pricing assumptions that underlie our rates are based upon our best estimates of mortality, persistency and interest rates at the time of issuance, sales force commission rates, issue and underwriting expenses, operating expenses and the characteristics of the insureds, including sex, age, underwriting class, product and amount of coverage. Our results will be affected to the extent there is a variance between our pricing assumptions and actual experience.
· |
Persistency. Persistency is a measure of how long our insurance policies stay in force. As a general matter, persistency that is lower than our pricing assumptions adversely affects our results over the long term because we lose the recurring revenue stream associated with the policies that lapse. Determining the near-term effects of changes in persistency is more complicated. When actual persistency is lower than our pricing assumptions, we must accelerate the amortization of deferred policy acquisition costs (“DAC”). The resultant increase in amortization expense is offset by a corresponding release of reserves associated with lapsed policies, which causes a reduction in benefits and claims expense. The future policy benefit reserves associated with any given policy will change over the term of such policy. As a general matter, future policy benefit reserves are lowest at the inception of a policy term and rise steadily to a peak before declining to zero at the expiration of the policy term. Accordingly, depending on when the lapse occurs in relation to the overall policy term, the reduction in benefits and claims expense may be greater or less than the increase in amortization expense, and, consequently, the effects on earnings for a given period could be positive or negative. Persistency levels will impact results to the extent actual experience deviates from the persistency assumptions used to price our products. |
· |
Mortality. Our profitability will fluctuate to the extent actual mortality rates differ from those used in our pricing assumptions. We mitigate a significant portion of our mortality exposure through reinsurance. |
· |
Interest Rates. We assume interest rates based on forecasted interest rates at the time a policy is issued. For policies issued in 2010 and after, we have been using an increasing interest rate assumption to reflect the historically low interest rate |
38
environment. Both DAC and the future policy benefit reserve liability increase with the assumed interest rate. Since DAC is higher than the future policy benefit reserve liability in the early years of a policy, a lower assumed interest rate generally will result in lower profits. In the later years, when the future policy benefit reserve liability is higher than DAC, a lower assumed interest rate generally will result in higher profits. These assumed interest rates, which like other pricing assumptions are locked in at issue, impact the timing but not the aggregate amount of DAC and future policy benefit reserve changes. Actual interest rates will impact net investment income allocated to the Term Life Insurance segment, but will not impact DAC or the future policy benefit reserve liability. |
Reinsurance. We use reinsurance extensively, which has a significant effect on our results of operations. Since the mid-1990s, we have reinsured between 60% and 90% of the mortality risk on our U.S. term life insurance policies on a quota share yearly renewable term (“YRT”) basis. In Canada, we previously utilized reinsurance arrangements similar to the U.S. in certain years and reinsured only face amounts above $500,000 in other years. However, in the first quarter of 2012, we entered into a YRT reinsurance arrangement in Canada similar to our U.S. program that reinsures 80% of the face amount for every policy sold. YRT reinsurance permits us to set future mortality at contractual rates by policy class. To the extent actual mortality experience is more or less favorable than the contractual rate, the reinsurer will earn incremental profits or bear the incremental cost, as applicable. In contrast to coinsurance, which is intended to eliminate all risks (other than counterparty risk of the reinsurer) and rewards associated with a specified percentage of the block of policies subject to the reinsurance arrangement, the YRT reinsurance arrangements we enter into are intended only to reduce volatility associated with variances between estimated and actual mortality rates.
In 2010, as part of our corporate reorganization, we entered into significant coinsurance transactions (the “coinsurance transactions”) with three affiliates (collectively, the “Citigroup reinsurers”) of Citigroup Inc. (“Citigroup”) and ceded between 80% and 90% of the risks and rewards of our term life insurance policies that were in force at year-end 2009. We continue to administer all policies subject to these coinsurance agreements. With each successive period, we expect revenue and earnings growth to continue to decelerate as the size of our in-force book grows and incremental sales have a reduced marginal effect on the size of the then-existing in force book.
The effect of our reinsurance arrangements on ceded premiums and benefits and expenses on our statement of income follows:
· |
Ceded premiums. Ceded premiums are the premiums we pay to reinsurers. These amounts are deducted from the direct premiums we earn to calculate our net premium revenues. Similar to direct premium revenues, ceded coinsurance premiums remain level over the initial term of the insurance policy. Ceded YRT premiums increase over the period that the policy has been in force. Accordingly, ceded YRT premiums generally constitute an increasing percentage of direct premiums over the policy term. |
· |
Benefits and claims. Benefits and claims include incurred claim amounts and changes in future policy benefit reserves. Reinsurance reduces incurred claims in direct proportion to the percentage ceded. Coinsurance also reduces the change in future policy benefit reserves in direct proportion to the percentage ceded, while YRT reinsurance does not significantly impact the change in these reserves. |
· |
Amortization of DAC. DAC, and therefore amortization of DAC, is reduced on a pro-rata basis for the coinsured business, including the business reinsured with Citigroup. There is no impact on amortization of DAC associated with our YRT contracts. |
· |
Insurance expenses. Insurance expenses are reduced by the allowances received from coinsurance, including the business reinsured with Citigroup. There is no impact on insurance expenses associated with our YRT contracts. |
We may alter our reinsurance practices at any time due to the unavailability of YRT reinsurance at attractive rates or the availability of alternatives to reduce our risk exposure. We presently intend to continue ceding approximately 90% of our U.S. mortality risk on new business and approximately 80% of our Canadian mortality risk on new business.
Net investment income. Net investment income is allocated to the Term Life Insurance segment based on the book value of the invested assets necessary to meet statutory reserve requirements and our targeted capital objectives. Net investment income is impacted by the performance of our invested asset portfolio, which can be affected by interest rates, credit spreads and the mix of invested assets.
Expenses. Results are also affected by variances in client acquisition, maintenance and administration expense levels.
Investment and Savings Products Segment. Our Investment and Savings Products segment results are primarily driven by sales, the value of assets in client accounts for which we earn ongoing management, investor service and distribution fees and the number of fee generating accounts we administer.
Sales. We earn commissions and fees, such as dealer re-allowances, and marketing and support fees, based on sales of mutual fund products and annuities. Sales of investment and savings products are influenced by the overall demand for investment products in the United States and Canada, as well as by the size and productivity of our sales force. We generally experience seasonality in our Investment and Savings Products segment results due to our high concentration of sales of retirement account products. These accounts are typically funded in February through April, coincident with our clients’ tax return preparation season. While we believe the size of our sales force is a factor in driving sales volume in this segment, there are a number of other variables, such as economic and market conditions, which may have a significantly greater effect on sales volume in any given fiscal period.
39
Asset values in client accounts. We earn marketing and distribution fees (trail commissions or, with respect to U.S. mutual funds, 12b-1 fees) on mutual fund and annuity assets in the United States and Canada. In the United States, we also earn investment advisory fees on assets in the managed investments program. In Canada, we earn management fees on certain mutual fund assets and on the segregated funds for which we serve as investment manager. Asset values are influenced by new product sales, ongoing contributions to existing accounts, redemptions and the change in market values in existing accounts. While we offer a wide variety of asset classes and investment styles, our clients’ accounts are primarily invested in equity funds.
Accounts. We earn recordkeeping fees for administrative functions we perform on behalf of several of our retail and managed mutual fund providers and custodial fees for services as a non-bank custodian for certain of our clients’ retirement plan accounts.
Sales mix. While our investment and savings products all provide similar long-term economic returns to the Company, our results in a given fiscal period will be affected by changes in the overall mix of products within these categories. Examples of changes in the sales mix that influence our results include the following:
· |
sales of annuity products in the United States will generate higher revenues in the period such sales occur than sales of other investment products that either generate lower upfront revenues or, in the case of managed investments and segregated funds, no upfront revenues; |
· |
sales of a higher proportion of managed investments and segregated funds products will generally extend the time over which revenues can be earned because we are entitled to higher revenues based on assets under management for these accounts in lieu of upfront revenues; and |
· |
sales of a higher proportion of mutual fund products and the composition of the fund families sold will impact the timing and amount of revenue we earn given the marketing, support, recordkeeping and custodial services we perform for the various mutual fund products we distribute. |
Corporate and Other Distributed Products Segment. We earn revenues and pay commissions and referral fees for various other insurance products, prepaid legal services and other financial products, all of which are originated by third parties. NBLIC also has in-force policies from several discontinued lines of insurance. During the first quarter of 2014, NBLIC sold its short-term statutory disability benefit insurance business (“DBL”) to AmTrust North America, Inc., and the operating results have been reported as discontinued operations for all periods presented. During the second quarter of 2014, NBLIC ceased the marketing and underwriting of new student life insurance policies but will continue to administer the existing block of student life business. Corporate and Other Distributed Products segment net investment income is composed of two elements: the remainder of net investment income not allocated to our Term Life Insurance segment and the market return associated with the deposit asset underlying a 10% coinsurance agreement with the Citigroup reinsurers (“10% Coinsurance Agreement”).
The Corporate and Other Distributed Products segment is affected by corporate income and expenses not allocated to our other segments, net investment income (other than net investment income allocated to our Term Life Insurance segment), general and administrative expenses (other than expenses that are allocated to our Term Life Insurance or Investment and Savings Products segments), equity awards granted to management and our sales force leaders at the time of our April 2010 initial public offering (“IPO”), interest expense on notes payable and realized gains and losses on our invested asset portfolio.
Capital Structure. Our financial results have also been affected by changes in our capital structure, including the issuance of our senior unsecured notes, as well as repurchases of shares and warrants of our common stock.
See Note 10 (Debt), Note 12 (Stockholders’ Equity) and Note 16 (Commitments and Contingent Liabilities) to our consolidated financial statements included elsewhere in this report for more information on changes in our capital structure.
Foreign Currency. The Canadian dollar is the functional currency for our Canadian subsidiaries and our financial results, reported in U.S. dollars, are affected by changes in the currency exchange rate. As such, the translated amount of revenues, expenses, assets and liabilities attributable to our Canadian subsidiaries will be higher or lower in periods where the Canadian dollar appreciates or weakens relative to the U.S. dollar. See “Results of Operations” and “Financial Condition” and “Quantitative and Qualitative Disclosures About Market Risk – Canadian Currency Risk” and Note 3 (Segment and Geographical Information) to our consolidated financial statements included elsewhere in this report for more information on our Canadian subsidiaries and the impact of foreign currency on our financial results.
Critical Accounting Estimates
We prepare our financial statements in accordance with U.S generally accepted accounting principles (“U.S. GAAP”). These principles are established primarily by the Financial Accounting Standards Board (“FASB”). The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions based on currently available information when recording transactions resulting from business operations. Our significant accounting policies are described in Note 1 (Description of Business, Basis of Presentation, and Summary of Significant Accounting Policies) to our consolidated financial statements included elsewhere in this report. The most significant items on our consolidated balance sheets are based on fair value determinations, accounting estimates and actuarial determinations, which are susceptible to changes in future periods and could affect our results of operations and financial position.
40
The estimates that we deem to be most critical to an understanding of our results of operations and financial position are those related to DAC, future policy benefit reserves and corresponding amounts due from reinsurers, income taxes, the valuation of investments, and litigation. The preparation and evaluation of these critical accounting estimates involve the use of various assumptions developed from management’s analyses and judgments. Subsequent experience or use of other assumptions could produce significantly different results.
Deferred Policy Acquisition Costs. We defer incremental direct costs of successful contract acquisitions that result directly from and are essential to the contract transaction(s) and that would not have been incurred had the contract transaction(s) not occurred. These costs include commissions and policy issue expenses. Deferrable term life insurance policy acquisition costs are amortized over the initial premium-paying period of the related policies in proportion to premium income and include assumptions made by us regarding persistency, expenses, interest rates and claims, which are updated on new business to reflect recent experience. These assumptions may not be modified, or unlocked on in-force term life insurance business, unless recoverability testing deems estimated future cash flows to be inadequate. DAC is subject to recoverability testing annually and when circumstances indicate that recoverability is uncertain.
If actual lapses or withdrawals are different from pricing assumptions for a particular period, DAC amortization for that period will be affected. If the rate of policies that lapse are 1% higher than the rate of policies that we expected to lapse in our original pricing assumptions, approximately 1% more of the existing DAC balance will be amortized, which would have been equal to approximately $12.6 million as of December 31, 2014 (assuming such lapses were distributed proportionately among policies of all durations). We believe that a lapse rate in the number of policies that is 1% higher than the rate assumed in our pricing assumptions is a reasonably possible variation. Higher lapses in the early durations would have a greater effect on DAC amortization since the DAC balances are higher at the earlier durations. Due to the inherent uncertainties in making assumptions about future events, materially different experience from expected results in persistency could result in a material increase or decrease of DAC amortization in a particular period.
Deferrable acquisition costs for Canadian segregated funds are amortized over the life of the policies in relation to historical and future estimated gross profits before amortization. The gross profits and resulting DAC amortization will vary with actual and anticipated fund returns, redemptions, commissions and expenses. DAC from our Canadian segregated funds reflects approximately 4% of our total DAC, and DAC amortization on these segregated funds reflects approximately 6% of our total DAC amortization for the year ended December 31, 2014.
For additional information on DAC, see Note 1 (Description of Business, Basis of Presentation, and Summary of Significant Accounting Policies) and Note 7 (Deferred Policy Acquisition Costs) to our consolidated financial statements.
Future Policy Benefit Reserves and Reinsurance. Liabilities for future policy benefits on our term life insurance products have been computed using a net level method and include assumptions as to mortality, persistency, interest rates, and other assumptions based on our historical experience, modified as necessary for new business to reflect anticipated trends and to include provisions for possible adverse deviation. Reserves related to reinsured policies are accounted for using assumptions consistent with those used to determine the future policy benefit reserves and are included in Due from reinsurers in our consolidated balance sheets. Similar to the term life insurance DAC discussion above, we do not modify the assumptions used to establish future policy benefit reserves during the policy term unless recoverability testing deems them to be inadequate and there is no remaining DAC associated with the underlying policies. Our results depend significantly upon the extent to which our actual experience is consistent with the assumptions we used in determining our future policy benefit reserves. Our future policy benefit reserve assumptions and estimates require significant judgment and, therefore, are inherently uncertain.
If the rate of policies that lapse are 1% higher than the rate of policies that we expected to lapse in our pricing assumptions, approximately 1% more of the future policy benefit reserves will be released, which would have been equal to approximately $50.5 million (assuming such lapses were distributed proportionately among policies of all durations), partially offset by the release of the corresponding due from reinsurers asset of approximately $38.4 million as of December 31, 2014, which decreases over time with the run-off of policies subject to the Citigroup coinsurance transactions. Higher lapses in later durations would have a greater effect on the release of future policy benefit reserves since the future policy benefit reserves are higher at the later durations.
We cannot determine with precision the ultimate amounts that we will pay for actual claims or the timing of those payments.
For additional information on future policy benefits and reinsurance, see Note 1 (Description of Business, Basis of Presentation, and Summary of Significant Accounting Policies) and Note 6 (Reinsurance) to our consolidated financial statements included elsewhere in this report.
Income Taxes. We account for income taxes using the asset and liability method. We recognize deferred tax assets and liabilities for the future tax consequences attributable to (i) temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and (ii) operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. We recognize the effect on deferred tax assets and liabilities of a change in tax rates in income in the period that includes the enactment date. Deferred tax assets are recognized subject to management’s judgment that realization is more likely than not applicable to the periods in which we expect the temporary difference will reverse.
41
In light of the multiple tax jurisdictions in which we operate, our tax returns are subject to routine audit by the Internal Revenue Service (“IRS”) and other taxation authorities. These audits at times may produce alternative views regarding particular tax positions taken in the year(s) of review. As a result, the Company records uncertain tax positions, which requires recognition at the time when it is more likely than not that the position in question will be upheld. Although management believes that the judgment and estimates involved are reasonable and that the necessary provisions have been recorded, changes in circumstances or unexpected events could adversely affect our financial position, results of operations, and cash flows.
For additional information on income taxes, see Note 1 (Description of Business, Basis of Presentation, and Summary of Significant Accounting Policies) and Note 11 (Income Taxes) to our consolidated financial statements included elsewhere in this report.
Invested Assets. We hold primarily fixed-maturity securities, including bonds and redeemable preferred stocks, and equity securities, including common and non-redeemable preferred stock. We have classified these invested assets as available-for-sale or held-to-maturity, except for the securities of our U.S. broker-dealer subsidiary, which we have classified as trading securities. All of these securities are carried at fair value, except for the held-to-maturity security, which is carried at cost. Unrealized gains and losses on available-for-sale securities are included as a separate component of accumulated other comprehensive income except for the credit loss components of other-than-temporary declines in fair value, which are recorded as realized losses in the accompanying consolidated statements of income. Changes in fair value of trading securities are included in net investment income in the period in which the change occurred.
Fair value. Fair value is the price that would be received upon the sale of an asset in an orderly transaction between market participants at the measurement date. Fair value measurements are based upon observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our view of market assumptions in the absence of observable market information. We classify and disclose all invested assets carried at fair value in one of the three categories prescribed by U.S. GAAP.
As of each reporting period, we classify all invested assets in their entirety based on the lowest level of input that is significant to the fair value measurement. Significant levels of estimation and judgment are required to determine the fair value of certain of our investments. The factors influencing these estimations and judgments are subject to change in subsequent reporting periods.
Other-than-temporary impairments. The determination of whether a decline in fair value of available-for-sale securities below amortized cost is other-than-temporary is subjective. Furthermore, this determination can involve a variety of assumptions and estimates, particularly for invested assets that are not actively traded in established markets. We evaluate a number of quantitative and qualitative factors when determining the impairment status of individual securities, including issuer-specific risks as well as relevant macroeconomic risks.
For available-for-sale securities in an unrealized loss position that we intend to sell or would more-likely-than-not be required to sell before the expected recovery of the amortized cost basis, we recognize an impairment charge for the difference between amortized cost and fair value as a realized investment loss in our statements of income. For available-for-sale securities in an unrealized loss position for which we have no intent to sell and believe that it is more-likely-than-not that we will not be required to sell before the expected recovery of the amortized cost basis, only the amount related to the principal cash flows not expected to be received over the remaining term of the security, or the credit loss component, of the difference between cost and fair value is recognized in earnings, while the remainder is recognized in accumulated other comprehensive income.
Other-than-temporary impairment analyses that we perform involve the use of estimates, assumptions, and subjectivity. If these factors or future events change, we could experience material other-than-temporary impairments in future periods, which could adversely affect our financial condition, results of operations and the size and quality of our invested assets portfolio.
For additional information on our invested assets, see Note 1 (Description of Business, Basis of Presentation, and Summary of Significant Accounting Policies), Note 4 (Investments) and Note 5 (Fair Value of Financial Instruments) to our consolidated financial statements included elsewhere in this report.
Litigation. The Company is involved from time to time in legal disputes, regulatory inquiries and arbitration proceedings in the normal course of business. These disputes are subject to uncertainties, including indeterminate amounts sought in certain of these matters and the inherent unpredictability of litigation. We recognize losses for legal contingencies when payments associated with the contingency become probable and can be reasonably estimated. Due to the difficulty of estimating litigation outcomes, actual costs may be substantially higher or lower than any amounts reserved. Legal costs, such as attorney’s fees and other litigation-related expenses that are incurred in connection with litigation, are expensed as incurred.
For additional information on legal issues and contingencies, see Note 16 (Commitments and Contingent Liabilities) to our consolidated financial statements included elsewhere in this report.
42
Results of Operations
Revenues. Our revenues consist of the following:
· |
Net premiums. Reflects direct premiums payable by our policyholders on our in-force insurance policies, primarily term life insurance, net of reinsurance premiums that we pay to reinsurers. |
· |
Commissions and fees. Consists primarily of dealer re-allowances earned on the sales of investment and savings products, trail commissions and management fees based on the asset values of client accounts, marketing and support fees from product originators, custodial fees for services rendered in our capacity as nominee on client retirement accounts funded by mutual funds on our servicing platform, recordkeeping fees for mutual funds on our servicing platform and fees associated with the sale of other distributed products. |
· |
Net investment income. Represents income, net of investment-related expenses, generated by our invested asset portfolio, which consists primarily of interest income earned on fixed-maturity investments. Investment income earned on assets supporting our statutory reserves and targeted capital is allocated to our Term Life Insurance segment, with the balance included in our Corporate and Other Distributed Products segment. Investment income recorded on our held-to-maturity invested asset and the offsetting interest expense recorded for our surplus note are included in net investment income. |
· |
Realized investment gains (losses), including other-than-temporary impairments (“OTTI”). Reflects the difference between amortized cost and amounts realized on the sale of invested assets, as well as OTTI charges. |
· |
Other, net. Reflects revenues generated primarily from the fees charged for access to our sales force support applications, as well as revenues from the sale of marketing materials and other miscellaneous items. |
Benefits and Expenses. Our operating expenses consist of the following:
· |
Benefits and claims. Reflects the benefits and claims payable on insurance policies, as well as changes in our reserves for future policy claims and reserves for other benefits payable, net of reinsurance. |
· |
Amortization of DAC. Represents the amortization of capitalized costs associated with the sale of an insurance policy or segregated fund, including sales commissions, medical examination and other underwriting costs, and other eligible policy issuance costs. |
· |
Insurance commissions. Reflects sales commissions in respect of insurance products that are not eligible for deferral. |
· |
Insurance expenses. Reflects non-capitalized insurance expenses, including staff compensation, technology and communications, insurance sales force-related costs, printing, postage and distribution of insurance sales materials, outsourcing and professional fees, premium taxes, amortization of our definite-lived intangible asset and other corporate and administrative fees and expenses related to our insurance operations. Insurance expenses also include both indirect policy issuance costs and costs associated with unsuccessful efforts to acquire new policies. |
· |
Sales commissions. Represents commissions to our sales representatives in connection with the sale of investment and savings products and products other than insurance products. |
· |
Interest expense. Reflects interest on our notes payable, the financing charges related to an issued letter of credit, fees paid for the credit enhancement feature on our held-to-maturity invested asset, and a finance charge incurred pursuant to one of our coinsurance agreements with Citigroup. |
· |
Other operating expenses. Consists primarily of expenses that are unrelated to the distribution of insurance products, including staff compensation, technology and communications, various sales force-related costs, printing, postage and distribution of sales materials, outsourcing and professional fees, amortization of our definite-lived intangible asset and other corporate and administrative fees and expenses. |
Insurance expenses and other operating expenses directly attributable to the Term Life Insurance and the Investment and Savings Products segments are recorded directly to the applicable segment. We allocate certain other operating expenses that are not directly attributable to a specific operating segment based on the relative sizes of our life-licensed and securities-licensed independent sales forces. These allocated costs include field technology, supervision, training and certain other costs. We also allocate certain technology and occupancy costs to our operating segments based on usage. Costs that are not directly charged or allocated to our two primary operating segments are included in our Corporate and Other Distributed Products segment.
43
Primerica, Inc. and Subsidiaries Results. Our results of operations for the years ended December 31, 2014, 2013, and 2012 were as follows:
|
|
Year ended December 31, |
|
|
2014 vs. 2013 change |
|
|
2013 vs. 2012 change |
|
|||||||||||||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|
$ |
|
|
% |
|
|
$ |
|
|
% |
|
|||||||
|
|
(Dollars in thousands) |
|
|||||||||||||||||||||||||
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct premiums |
|
$ |
2,301,332 |
|
|
$ |
2,265,191 |
|
|
$ |
2,231,032 |
|
|
$ |
36,141 |
|
|
|
2 |
% |
|
$ |
34,159 |
|
|
|
2 |
% |
Ceded premiums |
|
|
(1,616,817 |
) |
|
|
(1,644,158 |
) |
|
|
(1,663,753 |
) |
|
|
(27,341 |
) |
|
|
(2 |
)% |
|
|
(19,595 |
) |
|
|
(1 |
)% |
Net premiums |
|
|
684,515 |
|
|
|
621,033 |
|
|
|
567,279 |
|
|
|
63,482 |
|
|
|
10 |
% |
|
|
53,754 |
|
|
|
9 |
% |
Commissions and fees |
|
|
527,166 |
|
|
|
471,808 |
|
|
|
429,044 |
|
|
|
55,358 |
|
|
|
12 |
% |
|
|
42,764 |
|
|
|
10 |
% |
Net investment income |
|
|
86,473 |
|
|
|
88,752 |
|
|
|
100,804 |
|
|
|
(2,279 |
) |
|
|
(3 |
)% |
|
|
(12,052 |
) |
|
|
(12 |
)% |
Realized investment gains (losses), including other-than-temporary impairment losses |
|
|
(261 |
) |
|
|
6,246 |
|
|
|
11,382 |
|
|
|
(6,507 |
) |
|
* |
|
|
|
(5,136 |
) |
|
|
(45 |
)% |
|
Other, net |
|
|
42,137 |
|
|
|
42,731 |
|
|
|
45,263 |
|
|
|
(594 |
) |
|
|
(1 |
)% |
|
|
(2,532 |
) |
|
|
(6 |
)% |
Total revenues |
|
|
1,340,030 |
|
|
|
1,230,570 |
|
|
|
1,153,772 |
|
|
|
109,460 |
|
|
|
9 |
% |
|
|
76,798 |
|
|
|
7 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits and expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits and claims |
|
|
311,417 |
|
|
|
279,931 |
|
|
|
254,048 |
|
|
|
31,486 |
|
|
|
11 |
% |
|
|
25,883 |
|
|
|
10 |
% |
Amortization of deferred policy acquisition costs |
|
|
144,378 |
|
|
|
129,183 |
|
|
|
118,598 |
|
|
|
15,195 |
|
|
|
12 |
% |
|
|
10,585 |
|
|
|
9 |
% |
Sales commissions |
|
|
268,775 |
|
|
|
232,237 |
|
|
|
204,569 |
|
|
|
36,538 |
|
|
|
16 |
% |
|
|
27,668 |
|
|
|
14 |
% |
Insurance expenses |
|
|
115,452 |
|
|
|
105,457 |
|
|
|
90,894 |
|
|
|
9,995 |
|
|
|
9 |
% |
|
|
14,563 |
|
|
|
16 |
% |
Insurance commissions |
|
|
15,353 |
|
|
|
16,530 |
|
|
|
21,724 |
|
|
|
(1,177 |
) |
|
|
(7 |
)% |
|
|
(5,194 |
) |
|
|
(24 |
)% |
Interest expense |
|
|
34,570 |
|
|
|
35,018 |
|
|
|
33,101 |
|
|
|
(448 |
) |
|
|
(1 |
)% |
|
|
1,917 |
|
|
|
6 |
% |
Other operating expenses |
|
|
174,363 |
|
|
|
187,208 |
|
|
|
164,716 |
|
|
|
(12,845 |
) |
|
|
(7 |
)% |
|
|
22,492 |
|
|
|
14 |
% |
Total benefits and expenses |
|
|
1,064,308 |
|
|
|
985,564 |
|
|
|
887,650 |
|
|
|
78,744 |
|
|
|
8 |
% |
|
|
97,914 |
|
|
|
11 |
% |
Income from continuing operations before income taxes |
|
|
275,722 |
|
|
|
245,006 |
|
|
|
266,122 |
|
|
|
30,716 |
|
|
|
13 |
% |
|
|
(21,116 |
) |
|
|
(8 |
)% |
Income taxes on continuing operations |
|
|
95,888 |
|
|
|
86,305 |
|
|
|
92,813 |
|
|
|
9,583 |
|
|
|
11 |
% |
|
|
(6,508 |
) |
|
|
(7 |
)% |
Income from continuing operations |
|
|
179,834 |
|
|
|
158,701 |
|
|
|
173,309 |
|
|
|
21,133 |
|
|
|
13 |
% |
|
|
(14,608 |
) |
|
|
(8 |
)% |
Income from discontinued operations, net of income taxes |
|
|
1,578 |
|
|
|
4,024 |
|
|
|
497 |
|
|
|
(2,446 |
) |
|
|
(61 |
)% |
|
|
3,527 |
|
|
* |
|
|
Net income |
|
$ |
181,412 |
|
|
$ |
162,725 |
|
|
$ |
173,806 |
|
|
$ |
18,687 |
|
|
|
11 |
% |
|
$ |
(11,081 |
) |
|
|
(6 |
)% |
* |
Less than 1% or not meaningful. |
Total revenues. Total revenues for 2014 increased from 2013 primarily due to incremental premiums on term life insurance policies not subject to the Citigroup coinsurance transactions, higher investment and savings products sales, and positive client asset performance. Partially offsetting the increase in revenues were lower net investment income and realized investment gains (losses) in 2014 versus 2013. In comparing the realized investment losses in 2014 to realized investment gains in 2013, the difference was mostly attributable to large gains on tendered securities and gains on certain sales of fixed maturity securities in 2013, as well as OTTI losses recognized on certain investments in 2014. The decrease in net investment income was primarily driven by lower average yield on invested assets, partially offset by a higher average base of invested assets and the positive change in market value of the deposit asset underlying our 10% Coinsurance Agreement.
During 2013, total revenues increased from 2012 largely due to similar factors including incremental premiums on term life insurance policies not subject to the Citigroup coinsurance transactions, higher sales of investment and savings products, and growth in client asset values. In addition, declines in net investment income and realized investment gains partially offset the increase in total revenues in 2013 from 2012 primarily due to a lower average yield on invested assets, a lower average base of invested assets, and lower realized gains from the sale of invested assets.
Total benefits and expenses. Total benefits and expenses increased in 2014 from 2013 primarily as a result of the growth in revenue-related costs, which include sales commissions, benefits and claims, DAC amortization, and certain insurance expenses. Total benefits and expenses also increased due to accelerated expense recognition from amendments to retirement provisions in our 2014 management equity award agreements and Co-CEO transition expenses that were recognized in 2014 due to the modification of their employment terms. Partially offsetting these increases were lower legal fees and expenses within other operating expenses attributable to our Investment and Savings Product segment. For more information refer to our segment results as further described below.
The increase in total benefits and expenses in 2013 from 2012 was also driven by growth in revenue-related costs including benefits and claims, DAC amortization, and certain insurance expenses from the continued growth in our Term Life business. Additionally, sales commissions on investment products were higher and consistent with the increase in commissions and fees revenue. In 2013, we experienced higher other operating expenses than in 2012 primarily attributable to higher legal fees and settlement costs in our Investment and Savings Product segment as further described below. These increased costs were partially offset by lower non-
44
deferrable insurance commissions for 2013 reflecting changes in agent incentive programs that led to higher commission deferrals as compared to 2012.
Income taxes. Our effective income tax rate was relatively consistent each period at 34.8%, 35.2%, and 34.9% in 2014, 2013, and 2012, respectively.
For additional information, see the discussions of results of operations by segment below.
Term Life Insurance Segment. Our results for the Term Life Insurance segment for the years ended December 31, 2014, 2013, and 2012 were as follows:
|
|
Year ended December 31, |
|
|
2014 vs. 2013 change |
|
|
2013 vs. 2012 change |
|
|||||||||||||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|
$ |
|
|
% |
|
|
$ |
|
|
% |
|
|||||||
|
|
(Dollars in thousands) |
|
|||||||||||||||||||||||||
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct premiums |
|
$ |
2,266,649 |
|
|
$ |
2,229,204 |
|
|
$ |
2,193,280 |
|
|
$ |
37,445 |
|
|
|
2 |
% |
|
$ |
35,924 |
|
|
|
2 |
% |
Ceded premiums |
|
|
(1,605,965 |
) |
|
|
(1,632,042 |
) |
|
|
(1,649,622 |
) |
|
|
(26,077 |
) |
|
|
(2 |
)% |
|
|
(17,580 |
) |
|
|
(1 |
)% |
Net Premiums |
|
|
660,684 |
|
|
|
597,162 |
|
|
|
543,658 |
|
|
|
63,522 |
|
|
|
11 |
% |
|
|
53,504 |
|
|
|
10 |
% |
Allocated net investment income |
|
|
69,772 |
|
|
|
68,796 |
|
|
|
66,119 |
|
|
|
976 |
|
|
|
1 |
% |
|
|
2,677 |
|
|
|
4 |
% |
Other, net |
|
|
28,838 |
|
|
|
29,017 |
|
|
|
30,357 |
|
|
|
(179 |
) |
|
|
(1 |
)% |
|
|
(1,340 |
) |
|
|
(4 |
)% |
Total revenues |
|
|
759,294 |
|
|
|
694,975 |
|
|
|
640,134 |
|
|
|
64,319 |
|
|
|
9 |
% |
|
|
54,841 |
|
|
|
9 |
% |
Benefits and expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits and claims |
|
|
295,332 |
|
|
|
262,357 |
|
|
|
239,346 |
|
|
|
32,975 |
|
|
|
13 |
% |
|
|
23,011 |
|
|
|
10 |
% |
Amortization of DAC |
|
|
133,331 |
|
|
|
115,891 |
|
|
|
104,272 |
|
|
|
17,440 |
|
|
|
15 |
% |
|
|
11,619 |
|
|
|
11 |
% |
Insurance expenses |
|
|
109,198 |
|
|
|
98,081 |
|
|
|
85,156 |
|
|
|
11,117 |
|
|
|
11 |
% |
|
|
12,925 |
|
|
|
15 |
% |
Insurance commissions |
|
|
4,004 |
|
|
|
4,599 |
|
|
|
9,599 |
|
|
|
(595 |
) |
|
|
(13 |
)% |
|
|
(5,000 |
) |
|
|
(52 |
)% |
Interest expense |
|
|
16,396 |
|
|
|
16,846 |
|
|
|
15,835 |
|
|
|
(450 |
) |
|
|
(3 |
)% |
|
|
1,011 |
|
|
|
6 |
% |
Total benefits and expenses |
|
|
558,261 |
|
|
|
497,774 |
|
|
|
454,208 |
|
|
|
60,487 |
|
|
|
12 |
% |
|
|
43,566 |
|
|
|
10 |
% |
Income from continuing operations before income taxes |
|
$ |
201,033 |
|
|
$ |
197,201 |
|
|
$ |
185,926 |
|
|
$ |
3,832 |
|
|
|
2 |
% |
|
$ |
11,275 |
|
|
|
6 |
% |
Net premiums. Direct premiums grew in 2014 compared to 2013 largely due to incremental premiums on term life insurance policies not subject to the Citigroup coinsurance transactions. Ceded premiums declined primarily due to the run-off of business subject to the Citigroup coinsurance transactions. The continued impact of growth in direct premiums not subject to the Citigroup coinsurance transactions and the run-off of business subject to the Citigroup coinsurance transactions resulted in net premiums growing faster than direct premiums.
The increase in direct and net premiums in 2013 from 2012 was also primarily attributable to the continued addition to in-force business of term life insurance policies not subject to the Citigroup coinsurance transactions combined with the run-off of business subject to the Citigroup coinsurance transactions. The increase in net premiums was partially offset by ceded premium recoveries of $6.4 million in 2012, which resulted in a similar reduction in benefits and claims that did not reoccur in 2013.
Allocated net investment income. Allocated net investment income in 2014 remained consistent with 2013, as the higher allocation related to the growth in invested assets that support our statutory capital and reserves (“required assets”) of $7.0 million was mostly offset by the impact of the lower yield on invested assets of $6.5 million.
The increase in allocated net investment income from 2012 to 2013 was largely attributable to the growth in required assets, partially offset by lower yield on invested assets.
Benefits and claims. Benefits and claims in 2014 compared to 2013 increased slightly more than the growth in net premiums mostly due to higher policy reserves from improved persistency.
In comparing 2013 to 2012, benefits and claims increased primarily due to the growth in net premiums. Partially offsetting this increase was the impact of approximately $6.0 million of ceded premium recoveries during 2012 that did not reoccur during 2013.
Amortization of DAC. The increase in amortization of DAC in 2014 versus 2013 was impacted by a higher portion of commissions deferred in recent periods, resulting in a rate of DAC amortization in excess of the growth in net premiums, partially offset by improved persistency in 2014.
The increase in amortization of DAC in 2013 compared to 2012 was consistent with the increase in net premiums as higher amortization from increases in deferrable agent incentive program costs were partially offset by better persistency.
Insurance expenses. The increase in insurance expenses in 2014 from 2013 was partially due to higher growth-related expenses and the run-off of expense allowances related to the Citigroup coinsurance transactions. Additionally, higher employee incentive compensation, including accelerated expense recognition of approximately $2.3 million for the segment from amendments to retirement provisions in our 2014 management equity award agreements, contributed to the increase in insurance expenses in 2014.
45
Insurance expenses in 2013 increased compared to 2012 mainly due to higher employee compensation costs, the run-off of expense allowances received under the Citigroup coinsurance transactions, higher costs in support of our independent sales force, and higher premium-related taxes, licenses and fees.
Insurance commissions. Insurance commissions in 2014 were relatively consistent compared to 2013.
The decrease in year-over-year insurance commissions from 2012 to 2013 was largely driven by a higher rate of commission deferrals consistent with agent incentive program changes.
Interest expense. Interest expense in 2014 was consistent with the amount incurred in 2013.
The increase in interest expense in 2013 from 2012 was attributable to financing charges on an issued letter of credit associated with our redundant reserve financing transaction that was executed in March 2012.
Product Sales and Face Amount In Force. The changes in the face amount of our in-force book of term life insurance policies were as follows:
|
|
Year ended December 31, |
|||||||||||||||||||||||||
|
|
2014 |
|
|
% of beginning balance |
|
2013 |
|
|
% of beginning balance |
|
2012 |
|
|
% of beginning balance |
||||||||||||
|
|
(Dollars in millions) |
|||||||||||||||||||||||||
Face amount in force, beginning of period |
|
$ |
674,868 |
|
|
|
|
|
|
|
$ |
670,412 |
|
|
|
|
|
|
|
$ |
664,955 |
|
|
|
|
|
|
Net change in face amount: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issued face amount |
|
|
69,574 |
|
|
|
10 |
% |
|
|
|
67,783 |
|
|
|
10 |
% |
|
|
|
68,053 |
|
|
|
10 |
% |
|
Terminations |
|
|
(54,962 |
) |
|
|
(8 |
)% |
|
|
|
(57,730 |
) |
|
|
(9 |
)% |
|
|
|
(61,593 |
) |
|
|
(9 |
)% |
|
Foreign currency |
|
|
(7,553 |
) |
|
|
(1 |
)% |
|
|
|
(5,597 |
) |
|
|
(1 |
)% |
|
|
|
(1,003 |
) |
|
* |
|
|
|
Net change in face amount |
|
|
7,059 |
|
|
|
1 |
% |
|
|
|
4,456 |
|
|
|
1 |
% |
|
|
|
5,457 |
|
|
|
1 |
% |
|
Face amount in force, end of period |
|
$ |
681,927 |
|
|
|
|
|
|
|
$ |
674,868 |
|
|
|
|
|
|
|
$ |
670,412 |
|
|
|
|
|
|
* |
Less than 1% or not meaningful. |
Face amount of term life insurance policies in force increased in 2014 from 2013 primarily due to a rise in issued face amount from the higher number of new policies issued in 2014. However, the strengthening of the U.S. dollar in relation to the Canadian dollar reduced the translated face amount of Canadian in-force policies in 2014 and partially offset the overall increase in issued face amount. As a percentage of beginning face amount in force, issued face amount remained flat in 2014, while terminations improved as a result of better persistency compared to 2013.
The total face amount of policies in force increased in 2013 from 2012 mostly reflecting lower terminations on existing policies as a result of slightly better persistency. Issued face amount during 2013 remained largely consistent from 2012 due to the offsetting impacts of the year-over-year decline in the number of policies issued and the larger average size of policies underwritten. In addition, the strengthening of the U.S. dollar in relation to the Canadian dollar also reduced the translated face amount of Canadian in-force policies from 2012 to 2013.
46
Investment and Savings Product Segment. Our results of operations for the Investment and Savings Products segment for the years ended December 31, 2014, 2013, and 2012 were as follows:
|
|
Year ended December 31, |
|
|
2014 vs. 2013 change |
|
|
2013 vs. 2012 change |
|
|||||||||||||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|
$ |
|
|
% |
|
|
$ |
|
|
% |
|
|||||||
|
|
(Dollars in thousands) |
|
|||||||||||||||||||||||||
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commissions and fees: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales-based revenues |
|
$ |
237,757 |
|
|
$ |
208,084 |
|
|
$ |
186,066 |
|
|
$ |
29,673 |
|
|
|
14 |
% |
|
$ |
22,018 |
|
|
|
12 |
% |
Asset-based revenues |
|
|
225,799 |
|
|
|
201,511 |
|
|
|
179,926 |
|
|
|
24,288 |
|
|
|
12 |
% |
|
|
21,585 |
|
|
|
12 |
% |
Account-based revenues |
|
|
40,477 |
|
|
|
38,868 |
|
|
|
38,510 |
|
|
|
1,609 |
|
|
|
4 |
% |
|
|
358 |
|
|
|
1 |
% |
Other, net |
|
|
8,040 |
|
|
|
8,675 |
|
|
|
9,463 |
|
|
|
(635 |
) |
|
|
(7 |
)% |
|
|
(788 |
) |
|
|
(8 |
)% |
Total revenues |
|
|
512,073 |
|
|
|
457,138 |
|
|
|
413,965 |
|
|
|
54,935 |
|
|
|
12 |
% |
|
|
43,173 |
|
|
|
10 |
% |
Expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of DAC |
|
|
8,734 |
|
|
|
11,195 |
|
|
|
10,956 |
|
|
|
(2,461 |
) |
|
|
(22 |
)% |
|
|
239 |
|
|
|
2 |
% |
Insurance commissions |
|
|
8,799 |
|
|
|
9,046 |
|
|
|
9,070 |
|
|
|
(247 |
) |
|
|
(3 |
)% |
|
|
(24 |
) |
|
* |
|
|
Sales commissions: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales-based |
|
|
168,207 |
|
|
|
146,531 |
|
|
|
129,796 |
|
|
|
21,676 |
|
|
|
15 |
% |
|
|
16,735 |
|
|
|
13 |
% |
Asset-based |
|
|
88,974 |
|
|
|
73,267 |
|
|
|
61,609 |
|
|
|
15,707 |
|
|
|
21 |
% |
|
|
11,658 |
|
|
|
19 |
% |
Other operating expenses |
|
|
91,342 |
|
|
|
111,950 |
|
|
|
81,418 |
|
|
|
(20,608 |
) |
|
|
(18 |
)% |
|
|
30,532 |
|
|
|
38 |
% |
Total expenses |
|
|
366,056 |
|
|
|
351,989 |
|
|
|
292,849 |
|
|
|
14,067 |
|
|
|
4 |
% |
|
|
59,140 |
|
|
|
20 |
% |
Income from continuing operations before income taxes |
|
$ |
146,017 |
|
|
$ |
105,149 |
|
|
$ |
121,116 |
|
|
$ |
40,868 |
|
|
|
39 |
% |
|
$ |
(15,967 |
) |
|
|
(13 |
)% |
* |
Less than 1% or not meaningful. |
Supplemental information on the underlying metrics that drove results follows.
|
|
Year ended December 31, |
|
|
2014 vs. 2013 change |
|
|
2013 vs. 2012 change |
|
|||||||||||||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|
$ |
|
|
% |
|
|
$ |
|
|
% |
|
|||||||
|
|
(Dollars in millions) |
|
|||||||||||||||||||||||||
Product sales: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retail mutual funds |
|
$ |
3,210 |
|
|
$ |
2,766 |
|
|
$ |
2,346 |
|
|
$ |
444 |
|
|
|
16 |
% |
|
$ |
420 |
|
|
|
18 |
% |
Annuities and other |
|
|
1,971 |
|
|
|
1,935 |
|
|
|
1,902 |
|
|
|
36 |
|
|
|
2 |
% |
|
|
33 |
|
|
|
2 |
% |
Total sales-based revenue generating product sales |
|
|
5,181 |
|
|
|
4,701 |
|
|
|
4,248 |
|
|
|
480 |
|
|
|
10 |
% |
|
|
453 |
|
|
|
11 |
% |
Managed investments |
|
|
258 |
|
|
|
225 |
|
|
|
136 |
|
|
|
33 |
|
|
|
15 |
% |
|
|
89 |
|
|
|
65 |
% |
Segregated funds and other |
|
|
243 |
|
|
|
283 |
|
|
|
328 |
|
|
|
(40 |
) |
|
|
(14 |
)% |
|
|
(45 |
) |
|
|
(14 |
)% |
Total product sales |
|
$ |
5,682 |
|
|
$ |
5,209 |
|
|
$ |
4,712 |
|
|
$ |
473 |
|
|
|
9 |
% |
|
$ |
497 |
|
|
|
11 |
% |
Average client asset values: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retail mutual funds |
|
$ |
29,939 |
|
|
$ |
26,453 |
|
|
$ |
23,842 |
|
|
$ |
3,486 |
|
|
|
13 |
% |
|
$ |
2,611 |
|
|
|
11 |
% |
Annuities and other |
|
|
13,268 |
|
|
|
11,175 |
|
|
|
9,149 |
|
|
|
2,093 |
|
|
|
19 |
% |
|
|
2,026 |
|
|
|
22 |
% |
Managed investments |
|
|
1,238 |
|
|
|
831 |
|
|
|
372 |
|
|
|
407 |
|
|
|
49 |
% |
|
|
459 |
|
|
* |
|
|
Segregated funds |
|
|
2,491 |
|
|
|
2,576 |
|
|
|
2,541 |
|
|
|
(85 |
) |
|
|
(3 |
)% |
|
|
35 |
|
|
|
1 |
% |
Total average client asset values |
|
$ |
46,936 |
|
|
$ |
41,035 |
|
|
$ |
35,904 |
|
|
$ |
5,901 |
|
|
|
14 |
% |
|
$ |
5,131 |
|
|
|
14 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Accounts in thousands) |
|
|||||||||||||||||||||||||
Average number of fee-generating accounts: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recordkeeping accounts |
|
|
2,622 |
|
|
|
2,540 |
|
|
|
2,567 |
|
|
|
82 |
|
|
|
3 |
% |
|
|
(27 |
) |
|
|
(1 |
)% |
Custodial accounts |
|
|
2,015 |
|
|
|
1,954 |
|
|
|
1,945 |
|
|
|
61 |
|
|
|
3 |
% |
|
|
9 |
|
|
* |
|
* |
Less than 1% or not meaningful. |
Commissions and fees. The largest contributing factor to the increase in commissions and fees in 2014 from 2013 was the growth in sales-based revenues from strong sales of mutual funds. The growth in sales-based revenues exceeded the increase in sales-based revenue generating product sales mainly due to the change in sales mix to product offerings with higher sales commission rates. Commissions and fees also increased due to higher asset-based revenues attributable to the rise in average client asset values, which was indicative of favorable market performance. Additionally, the higher number of client managed investments and retail mutual funds added during 2014 contributed to the growth in account-based revenues compared to 2013.
The increase in commissions and fees in 2013 compared to 2012 was also largely due to higher product sales and growth in average client asset values. The increase in product sales was also led by higher mutual fund sales in 2013 as compared with 2012. The rise in
47
average client asset values, which was indicative of favorable market performance from 2012 to 2013, also contributed to the increase in commissions and fees in the form of higher asset-based revenues.
Amortization of DAC. Amortization of DAC in 2014 compared to 2013 slowed due to favorable market performance experienced by assets held within segregated funds as well as the positive impact of revised assumptions for future redemptions used in the estimate of DAC amortization.
DAC amortization was relatively consistent in 2013 compared to 2012.
Sales commissions. In 2014, sales-based commissions grew from 2013 in line with the increase in sales-based revenues noted above. The increase in asset-based commissions in 2014 compared to 2013 was mostly consistent with the increase in asset-based revenues when including the relevant costs associated with asset-based revenue from segregated funds, which are recorded within insurance commissions and amortization of DAC. Additionally, changes in product mix contributed slightly to the increase in asset-based commissions in 2014 from 2013.
The increase in 2013 sales-based commissions compared to 2012 was also primarily the result of the increase in product sales noted above. The increase in asset-based commissions in 2013 from 2012 was consistent with the increase in asset-based revenues when excluding segregated funds.
Other operating expenses. Other operating expenses in 2014 decreased from 2013 due to lower legal fees and expenses attributable to defending claims alleged by certain participants in the Florida Retirement System’s benefit plan (“FRS”) and costs from the settlement of these FRS claims, which accounted for approximately $27.1 million of other operating costs in 2013. Higher employee compensation costs and other growth-related costs in 2014 partially offset the favorable impact of the lower FRS-related costs.
In 2013, other operating expenses increased from 2012 mainly due to higher legal fees and expenses associated with the FRS-related claims. Legal fees and expenses incurred in 2013 included approximately $11.4 million of expenses attributable to defending FRS claims, which was up from $2.9 million in 2012. Additionally, a charge of approximately $15.7 million associated with the settlement reached with the FRS claimants contributed to higher legal fees and expenses in 2013 compared to 2012. An increase in growth-related expenses, higher employee compensation costs, and higher costs in support of our independent sales force further contributed to the increase in other operating expenses in 2013 from 2012.
Product sales. Investment and savings products sales increased progressively from 2012 to 2014 as a result of the impact of new product introductions and favorable market performance during this period.
Asset Values in Client Accounts. Changes in asset values in client accounts were as follows:
|
|
Year ended December 31, |
|||||||||||||||||||||||||
|
|
2014 |
|
|
% of beginning balance |
|
2013 |
|
|
% of beginning balance |
|
2012 |
|
|
% of beginning balance |
||||||||||||
|
|
(Dollars in millions) |
|||||||||||||||||||||||||
Asset values, beginning of period |
|
$ |
44,990 |
|
|
|
|
|
|
|
$ |
37,386 |
|
|
|
|
|
|
|
$ |
33,664 |
|
|
|
|
|
|
Net change in asset values: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inflows |
|
|
5,682 |
|
|
|
13 |
% |
|
|
|
5,209 |
|
|
|
14 |
% |
|
|
|
4,712 |
|
|
|
14 |
% |
|
Redemptions |
|
|
(4,823 |
) |
|
|
(11 |
)% |
|
|
|
(4,733 |
) |
|
|
(13 |
)% |
|
|
|
(4,370 |
) |
|
|
(13 |
)% |
|
Change in market value, net |
|
|
3,555 |
|
|
|
8 |
% |
|
|
|
7,657 |
|
|
|
20 |
% |
|
|
|
3,206 |
|
|
|
10 |
% |
|
Foreign currency, net |
|
|
(748 |
) |
|
|
(2 |
)% |
|
|
|
(529 |
) |
|
|
(1 |
)% |
|
|
|
174 |
|
|
|
1 |
% |
|
Net change in asset values |
|
|
3,666 |
|
|
|
8 |
% |
|
|
|
7,604 |
|
|
|
20 |
% |
|
|
|
3,722 |
|
|
|
11 |
% |
|
Asset values, end of period |
|
$ |
48,656 |
|
|
|
|
|
|
|
$ |
44,990 |
|
|
|
|
|
|
|
$ |
37,386 |
|
|
|
|
|
|
The increase in client asset values in 2014 from 2013 was led by favorable market performance that continued in 2014 combined with the positive impact of sales volumes in excess of redemptions. This increase was partially offset by a reduction in the translated value of client assets in Canada due to the strengthening of the U.S. dollar relative to the Canadian dollar.
Client asset values also increased in 2013 from 2012 primarily due to strong market performance in 2013 along with product sales in excess of redemptions.
48
Corporate and Other Distributed Products Segment. Our results of operations for the Corporate and Other Distributed Products segment for the years ended December 31, 2014, 2013, and 2012 were as follows:
|
|
Year ended December 31, |
|
|
2014 vs. 2013 change |
|
|
2013 vs. 2012 change |
|
|||||||||||||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|
$ |
|
|
% |
|
|
$ |
|
|
% |
|
|||||||
|
|
(Dollars in thousands) |
|
|||||||||||||||||||||||||
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct premiums |
|
$ |
34,683 |
|
|
$ |
35,987 |
|
|
$ |
37,752 |
|
|
$ |
(1,304 |
) |
|
|
(4 |
)% |
|
$ |
(1,765 |
) |
|
|
(5 |
)% |
Ceded premiums |
|
|
(10,852 |
) |
|
|
(12,116 |
) |
|
|
(14,131 |
) |
|
|
(1,264 |
) |
|
|
(10 |
)% |
|
|
(2,015 |
) |
|
|
(14 |
)% |
Net Premiums |
|
|
23,831 |
|
|
|
23,871 |
|
|
|
23,621 |
|
|
|
(40 |
) |
|
* |
|
|
|
250 |
|
|
|
1 |
% |
|
Commissions and fees |
|
|
23,133 |
|
|
|
23,345 |
|
|
|
24,542 |
|
|
|
(212 |
) |
|
|
(1 |
)% |
|
|
(1,197 |
) |
|
|
(5 |
)% |
Allocated net investment income |
|
|
16,701 |
|
|
|
19,956 |
|
|
|
34,685 |
|
|
|
(3,255 |
) |
|
|
(16 |
)% |
|
|
(14,729 |
) |
|
|
(42 |
)% |
Realized investment gains (losses), including other-than-temporary impairment losses |
|
|
(261 |
) |
|
|
6,246 |
|
|
|
11,382 |
|
|
|
(6,507 |
) |
|
* |
|
|
|
(5,136 |
) |
|
|
(45 |
)% |
|
Other, net |
|
|
5,259 |
|
|
|
5,039 |
|
|
|
5,443 |
|
|
|
220 |
|
|
|
4 |
% |
|
|
(404 |
) |
|
|
(7 |
)% |
Total revenues |
|
|
68,663 |
|
|
|
78,457 |
|
|
|
99,673 |
|
|
|
(9,794 |
) |
|
|
(12 |
)% |
|
|
(21,216 |
) |
|
|
(21 |
)% |
Benefits and expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits and claims |
|
|
16,085 |
|
|
|
17,574 |
|
|
|
14,702 |
|
|
|
(1,489 |
) |
|
|
(8 |
)% |
|
|
2,872 |
|
|
|
20 |
% |
Amortization of DAC |
|
|
2,313 |
|
|
|
2,097 |
|
|
|
3,370 |
|
|
|
216 |
|
|
|
10 |
% |
|
|
(1,273 |
) |
|
|
(38 |
)% |
Insurance expenses |
|
|
6,254 |
|
|
|
7,376 |
|
|
|
5,738 |
|
|
|
(1,122 |
) |
|
|
(15 |
)% |
|
|
1,638 |
|
|
|
29 |
% |
Insurance commissions |
|
|
2,550 |
|
|
|
2,885 |
|
|
|
3,055 |
|
|
|
(335 |
) |
|
|
(12 |
)% |
|
|
(170 |
) |
|
|
(6 |
)% |
Sales commissions |
|
|
11,594 |
|
|
|
12,439 |
|
|
|
13,164 |
|
|
|
(845 |
) |
|
|
(7 |
)% |
|
|
(725 |
) |
|
|
(6 |
)% |
Interest expense |
|
|
18,174 |
|
|
|
18,172 |
|
|
|
17,266 |
|
|
|
2 |
|
|
* |
|
|
|
906 |
|
|
|
5 |
% |
|
Other operating expenses |
|
|
83,021 |
|
|
|
75,258 |
|
|
|
83,298 |
|
|
|
7,763 |
|
|
|
10 |
% |
|
|
(8,040 |
) |
|
|
(10 |
)% |
Total benefits and expenses |
|
|
139,991 |
|
|
|
135,801 |
|
|
|
140,593 |
|
|
|
4,190 |
|
|
|
3 |
% |
|
|
(4,792 |
) |
|
|
(3 |
)% |
Loss from continuing operations before income taxes |
|
$ |
(71,328 |
) |
|
$ |
(57,344 |
) |
|
$ |
(40,920 |
) |
|
$ |
13,984 |
|
|
|
24 |
% |
|
$ |
16,424 |
|
|
|
40 |
% |
* |
Less than 1% or not meaningful. |
Total revenues. Total revenues decreased in 2014 from 2013 mainly due to the impact of net realized investment losses in 2014 versus net realized investment gains in 2013. Realized investment gains decreased in 2014 due to the impact of income received in 2013 from the tender of certain fixed income securities. In addition, we recognized impairment losses in the fourth quarter of 2014 on certain invested assets held at the Parent Company that we intended to sell to fund share repurchases, as well as credit impairments on certain other investments. Also contributing to the decline in total revenues was lower allocated net investment income in 2014 versus 2013, which was attributable to lower assets allocated to the Corporate and Other Distributed Products segment and lower average yield on our total portfolio of invested assets, partially offset by the change in market value of the deposit asset underlying our 10% Coinsurance Agreement. Net premiums and commissions and fees in 2014 remained consistent with 2013.
Total revenues decreased in 2013 from 2012 also in large part due to declines in net investment income and realized investment gains. The decrease in net investment income was due to the higher allocation of assets and net investment income to the Term Life Insurance segment, a lower average base of our total portfolio of invested assets subsequent to repurchases of common stock and warrants, a lower return on the deposit asset underlying our 10% Coinsurance Agreement driven by the overall rise in interest rates, and lower yield on our total portfolio of invested assets as a result of replacing maturing investments with lower yielding securities. Realized investment gains decreased year-over-year largely due to higher income received from proceeds of invested assets sold to fund share repurchases during 2012 compared with 2013. Net premiums and commissions and fees were relatively similar in 2013 as compared to 2012.
Total Benefits and Expenses. The increase in total benefits and expenses in 2014 from 2013 was driven by higher other operating expenses mainly related to charges of approximately $4.2 million, reflecting Co-CEO transition expenses that were recognized in 2014 due to the modification of their employment terms, including ending their employment on April 1, 2015 instead of in August 2015. Other operating expenses also increased due to accelerated expense recognition from amendments to retirement provisions in our 2014 management equity award agreements, which, for the segment, were approximately $1.6 million.
In 2013, total benefits and expenses decreased from 2012 primarily due to lower other operating expenses which included a reduction in stock compensation costs related to the completion of the vesting of restricted stock granted in connection with our April 2010 initial public offering, partially offset by higher employee compensation costs from merit increases and one-time expenses related to the relocation of our corporate headquarters.
Financial Condition
Investments. Our insurance business is primarily focused on selling term life insurance, which does not include an investment component for the policyholder. The invested asset portfolio supporting our term life insurance business does not involve the substantial asset accumulations and spread requirements that exist with other non-term life insurance products. As a result, the
49
profitability of our term life insurance business is not as sensitive to the impact that interest rates have on our invested asset portfolio and investment income as the profitability of other companies that distribute non-term life insurance products.
We follow a conservative investment strategy designed to emphasize the preservation of our invested assets and provide adequate liquidity for the prompt payment of claims. To meet business needs and mitigate risks, our investment guidelines provide restrictions on our portfolio’s composition, including limits on asset type, sector limits, credit quality limits, portfolio duration, limits on the amount of investments in approved countries and permissible security types. We may also direct our investment managers to invest some of our invested asset portfolio in currencies other than the U.S. dollar. For example, a portion of our portfolio is invested in assets denominated in Canadian dollars, which, at minimum, would equal our reserves for policies denominated in Canadian dollars. Additionally, to ensure adequate liquidity for payment of claims, we take into account the maturity and duration of our invested asset portfolio and our general liability profile.
We also hold within our invested asset portfolio a credit enhanced note (“LLC Note”) issued by a limited liability company owned by a third party service provider which is classified as a held-to-maturity security. The LLC Note, which is scheduled to mature on December 31, 2029, was obtained in exchange for a surplus note of equal principal amount issued (“Surplus Note”) by Vidalia Re, Inc. (“Vidalia Re”), a newly formed special purpose financial captive insurance company and wholly owned subsidiary of Primerica Life. For more information on the LLC Note held-to-maturity security, see Note 4 (Investments) to our consolidated financial statements included elsewhere in this report.
We have an investment committee composed of members of our senior management team that is responsible for establishing and maintaining our investment guidelines and supervising our investment activity. Our investment committee regularly monitors our overall investment results and our compliance with our investment objectives and guidelines. We use a third-party investment advisor to manage our investing activities. Our investment advisor reports to our investment committee.
Our invested asset portfolio is subject to a variety of risks, including risks related to general economic conditions, market volatility, interest rate fluctuations, liquidity risk and credit and default risk. Investment guideline restrictions have been established to mitigate the effect of these risks but may not always be effective due to factors beyond our control. Interest rates are highly sensitive to many factors, including governmental monetary policies, domestic and international economic and political conditions and other factors beyond our control. A significant increase in interest rates could result in significant losses, realized or unrealized, in the value of our invested asset portfolio. Additionally, with respect to some of our investments, we are subject to prepayment and, therefore, reinvestment risk.
Details on asset mix (excluding our held-to-maturity security) were as follows:
|
|
December 31, 2014 |
|
|
December 31, 2013 |
|
||||||||||
|
|
Fair value |
|
|
Cost or amortized cost |
|
|
Fair value |
|
|
Cost or amortized cost |
|
||||
U.S. government and agencies |
|
|
1% |
|
|
|
1% |
|
|
* |
|
|
* |
|
||
Foreign government |
|
|
6% |
|
|
|
6% |
|
|
|
6% |
|
|
|
6% |
|
States and political subdivisions |
|
|
2% |
|
|
|
2% |
|
|
|
2% |
|
|
|
2% |
|
Corporates |
|
|
65% |
|
|
|
65% |
|
|
|
67% |
|
|
|
67% |
|
Mortgage- and asset-backed securities |
|
|
13% |
|
|
|
13% |
|
|
|
14% |
|
|
|
14% |
|
Equity securities |
|
|
3% |
|
|
|
3% |
|
|
|
2% |
|
|
|
2% |
|
Trading securities |
|
* |
|
|
* |
|
|
|
1% |
|
|
|
1% |
|
||
Cash and cash equivalents |
|
|
10% |
|
|
|
10% |
|
|
|
8% |
|
|
|
8% |
|
Total |
|
|
100% |
|
|
|
100% |
|
|
|
100% |
|
|
|
100% |
|
* |
Less than 1%. |
The composition and duration of our portfolio will vary depending on several factors, including the yield curve and our opinion of the relative value among various asset classes. The year-end average rating, duration and book yield of our fixed-maturity portfolio (excluding our held-to-maturity security) were as follows:
|
|
December 31, 2014 |
|
|
December 31, 2013 |
|
||
Average rating of our fixed-maturity portfolio |
|
A |
|
|
A |
|
||
Average duration of our fixed-maturity portfolio |
|
|
4.2 years |
|
|
4.0 years |
|
|
Average book yield of our fixed-maturity portfolio |
|
|
4.61% |
|
|
|
4.93% |
|
50
Ratings for our investments in fixed-maturity securities are determined using Nationally Recognized Statistical Rating Organizations designations and/or equivalent ratings. The distribution of our investments in fixed-maturity securities (excluding our held-to-maturity security) by rating, including those classified as trading securities, were as follows:
|
|
December 31, 2014 |
|
|
December 31, 2013 |
|
||||||||||
|
|
Amortized cost |
|
|
% |
|
|
Amortized cost |
|
|
% |
|
||||
|
|
(Dollars in thousands) |
|
|||||||||||||
AAA |
|
$ |
292,239 |
|
|
|
17 |
% |
|
$ |
296,717 |
|
|
|
18 |
% |
AA |
|
|
117,423 |
|
|
|
7 |
% |
|
|
133,406 |
|
|
|
8 |
% |
A |
|
|
375,781 |
|
|
|
23 |
% |
|
|
386,460 |
|
|
|
23 |
% |
BBB |
|
|
804,765 |
|
|
|
48 |
% |
|
|
777,111 |
|
|
|
46 |
% |
Below investment grade |
|
|
84,498 |
|
|
|
5 |
% |
|
|
80,835 |
|
|
|
5 |
% |
Not rated |
|
|
505 |
|
|
* |
|
|
|
1,484 |
|
|
* |
|
||
Total |
|
$ |
1,675,211 |
|
|
|
100 |
% |
|
$ |
1,676,013 |
|
|
|
100 |
% |
* |
Less than 1%. |
The ten largest holdings within our invested asset portfolio (excluding our held-to-maturity security) were as follows:
|
|
December 31, 2014 |
||||||||||||
Issuer |
|
Fair value |
|
|
Cost or amortized cost |
|
|
Unrealized gain (loss) |
|
|
Credit rating |
|||
|
|
(Dollars in thousands) |
||||||||||||
Government of Canada |
|
$ |
27,007 |
|
|
$ |
28,056 |
|
|
$ |
(1,050 |
) |
|
AAA |
General Electric Co |
|
|
19,180 |
|
|
|
16,780 |
|
|
|
2,400 |
|
|
AA- |
Washington Real Estate Investment |
|
|
11,039 |
|
|
|
10,514 |
|
|
|
524 |
|
|
BBB |
Province of Ontario Canada |
|
|
10,867 |
|
|
|
10,373 |
|
|
|
494 |
|
|
AA- |
Wells Fargo & Co |
|
|
10,544 |
|
|
|
10,397 |
|
|
|
147 |
|
|
A |
National Rural Utilities Cooperative |
|
|
9,904 |
|
|
|
7,758 |
|
|
|
2,146 |
|
|
A |
Iberdrola SA |
|
|
9,421 |
|
|
|
8,471 |
|
|
|
950 |
|
|
BBB |
Enel SpA |
|
|
7,729 |
|
|
|
6,983 |
|
|
|
746 |
|
|
BBB |
National Fuel Gas Co |
|
|
7,641 |
|
|
|
6,560 |
|
|
|
1,081 |
|
|
BBB |
Discover Financial Services |
|
|
7,572 |
|
|
|
6,550 |
|
|
|
1,022 |
|
|
BBB- |
Total – ten largest holdings |
|
$ |
120,903 |
|
|
$ |
112,443 |
|
|
$ |
8,461 |
|
|
|
Total – fixed-maturity and equity securities |
|
$ |
1,820,221 |
|
|
$ |
1,718,949 |
|
|
|
|
|
|
|
Percent of total fixed-maturity and equity securities |
|
|
7 |
% |
|
|
7 |
% |
|
|
|
|
|
|
For additional information on our invested asset portfolio, see Note 4 (Investments) and Note 5 (Fair Value of Financial Instruments) to our consolidated financial statements included elsewhere in this report.
Other Significant Assets and Liabilities. The balances of and changes in other significant assets and liabilities were as follows:
|
|
December 31, |
|
|
Change |
|
||||||||||
|
|
2014 |
|
|
2013 |
|
|
$ |
|
|
% |
|
||||
|
|
(Dollars in thousands) |
|
|||||||||||||
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Due from reinsurers |
|
$ |
4,115,533 |
|
|
$ |
4,055,054 |
|
|
$ |
60,479 |
|
|
|
1 |
% |
Deferred policy acquisition costs, net |
|
|
1,351,180 |
|
|
|
1,208,466 |
|
|
|
142,714 |
|
|
|
12 |
% |
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Future policy benefits |
|
|
5,264,608 |
|
|
|
5,063,103 |
|
|
|
201,505 |
|
|
|
4 |
% |
Due from reinsurers. Due from reinsurers reflects future policy benefit and claim reserves due from third-party reinsurers, including the Citigroup reinsurers. Such amounts are reported as due from reinsurers rather than offsetting future policy benefits.
Deferred policy acquisition costs, net. The increase in DAC was primarily a result of incremental commissions and expenses deferred as a result of new business, which was not subject to the Citigroup reinsurance agreements.
Future policy benefits. The increase in future policy benefits was primarily a result of the aging of and growth in our in-force book of business.
For additional information, see the notes to our consolidated financial statements included elsewhere in this report.
Liquidity and Capital Resources
Dividends and other payments to the Parent Company from its subsidiaries are our principal sources of cash. The amount of dividends paid by the subsidiaries is dependent on their capital needs to fund future growth and applicable regulatory restrictions. The primary uses of funds by the Parent Company include the payments of stockholder dividends, interest on outstanding debt, general operating expenses, and income taxes, as well as repurchases of shares outstanding. During 2014, our life insurance underwriting companies
51
declared and paid ordinary dividends of $248.4 million to the Parent Company primarily for repurchases of our common stock. See Note 15 (Statutory Accounting and Dividend Restrictions) to our consolidated financial statements included elsewhere in this report for more information on insurance subsidiary dividends and statutory restrictions. In addition, our non-life insurance subsidiaries declared and paid dividends of approximately $71.3 million to the Parent Company in 2014. At December 31, 2014, the Parent Company had cash and invested assets of approximately $194.5 million.
The Parent Company’s subsidiaries generate operating cash flows primarily from term life insurance premiums (net of premiums ceded to reinsurers), income from invested assets, commissions and fees collected from the distribution of investment and savings products as well as other financial products. The subsidiaries’ principal operating cash outflows include the payment of insurance claims and benefits (net of ceded claims recovered from reinsurers), commissions to our sales force, insurance and other operating expenses, interest expense for future policy benefit reserves financing transactions, and income taxes.
The distribution and underwriting of term life insurance requires upfront cash outlays at the time the policy is issued as we pay a substantial majority of the sales commission during the first year following the sale of a policy and incur costs for underwriting activities at the inception of a policy’s term. During the early years of a policy’s term, we generally receive level term premiums in excess of claims paid. We invest the excess cash generated during earlier policy years in fixed-maturity and equity securities held in support of future policy benefit reserves. In later policy years, cash received from the maturity or sale of invested assets is used to pay claims in excess of level term premiums received.
Historically, cash flows generated by our businesses, primarily from our existing block of term life policies and our investment and savings products, have provided us with sufficient liquidity to meet our operating requirements. We anticipate that cash flows from our businesses will continue to provide sufficient operating liquidity over the next 12 months.
We may seek to enhance our liquidity position or capital structure through borrowings from third-party sources, sales of debt or equity securities, reserve financings or some combination of these sources. Additionally, we believe that cash flows from our businesses and potential sources of funding will sufficiently support our long-term liquidity needs.
Cash Flows. The components of the changes in cash and cash equivalents were as follows:
|
|
Year ended December 31, |
|
|||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|||
|
|
(In thousands) |
|
|||||||||
Net cash provided by (used in) operating activities |
|
$ |
237,644 |
|
|
$ |
187,899 |
|
|
$ |
124,333 |
|
Net cash provided by (used in) investing activities |
|
|
(15,645 |
) |
|
|
35,484 |
|
|
|
62,294 |
|
Net cash provided by (used in) financing activities |
|
|
(175,883 |
) |
|
|
(184,940 |
) |
|
|
(211,086 |
) |
Effect of foreign exchange rate changes on cash |
|
|
(2,789 |
) |
|
|
(1,470 |
) |
|
|
597 |
|
Change in cash and cash equivalents |
|
$ |
43,327 |
|
|
$ |
36,973 |
|
|
$ |
(23,862 |
) |
Operating activities. Cash provided by operations increased in 2014 from 2013 primarily due to cash received from the collection of premium revenues in excess of benefits and claims paid in our Term Life Insurance segment. The additional layering of net premiums from term life insurance policies not subject to the coinsurance transactions with Citigroup has continued to generate positive incremental cash flows after payments are made for policy acquisition costs during the first year that policies are issued. Partially offsetting the increase in cash provided by operating activities is higher policy acquisition costs due to a higher volume of policies issued in 2014.
The increase in net cash provided by operating activities in 2013 from 2012 was also driven by the impact of an additional year of term life insurance policies issued subsequent to the coinsurance transactions with Citigroup. In addition, timing differences in payments to fund obligations under the 10% Coinsurance Agreement with Citigroup contributed to the increase in operating cash flows in 2013 from 2012. This increase was partially offset by proceeds from maturities of trading investments during 2012.
Investing activities. Cash flows from investing activities changed to a use of cash in 2014 from a source of cash in 2013, primarily due to activity in our available-for-sale invested asset portfolio. In 2014, cash proceeds from sales and, maturities of available-for-sale investments were largely offset by purchases of available-for-sale investments. In 2013, net cash proceeds from available-for-sale investments were received and used to fund share and warrant repurchases. The decrease in net cash from available-for-sale investments in 2014 was partially offset by lower purchases of property and equipment in 2014 mostly from assets purchased in connection with the move of our corporate headquarters in 2013.
The decline in cash provided by investing activities in 2013 compared to 2012 was primarily attributable to lower net proceeds from sales and purchases of invested assets used to fund share repurchases. Additionally, capital expenditures related to the relocation of our corporate headquarters in 2013 resulted in higher investing cash outflows than in 2012.
Financing activities. Net cash used in financing activities during 2014 decreased compared to 2013 primarily due to a lower amount of employee equity awards that were withheld by the Company to satisfy income tax withholding obligations upon vesting. This decrease is attributable to a decline in the amount of employee equity awards that vested in 2014 compared with 2013 as the last tranche of large equity awards issued in connection with the IPO vested in 2013.
52
Cash used in financing activities during 2013 was lower compared to 2012 due to fewer repurchases of shares and warrants. This was partially offset by the net increase in borrowings from the refinancing of our notes payable in 2012 and higher dividends paid to stockholders in 2013.
Risk-Based Capital. The National Association of Insurance Commissioners (“NAIC”) has established RBC standards for U.S. life insurers, as well as a risk-based capital model act (the “RBC Model Act”) that has been adopted by the insurance regulatory authorities. The RBC Model Act requires that life insurers annually submit a report to state regulators regarding their RBC based upon four categories of risk: asset risk; insurance risk; interest rate risk and business risk. The capital requirement for each is determined by applying factors that vary based upon the degree of risk to various asset, premiums and policy benefit reserve items. The formula is an early warning tool to identify possible weakly capitalized companies for purposes of initiating further regulatory action.
As of December 31, 2014, our U.S. life insurance subsidiaries had statutory capital substantially in excess of the applicable statutory requirements to support existing operations and to fund future growth. Primerica Life’s RBC ratio remained well positioned to support existing operations and fund future growth.
In Canada, an insurer’s minimum capital requirement is overseen by the Office of the Superintendent of Financial Institutions Canada (“OSFI”) and determined as the sum of the capital requirements for five categories of risk: asset default risk; mortality/morbidity/lapse risks; changes in interest rate environment risk; segregated funds risk; and foreign exchange risk. As of December 31, 2014, Primerica Life Canada was in compliance with Canada’s minimum capital requirements as determined by OSFI.
For more information regarding statutory capital requirements and dividend capacities of our insurance subsidiaries see Note 15 (Statutory Accounting and Dividend Restrictions) to our consolidated financial statements included elsewhere in this report for more information.
Redundant Reserve Financings. The Model Regulation entitled Valuation of Life Insurance Policies, commonly known as Regulation XXX, requires insurers to carry statutory policy benefit reserves for term life insurance policies with long-term premium guarantees which are often significantly in excess of the future policy benefit reserves that insurers deem necessary to satisfy claim obligations (“redundant policy benefit reserves”). Accordingly, many insurance companies have sought ways to reduce their capital needs by financing redundant policy benefit reserves through bank financing, reinsurance arrangements and other financing transactions.
In March 2012, Peach Re, Inc. (“Peach Re”), a special purpose financial captive insurance company and wholly owned subsidiary of Primerica Life, and Primerica Life entered into a Regulation XXX redundant reserve financing transaction (the “Peach Re Redundant Reserve Financing Transaction”) to more efficiently manage and deploy our capital. See Note 16 (Commitments and Contingent Liabilities) to our consolidated financial statements included elsewhere in this report for more information on this redundant reserve financing transaction.
In July 2014, Vidalia Re and Primerica Life entered into a Regulation XXX redundant reserve financing transaction (the “Vidalia Re Redundant Reserve Financing Transaction”) to more efficiently manage and deploy our capital. During 2014, Primerica Life ceded certain term life policies issued in 2011, 2012, 2013 and 2014 to Vidalia Re as part of the Vidalia Re Redundant Reserve Financing Transaction. For more information on the Vidalia Re Redundant Reserve Financing Transaction, see Note 4 (Investments) and Note 10 (Debt) to our consolidated financial statements included elsewhere in this report.
Notes Payable. The Company has $375.0 million of publicly-traded, senior unsecured notes outstanding issued at a price of 99.843% with an annual rate of 4.75%, payable semi-annually in arrears on January 15 and July 15. The Senior Notes mature July 15, 2022.
We were in compliance with the covenants of the Senior Notes at December 31, 2014. No events of default(s) occurred on the Senior Notes during the year ended December 31, 2014.
Financial Ratings. As of December 31, 2014, the investment grade credit ratings for our Senior Notes were as follows:
Agency |
|
Senior debt rating |
Moody's |
|
Baa2, stable outlook |
Standard & Poor's |
|
A-, stable outlook |
A.M. Best Company |
|
a-, stable outlook |
As of December 31, 2014, Primerica Life’s financial strength ratings were as follows:
Agency |
|
Financial strength rating |
Moody’s |
|
A2, stable outlook |
Standard & Poor's |
|
AA-, stable outlook |
A.M. Best Company |
|
A+, stable outlook |
Securities Lending. We participate in securities lending transactions with brokers to increase investment income with minimal risk. See Note 1 (Description of Business, Basis of Presentation, and Summary of Significant Accounting Policies) and Note 4 (Investments) to our consolidated financial statements included elsewhere in this report for additional information.
Short-Term Borrowings. We had no short-term borrowings as of or during the year ended December 31, 2014.
53
Surplus Note. Vidalia Re issued the Surplus Note in exchange for the LLC Note as a part of the Vidalia Re Redundant Reserve Financing Transaction. The Surplus Note has a principal amount equal to the LLC Note and is scheduled to mature on December 31, 2029. For more information on the Surplus Note, see Note 10 (Debt) to our consolidated financial statements included elsewhere in this report.
Off-Balance Sheet Arrangements. Our off-balance sheet arrangements as of December 31, 2014 consisted of the letter of credit issued under the credit facility agreement with Deutsche Bank (the “Credit Facility Agreement”) and associated with the Peach Re Redundant Reserve Financing Transaction as described in Note 16 (Commitments and Contingent Liabilities) to our consolidated financial statements included elsewhere in this report.
Contractual Obligations. Our contractual obligations, including payments due by period, were as follows:
|
|
December 31, 2014 |
|
|||||||||||||||||||||
|
|
Total Liability |
|
|
Total Payments |
|
|
Less than 1 year |
|
|
1-3 years |
|
|
3-5 years |
|
|
More than 5 years |
|
||||||
|
|
(In millions) |
|
|||||||||||||||||||||
Future policy benefits |
|
$ |
5,265 |
|
|
$ |
16,357 |
|
|
$ |
1,128 |
|
|
$ |
2,204 |
|
|
$ |
2,055 |
|
|
$ |
10,970 |
|
Policy claims and other benefits payable |
|
|
265 |
|
|
|
265 |
|
|
|
265 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Other policyholder funds |
|
|
344 |
|
|
|
344 |
|
|
|
344 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Long-term debt principal |
|
|
595 |
|
|
|
595 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
595 |
|
Interest obligations |
|
|
9 |
|
|
|
258 |
|
|
|
34 |
|
|
|
64 |
|
|
|
62 |
|
|
|
98 |
|
Commissions |
|
|
28 |
|
|
|
345 |
|
|
|
111 |
|
|
|
38 |
|
|
|
34 |
|
|
|
162 |
|
Purchase obligations |
|
|
4 |
|
|
|
39 |
|
|
|
24 |
|
|
|
14 |
|
|
|
1 |
|
|
|
- |
|
Operating lease obligations |
|
n/a |
|
|
|
78 |
|
|
|
7 |
|
|
|
13 |
|
|
|
12 |
|
|
|
46 |
|
|
Current income tax payable |
|
|
15 |
|
|
|
15 |
|
|
|
15 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Other liabilities |
|
|
352 |
|
|
|
343 |
|
|
|
318 |
|
|
|
25 |
|
|
|
- |
|
|
|
- |
|
Total contractual obligations |
|
$ |
6,877 |
|
|
$ |
18,639 |
|
|
$ |
2,246 |
|
|
$ |
2,358 |
|
|
$ |
2,164 |
|
|
$ |
11,871 |
|
Our liability for future policy benefits represents the present value of estimated future policy benefits to be paid, less the present value of estimated future net premiums to be collected. Net benefit premiums represent the portion of gross premiums required to provide for all benefits and associated expenses. These benefit payments are contingent on policyholders continuing to renew their policies and make their premium payments. Our contractual obligations table discloses the impact of benefit payments that will be due assuming the underlying policy renewals and premium payments continue as expected in our actuarial models. The future policy benefit payments represented in the table are presented on an undiscounted basis, gross of any amounts recoverable through reinsurance agreements and gross of any premiums to be collected. We expect to fully fund the obligations for future policy benefits from cash flows from general account invested assets and from future premiums. These estimations are based on mortality and lapse assumptions comparable with our historical experience. Due to the significance of the assumptions used, the amounts presented could materially differ from actual results.
Policy claims and other benefits payable represents claims and benefits currently owed to policyholders.
Other policyholders’ funds primarily represent claim payments left on deposit with us.
Long-term debt principal relates to our Senior Notes and the Surplus Note. Interest obligations (reported within other liabilities in our consolidated balance sheets) reflect expected interest on our notes payable, the financing charges related to an issued letter of credit, fees paid for the credit enhancement feature on our held-to-maturity invested asset, and a finance charge incurred pursuant to one of our coinsurance agreements with Citigroup as of December 31, 2014.
Commissions represent gross, undiscounted commissions that we expect to incur, contingent on the policyholders continuing to renew their policies and make their premium payments as noted above. The total liability amount is reported within other liabilities in our consolidated balance sheets.
Purchase obligations include agreements to purchase goods or services that are enforceable and legally binding and that specify all significant terms. These obligations consist primarily of accounts payable and certain accrued liabilities, including committed funds related to meetings and conventions for our independent sales force, plus a variety of vendor commitments funding our ongoing business operations. The total liability amount is reported within other liabilities in our consolidated balance sheets.
Our operating lease obligations primarily relate to office, warehouse, printing, and distribution properties. Our executive and home operations for all of our domestic U.S. operations (except New York) are located in Duluth, Georgia, in a build-to-suit facility that was completed in 2013.
Other liabilities are obligations reported within the consolidated balance sheets and consist primarily of amounts due under reinsurance agreements and general accruals and payables. The total payments within the table differ from the amounts presented in our consolidated balance sheets due to the exclusion of amounts where a reasonable estimate of the period of settlement cannot be determined.
54
For additional information concerning our commitments and contingencies, see Note 16 (Commitments and Contingent Liabilities) to our consolidated financial statements included elsewhere in this report.
Market risk is the risk of the loss of fair value resulting from adverse changes in market rates and prices, such as interest rates and foreign currency exchange rates. Market risk is directly influenced by the volatility and liquidity in the markets in which the related underlying financial instruments are traded. Sensitivity analysis measures the impact of hypothetical changes in interest rates, foreign exchange rates and other market rates or prices on the profitability of market-sensitive financial instruments.
The following discussion about the potential effects of changes in interest rates and Canadian currency exchange rates is based on shock-tests, which model the effects of interest rate and Canadian exchange rate shifts on our financial condition and results of operations. Although we believe shock tests provide the most meaningful analysis permitted by the rules and regulations of the SEC, they are constrained by several factors, including the necessity to conduct the analysis based on a single point in time and by their inability to include the extraordinarily complex market reactions that normally would arise from the market shifts modeled. Although the following results of shock tests for changes in interest rates and Canadian currency exchange rates may have some limited use as benchmarks, they should not be viewed as forecasts. These disclosures also are selective in nature and address, in the case of interest rates, only the potential direct impact on our financial instruments and, in the case of Canadian currency exchange rates, the potential translation impact on net income from our Canadian subsidiaries. They do not include a variety of other potential factors that could affect our business as a result of these changes in interest rates and Canadian currency exchange rates.
Interest Rate Risk. The fair value of the fixed-maturity securities in our invested asset portfolio as of December 31, 2014 was approximately $1.8 billion. The primary market risk for this portion of our invested asset portfolio is interest rate risk. One means of assessing the exposure of our fixed-maturity securities portfolios to interest rate changes is a duration-based analysis that measures the potential changes in market value resulting from a hypothetical change in interest rates of 100 basis points across all maturities. This model is sometimes referred to as a parallel shift in the yield curve. Under this model, with all other factors constant and assuming no offsetting change in the value of our liabilities, we estimated that such an increase in interest rates would cause the market value of our fixed-maturity securities portfolios to decline by approximately $67.8 million, or approximately 4%, based on our actual securities positions as of December 31, 2014.
If interest rates remain at or near historically low levels, we anticipate the average yield of our fixed income investment portfolio, and therefore the investment income derived from it, to decrease as maturing fixed income investments will be replaced with purchases of lower yielding investments. Approximately $173.5 million of our fixed income investment portfolio with an average book yield of around 3.3% is scheduled to mature during 2015. The yield on maturities will increase after 2015.
Canadian Currency Risk. We also have exposure to foreign currency exchange risk to the extent we conduct business in Canada. A strong Canadian dollar relative to the U.S. dollar results in higher levels of reported revenues, expenses, net income, assets, liabilities, and accumulated comprehensive income (loss) in our U.S. dollar financial statements, and a weaker Canadian dollar would have the opposite effect. Generally, our Canadian dollar-denominated assets are held in support of our Canadian dollar-denominated liabilities. For the year ended December 31, 2014, 18% of our revenues from operations, excluding realized investment gains, and 26% of income from continuing operations before income taxes were generated by our Canadian operations. Historically, we have not hedged this exposure, although we may elect to do so in future periods.
One means of assessing exposure to changes in Canadian currency exchange rates is to model the effects on reported income using a sensitivity analysis. We analyzed our Canadian currency exposure for the year ended December 31, 2014. Net exposure was measured assuming a 10% decrease in Canadian currency exchange rates compared to the U.S. dollar. We estimated that such a decrease would decrease our income before income taxes for the year ended December 31, 2014 by approximately $7.3 million.
Credit Risk. We extensively use reinsurance in the United States to diversify our insurance and underwriting risk and to manage our loss exposure to mortality risk. Reinsurance does not relieve us of our direct liability to our policyholders. Due to factors such as insolvency, adverse underwriting results or inadequate investment returns, our reinsurers may not be able to pay the amounts they owe us on a timely basis or at all. Further, reinsurers might refuse or fail to pay losses that we cede to them or might delay payment. To limit our exposure with any one reinsurer, we monitor the concentration of credit risk we have with our reinsurance counterparties, as well as their financial condition. We manage this reinsurer credit risk through analysis and monitoring of the credit-worthiness of each of our reinsurance partners to minimize collection issues. Also, for reinsurance contracts with unauthorized reinsurers, we require collateral such as letters of credit. For information on our reinsurance exposure and reinsurers, see Note 6 (Reinsurance) to our consolidated financial statements included elsewhere in this report.
In connection with our Credit Facility Agreement, the Company assumes credit risk associated with Deutsche Bank’s ability to make payment to us as fulfillment of their obligations under the letter of credit. Such a draw on the letter of credit would only be requested in the event that the assets held in support of the liabilities assumed by Peach Re were insufficient, which, based on actuarial analysis, is unlikely.
55
Concurrent with the execution of the Regulation XXX redundant reserve financing transaction between Vidalia Re and Primerica Life, Vidalia Re entered into a Surplus Note Purchase Agreement (the “Surplus Note Purchase Agreement”) with Hannover Life Reassurance Company of America and certain of its affiliates (collectively, “Hannover Re”) and a newly formed limited liability company (the “LLC”) owned by a third party service provider. Under the Surplus Note Purchase Agreement, Vidalia Re issued the Surplus Note to the LLC in exchange for the LLC Note of equal principal amount. The Company assumes credit risk associated with a credit enhancement feature provided by Hannover Re, which bears the obligation to absorb the LLC’s losses in the event of a Surplus Note default in exchange for a fee.
For information on our Credit Facility Agreement and Surplus Note Purchase Agreement, see Note 16 (Commitments and Contingent Liabilities), Note 4 (Investments), and Note 10 (Debt) to our consolidated financial statements included elsewhere in this report.
We also bear credit risk on our investment portfolio related to the uncertainty associated with the continued ability of an obligor to make timely payments of principal and interest. In an effort to meet business needs and mitigate credit and other portfolio risks, we established investment guidelines that provide restrictions on our portfolio’s composition, including limits on asset type, sector limits, credit quality limits, portfolio duration, limits on the amount of investments in approved countries and permissible security types. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Financial Condition” included elsewhere in this report for details on our investment portfolio, including investment strategy, asset mix, and credit ratings.
56
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Stockholders of Primerica, Inc.:
We have audited the accompanying consolidated balance sheets of Primerica, Inc. and subsidiaries (the Company) as of December 31, 2014 and 2013, and the related consolidated statements of income, comprehensive income, stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2014. These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Primerica, Inc. and subsidiaries as of December 31, 2014 and 2013, and the results of their operations and their cash flows for each of the years in the three-year period ended December 31, 2014, in conformity with U.S. generally accepted accounting principles.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), Primerica, Inc.’s internal control over financial reporting as of December 31, 2014, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), and our report dated February 26, 2015 expressed an unqualified opinion on the effectiveness of the Company’s internal control over financial reporting.
/s/ KPMG LLP
Atlanta, Georgia
February 26, 2015
57
PRIMERICA, INC. AND SUBSIDIARIES
|
|
December 31, 2014 |
|
|
December 31, 2013 |
|
||
|
|
(In thousands) |
|
|||||
Assets |
|
|
|
|
|
|
|
|
Investments: |
|
|
|
|
|
|
|
|
Fixed-maturity securities available-for-sale, at fair value (amortized cost: $1,667,500 in 2014 and $1,663,022 in 2013) |
|
$ |
1,759,120 |
|
|
$ |
1,755,712 |
|
Fixed-maturity securities held-to-maturity, at amortized cost (fair value: $228,809 in 2014 and $0 in 2013) |
|
|
220,000 |
|
|
|
- |
|
Equity securities available-for-sale, at fair value (cost: $43,738 in 2014 and $32,592 in 2013) |
|
|
53,390 |
|
|
|
39,894 |
|
Trading securities, at fair value (cost: $7,710 in 2014 and $13,025 in 2013) |
|
|
7,711 |
|
|
|
12,991 |
|
Policy loans |
|
|
28,095 |
|
|
|
26,806 |
|
Total investments |
|
|
2,068,316 |
|
|
|
1,835,403 |
|
Cash and cash equivalents |
|
|
192,516 |
|
|
|
149,189 |
|
Accrued investment income |
|
|
17,401 |
|
|
|
18,127 |
|
Due from reinsurers |
|
|
4,115,533 |
|
|
|
4,055,054 |
|
Deferred policy acquisition costs, net |
|
|
1,351,180 |
|
|
|
1,208,466 |
|
Premiums and other receivables |
|
|
181,660 |
|
|
|
175,785 |
|
Intangible assets, net |
|
|
61,720 |
|
|
|
68,863 |
|
Deferred income taxes |
|
|
36,082 |
|
|
|
32,450 |
|
Other assets |
|
|
273,403 |
|
|
|
282,784 |
|
Separate account assets |
|
|
2,440,303 |
|
|
|
2,503,829 |
|
Total assets |
|
$ |
10,738,114 |
|
|
$ |
10,329,950 |
|
|
|
|
|
|
|
|
|
|
Liabilities and Stockholders’ Equity |
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
Future policy benefits |
|
$ |
5,264,608 |
|
|
$ |
5,063,103 |
|
Unearned premiums |
|
|
912 |
|
|
|
1,802 |
|
Policy claims and other benefits payable |
|
|
264,832 |
|
|
|
253,304 |
|
Other policyholders’ funds |
|
|
344,313 |
|
|
|
337,977 |
|
Notes payable |
|
|
374,532 |
|
|
|
374,481 |
|
Surplus note |
|
|
220,000 |
|
|
|
- |
|
Current income tax payable |
|
|
15,014 |
|
|
|
15,019 |
|
Deferred income taxes |
|
|
125,453 |
|
|
|
90,866 |
|
Other liabilities |
|
|
392,810 |
|
|
|
377,690 |
|
Payable under securities lending |
|
|
50,211 |
|
|
|
89,852 |
|
Separate account liabilities |
|
|
2,440,303 |
|
|
|
2,503,829 |
|
Commitments and contingent liabilities (see Commitments and Contingent Liabilities note) |
|
|
|
|
|
|
|
|
Total liabilities |
|
|
9,492,988 |
|
|
|
9,107,923 |
|
|
|
|
|
|
|
|
|
|
Stockholders’ equity: |
|
|
|
|
|
|
|
|
Common stock ($0.01 par value; authorized 500,000 in 2014 and 2013; issued and outstanding 52,169 shares in 2014 and 54,834 shares in 2013) |
|
|
522 |
|
|
|
548 |
|
Paid-in capital |
|
|
353,337 |
|
|
|
472,633 |
|
Retained earnings |
|
|
795,740 |
|
|
|
640,840 |
|
Accumulated other comprehensive income (loss), net of income tax: |
|
|
|
|
|
|
|
|
Unrealized foreign currency translation gains (losses) |
|
|
21,681 |
|
|
|
41,974 |
|
Net unrealized investment gains (losses): |
|
|
|
|
|
|
|
|
Net unrealized investment gains not other-than-temporarily impaired |
|
|
74,308 |
|
|
|
67,379 |
|
Net unrealized investment losses other-than-temporarily impaired |
|
|
(462 |
) |
|
|
(1,347 |
) |
Total stockholders’ equity |
|
|
1,245,126 |
|
|
|
1,222,027 |
|
Total liabilities and stockholders’ equity |
|
$ |
10,738,114 |
|
|
$ |
10,329,950 |
|
See accompanying notes to consolidated financial statements.
58
PRIMERICA, INC. AND SUBSIDIARIES
Consolidated Statements of Income
|
|
Year ended December 31, |
|
|||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|||
|
|
(In thousands, except per-share amounts) |
|
|||||||||
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
Direct premiums |
|
$ |
2,301,332 |
|
|
$ |
2,265,191 |
|
|
$ |
2,231,032 |
|
Ceded premiums |
|
|
(1,616,817 |
) |
|
|
(1,644,158 |
) |
|
|
(1,663,753 |
) |
Net premiums |
|
|
684,515 |
|
|
|
621,033 |
|
|
|
567,279 |
|
Commissions and fees |
|
|
527,166 |
|
|
|
471,808 |
|
|
|
429,044 |
|
Net investment income |
|
|
86,473 |
|
|
|
88,752 |
|
|
|
100,804 |
|
Realized investment gains (losses), including other-than-temporary impairment losses |
|
|
(261 |
) |
|
|
6,246 |
|
|
|
11,382 |
|
Other, net |
|
|
42,137 |
|
|
|
42,731 |
|
|
|
45,263 |
|
Total revenues |
|
|
1,340,030 |
|
|
|
1,230,570 |
|
|
|
1,153,772 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits and expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
Benefits and claims |
|
|
311,417 |
|
|
|
279,931 |
|
|
|
254,048 |
|
Amortization of deferred policy acquisition costs |
|
|
144,378 |
|
|
|
129,183 |
|
|
|
118,598 |
|
Sales commissions |
|
|
268,775 |
|
|
|
232,237 |
|
|
|
204,569 |
|
Insurance expenses |
|
|
115,452 |
|
|
|
105,457 |
|
|
|
90,894 |
|
Insurance commissions |
|
|
15,353 |
|
|
|
16,530 |
|
|
|
21,724 |
|
Interest expense |
|
|
34,570 |
|
|
|
35,018 |
|
|
|
33,101 |
|
Other operating expenses |
|
|
174,363 |
|
|
|
187,208 |
|
|
|
164,716 |
|
Total benefits and expenses |
|
|
1,064,308 |
|
|
|
985,564 |
|
|
|
887,650 |
|
Income from continuing operations before income taxes |
|
|
275,722 |
|
|
|
245,006 |
|
|
|
266,122 |
|
Income taxes |
|
|
95,888 |
|
|
|
86,305 |
|
|
|
92,813 |
|
Income from continuing operations |
|
|
179,834 |
|
|
|
158,701 |
|
|
|
173,309 |
|
Income from discontinued operations, net of income taxes |
|
|
1,578 |
|
|
|
4,024 |
|
|
|
497 |
|
Net income |
|
$ |
181,412 |
|
|
$ |
162,725 |
|
|
$ |
173,806 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per share: |
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
3.26 |
|
|
$ |
2.80 |
|
|
$ |
2.76 |
|
Discontinued operations |
|
|
0.03 |
|
|
|
0.07 |
|
|
|
0.01 |
|
Basic earnings per share |
|
$ |
3.29 |
|
|
$ |
2.87 |
|
|
$ |
2.77 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share: |
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
3.26 |
|
|
$ |
2.76 |
|
|
$ |
2.70 |
|
Discontinued operations |
|
|
0.03 |
|
|
|
0.07 |
|
|
|
0.01 |
|
Diluted earnings per share |
|
$ |
3.29 |
|
|
$ |
2.83 |
|
|
$ |
2.71 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average shares used in computing earnings per share: |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
54,567 |
|
|
|
55,834 |
|
|
|
61,059 |
|
Diluted |
|
|
54,598 |
|
|
|
56,625 |
|
|
|
62,401 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental disclosures: |
|
|
|
|
|
|
|
|
|
|
|
|
Total impairment losses |
|
$ |
(4,045 |
) |
|
$ |
(1,095 |
) |
|
$ |
(1,204 |
) |
Impairment losses recognized in other comprehensive income before income taxes |
|
|
- |
|
|
|
479 |
|
|
|
563 |
|
Net impairment losses recognized in earnings |
|
|
(4,045 |
) |
|
|
(616 |
) |
|
|
(641 |
) |
Other net realized investment gains (losses) |
|
|
3,784 |
|
|
|
6,862 |
|
|
|
12,023 |
|
Realized investment gains (losses), including other-than- temporary impairment losses |
|
$ |
(261 |
) |
|
$ |
6,246 |
|
|
$ |
11,382 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends declared per share |
|
$ |
0.48 |
|
|
$ |
0.44 |
|
|
$ |
0.24 |
|
See accompanying notes to consolidated financial statements.
59
PRIMERICA, INC. AND SUBSIDIARIES
Consolidated Statements of Comprehensive Income
|
|
Year ended December 31, |
|
|||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|||
|
|
(In thousands) |
|
|||||||||
Net income |
|
$ |
181,412 |
|
|
$ |
162,725 |
|
|
$ |
173,806 |
|
Other comprehensive income (loss) before income taxes: |
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized investment gains (losses): |
|
|
|
|
|
|
|
|
|
|
|
|
Change in unrealized holding gains/(losses) on investment securities |
|
|
11,228 |
|
|
|
(68,769 |
) |
|
|
39,945 |
|
Reclassification adjustment for realized investment (gains) losses included in net income |
|
|
794 |
|
|
|
(4,909 |
) |
|
|
(11,475 |
) |
Foreign currency translation adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
Change in unrealized foreign currency translation gains (losses) |
|
|
(20,527 |
) |
|
|
(13,695 |
) |
|
|
4,221 |
|
Total other comprehensive income (loss) before income taxes |
|
|
(8,505 |
) |
|
|
(87,373 |
) |
|
|
32,691 |
|
Income tax expense (benefit) related to items of other comprehensive income (loss) |
|
|
3,974 |
|
|
|
(25,969 |
) |
|
|
9,946 |
|
Other comprehensive income (loss), net of income taxes |
|
|
(12,479 |
) |
|
|
(61,404 |
) |
|
|
22,745 |
|
Total comprehensive income (loss) |
|
$ |
168,933 |
|
|
$ |
101,321 |
|
|
$ |
196,551 |
|
See accompanying notes to consolidated financial statements.
60
PRIMERICA, INC. AND SUBSIDIARIES
Consolidated Statements of Stockholders’ Equity
|
|
Year ended December 31, |
|
|||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|||
|
|
(In thousands) |
|
|||||||||
Common stock: |
|
|
|
|
|
|
|
|
|
|
|
|
Balance, beginning of period |
|
$ |
548 |
|
|
$ |
564 |
|
|
$ |
649 |
|
Repurchases of common stock |
|
|
(31 |
) |
|
|
(29 |
) |
|
|
(99 |
) |
Net issuance of common stock |
|
|
5 |
|
|
|
13 |
|
|
|
14 |
|
Balance, end of period |
|
|
522 |
|
|
|
548 |
|
|
|
564 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Paid-in capital: |
|
|
|
|
|
|
|
|
|
|
|
|
Balance, beginning of period |
|
|
472,633 |
|
|
|
602,269 |
|
|
|
835,232 |
|
Share-based compensation |
|
|
37,494 |
|
|
|
39,195 |
|
|
|
33,236 |
|
Net issuance of common stock |
|
|
(5 |
) |
|
|
(13 |
) |
|
|
(14 |
) |
Repurchases of common stock |
|
|
(154,268 |
) |
|
|
(101,044 |
) |
|
|
(268,113 |
) |
Repurchases of warrants |
|
|
- |
|
|
|
(68,399 |
) |
|
|
- |
|
Adjustments to paid-in capital, other |
|
|
(2,517 |
) |
|
|
625 |
|
|
|
1,928 |
|
Balance, end of period |
|
|
353,337 |
|
|
|
472,633 |
|
|
|
602,269 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retained earnings: |
|
|
|
|
|
|
|
|
|
|
|
|
Balance, beginning of period |
|
|
640,840 |
|
|
|
503,173 |
|
|
|
344,104 |
|
Net income |
|
|
181,412 |
|
|
|
162,725 |
|
|
|
173,806 |
|
Dividends |
|
|
(26,512 |
) |
|
|
(25,058 |
) |
|
|
(14,737 |
) |
Balance, end of period |
|
|
795,740 |
|
|
|
640,840 |
|
|
|
503,173 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated other comprehensive income (loss): |
|
|
|
|
|
|
|
|
|
|
|
|
Balance, beginning of period |
|
|
108,006 |
|
|
|
169,410 |
|
|
|
146,665 |
|
Change in foreign currency translation adjustment, net of income tax expense (benefit) of $(234) in 2014, $(182) in 2013, and $(18) in 2012 |
|
|
(20,293 |
) |
|
|
(13,513 |
) |
|
|
4,239 |
|
Change in net unrealized investment gains (losses) during the period, net of income taxes: |
|
|
|
|
|
|
|
|
|
|
|
|
Change in net unrealized investment gains (losses) not-other-than temporarily impaired, net of income tax expense (benefit) of $3,731 in 2014, $(25,619) in 2013, and $9,624 in 2012 |
|
|
6,929 |
|
|
|
(47,579 |
) |
|
|
17,876 |
|
Change in net unrealized investment losses other-than-temporarily impaired, net of income tax expense (benefit) of $477 in 2014, $(168) in 2013, and $340 in 2012 |
|
|
885 |
|
|
|
(312 |
) |
|
|
630 |
|
Balance, end of period |
|
|
95,527 |
|
|
|
108,006 |
|
|
|
169,410 |
|
Total stockholders’ equity |
|
$ |
1,245,126 |
|
|
$ |
1,222,027 |
|
|
$ |
1,275,416 |
|
See accompanying notes to consolidated financial statements.
61
PRIMERICA, INC. AND SUBSIDIARIES
Consolidated Statements of Cash Flows
|
|
Year ended December 31, |
|
|||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|||
|
|
(In thousands) |
|
|||||||||
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
181,412 |
|
|
$ |
162,725 |
|
|
$ |
173,806 |
|
Adjustments to reconcile net income to cash provided by (used in) operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Change in future policy benefits and other policy liabilities |
|
|
263,225 |
|
|
|
228,341 |
|
|
|
243,062 |
|
Deferral of policy acquisition costs |
|
|
(289,945 |
) |
|
|
(267,523 |
) |
|
|
(268,154 |
) |
Amortization of deferred policy acquisition costs |
|
|
144,378 |
|
|
|
129,183 |
|
|
|
118,598 |
|
Deferred tax provision |
|
|
25,757 |
|
|
|
18,333 |
|
|
|
13,332 |
|
Change in income taxes |
|
|
1,090 |
|
|
|
(6,423 |
) |
|
|
(10,967 |
) |
Realized investment (gains) losses, including other-than-temporary impairments |
|
|
261 |
|
|
|
(6,246 |
) |
|
|
(11,382 |
) |
Gain from sale of business, net |
|
|
(1,578 |
) |
|
|
- |
|
|
|
- |
|
Accretion and amortization of investments |
|
|
(4,825 |
) |
|
|
(4,554 |
) |
|
|
(2,766 |
) |
Depreciation and amortization |
|
|
12,266 |
|
|
|
10,803 |
|
|
|
10,095 |
|
Change in due from reinsurers |
|
|
(90,024 |
) |
|
|
(73,070 |
) |
|
|
(141,918 |
) |
Change in premiums and other receivables |
|
|
(11,067 |
) |
|
|
(8,241 |
) |
|
|
(762 |
) |
Trading securities sold, matured, or called (acquired), net |
|
|
5,232 |
|
|
|
(5,265 |
) |
|
|
35,738 |
|
Share-based compensation |
|
|
17,982 |
|
|
|
13,788 |
|
|
|
18,944 |
|
Change in other operating assets and liabilities, net |
|
|
(16,520 |
) |
|
|
(3,952 |
) |
|
|
(53,293 |
) |
Net cash provided by (used in) operating activities |
|
|
237,644 |
|
|
|
187,899 |
|
|
|
124,333 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Available-for-sale investments sold, matured or called: |
|
|
|
|
|
|
|
|
|
|
|
|
Fixed-maturity securities — sold |
|
|
109,681 |
|
|
|
98,277 |
|
|
|
304,838 |
|
Fixed-maturity securities — matured or called |
|
|
314,589 |
|
|
|
266,738 |
|
|
|
263,351 |
|
Equity securities |
|
|
2,351 |
|
|
|
6,200 |
|
|
|
2,828 |
|
Available-for-sale investments acquired: |
|
|
|
|
|
|
|
|
|
|
|
|
Fixed-maturity securities |
|
|
(425,904 |
) |
|
|
(308,904 |
) |
|
|
(492,094 |
) |
Equity securities |
|
|
(11,878 |
) |
|
|
(3,009 |
) |
|
|
(5,680 |
) |
Purchases of property and equipment and other investing activities, net |
|
|
(7,484 |
) |
|
|
(23,818 |
) |
|
|
(10,949 |
) |
Proceeds from sale of business |
|
|
3,000 |
|
|
|
- |
|
|
|
- |
|
Cash collateral received (returned) on loaned securities, net |
|
|
(39,641 |
) |
|
|
(50,075 |
) |
|
|
(9,431 |
) |
Sales (purchases) of short-term investments using securities lending collateral, net |
|
|
39,641 |
|
|
|
50,075 |
|
|
|
9,431 |
|
Net cash provided by (used in) investing activities |
|
|
(15,645 |
) |
|
|
35,484 |
|
|
|
62,294 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Dividends paid |
|
|
(26,512 |
) |
|
|
(25,058 |
) |
|
|
(14,737 |
) |
Common stock repurchased |
|
|
(147,922 |
) |
|
|
(86,280 |
) |
|
|
(257,584 |
) |
Warrants repurchased |
|
|
- |
|
|
|
(68,399 |
) |
|
|
- |
|
Excess tax benefits on share-based compensation |
|
|
5,804 |
|
|
|
9,590 |
|
|
|
5,266 |
|
Tax withholdings on share-based compensation |
|
|
(6,377 |
) |
|
|
(14,793 |
) |
|
|
(10,628 |
) |
Proceeds from issuance of Senior Notes, net of discount |
|
|
- |
|
|
|
- |
|
|
|
374,411 |
|
Payment of note issued to Citigroup |
|
|
- |
|
|
|
- |
|
|
|
(300,000 |
) |
Payments of deferred financing costs |
|
|
(876 |
) |
|
|
- |
|
|
|
(7,814 |
) |
Net cash provided by (used in) financing activities |
|
|
(175,883 |
) |
|
|
(184,940 |
) |
|
|
(211,086 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of foreign exchange rate changes on cash |
|
|
(2,789 |
) |
|
|
(1,470 |
) |
|
|
597 |
|
Change in cash and cash equivalents |
|
|
43,327 |
|
|
|
36,973 |
|
|
|
(23,862 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, beginning of period |
|
|
149,189 |
|
|
|
112,216 |
|
|
|
136,078 |
|
Cash and cash equivalents, end of period |
|
$ |
192,516 |
|
|
$ |
149,189 |
|
|
$ |
112,216 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental disclosures of cash flow information: |
|
|
|
|
|
|
|
|
|
|
|
|
Income taxes paid |
|
$ |
66,077 |
|
|
$ |
68,599 |
|
|
$ |
85,365 |
|
Interest paid |
|
|
33,058 |
|
|
|
32,905 |
|
|
|
38,416 |
|
See accompanying notes to consolidated financial statements.
62
PRIMERICA, INC. AND SUBSIDIARIES
Notes to Consolidated Financial Statements
(1) Description of Business, Basis of Presentation, and Summary of Significant Accounting Policies
Description of Business. Primerica, Inc. (the “Parent Company”), together with its subsidiaries (collectively, “we”, “us” or the “Company”), is a leading distributor of financial products to middle income households in the United States and Canada. We assist our clients in meeting their needs for term life insurance, which we underwrite, and mutual funds, annuities and other financial products, which we distribute primarily on behalf of third parties. Our primary subsidiaries include the following entities: Primerica Financial Services, Inc. (“PFS”), a general agency and marketing company; Primerica Life Insurance Company (“Primerica Life”), our principal life insurance company; Primerica Financial Services (Canada) Ltd., a holding company for our Canadian operations, which includes Primerica Life Insurance Company of Canada (“Primerica Life Canada”) and PFSL Investments Canada Ltd. (“PFSL Investments Canada”); and PFS Investments Inc. (“PFS Investments”), an investment products company and broker-dealer. Primerica Life, domiciled in Massachusetts, owns National Benefit Life Insurance Company (“NBLIC”), a New York life insurance company.
Prior to April 1, 2010, we were wholly owned by Citigroup Inc. (“Citigroup”). In April 2010, we completed a series of transactions (the “corporate reorganization”) that included an initial public offering of our common stock by Citigroup pursuant to the Securities Act of 1933, as amended (the “IPO”).
We capitalized Peach Re, Inc. (“Peach Re”), a special purpose financial captive insurance company and wholly owned subsidiary of Primerica Life, and Primerica Life ceded to Peach Re certain level premium term life insurance policies pursuant to a coinsurance agreement (the “Peach Re Coinsurance Agreement”) effective March 31, 2012.
In June 2014, we established Vidalia Re, Inc. (“Vidalia Re”) as a special purpose financial captive insurance company and wholly owned subsidiary of Primerica Life. Vidalia Re and Primerica Life entered into a coinsurance agreement whereby Primerica Life ceded to Vidalia Re certain level premium term life insurance policies (the “Vidalia Re Coinsurance Agreement”) effective July 31, 2014 and December 31, 2014.
Basis of Presentation. We prepare our financial statements in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). These principles are established primarily by the Financial Accounting Standards Board (“FASB”). The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect financial statement balances, revenues and expenses and cash flows, as well as the disclosure of contingent assets and liabilities. Management considers available facts and knowledge of existing circumstances when establishing the estimates included in our financial statements.
Use of Estimates. The most significant items that involve a greater degree of accounting estimates and actuarial determinations subject to change in the future are the valuation of investments, deferred policy acquisition costs (“DAC”), and liabilities for future policy benefits and unpaid policy claims. Estimates for these and other items are subject to change and are reassessed by management in accordance with U.S. GAAP. Actual results could differ from those estimates.
Consolidation. The accompanying consolidated financial statements include the accounts of the Company and those entities required to be consolidated under applicable accounting standards. All material intercompany profits, transactions, and balances among the consolidated entities have been eliminated.
Reclassifications. Certain reclassifications have been made to prior-period amounts to conform to current-period reporting classifications. These reclassifications had no impact on net income or total stockholders’ equity and were primarily related to discontinued operations. See Note 2 (Discontinued Operations) for more information.
Subsequent Events. The Company has evaluated subsequent events for recognition and disclosure for occurrences and transactions after the date of the consolidated financial statements at December 31, 2014.
Foreign Currency Translation. Assets and liabilities denominated in Canadian dollars are translated into U.S. dollars using year-end exchange rates. Revenues and expenses are translated monthly at amounts that approximate weighted-average exchange rates. Translation adjustments are reported in other comprehensive income (loss).
Investments. Investments are reported on the following bases:
· |
Available-for-sale fixed-maturity securities, including bonds and redeemable preferred stocks not classified as trading securities, are carried at fair value. When quoted market values are unavailable, we obtain estimates from independent pricing services or estimate fair value based upon a comparison to quoted issues of the same issuer or of other issuers with similar characteristics. |
· |
Held-to-maturity fixed maturity security, which is carried at amortized cost. |
· |
Equity securities, including common and nonredeemable preferred stocks, are classified as available-for-sale and are carried at fair value. When quoted market values are unavailable, we obtain estimates from independent pricing services or estimates fair value based upon a comparison to quoted issues of the same issuer or of other issuers with similar characteristics. |
· |
Trading securities, which primarily consist of bonds, are carried at fair value. Changes in fair value of trading securities are included in net investment income in the period in which the change occurred. |
· |
Policy loans are carried at unpaid principal balances, which approximate fair value. |
63
Investment transactions are recorded on a trade-date basis. We use the specific-identification method to determine the realized gains or losses from securities transactions and report the realized gains or losses in the accompanying consolidated statements of income.
Unrealized gains and losses on available-for-sale securities are included as a separate component of accumulated other comprehensive income except for the credit loss components of other-than-temporary declines in fair value, which are recorded as realized losses in the accompanying consolidated statements of income.
Investments are reviewed on a quarterly basis for other-than-temporary impairments (“OTTI”). Credit risk, interest rate risk, the amount of time the security has been in an unrealized loss position, actions taken by ratings agencies, and other factors are considered in determining whether an unrealized loss is other-than-temporary. Our consolidated statements of income for the three years ended December 31, 2014 reflect the impairment on debt securities that we intend to sell or would more likely than not be required to sell before the expected recovery of the amortized cost basis. For available-for-sale (“AFS”) debt securities that we have no intent to sell and believe that it is more likely than not we will not be required to sell prior to recovery, only the credit loss component of the impairment is recognized in earnings, while the remainder is recognized in accumulated other comprehensive income (“AOCI”) in the accompanying consolidated financial statements. The credit loss component recognized in earnings is identified as the amount of principal cash flows not expected to be received over the remaining term of the security. Any subsequent changes in fair value of the security related to non-credit factors recognized in other comprehensive income are presented as an adjustment to the amount previously presented in the net unrealized investment gains (losses) other-than-temporarily impaired category of accumulated other comprehensive income.
Interest income on fixed-maturity securities is recorded when earned using the effective-yield method, which gives consideration to amortization of premiums and accretion of discounts. Dividend income on equity securities is recorded when declared. These amounts are included in net investment income in the accompanying consolidated statements of income.
Included within fixed-maturity securities are loan-backed and asset-backed securities. Amortization of the premium or accretion of the discount uses the retrospective method. The effective yield used to determine amortization/accretion is calculated based on actual and historical projected future cash flows, which are obtained from a widely accepted data provider and updated quarterly.
Embedded conversion options associated with fixed-maturity securities are bifurcated from the fixed-maturity security host contracts and separately recognized as equity securities. The change in fair value of these bifurcated conversion options is reflected in realized investment gains (losses), including OTTI losses.
Cash and Cash Equivalents. Cash and cash equivalents include cash on hand, money market instruments, and all other highly liquid investments purchased with an original or remaining maturity of three months or less at the date of acquisition.
Reinsurance. We use reinsurance extensively, utilizing yearly renewable term (“YRT”) and coinsurance agreements. Under YRT agreements, we reinsure only the mortality risk, while under coinsurance, we reinsure a proportionate part of all risks arising under the reinsured policy. Under coinsurance, the reinsurer receives a proportionate part of the premiums, less commission allowances, and is liable for a corresponding part of all benefit payments.
All reinsurance contracts in effect for the three-year period ended December 31, 2014 transfer a reasonable possibility of substantial loss to the reinsurer or are accounted for under the deposit method of accounting.
Ceded premiums are treated as a reduction to direct premiums and are recognized when due to the assuming company. Ceded claims are treated as a reduction to direct benefits and are recognized when the claim is incurred on a direct basis. Ceded policy reserve changes are also treated as a reduction to benefits expense and are recognized during the applicable financial reporting period.
Reinsurance premiums, commissions, expense reimbursements and benefits and reserves related to reinsured long-duration contracts are accounted for over the life of the underlying contracts using assumptions consistent with those used to account for the underlying policies. Amounts recoverable from reinsurers are estimated in a manner consistent with the claim liabilities and policy benefits associated with reinsured policies. Ceded policy reserves and claims liabilities relating to insurance ceded are shown as due from reinsurers on the accompanying consolidated balance sheets.
We analyze and monitor the credit-worthiness of each of our reinsurance partners to minimize collection issues. For reinsurance contracts with unauthorized reinsurers, we require collateral such as letters of credit.
To the extent we receive ceding allowances to cover policy and claims administration under reinsurance contracts, these allowances are treated as a reduction to insurance commissions and expenses and are recognized when due from the assuming company. To the extent we receive ceding allowances reimbursing commissions that would otherwise be deferred, the amount of commissions deferrable will be reduced. The corresponding DAC balances are reduced on a pro rata basis by the portion of the business reinsured with reinsurance agreements that meet risk transfer provisions. The reduced DAC will result in a corresponding reduction of amortization expense.
Deferred Policy Acquisition Costs. We only defer the costs of acquiring new business to the extent that they result directly from and are essential to the contract transaction(s) and would not have been incurred had the contract transaction(s) not occurred. These deferred policy acquisition costs mainly include commissions and policy issue expenses. All other acquisition-related costs, including
64
unsuccessful acquisition and renewal efforts, are charged to expense as incurred. Also, administrative costs, rent, depreciation, occupancy, equipment, and all other general overhead costs are considered indirect costs and are charged to expense as incurred.
DAC for term life insurance policies is amortized over the initial premium-paying period of the related policies in proportion to premium income. DAC for Canadian segregated funds is amortized over the life of the underlying policies at a constant rate based on the present value of the estimated gross profits expected to be realized over the life of the underlying policies. DAC is subject to recoverability testing annually and when impairment indicators exist.
See Note 7 (Deferred Policy Acquisition Costs) for more information related to our accounting for DAC.
Intangible Assets. Intangible assets are amortized over their estimated useful lives. Any intangible asset that was deemed to have an indefinite useful life is not amortized but is subject to an annual impairment test. An impairment exists if the carrying value of the indefinite-lived intangible asset exceeds its fair value. For the other intangible assets, which are subject to amortization, an impairment is recognized if the carrying amount is not recoverable and exceeds the fair value of the intangible asset.
The components of intangible assets were as follows:
|
|
December 31, |
|
|||||||||||||||||||||
|
|
2014 |
|
|
2013 |
|
||||||||||||||||||
|
|
Gross carrying amount |
|
|
Accumulated amortization |
|
|
Net carrying amount |
|
|
Gross carrying amount |
|
|
Accumulated amortization |
|
|
Net carrying amount |
|
||||||
|
|
(In thousands) |
|
|||||||||||||||||||||
Indefinite-lived intangible asset |
|
$ |
45,275 |
|
|
n/a |
|
|
$ |
45,275 |
|
|
$ |
45,275 |
|
|
n/a |
|
|
$ |
45,275 |
|
||
Amortizing intangible assets |
|
|
84,871 |
|
|
|
(68,426 |
) |
|
|
16,445 |
|
|
|
88,719 |
|
|
|
(65,131 |
) |
|
|
23,588 |
|
Total intangible assets |
|
$ |
130,146 |
|
|
$ |
(68,426 |
) |
|
$ |
61,720 |
|
|
$ |
133,994 |
|
|
$ |
(65,131 |
) |
|
$ |
68,863 |
|
We have an indefinite-lived intangible asset related to the 1989 purchase of the right to contract with our sales force. This asset represents the core distribution model of our business, which is our primary competitive advantage to profitably distribute term life insurance and investment and savings products on a significant scale, and as such, is considered to have an indefinite life. This indefinite-lived intangible asset is supported by a significant portion of the discounted cash flows of our future business. We assessed this asset for impairment as of October 1, 2014 and determined that no impairment had occurred. There have been no subsequent events requiring further analysis.
We also have an amortizing intangible asset related to a 1995 sales agreement termination payment to Management Financial Services, Inc. This asset is supported by a non-compete agreement with the founder of our business model. We calculate the amortization of this contract buyout on a straight-line basis over 24 years, which represents the life of the non-compete agreement. Intangible asset amortization expense was approximately $3.4 million in 2014, 2013 and 2012. Amortization expense is expected to be approximately $3.4 million annually during the remainder of the amortization period. No events have occurred during 2014, and no factors exist as of December 31, 2014 that would indicate that the net carrying value of our amortizing intangible asset may not be recoverable or will not be used throughout its estimated useful life.
Property and Equipment. Property and equipment, which are included in other assets, are stated at cost, less accumulated depreciation. Depreciation is recognized on a straight-line basis over the asset’s estimated useful life, which is estimated as follows:
|
|
Estimated Useful Life |
Data processing equipment and software |
|
3 to 7 years |
Leasehold improvements |
|
Lesser of 15 years or remaining life of lease |
Furniture and other equipment |
|
5 to 15 years |
Depreciation expense is included in other operating expenses in the accompanying consolidated statements of income. Depreciation expense was $7.0 million, $7.3 million, and $6.1 million for the years ended December 31, 2014, 2013, and 2012, respectively.
Property and equipment balances were as follows:
|
|
December 31, |
|
|||||
|
|
2014(1) |
|
|
2013 |
|
||
|
|
(In thousands) |
|
|||||
Data processing equipment and software |
|
$ |
50,956 |
|
|
$ |
59,237 |
|
Leasehold improvements |
|
|
13,910 |
|
|
|
19,090 |
|
Other, principally furniture and equipment |
|
|
26,763 |
|
|
|
34,783 |
|
|
|
|
91,629 |
|
|
|
113,110 |
|
Accumulated depreciation |
|
|
(65,166 |
) |
|
|
(88,060 |
) |
Net property and equipment |
|
$ |
26,463 |
|
|
$ |
25,050 |
|
(1) In 2014, property and equipment with no remaining net book value was disposed of in connection with asset maintenance activities and the move of our corporate headquarters. The gross carrying amount of assets and accumulated depreciation written off were each $28.9 million.
65
Separate Accounts. The separate accounts are primarily comprised of contracts issued by the Company through its subsidiary, Primerica Life Canada, pursuant to the Insurance Companies Act (Canada). The Insurance Companies Act authorizes Primerica Life Canada to establish the separate accounts.
The separate accounts are represented by individual variable annuity contracts. Purchasers of variable annuity contracts issued by Primerica Life Canada have a direct claim to the benefits of the contract that entitles the holder to units in one or more investment funds (the “Funds”) maintained by Primerica Life Canada. The Funds invest in assets that are held for the benefit of the owners of the contracts. The benefits provided vary in amount depending on the market value of the Funds’ assets. The Funds’ assets are administered by Primerica Life Canada and are held separate and apart from the general assets of the Company. The liabilities reflect the variable insurance annuity contract holders’ interests in variable annuity assets based upon actual investment performance of the respective Funds. Separate account operating results relating to contract holders’ interests are excluded from our consolidated statements of income.
Primerica Life Canada’s contract offerings guarantee the maturity value at the date of maturity (or upon death, whichever occurs first) to be equal to 75% of the sum of all contributions made, net of withdrawals, on a first-in first-out basis. Otherwise, the maturity value or death benefit will be the accumulated value of units allocated to the contract at the specified valuation date. The amount of this value is not guaranteed, but will fluctuate with the fair value of the Funds.
Policyholder Liabilities. Future policy benefits are accrued over the current and expected renewal periods of the contracts. Liabilities for future policy benefits on traditional life insurance products have been computed using a net level method, including assumptions as to interest rates, mortality, persistency, and other assumptions based on our experience, modified as necessary to reflect anticipated trends and to include provisions for possible adverse deviation. The underlying mortality tables are the Society of Actuaries (“SOA”) 65-70, SOA 75-80, SOA 85-90, and the 91 Bragg, modified to reflect various underwriting classifications and assumptions. Interest rate reserve assumptions at December 31, 2014 and 2013 ranged from approximately 3.5% to 7.0%. For policies issued in 2010 and after, we have been using an increasing interest rate assumption to reflect the historically low interest rate environment. The liability for policy claims and other benefits payable on traditional life insurance products includes estimated unpaid claims that have been reported to us and claims incurred but not yet reported.
The future policy benefit reserves we establish are necessarily based on estimates, assumptions and our analysis of historical experience. Our results depend significantly upon the extent to which our actual claims experience is consistent with the assumptions we used in determining our future policy benefit reserves and pricing our products. Our future policy benefit reserve assumptions and estimates require significant judgment and, therefore, are inherently uncertain. We cannot determine with precision the ultimate amounts that we will pay for actual claims or the timing of those payments.
Other Policyholders’ Funds. Other policyholders’ funds primarily represent claim payments left on deposit with us.
Litigation. The Company is involved from time to time in legal disputes, regulatory inquiries and arbitration proceedings in the normal course of business. Legal contingencies are recognized when probable and can be reasonably estimated. Legal costs, such as attorney’s fees and other litigation-related expenses, that are incurred in connection with resolving litigation are expensed as incurred. These disputes are subject to uncertainties, including indeterminate amounts sought in certain of these matters and the inherent unpredictability of litigation. Due to the difficulty of estimating costs of litigation, actual costs may be substantially higher or lower than any amounts reserved.
Income Taxes. We are subject to the income tax laws of the United States, its states, municipalities, and certain unincorporated territories, and those of Canada. These tax laws can be complex and subject to different interpretations by the taxpayer and the relevant governmental taxing authorities. In establishing a provision for income tax expense, we must make judgments and interpretations about the applicability of these tax laws. We also must make estimates about the future impact certain items will have on taxable income in the various tax jurisdictions, both domestic and foreign.
Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to (i) differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and (ii) operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred tax assets are recognized subject to management’s judgment that realization is more likely than not applicable to the periods in which we expect the temporary difference will reverse.
Premium Revenues. Traditional life insurance products consist principally of those products with fixed and guaranteed premiums and benefits, and are primarily related to term products. Premiums are recognized as revenues when due.
Commissions and Fees. We receive commission revenues from the sale of various non-life insurance products on a monthly basis. Commissions are generally received on sales of mutual funds and annuities. We also receive trail commission revenues from mutual fund and annuity products on a monthly basis based on the daily net asset value of shares sold by us. We, in turn, pay certain commissions to our sales force. Additionally, we receive marketing and support fees from product originators. We also receive management fees based on the average daily net asset value of managed investments and contracts related to separate account assets issued by Primerica Life Canada. We earn recordkeeping fees for administrative functions that we perform on behalf of several of our
66
mutual fund providers and custodial fees for services performed as a non-bank custodian of our clients’ retirement plan accounts. We also receive recordkeeping fees monthly from mutual fund accounts on our servicing platform and, in turn, pay a third-party provider for its servicing of certain of these accounts. Commissions and fees are recognized as income during the period in which they are earned.
Benefits and Expenses. Benefit and expense items are charged to income in the period in which they are incurred. Both the change in policyholder liabilities, which is included in benefits and claims, and the amortization of deferred policy acquisition costs will vary with policyholder persistency.
Share-Based Transactions. For employee and director share-based compensation awards, we determine a grant date fair value, based on the price of our publicly-traded common stock, and recognize the related compensation expense, adjusted for expected forfeitures, in the statement of income on a straight-line basis over the requisite service period for the entire award. For non-employee share-based compensation, we recognize the impact during the period of performance, and the fair value of the award is measured as of the date performance is complete, which is the vesting date. To the extent that a share-based award contains sale restrictions extending beyond the vesting date, we reduce the recognized fair value of the award to reflect the corresponding illiquidity discount. Most non-employee share-based compensation is an incremental direct cost of successful acquisitions or renewals of life insurance policies that result directly from and are essential to the policy acquisition(s) and would not have been incurred had the policy acquisition(s) not occurred. We defer these expenses and amortize the impact over the life of the underlying life insurance policies acquired.
Earnings Per Share (“EPS”). The Company has outstanding common stock and equity awards that consist of restricted stock, restricted stock units (“RSUs”), and stock options. The restricted stock and RSUs maintain non-forfeitable dividend rights that result in dividend payment obligations on a one-to-one ratio with common shares for any future dividend declarations. Unvested restricted stock and unvested RSUs are deemed participating securities for purposes of calculating EPS as they maintain dividend rights.
See Note 13 (Earnings Per Share) for details related to the calculations of our basic and diluted EPS using the two-class method.
New Accounting Principles. In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”). ASU 2014-09 clarifies the principles for recognizing revenue by establishing the core principle that an entity should recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2014-09 also requires additional disclosure about the nature, amount, timing and uncertainty of revenue that is recognized. Insurance contracts are specifically excluded from the scope of ASU 2014-09 and therefore revenue from our insurance product lines will not be affected by the new standard. The amendments in ASU 2014-09 are effective retrospectively for the Company beginning in fiscal year 2017. Early adoption is not permitted. While we are still in the process of evaluating the guidance in ASU 2014-09, we do not expect it will have a material impact on our consolidated financial statements.
Future Application of Accounting Standards. Recent accounting guidance not discussed is not applicable, is immaterial to our financial statements, or did not or will not have an impact on our business.
(2) Discontinued Operations
In January 2014, NBLIC sold the assets and liabilities of its short-term statutory disability benefit insurance business (“DBL”) to AmTrust North America, Inc. and its affiliates (the “buyer”). As part of the sale agreement, the buyer assumed all liabilities for DBL insurance policies. In addition, NBLIC transferred the assets held in support of DBL’s insurance liabilities and all other premium-related assets and liabilities to the buyer as of January 1, 2014. The results of DBL’s operations from January 1, 2014 forward were also transferred to the buyer. NBLIC received cash proceeds from the sale of $3.0 million and recognized a pre-tax gain on the sale of approximately $2.4 million, which comprised income from discontinued operations before income taxes in our results of operations for the year ended December 31, 2014.
We no longer have significant continuing involvement in the operations of DBL, and its direct cash flows have been eliminated from our ongoing operations. As a result, beginning in 2014, the results of operations for DBL have been reported in discontinued operations for all periods presented in the consolidated statements of income. The results of operations and the carrying values of the assets and liabilities related to DBL were as follows:
|
|
Year ended December 31, |
|
|||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|||
|
|
(In thousands) |
|
|||||||||
Total revenues from discontinued operations |
|
$ |
- |
|
|
$ |
36,878 |
|
|
$ |
36,943 |
|
Income from discontinued operations before income taxes |
|
|
2,427 |
|
|
|
6,192 |
|
|
|
766 |
|
Provision for income taxes |
|
|
849 |
|
|
|
2,168 |
|
|
|
269 |
|
Income from discontinued operations, net income taxes |
|
$ |
1,578 |
|
|
$ |
4,024 |
|
|
$ |
497 |
|
67
|
|
December 31, 2014 |
|
|
December 31, 2013 |
|
||
|
|
(In thousands) |
|
|||||
Premiums and other receivables |
|
$ |
- |
|
|
$ |
6,439 |
|
Policy claims and other benefits payable |
|
|
- |
|
|
|
5,047 |
|
Other liabilities |
|
|
- |
|
|
|
1,197 |
|
(3) Segment and Geographical Information
Segments. We have two primary operating segments — Term Life Insurance and Investment and Savings Products. The Term Life Insurance segment includes underwriting profits on our in-force book of term life insurance policies, net of reinsurance, which are underwritten by our life insurance company subsidiaries. The Investment and Savings Products segment includes retail and managed mutual funds and annuities distributed through licensed broker-dealer subsidiaries and includes segregated funds, an individual annuity savings product that we underwrite in Canada through Primerica Life Canada. In the United States, we distribute mutual fund and annuity products of several third-party companies. We also earn fees for account servicing on a subset of the mutual funds we distribute. In Canada, we offer a Primerica-branded fund-of-funds mutual fund product, as well as mutual funds of well-known mutual fund companies. These two operating segments are managed separately because their products serve different needs — term life insurance protection versus wealth-building savings products.
We also have a Corporate and Other Distributed Products segment, which consists primarily of revenues and expenses related to the distribution of non-core products, prepaid legal services and various financial products other than our core term life insurance products generally underwritten or offered by third-party providers. The results of operations for DBL were previously reported in our Corporate and Other Distributed Products segment and have been reclassified into discontinued operations as discussed in Note 2 (Discontinued Operations).
Results of continuing operations by segment were as follows:
|
|
Year ended December 31, |
|
|||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|||
|
|
(In thousands) |
|
|||||||||
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
Term life insurance segment |
|
$ |
759,294 |
|
|
$ |
694,975 |
|
|
$ |
640,134 |
|
Investment and savings products segment |
|
|
512,073 |
|
|
|
457,138 |
|
|
|
413,965 |
|
Corporate and other distributed products segment |
|
|
68,663 |
|
|
|
78,457 |
|
|
|
99,673 |
|
Total revenues |
|
$ |
1,340,030 |
|
|
$ |
1,230,570 |
|
|
$ |
1,153,772 |
|
Income (loss) from continuing operations before income taxes: |
|
|
|
|
|
|
|
|
|
|
|
|
Term life insurance segment |
|
$ |
201,033 |
|
|
$ |
197,201 |
|
|
$ |
185,926 |
|
Investment and savings products segment |
|
|
146,017 |
|
|
|
105,149 |
|
|
|
121,116 |
|
Corporate and other distributed products segment |
|
|
(71,328 |
) |
|
|
(57,344 |
) |
|
|
(40,920 |
) |
Total income from continuing operations before income taxes |
|
$ |
275,722 |
|
|
$ |
245,006 |
|
|
$ |
266,122 |
|
In connection with our IPO in 2010, we entered into a reinsurance agreement subject to deposit accounting (the “10% Coinsurance Agreement”) with Prime Reinsurance Company, Inc. (“Prime Re”), an affiliate of Citigroup. The deposit asset recognized in connection with our 10% Coinsurance Agreement generates an effective yield, which is reported in the Corporate and Other Distributed Products segment and reflected in net investment income in our consolidated statements of income. We then allocate the remaining net investment income based on the book value of the invested assets allocated to the Term Life Insurance segment compared to the book value of total invested assets.
Insurance expenses and other operating expenses directly attributable to the Term Life Insurance and the Investment and Savings Products segments are recorded directly to the applicable segment. We allocate certain other operating expenses that are not directly attributable to a specific operating segment based on the relative sizes of our life-licensed and securities-licensed independent sales forces. These allocated costs include field technology, supervision, training and certain miscellaneous costs. We also allocate certain technology and occupancy costs to our operating segments based on usage. Any remaining unallocated revenue and expense items, as well as realized investment gains and losses, are reported in the Corporate and Other Distributed Products segment. We measure income and loss for the segments on an income before income taxes basis.
68
Total assets by segment were as follows:
|
|
December 31, 2014 |
|
|
December 31, 2013 |
|
|
December 31, 2012 |
|
|||
|
|
(In thousands) |
|
|||||||||
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Term life insurance segment |
|
$ |
7,165,373 |
|
|
$ |
6,783,194 |
|
|
$ |
6,400,126 |
|
Investment and savings products segment |
|
|
2,642,753 |
|
|
|
2,699,000 |
|
|
|
2,810,137 |
|
Corporate and other distributed products segment |
|
|
929,988 |
|
|
|
847,756 |
|
|
|
1,127,614 |
|
Total assets |
|
$ |
10,738,114 |
|
|
$ |
10,329,950 |
|
|
$ |
10,337,877 |
|
Assets specifically related to a segment are held in that segment. We allocate invested assets to the Term Life Insurance segment based on the book value of invested assets necessary to meet statutory reserve requirements and our targeted capital objectives. Remaining invested assets and all unrealized gains and losses are allocated to the Corporate and Other Distributed Products segment. The deposit asset recognized in connection with our 10% Coinsurance Agreement is reported in the Corporate and Other Distributed Products segment. A held-to-maturity security received in connection with the Vidalia Re Coinsurance Agreement is reported as part of our invested assets within the Term Life Insurance segment. DAC is recognized in a particular segment based on the product to which it relates. Separate account assets supporting the segregated funds product in Canada are held in the Investment and Savings Products segment. Any remaining unallocated assets are reported in the Corporate and Other Distributed Products segment.
Excluding separate accounts, the Investment and Savings Product segment assets were approximately $202.9 million, $195.8 million, and $192.8 million as of December 31, 2014, 2013, and 2012, respectively.
See “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included elsewhere in this report for more information regarding our operating segments.
Geographical Information. Results of continuing operations by country and long-lived assets — primarily tangible assets reported in other assets in our consolidated balance sheets —were as follows:
|
|
Year ended December 31, |
|
|||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|||
|
|
(In thousands) |
|
|||||||||
Revenues by country: |
|
|
|
|
|
|
|
|
|
|
|
|
United States |
|
$ |
1,095,888 |
|
|
$ |
998,186 |
|
|
$ |
934,672 |
|
Canada |
|
|
244,142 |
|
|
|
232,384 |
|
|
|
219,100 |
|
Total revenues |
|
$ |
1,340,030 |
|
|
$ |
1,230,570 |
|
|
$ |
1,153,772 |
|
Income from continuing operations before income taxes by country: |
|
|
|
|
|
|
|
|
|
|
|
|
United States |
|
$ |
203,120 |
|
|
$ |
177,312 |
|
|
$ |
201,625 |
|
Canada |
|
|
72,602 |
|
|
|
67,694 |
|
|
|
64,497 |
|
Total income from continuing operations before income taxes |
|
$ |
275,722 |
|
|
$ |
245,006 |
|
|
$ |
266,122 |
|
|
|
December 31, 2014 |
|
|
December 31, 2013 |
|
|
December 31, 2012 |
|
|||
|
|
(In thousands) |
|
|||||||||
Long-lived assets by country: |
|
|
|
|
|
|
|
|
|
|
|
|
United States |
|
$ |
25,897 |
|
|
$ |
24,413 |
|
|
$ |
12,908 |
|
Canada |
|
|
566 |
|
|
|
637 |
|
|
|
450 |
|
Total long-lived assets |
|
$ |
26,463 |
|
|
$ |
25,050 |
|
|
$ |
13,358 |
|
69
(4) Investments
Available-for-sale Securities. The period-end cost or amortized cost, gross unrealized gains and losses, and fair value of available-for-sale fixed-maturity and equity securities follow:
|
|
December 31, 2014 |
|
|||||||||||||
|
|
Cost or amortized cost |
|
|
Gross unrealized gains |
|
|
Gross unrealized losses |
|
|
Fair value |
|
||||
|
|
(In thousands) |
|
|||||||||||||
Securities available-for-sale, carried at fair value: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed-maturity securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. government and agencies |
|
$ |
15,145 |
|
|
$ |
557 |
|
|
$ |
(55 |
) |
|
$ |
15,647 |
|
Foreign government |
|
|
120,910 |
|
|
|
5,388 |
|
|
|
(3,801 |
) |
|
|
122,497 |
|
States and political subdivisions |
|
|
38,163 |
|
|
|
2,719 |
|
|
|
(188 |
) |
|
|
40,694 |
|
Corporates |
|
|
1,241,526 |
|
|
|
82,167 |
|
|
|
(7,825 |
) |
|
|
1,315,868 |
|
Mortgage- and asset-backed securities |
|
|
251,756 |
|
|
|
13,050 |
|
|
|
(392 |
) |
|
|
264,414 |
|
Total fixed-maturity securities(1) |
|
|
1,667,500 |
|
|
|
103,881 |
|
|
|
(12,261 |
) |
|
|
1,759,120 |
|
Equity securities |
|
|
43,738 |
|
|
|
10,711 |
|
|
|
(1,059 |
) |
|
|
53,390 |
|
Total fixed-maturity and equity securities |
|
$ |
1,711,238 |
|
|
$ |
114,592 |
|
|
$ |
(13,320 |
) |
|
$ |
1,812,510 |
|
(1) |
Includes approximately $0.7 million of other-than-temporary impairment losses related to corporates and mortgage- and asset-backed securities recognized in accumulated other comprehensive income. |
|
|
December 31, 2013 |
|
|||||||||||||
|
|
Cost or amortized cost |
|
|
Gross unrealized gains |
|
|
Gross unrealized losses |
|
|
Fair value |
|
||||
|
|
(In thousands) |
|
|||||||||||||
Securities available-for-sale, carried at fair value: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed-maturity securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. government and agencies |
|
$ |
8,696 |
|
|
$ |
485 |
|
|
$ |
(127 |
) |
|
$ |
9,054 |
|
Foreign government |
|
|
111,610 |
|
|
|
7,512 |
|
|
|
(2,766 |
) |
|
|
116,356 |
|
States and political subdivisions |
|
|
32,308 |
|
|
|
1,860 |
|
|
|
(468 |
) |
|
|
33,700 |
|
Corporates |
|
|
1,240,100 |
|
|
|
84,545 |
|
|
|
(11,931 |
) |
|
|
1,312,714 |
|
Mortgage- and asset-backed securities |
|
|
270,308 |
|
|
|
14,610 |
|
|
|
(1,030 |
) |
|
|
283,888 |
|
Total fixed-maturity securities(1) |
|
|
1,663,022 |
|
|
|
109,012 |
|
|
|
(16,322 |
) |
|
|
1,755,712 |
|
Equity securities |
|
|
32,592 |
|
|
|
7,935 |
|
|
|
(633 |
) |
|
|
39,894 |
|
Total fixed-maturity and equity securities |
|
$ |
1,695,614 |
|
|
$ |
116,947 |
|
|
$ |
(16,955 |
) |
|
$ |
1,795,606 |
|
(1) |
Includes approximately $2.1 million of other-than-temporary impairment losses related to corporates and mortgage- and asset-backed securities recognized in accumulated other comprehensive income. |
All of our available-for-sale mortgage- and asset-backed securities represent variable interests in variable interest entities (“VIEs”). We are not the primary beneficiary of these VIEs because we do not have the power to direct the activities that most significantly impact the entities’ economic performance. The maximum exposure to loss as a result of our involvement in these VIEs equals the carrying value of the securities.
The scheduled maturity distribution of the available-for-sale fixed-maturity portfolio at December 31, 2014 follows:
|
|
Amortized cost |
|
|
Fair value |
|
||
|
|
(In thousands) |
|
|||||
Due in one year or less |
|
$ |
96,063 |
|
|
$ |
97,085 |
|
Due after one year through five years |
|
|
584,737 |
|
|
|
632,934 |
|
Due after five years through 10 years |
|
|
686,366 |
|
|
|
711,668 |
|
Due after 10 years |
|
|
48,578 |
|
|
|
53,019 |
|
|
|
|
1,415,744 |
|
|
|
1,494,706 |
|
Mortgage- and asset-backed securities |
|
|
251,756 |
|
|
|
264,414 |
|
Total fixed-maturity securities |
|
$ |
1,667,500 |
|
|
$ |
1,759,120 |
|
Expected maturities may differ from scheduled contractual maturities because issuers of securities may have the right to call or prepay obligations with or without call or prepayment penalties.
70
Unrealized Gains and Losses on Investments. The net effect on stockholders’ equity of unrealized gains and losses on available-for-sale securities was as follows:
|
|
December 31, 2014 |
|
|
December 31, 2013 |
|
||
|
|
(In thousands) |
|
|||||
Net unrealized investment gains including foreign currency translation adjustment and other-than-temporary impairments: |
|
|
|
|
|
|
|
|
Fixed-maturity and equity securities |
|
$ |
101,272 |
|
|
$ |
99,992 |
|
Currency swaps |
|
|
23 |
|
|
|
72 |
|
Foreign currency translation adjustment |
|
|
12,314 |
|
|
|
1,523 |
|
Other-than-temporary impairments |
|
|
710 |
|
|
|
2,072 |
|
Net unrealized investment gains excluding foreign currency translation adjustment and other-than-temporary impairments |
|
|
114,319 |
|
|
|
103,659 |
|
Deferred income taxes |
|
|
(40,011 |
) |
|
|
(36,280 |
) |
Net unrealized investment gains excluding foreign currency translation adjustment and other-than-temporary impairments, net of tax |
|
$ |
74,308 |
|
|
$ |
67,379 |
|
Trading Securities. We maintain a portfolio of fixed-maturity securities that are classified as trading securities. The carrying values of the fixed-maturity securities classified as trading securities were approximately $7.7 million and $13.0 million as of December 31, 2014 and 2013, respectively.
Held-to-maturity Security. Concurrent with the execution of the Vidalia Re Coinsurance Agreement, Vidalia Re entered into a Surplus Note Purchase Agreement (the “Surplus Note Purchase Agreement”) with Hannover Life Reassurance Company of America and certain of its affiliates (collectively, “Hannover Re”) and a newly formed limited liability company (the “LLC”) owned by a third party service provider. Under the Surplus Note Purchase Agreement, Vidalia Re issued a surplus note (the “Surplus Note”) to the LLC in exchange for a credit enhanced note from the LLC with an equal principal amount (the “LLC Note”). The principal amount of both the LLC Note and the Surplus Note will fluctuate over time to coincide with the amount of reserves contractually supported under the Vidalia Re Coinsurance Agreement. Both the LLC Note and the Surplus Note mature on December 31, 2029 and bear interest at an annual interest rate of 4.50%. The LLC Note is guaranteed by Hannover Re through a credit enhancement feature in exchange for a fee.
The LLC is a variable interest entity as its owner does not have an equity investment at risk that is sufficient to permit the LLC to finance its activities without Vidalia Re or Hannover Re. The Parent Company, Primerica Life, and Vidalia Re share the power to direct the activities of the LLC with Hannover Re, but do not have the obligation to absorb losses or the right to receive any residual returns related to the LLC’s primary risks or sources of variability. Through the credit enhancement feature, Hannover Re is the ultimate risk taker in this transaction and bears the obligation to absorb the LLC’s losses in the event of a Surplus Note default in exchange for the fee. Accordingly, the Company is not the primary beneficiary of the LLC and does not consolidate the LLC within its consolidated financial statements.
The LLC Note is classified as a held-to-maturity debt security in the Company’s invested asset portfolio as we have the positive intent and ability to hold the security until maturity. The LLC Note, which was rated AA- by Fitch Ratings, had an estimated unrealized holding gain of $8.8 million based on its amortized cost and estimated fair value as of December 31, 2014.
See Note 10 (Debt) for more information on the Surplus Note.
Investments on Deposit with Governmental Authorities. As required by law, we have investments on deposit with governmental authorities and banks for the protection of policyholders. The fair values of investments on deposit were $19.9 million and $18.4 million as of December 31, 2014 and 2013, respectively.
Securities Lending Transactions. We participate in securities lending transactions with broker-dealers and other financial institutions to increase investment income with minimal risk. We require minimum collateral on securities loaned equal to 102% of the fair value of the loaned securities. We accept collateral in the form of securities, which we are not able to sell or encumber, and to the extent the collateral declines in value below 100%, we require additional collateral from the borrower. Any securities collateral received is not reflected on our consolidated balance sheets. We also accept collateral in the form of cash, all of which we reinvest. For loans involving unrestricted cash collateral, the collateral is reported as an asset with a corresponding liability representing our obligation to return the collateral. We continue to carry the loaned securities as invested assets on our consolidated balance sheets during the terms of the loans, and we do not report them as sales. Cash collateral received and reinvested was approximately $50.2 million and $89.9 million as of December 31, 2014 and 2013, respectively.
71
Investment Income. The components of net investment income were as follows:
|
|
Year ended December 31, |
|
|||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|||
|
|
(In thousands) |
|
|||||||||
Fixed-maturity securities (available-for-sale) |
|
$ |
84,687 |
|
|
$ |
89,860 |
|
|
$ |
100,520 |
|
Fixed-maturity security (held-to-maturity) |
|
|
3,482 |
|
|
|
- |
|
|
|
- |
|
Equity securities |
|
|
1,862 |
|
|
|
1,186 |
|
|
|
1,051 |
|
Policy loans and other invested assets |
|
|
1,448 |
|
|
|
1,363 |
|
|
|
1,251 |
|
Cash and cash equivalents |
|
|
247 |
|
|
|
272 |
|
|
|
454 |
|
Market return on deposit asset underlying 10% coinsurance agreement |
|
|
3,095 |
|
|
|
938 |
|
|
|
2,903 |
|
Gross investment income |
|
|
94,821 |
|
|
|
93,619 |
|
|
|
106,179 |
|
Investment expenses |
|
|
(4,866 |
) |
|
|
(4,867 |
) |
|
|
(5,375 |
) |
Interest expense on Surplus Note |
|
|
(3,482 |
) |
|
|
- |
|
|
|
- |
|
Net investment income |
|
$ |
86,473 |
|
|
$ |
88,752 |
|
|
$ |
100,804 |
|
The components of net realized investment gains (losses), as well as details on gross realized investment gains (losses) and proceeds from sales or other redemptions, were as follows:
|
|
Year ended December 31, |
|
|||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|||
|
|
(In thousands) |
|
|||||||||
Net realized investment gains (losses): |
|
|
|
|
|
|
|
|
|
|
|
|
Gross gains from sales |
|
$ |
3,687 |
|
|
$ |
6,734 |
|
|
$ |
11,882 |
|
Gross losses from sales |
|
|
(436 |
) |
|
|
(1,209 |
) |
|
|
(83 |
) |
Gains from securities transferred from available-for-sale to trading securities |
|
|
- |
|
|
|
- |
|
|
|
323 |
|
Losses from securities transferred from available-for-sale to trading securities |
|
|
- |
|
|
|
- |
|
|
|
(6 |
) |
Other-than-temporary impairment losses |
|
|
(4,045 |
) |
|
|
(616 |
) |
|
|
(641 |
) |
Gains (losses) from bifurcated options |
|
|
533 |
|
|
|
1,337 |
|
|
|
(93 |
) |
Net realized investment gains (losses) |
|
$ |
(261 |
) |
|
$ |
6,246 |
|
|
$ |
11,382 |
|
Supplemental information: |
|
|
|
|
|
|
|
|
|
|
|
|
Gross realized investment gains (losses) reclassified from accumulated other comprehensive income into earnings |
|
$ |
(794 |
) |
|
$ |
4,909 |
|
|
$ |
11,475 |
|
Tax expense (benefit) associated with realized investment gains (losses) reclassified from accumulated other comprehensive income into earnings |
|
$ |
(278 |
) |
|
$ |
1,718 |
|
|
$ |
4,016 |
|
Proceeds from sales or other redemptions |
|
$ |
426,621 |
|
|
$ |
371,215 |
|
|
$ |
571,017 |
|
Other-Than-Temporary Impairment. We conduct a review each quarter to identify and evaluate impaired investments that have indications of possible OTTI. An investment in a debt or equity security is impaired if its fair value falls below its cost. Factors considered in determining whether an unrealized loss is temporary include the length of time and extent to which fair value has been below cost, the financial condition and near-term prospects for the issue, and our ability and intent to hold the investment for a period of time sufficient to allow for any anticipated recovery, which may be maturity.
Our review for other-than-temporary impairment generally entails:
· |
Analysis of individual investments that have fair values less than a pre-defined percentage of amortized cost, including consideration of the length of time the investment has been in an unrealized loss position; |
· |
Analysis of corporate fixed-maturity securities by reviewing the issuer’s most recent performance to date, including analyst reviews, analyst outlooks and rating agency information; |
· |
Analysis of commercial mortgage-backed securities based on an assessment of performance to date, credit enhancement, risk analytics and outlook, underlying collateral, loss projections, rating agency information and available third-party reviews and analytics; |
· |
Analysis of residential mortgage-backed securities based on loss projections provided by models compared to current credit enhancement levels; |
· |
Analysis of our other fixed-maturity and equity security investments, as required based on the type of investment; and |
· |
Analysis of downward credit migrations that occurred during the quarter. |
Available-for-sale fixed-maturity and equity securities with a cost basis in excess of their fair values were approximately $340.8 million and $454.2 million as of December 31, 2014 and 2013, respectively.
72
The following tables summarize, for all available-for-sale securities in an unrealized loss position, the aggregate fair value and the gross unrealized loss by length of time such securities have continuously been in an unrealized loss position:
|
|
December 31, 2014 |
|
|||||||||||||||||||||
|
|
Less than 12 months |
|
|
12 months or longer |
|
||||||||||||||||||
|
|
Fair value |
|
|
Unrealized losses |
|
|
Number of securities |
|
|
Fair value |
|
|
Unrealized losses |
|
|
Number of securities |
|
||||||
|
|
(Dollars in thousands) |
|
|||||||||||||||||||||
Fixed-maturity securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. government and agencies |
|
$ |
7,201 |
|
|
$ |
(1 |
) |
|
|
2 |
|
|
$ |
896 |
|
|
$ |
(54 |
) |
|
|
2 |
|
Foreign government |
|
|
28,038 |
|
|
|
(1,317 |
) |
|
|
35 |
|
|
|
23,330 |
|
|
|
(2,484 |
) |
|
|
40 |
|
States and political subdivisions |
|
|
1,694 |
|
|
|
(4 |
) |
|
|
3 |
|
|
|
2,720 |
|
|
|
(184 |
) |
|
|
4 |
|
Corporates |
|
|
144,262 |
|
|
|
(3,818 |
) |
|
|
153 |
|
|
|
43,736 |
|
|
|
(4,007 |
) |
|
|
78 |
|
Mortgage-and asset-backed securities |
|
|
49,591 |
|
|
|
(109 |
) |
|
|
43 |
|
|
|
16,847 |
|
|
|
(283 |
) |
|
|
20 |
|
Total fixed-maturity securities |
|
|
230,786 |
|
|
|
(5,249 |
) |
|
|
|
|
|
|
87,529 |
|
|
|
(7,012 |
) |
|
|
|
|
Equity securities |
|
|
6,849 |
|
|
|
(862 |
) |
|
|
15 |
|
|
|
2,303 |
|
|
|
(197 |
) |
|
|
1 |
|
Total fixed-maturity and equity securities |
|
$ |
237,635 |
|
|
$ |
(6,111 |
) |
|
|
|
|
|
$ |
89,832 |
|
|
$ |
(7,209 |
) |
|
|
|
|
|
|
December 31, 2013 |
|
|||||||||||||||||||||
|
|
Less than 12 months |
|
|
12 months or longer |
|
||||||||||||||||||
|
|
Fair value |
|
|
Unrealized losses |
|
|
Number of securities |
|
|
Fair value |
|
|
Unrealized losses |
|
|
Number of securities |
|
||||||
|
|
(Dollars in thousands) |
|
|||||||||||||||||||||
Fixed-maturity securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. government and agencies |
|
$ |
3,817 |
|
|
$ |
(36 |
) |
|
|
3 |
|
|
$ |
859 |
|
|
$ |
(91 |
) |
|
|
2 |
|
Foreign government |
|
|
34,869 |
|
|
|
(2,190 |
) |
|
|
47 |
|
|
|
5,999 |
|
|
|
(576 |
) |
|
|
13 |
|
States and political subdivisions |
|
|
8,520 |
|
|
|
(468 |
) |
|
|
11 |
|
|
|
152 |
|
|
|
- |
|
(1) |
|
1 |
|
Corporates |
|
|
296,192 |
|
|
|
(9,510 |
) |
|
|
295 |
|
|
|
19,022 |
|
|
|
(2,421 |
) |
|
|
31 |
|
Mortgage-and asset-backed securities |
|
|
54,215 |
|
|
|
(536 |
) |
|
|
46 |
|
|
|
10,523 |
|
|
|
(494 |
) |
|
|
9 |
|
Total fixed-maturity securities |
|
|
397,613 |
|
|
|
(12,740 |
) |
|
|
|
|
|
|
36,555 |
|
|
|
(3,582 |
) |
|
|
|
|
Equity securities |
|
|
3,081 |
|
|
|
(633 |
) |
|
|
7 |
|
|
|
- |
|
|
|
- |
|
|
- |
|
|
Total fixed-maturity and equity securities |
|
$ |
400,694 |
|
|
$ |
(13,373 |
) |
|
|
|
|
|
$ |
36,555 |
|
|
$ |
(3,582 |
) |
|
|
|
|
(1) |
Less than one thousand. |
The amortized cost and fair value of available-for-sale fixed-maturity securities in default were as follows:
|
|
December 31, 2014 |
|
|
December 31, 2013 |
|
||||||||||
|
|
Amortized cost |
|
|
Fair value |
|
|
Amortized cost |
|
|
Fair value |
|
||||
|
|
(In thousands) |
|
|||||||||||||
Fixed-maturity securities in default |
|
$ |
144 |
|
|
$ |
611 |
|
|
$ |
31 |
|
|
$ |
267 |
|
Impairment charges recognized in earnings on available-for-sale securities were as follows:
|
|
Year ended December 31, |
|
|||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|||
|
|
(In thousands) |
|
|||||||||
Impairments on fixed-maturity securities not in default |
|
$ |
3,656 |
|
|
$ |
609 |
|
|
$ |
479 |
|
Impairments on equity securities |
|
|
389 |
|
|
|
7 |
|
|
|
162 |
|
Total impairment charges |
|
$ |
4,045 |
|
|
$ |
616 |
|
|
$ |
641 |
|
The securities noted above were considered to be other-than-temporarily impaired due to our intent to sell them; adverse credit events, such as news of an impending filing for bankruptcy; analyses of the issuer’s most recent financial statements or other information in which liquidity deficiencies, significant losses and large declines in capitalization were evident; or analyses of rating agency information for issuances with severe ratings downgrades that indicated a significant increase in the possibility of default. During 2014, we recognized impairment losses related to invested assets held at the Parent Company that we intended to sell to fund share repurchases, as well as credit impairments on certain other investments.
As of December 31, 2014, the unrealized losses on our available-for-sale invested asset portfolio were largely caused by interest rate sensitivity, foreign currency exchange rates on our Canadian dollar-denominated investments, and changes in credit spreads. We believe that fluctuations caused by interest rate movement have little bearing on the recoverability of our investments. Because we have the ability to hold these investments until a market price recovery or maturity and we have no present intention to dispose of them, we do not consider these investments to be other-than-temporarily impaired.
73
Net impairment losses recognized in earnings were as follows:
|
|
Year ended December 31, |
|
|||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|||
|
|
(In thousands) |
|
|||||||||
Total impairment losses related to securities which the Company does not intend to sell or more-likely-than-not will not be required to sell: |
|
|
|
|
|
|
|
|
|
|
|
|
Total OTTI losses recognized |
|
$ |
1,579 |
|
|
$ |
832 |
|
|
$ |
991 |
|
Less portion of OTTI loss recognized in accumulated other comprehensive income (loss) |
|
|
- |
|
|
|
(479 |
) |
|
|
(563 |
) |
Net impairment losses recognized in earnings for securities which the Company does not intend to sell or more-likely-than-not will not be required to sell before recovery |
|
|
1,579 |
|
|
|
353 |
|
|
|
428 |
|
OTTI losses recognized in earnings for securities which the Company intends to sell or more-likely-than-not will be required to sell before recovery |
|
|
2,466 |
|
|
|
263 |
|
|
|
213 |
|
Net impairment losses recognized in earnings |
|
$ |
4,045 |
|
|
$ |
616 |
|
|
$ |
641 |
|
The roll-forward of the credit-related losses recognized in income for all fixed-maturity securities still held follows.
|
|
Year ended December 31, |
|
|||||
|
|
2014 |
|
|
2013 |
|
||
|
|
(In thousands) |
|
|||||
Cumulative OTTI credit losses recognized for securities still held, beginning of period |
|
$ |
14,516 |
|
|
$ |
14,171 |
|
Additions for OTTI securities where no credit losses were recognized prior to the beginning of the period |
|
|
3,654 |
|
|
|
606 |
|
Additions for OTTI securities where credit losses have been recognized prior to the beginning of the period |
|
|
2 |
|
|
|
3 |
|
Reductions due to sales, maturities or calls of credit impaired securities |
|
|
(1,723 |
) |
|
|
(264 |
) |
Cumulative OTTI credit losses recognized for securities still held, end of period |
|
$ |
16,449 |
|
|
$ |
14,516 |
|
Derivatives. Embedded conversion options associated with fixed-maturity securities are bifurcated from the fixed-maturity security host contracts and separately recognized as equity securities. The change in fair value of these bifurcated conversion options is reflected in realized investment gains (losses), including OTTI losses. As of December 31, 2014 and 2013, the fair value of these bifurcated options was approximately $5.8 million and $4.6 million, respectively.
We have a deferred loss related to closed forward contracts, which were settled several years ago, that were used to mitigate our exposure to foreign currency exchange rates that resulted from the net investment in our Canadian operations. The amount of deferred loss included in accumulated other comprehensive income was approximately $26.4 million as of December 31, 2014 and 2013. While we have no current intention to do so, these deferred losses will not be recognized until such time as we sell or substantially liquidate our Canadian operations.
(5) Fair Value of Financial Instruments
Fair value is the price that would be received upon the sale of an asset in an orderly transaction between market participants at the measurement date. Fair value measurements are based upon observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our view of market assumptions in the absence of observable market information. We classify and disclose all invested assets carried at fair value in one of the following three categories:
· |
Level 1. Quoted prices for identical instruments in active markets. Level 1 primarily consists of financial instruments whose value is based on quoted market prices in active markets, such as exchange-traded common stocks and actively traded mutual fund investments; |
· |
Level 2. Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets. Level 2 includes those financial instruments that are valued using industry-standard pricing methodologies, models or other valuation methodologies. Various inputs are considered in deriving the fair value of the underlying financial instrument, including interest rate, credit spread, and foreign exchange rates. All significant inputs are observable, or derived from observable information in the marketplace or are supported by observable levels at which transactions are executed in the marketplace. Financial instruments in this category primarily include: certain public and private corporate fixed-maturity and equity securities; government or agency securities; certain mortgage- and asset-backed securities and bifurcated conversion options; and |
· |
Level 3. Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. Level 3 consists of financial instruments whose fair value is estimated based on industry-standard pricing methodologies and models using significant inputs not based on, nor corroborated by, readily available market information. Valuations for this category primarily consist of non-binding broker quotes. Financial instruments in this category primarily include less liquid fixed-maturity corporate securities, mortgage- and asset-backed securities. |
74
As of each reporting period, all assets and liabilities recorded at fair value are classified in their entirety based on the lowest level of input (Level 3 being the lowest) that is significant to the fair value measurement. Significant levels of estimation and judgment are required to determine the fair value of certain of our investments. The factors influencing these estimations and judgments are subject to change in subsequent reporting periods.
The estimated fair value and hierarchy classifications for assets and liabilities that are measured at fair value on a recurring basis were as follows:
|
|
December 31, 2014 |
|
|||||||||||||
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total |
|
||||
|
|
(In thousands) |
|
|||||||||||||
Fair value assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed-maturity securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. government and agencies |
|
$ |
- |
|
|
$ |
15,647 |
|
|
$ |
- |
|
|
$ |
15,647 |
|
Foreign government |
|
|
- |
|
|
|
122,497 |
|
|
|
- |
|
|
|
122,497 |
|
States and political subdivisions |
|
|
- |
|
|
|
40,694 |
|
|
|
- |
|
|
|
40,694 |
|
Corporates |
|
|
2,104 |
|
|
|
1,313,534 |
|
|
|
230 |
|
|
|
1,315,868 |
|
Mortgage- and asset-backed securities |
|
|
- |
|
|
|
263,527 |
|
|
|
887 |
|
|
|
264,414 |
|
Total fixed-maturity securities |
|
|
2,104 |
|
|
|
1,755,899 |
|
|
|
1,117 |
|
|
|
1,759,120 |
|
Equity securities |
|
|
47,169 |
|
|
|
6,173 |
|
|
|
48 |
|
|
|
53,390 |
|
Trading securities |
|
|
- |
|
|
|
7,711 |
|
|
|
- |
|
|
|
7,711 |
|
Separate accounts |
|
|
- |
|
|
|
2,440,303 |
|
|
|
- |
|
|
|
2,440,303 |
|
Total fair value assets |
|
$ |
49,273 |
|
|
$ |
4,210,086 |
|
|
$ |
1,165 |
|
|
$ |
4,260,524 |
|
Fair value liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Separate accounts |
|
$ |
- |
|
|
$ |
2,440,303 |
|
|
$ |
- |
|
|
$ |
2,440,303 |
|
Total fair value liabilities |
|
$ |
- |
|
|
$ |
2,440,303 |
|
|
$ |
- |
|
|
$ |
2,440,303 |
|
|
|
December 31, 2013 |
|
|||||||||||||
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total |
|
||||
|
|
(In thousands) |
|
|||||||||||||
Fair value assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed-maturity securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. government and agencies |
|
$ |
- |
|
|
$ |
9,054 |
|
|
$ |
- |
|
|
$ |
9,054 |
|
Foreign government |
|
|
- |
|
|
|
116,356 |
|
|
|
- |
|
|
|
116,356 |
|
States and political subdivisions |
|
|
- |
|
|
|
33,700 |
|
|
|
- |
|
|
|
33,700 |
|
Corporates |
|
|
1,282 |
|
|
|
1,310,739 |
|
|
|
693 |
|
|
|
1,312,714 |
|
Mortgage- and asset-backed securities |
|
|
- |
|
|
|
282,341 |
|
|
|
1,547 |
|
|
|
283,888 |
|
Total fixed-maturity securities |
|
|
1,282 |
|
|
|
1,752,190 |
|
|
|
2,240 |
|
|
|
1,755,712 |
|
Equity securities |
|
|
34,868 |
|
|
|
4,978 |
|
|
|
48 |
|
|
|
39,894 |
|
Trading securities |
|
|
- |
|
|
|
12,991 |
|
|
|
- |
|
|
|
12,991 |
|
Separate accounts |
|
|
- |
|
|
|
2,503,829 |
|
|
|
- |
|
|
|
2,503,829 |
|
Total fair value assets |
|
$ |
36,150 |
|
|
$ |
4,273,988 |
|
|
$ |
2,288 |
|
|
$ |
4,312,426 |
|
Fair value liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Separate accounts |
|
$ |
- |
|
|
$ |
2,503,829 |
|
|
$ |
- |
|
|
$ |
2,503,829 |
|
Total fair value liabilities |
|
$ |
- |
|
|
$ |
2,503,829 |
|
|
$ |
- |
|
|
$ |
2,503,829 |
|
In assessing fair value of our investments, we use a third-party pricing service for approximately 95% of our securities. The remaining securities are primarily thinly traded securities valued using models based on observable inputs on public corporate spreads having similar characteristics (e.g., sector, average life and quality rating) and liquidity and yield based on quality rating, average life and treasury yields. All observable data inputs are corroborated by independent third-party data. In the absence of sufficient observable inputs, we utilize non-binding broker quotes, which are reflected in our Level 3 classification as we are unable to evaluate the valuation technique(s) or significant inputs used to develop the quotes. Therefore, we do not internally develop the quantitative unobservable inputs used in measuring the fair value of Level 3 investments. However, we do corroborate pricing information provided by our third-party pricing servicing by performing a review of selected securities. Our review activities include obtaining detailed information about the assumptions, inputs and methodologies used in pricing the security; documenting this information; and corroborating it by comparison to independently obtained prices and or independently developed pricing methodologies.
Furthermore, we perform internal reasonableness assessments on fair value determinations within our portfolio throughout the quarter and at quarter-end, including pricing variance analyses and comparisons to alternative pricing sources and benchmark returns. If a fair value appears unusual relative to these assessments, we will re-examine the inputs and may challenge a fair value assessment made by the pricing service. If there is a known pricing error, we will request a reassessment by the pricing service. If the pricing service is unable to perform the reassessment on a timely basis, we will determine the appropriate price by requesting a reassessment from an alternative pricing service or other qualified source as necessary. We do not adjust quotes or prices except in a rare circumstance to resolve a known error.
75
Because many fixed-maturity securities do not trade on a daily basis, fair value is determined using industry-standard methodologies by applying available market information through processes such as U.S. Treasury curves, benchmarking of similar securities, sector groupings, quotes from market participants and matrix pricing. Observable information is compiled and integrates relevant credit information, perceived market movements and sector news. Additionally, security prices are periodically back-tested to validate and/or refine models as conditions warrant. Market indicators and industry and economic events are also monitored as triggers to obtain additional data. For certain structured securities with limited trading activity, industry-standard pricing methodologies use adjusted market information, such as index prices or discounting expected future cash flows, to estimate fair value. If these measures are not deemed observable for a particular security, the security will be classified as Level 3 in the fair value hierarchy.
Where specific market information is unavailable for certain securities, pricing models produce estimates of fair value primarily using Level 2 inputs along with certain Level 3 inputs. These models include matrix pricing. The pricing matrix uses current treasury rates and credit spreads received from third-party sources to estimate fair value. The credit spreads incorporate the issuer’s industry- or issuer-specific credit characteristics and the security’s time to maturity, if warranted. Remaining unpriced securities are valued using an estimate of fair value based on indicative market prices that include significant unobservable inputs not based on, nor corroborated by, market information, including the utilization of non-binding broker quotes.
The roll-forward of the Level 3 assets measured at fair value on a recurring basis was as follows:
|
|
Year ended December 31, |
|
|||||
|
|
2014 |
|
|
2013 |
|
||
|
|
(In thousands) |
|
|||||
Level 3 assets, beginning of period |
|
$ |
2,288 |
|
|
$ |
5,221 |
|
Net unrealized gains (losses) included in other comprehensive income |
|
|
(153 |
) |
|
|
(116 |
) |
Realized gains (losses) and accretion (amortization) recognized in earnings, including OTTI |
|
|
439 |
|
|
|
(278 |
) |
Purchases |
|
|
- |
|
|
|
2 |
|
Sales |
|
|
- |
|
|
|
- |
|
Settlements |
|
|
(1,409 |
) |
|
|
(314 |
) |
Transfers into Level 3 |
|
|
- |
|
|
|
25 |
|
Transfers out of Level 3 |
|
|
- |
|
|
|
(2,252 |
) |
Level 3 assets, end of period |
|
$ |
1,165 |
|
|
$ |
2,288 |
|
We obtain independent pricing quotes based on observable inputs as of the end of the reporting period for all securities in Level 2. Those inputs include benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, market bids/offers, quoted prices for similar instruments in markets that are not active, and other relevant data. We monitor these inputs for market indicators as well as industry and economic events. We recognize transfers into new levels and out of previous levels as of the end of the reporting period, including interim reporting periods, as applicable. There were no transfers between Level 1 and Level 2 or Level 1 and Level 3 during the years ended December 31, 2014 and 2013.
Invested assets included in the transfer from Level 3 to Level 2 primarily were fixed-maturity investments for which we were able to obtain independent pricing quotes based on observable inputs.
The carrying values and estimated fair values of our financial instruments were as follows:
|
|
December 31, 2014 |
|
|
December 31, 2013 |
|
||||||||||
|
|
Carrying value |
|
|
Estimated fair value |
|
|
Carrying value |
|
|
Estimated fair value |
|
||||
|
|
(In thousands) |
|
|||||||||||||
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed-maturity securities (available-for-sale) |
|
$ |
1,759,120 |
|
|
$ |
1,759,120 |
|
|
$ |
1,755,712 |
|
|
$ |
1,755,712 |
|
Fixed-maturity security (held-to-maturity) |
|
|
220,000 |
|
|
|
228,809 |
|
|
|
- |
|
|
|
- |
|
Equity securities |
|
|
53,390 |
|
|
|
53,390 |
|
|
|
39,894 |
|
|
|
39,894 |
|
Trading securities |
|
|
7,711 |
|
|
|
7,711 |
|
|
|
12,991 |
|
|
|
12,991 |
|
Policy loans |
|
|
28,095 |
|
|
|
28,095 |
|
|
|
26,806 |
|
|
|
26,806 |
|
Deposit asset underlying 10% coinsurance agreement |
|
|
157,256 |
|
|
|
157,256 |
|
|
|
124,413 |
|
|
|
124,413 |
|
Separate accounts |
|
|
2,440,303 |
|
|
|
2,440,303 |
|
|
|
2,503,829 |
|
|
|
2,503,829 |
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notes payable |
|
$ |
374,532 |
|
|
$ |
411,916 |
|
|
$ |
374,481 |
|
|
$ |
385,161 |
|
Surplus note |
|
|
220,000 |
|
|
|
227,127 |
|
|
|
- |
|
|
|
- |
|
Separate accounts |
|
|
2,440,303 |
|
|
|
2,440,303 |
|
|
|
2,503,829 |
|
|
|
2,503,829 |
|
The fair values of financial instruments presented above are estimates of the fair values at a specific point in time using various sources and methods, including market quotations and a complex matrix system that takes into account issuer sector, quality, and spreads in the current marketplace.
Recurring fair value measurements. Estimated fair values of investments in available-for-sale fixed-maturity securities are principally a function of current spreads and interest rates that are corroborated by independent third-party data. Therefore, the fair values presented are indicative of amounts we could realize or settle at the respective balance sheet date. We do not necessarily intend to dispose of or liquidate such instruments prior to maturity. Trading securities, which primarily consist of fixed-maturity securities,
76
are carried at fair value. Equity securities, including common and nonredeemable preferred stocks, are carried at fair value. Segregated funds in separate accounts are carried at the underlying value of the variable insurance contracts, which is fair value.
Nonrecurring fair value measurements. The estimated fair value of the held-to-maturity fixed-maturity security, which is classified as a Level 3 fair value measurement, is derived using the credit spread on similarly rated debt securities and the hypothetical spread of the security’s credit enhancement feature. Policy loans, which are categorized as Level 3 fair value measurements, are carried at the unpaid principal balances. The fair value of policy loans approximate the unpaid principal balances as the timing of repayment is uncertain and the loans are collateralized by the amount of the policy. The deposit asset underlying the 10% Coinsurance Agreement represents the value of the assets necessary to back the economic reserves held in support of the reinsurance agreement. The carrying value of this deposit asset approximates fair value, which is categorized as Level 3 in the fair value hierarchy. Notes payable represent our publicly-traded senior notes and are valued as a Level 2 fair value measurement using the quoted market price for our notes. The estimated fair value of the Surplus Note is derived by using an assumed credit spread we would expect if Vidalia Re was a credit-rated entity and the hypothetical spread of the Surplus Note’s subordinated structure. The Surplus Note is classified as a Level 3 fair value measurement.
The carrying amounts for cash and cash equivalents, receivables, accrued investment income, accounts payable, cash collateral and payables for security transactions approximate their fair values due to the short-term nature of these instruments. Consequently, such instruments are not included in the above table.
(6) Reinsurance
We use reinsurance extensively, which has a significant effect on our results of operations. Reinsurance arrangements do not relieve us of our primary obligation to the policyholder. Our reinsurance contracts typically do not have a fixed term. In general, the reinsurers’ ability to terminate coverage for existing cessions is limited to such circumstances as material breach of contract or nonpayment of premiums by the ceding company. Our reinsurance contracts generally contain provisions intended to provide the ceding company with the ability to cede future business on a basis consistent with historical terms. However, either party may terminate any of the contracts with respect to the future business upon appropriate notice to the other party. Generally, the reinsurance contracts do not limit the overall amount of the loss that can be incurred by the reinsurer.
Our policy is to limit the amount of life insurance retained on the life of any one person to $1 million. To limit our exposure with any one reinsurer, we monitor the concentration of credit risk we have with our reinsurance counterparties, as well as their financial condition. No credit losses related to our reinsurance counterparties have been experienced by the Company during the three-year period ended December 31, 2014.
Due from reinsurers represents ceded policy reserve balances and ceded claim liabilities. The amounts of ceded claim liabilities included in due from reinsurers that we paid and which are recoverable from those reinsurers were $26.0 million and $32.9 million as of December 31, 2014 and 2013, respectively.
In connection with our corporate reorganization, Primerica Life, Primerica Life Canada and NBLIC entered into significant coinsurance transactions (the “coinsurance agreements”) on March 30, 2010 with Prime Re and two other affiliates of Citigroup (collectively, the “Citigroup reinsurers”). Under the coinsurance agreements, we ceded between 80% and 90% of the risks and rewards of our term life insurance policies in force at year-end 2009. Because these agreements were part of a business reorganization among entities under common control, they did not generate any deferred gain or loss upon their execution. Concurrent with signing these agreements, we transferred the corresponding account balances in respect of the coinsured policies along with the assets to support the statutory liabilities assumed by the Citigroup reinsurers. Each of the account balances transferred were at book value with no gain or loss recorded in net income.
Three of the Citigroup coinsurance agreements satisfy U.S. GAAP risk transfer rules. Under these agreements, we ceded between 80% and 90% of our term life future policy benefit reserves, and we transferred a corresponding amount of assets to the Citigroup reinsurers. These transactions did not impact our future policy benefit reserves. As such, we have recorded an asset for the same amount of risk transferred in due from reinsurers. We also reduced DAC by a corresponding amount, which reduces future amortization expenses. In addition, we are transferring between 80% and 90% of all future premiums and benefits and claims associated with these policies to the corresponding reinsurance entities. We receive ongoing ceding allowances, which are reflected as a reduction to insurance expenses, to cover policy and claims administration expenses as well as certain corporate overhead charges under each of these reinsurance contracts.
77
A fourth agreement, the 10% Coinsurance Agreement, relates to a reinsurance transaction with Prime Re that includes an experience refund provision. This agreement does not satisfy U.S. GAAP risk transfer rules. As a result, we have accounted for this contract using deposit method accounting and have recognized a deposit asset in other assets on our consolidated balance sheets for assets backing the economic reserves. The deposit asset held in support of this agreement was $157.3 million and $124.4 million at December 31, 2014 and 2013, respectively. We make contributions to the deposit asset during the life of the agreement to fulfill our responsibility of funding the economic reserve. The market return on the deposit asset is reflected in net investment income during the life of the agreement. Prime Re is responsible for ensuring that there are sufficient assets to meet all statutory requirements. We pay Prime Re a 3% finance charge for any statutory reserves required above the economic reserves. This finance charge is reflected in interest expense in our statements of income.
The following table represents the Company’s in-force life insurance at December 31, 2014 and 2013:
|
|
December 31, 2014 |
|
|
December 31, 2013 |
|
||
|
|
(Dollars in thousands) |
|
|||||
Direct life insurance in force |
|
$ |
685,998,013 |
|
|
$ |
679,337,825 |
|
Amounts ceded to other companies |
|
|
(607,218,906 |
) |
|
|
(601,309,340 |
) |
Net life insurance in force |
|
$ |
78,779,107 |
|
|
$ |
78,028,485 |
|
Percentage of reinsured life insurance in force |
|
|
89 |
% |
|
|
89 |
% |
Due from reinsurers includes ceded reserve balances and ceded claim liabilities. Reinsurance receivable and financial strength ratings by reinsurer were as follows:
|
|
December 31, 2014 |
|
December 31, 2013 |
||||||||
|
|
Reinsurance receivable |
|
|
A.M. Best rating |
|
Reinsurance receivable |
|
|
A.M. Best rating |
||
|
|
(In thousands) |
||||||||||
Prime Reinsurance Company(1) |
|
$ |
2,645,011 |
|
|
NR |
|
$ |
2,572,800 |
|
|
NR |
SCOR Global Life Reinsurance Companies(2) |
|
|
373,947 |
|
|
A |
|
|
372,479 |
|
|
A |
Financial Reassurance Company 2010, Ltd.(1) |
|
|
320,718 |
|
|
NR |
|
|
343,144 |
|
|
NR |
Swiss Re Life & Health America Inc.(3) |
|
|
260,734 |
|
|
A+ |
|
|
260,775 |
|
|
A+ |
American Health and Life Insurance Company(1) |
|
|
175,755 |
|
|
A- |
|
|
174,722 |
|
|
A- |
Munich American Reassurance Company |
|
|
100,846 |
|
|
A+ |
|
|
100,856 |
|
|
A+ |
Korean Reinsurance Company |
|
|
89,300 |
|
|
A |
|
|
89,405 |
|
|
A |
RGA Reinsurance Company |
|
|
78,143 |
|
|
A+ |
|
|
75,629 |
|
|
A+ |
TOA Reinsurance Company |
|
|
20,139 |
|
|
A+ |
|
|
18,824 |
|
|
A+ |
Hannover Life Reassurance Company |
|
|
18,694 |
|
|
A+ |
|
|
16,862 |
|
|
A+ |
All other reinsurers |
|
|
32,246 |
|
|
- |
|
|
29,558 |
|
|
- |
Due from reinsurers |
|
$ |
4,115,533 |
|
|
|
|
$ |
4,055,054 |
|
|
|
NR – not rated
(1) |
Reinsurers are affiliates of Citigroup. Amounts shown are net of their share of the reinsurance receivable from other reinsurers. |
(2) |
Includes amounts ceded to Transamerica Reinsurance Companies and fully retroceded to SCOR Global Life Reinsurance Companies. |
(3) |
Includes amounts ceded to Lincoln National Life Insurance and 100% retroceded to Swiss Re Life & Health America Inc. |
Certain reinsurers with which we do business receive group ratings. Individually, those reinsurers are SCOR Global Life Americas Reinsurance Company, SCOR Global Life U.S.A. Reinsurance Company, SCOR Global Life Re Insurance Company of Delaware, and SCOR Global Life of Canada.
As Prime Re and Financial Reassurance Company 2010, Ltd. (“FRAC”) do not have financial strength ratings, we required various safeguards prior to executing the coinsurance agreements with these entities. Both coinsurance agreements include provisions to ensure that Primerica Life and Primerica Life Canada receive full regulatory credit for the reinsurance treaties. Under these agreements, Primerica Life and Primerica Life Canada will be able to recapture the ceded business with no fee in the event Prime Re or FRAC do not comply with the various safeguard provisions in their respective coinsurance agreements. Prime Re also has entered into a capital maintenance agreement requiring Citigroup to provide additional funding, if needed, at any point during the term of the agreement up to the maximum as described in the capital maintenance agreement.
78
(7) Deferred Policy Acquisition Costs
We defer the costs of acquiring new business to the extent that they result directly from and are essential to the contract transaction(s) and would not have been incurred had the contract transaction(s) not occurred. The amortization of DAC requires us to make certain assumptions regarding persistency, expenses, interest rates and claims. For DAC associated with term life insurance policies, these assumptions may not be modified, or unlocked, unless recoverability testing deems them to be inadequate. We update assumptions for new business to reflect the most recent experience. For DAC associated with Canadian segregated funds, the assumptions used in determining amortization expense are evaluated regularly and are updated if actual experience or other evidence suggests revisions to earlier estimates are appropriate.
DAC amortization for term life insurance policies is affected by differences between the original assumptions used for persistency, expenses, interest rates and claims and actual results and are recognized in the period in which the change occurs. For policies underlying the Canadian segregated funds, gross profits and the resulting DAC amortization will vary with actual fund returns, redemptions and expenses. Due to the inherent uncertainties in making assumptions about future events, materially different experience from expected results could result in a material increase or decrease of DAC amortization in a particular period.
In determining DAC amortization expense for term life insurance policies, we use interest rates available at the time a policy is issued. For policies issued in 2010 and after, we have been using an increasing interest rate assumption based on the historically low interest rate environment. Interest rate assumptions at December 31, 2014 and 2013 ranged from 3.5% to 7.0%.
DAC is subject to recoverability testing annually and when impairment indicators exist. The recoverability of DAC is dependent on the future profitability of the related policies, which, in turn, is dependent principally upon mortality, persistency, investment returns, and the expense of administering the business, as well as upon certain economic variables, such as inflation.
The balances of and activity in DAC were as follows:
|
|
Year ended December 31, |
|
|||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|||
|
|
(In thousands) |
|
|||||||||
DAC balance, beginning of period |
|
$ |
1,208,466 |
|
|
$ |
1,066,422 |
|
|
$ |
904,485 |
|
Capitalization |
|
|
303,543 |
|
|
|
283,341 |
|
|
|
276,840 |
|
Amortization |
|
|
(144,378 |
) |
|
|
(129,183 |
) |
|
|
(118,598 |
) |
Foreign exchange and other |
|
|
(16,451 |
) |
|
|
(12,114 |
) |
|
|
3,695 |
|
DAC balance, end of period |
|
$ |
1,351,180 |
|
|
$ |
1,208,466 |
|
|
$ |
1,066,422 |
|
(8) Separate Accounts
The Funds primarily consist of a series of banded investment funds known as the Asset Builder Funds and a money market fund known as the Cash Management Fund. In 2014, the Funds introduced a registered retirement income fund known as the Strategic Retirement Income Fund. The principal investment objective of the Asset Builder Funds is to achieve long-term growth while preserving capital. The principal objective of the Strategic Retirement Income Fund is to provide a stream of investment income while at the same time defensively preserving capital. The Asset Builder Funds and the Strategic Retirement Income Fund use diversified portfolios of publicly-traded Canadian stocks, investment-grade corporate bonds, Government of Canada bonds, and foreign equity investments to achieve their objectives. The Cash Management Fund invests in government guaranteed short-term bonds and short-term commercial and bank papers, with the principal investment objective being the provision of interest income while maintaining liquidity and preserving capital.
Under these contract offerings, benefit payments to contract holders or their designated beneficiaries are only due upon death of the annuitant or upon reaching a specific maturity date. Benefit payments are based on the value of the contract holder’s units in the portfolio at the payment date, but are guaranteed to be no less than 75% of the contract holder’s contribution, adjusted for withdrawals. Account values are not guaranteed for withdrawn units if contract holders make withdrawals prior to the maturity dates. Maturity dates for contracts investing in the Asset Builder Funds and Cash Management Fund vary by contract and range from 10 to 56 years from the contract issuance date. Contracts investing in the Strategic Retirement Income Fund mature when the policyholder reaches age 100, which is a minimum of 20 years after issue. The Strategic Retirement Income Fund is designed to provide periodic retirement income payments and as such, regular withdrawals, subject to legislated minimums, are anticipated. The cumulative effects of the periodic withdrawals are expected to substantially reduce both account and minimum guaranteed values prior to maturity.
Both the asset and the liability for the separate accounts reflect the net value of the underlying assets in the portfolio as of the reporting date. Primerica Life Canada’s exposure to losses under the guarantee at the time of account maturity is limited to contract holder accounts that have declined in value more than 25%, adjusted for withdrawals, since the contribution date prior to maturity. Because maturity dates are of a long-term nature, the likelihood guarantee payments are required at any given point is very small. Additionally, the portfolios consist of a very large number of individual contracts, further spreading the risk related to the guarantee being exercised upon death. The length of the contract terms provides significant opportunity for the underlying portfolios to recover any short-term losses prior to maturities or deaths of the contract holders. Furthermore, the funds’ investment allocations are aligned with the maturity risks of the related contracts and include investments in Government Strip Bonds and floating rate notes.
79
We periodically assess the exposure related to these contracts to determine whether any additional liability should be recorded. As of December 31, 2014 and 2013, an additional liability for these contracts was deemed to be unnecessary.
The following table represents the fair value of assets supporting separate accounts by major investment category:
|
|
Year ended December 31, |
|
|||||
|
|
2014 |
|
|
2013 |
|
||
|
|
(In thousands) |
|
|||||
Fixed income securities |
|
$ |
1,019,034 |
|
|
$ |
1,044,231 |
|
Equity securities |
|
|
1,318,382 |
|
|
|
1,425,491 |
|
Cash and cash equivalents |
|
|
104,983 |
|
|
|
35,685 |
|
Due to/from funds |
|
|
(2,536 |
) |
|
|
(2,210 |
) |
Other |
|
|
440 |
|
|
|
632 |
|
Total separate accounts assets |
|
$ |
2,440,303 |
|
|
$ |
2,503,829 |
|
(9) Insurance Reserves
Changes in policy claims and other benefits payable were as follows:
|
|
Year ended December 31, |
|
|||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|||
|
|
(In thousands) |
|
|||||||||
Policy claims and other benefits payable, beginning of period |
|
$ |
253,304 |
|
|
$ |
254,533 |
|
|
$ |
241,754 |
|
Less reinsured policy claims and other benefits payable |
|
|
248,185 |
|
|
|
269,279 |
|
|
|
236,930 |
|
Net balance, beginning of period |
|
|
5,119 |
|
|
|
(14,746 |
) |
|
|
4,824 |
|
Incurred related to current year |
|
|
130,075 |
|
|
|
147,639 |
|
|
|
150,352 |
|
Incurred related to prior years |
|
|
468 |
|
|
|
(4,956 |
) |
|
|
(3,208 |
) |
Total incurred |
|
|
130,543 |
|
|
|
142,683 |
|
|
|
147,144 |
|
Claims paid related to current year, net of reinsured policy claims received |
|
|
(136,873 |
) |
|
|
(150,922 |
) |
|
|
(183,208 |
) |
Reinsured policy claims received related to prior years, net of claims paid |
|
|
7,534 |
|
|
|
28,601 |
|
|
|
16,307 |
|
Total paid |
|
|
(129,339 |
) |
|
|
(122,321 |
) |
|
|
(166,901 |
) |
Sale of DBL |
|
|
(5,047 |
) |
|
|
- |
|
|
|
- |
|
Foreign currency |
|
|
(493 |
) |
|
|
(497 |
) |
|
|
187 |
|
Net balance, end of period |
|
|
783 |
|
|
|
5,119 |
|
|
|
(14,746 |
) |
Add reinsured policy claims and other benefits payable |
|
|
264,049 |
|
|
|
248,185 |
|
|
|
269,279 |
|
Balance, end of period |
|
$ |
264,832 |
|
|
$ |
253,304 |
|
|
$ |
254,533 |
|
See Note 1 (Description of Business, Basis of Presentation, and Summary of Significant Accounting Policies) for details regarding the accounting for policyholder liabilities.
(10) Debt
Notes Payable. Notes payable consisted of the following:
|
|
December 31, 2014 |
|
|
December 31, 2013 |
|
||
|
|
(Dollars in thousands) |
|
|||||
4.75% senior notes payable, due July 15, 2022 |
|
$ |
375,000 |
|
|
$ |
375,000 |
|
Unamortized issuance discount on notes payable |
|
|
(468 |
) |
|
|
(519 |
) |
Total notes payable |
|
$ |
374,532 |
|
|
$ |
374,481 |
|
At December 31, 2014, we had $375.0 million in principal amount of publicly-traded, senior unsecured notes (the “Senior Notes”). The Senior Notes were issued in 2012 at a price of 99.843% of the principal amount with an annual interest rate of 4.75%, payable semi-annually in arrears on January 15 and July 15, and are scheduled to mature on July 15, 2022. We were in compliance with the covenants of the Senior Notes at December 31, 2014. No events of default occurred on the Senior Notes during the year ended December 31, 2014.
As unsecured senior obligations, the Senior Notes rank equally in right of payment with all existing and future unsubordinated indebtedness and senior to all existing and future subordinated indebtedness of the Parent Company. The Senior Notes are structurally subordinated in right of payment to all existing and future liabilities of our subsidiaries. In addition, the Senior Notes contain covenants that restrict our ability to, among other things, create or incur any indebtedness that is secured by a lien on the capital stock of certain of our subsidiaries, and merge, consolidate or sell all or substantially all of our properties and assets.
80
Surplus Note. As of December 31, 2014, the principal amount outstanding on the Surplus Note issued by Vidalia Re was approximately $220.0 million, equal to the principal amount of the LLC Note invested asset. The Surplus Note was issued in exchange for the LLC Note, which supports certain obligations of Vidalia Re for a portion of the statutory accounting-based reserves (commonly referred to as Regulation XXX reserves) related to the Vidalia Re Coinsurance Agreement. The principal amount of the Surplus Note and the LLC Note will fluctuate over time to coincide with the amount of reserves contractually supported. Both the LLC Note and the Surplus Note mature on December 31, 2029 and bear interest at an annual interest rate of 4.50%. Based on the estimated reserves for ceded policies issued in 2011, 2012, 2013, and 2014, the maximum principal amounts of the Surplus Note and the LLC Note are expected to be approximately $915.0 million each. This financing arrangement is non-recourse to the Parent Company and Primerica Life, meaning that neither of these companies has guaranteed the Surplus Note or is otherwise liable for reimbursement for any payments triggered by the credit enhancement feature underlying the LLC Note. The Parent Company has agreed to support Vidalia Re’s obligation to pay the credit enhancement fee incurred on the LLC Note.
See Note 4 (Investments) for more information on the LLC Note.
(11) Income Taxes
Income tax expense (benefit) from continuing operations consists of the following:
|
|
Current |
|
|
Deferred |
|
|
Total |
|
|||
|
|
(In thousands) |
|
|||||||||
Year ended December 31, 2014 |
|
|
|
|
|
|
|
|
|
|
|
|
Federal |
|
$ |
44,356 |
|
|
$ |
31,590 |
|
|
$ |
75,946 |
|
Foreign |
|
|
24,403 |
|
|
|
(4,826 |
) |
|
|
19,577 |
|
State and local |
|
|
1,372 |
|
|
|
(1,007 |
) |
|
|
365 |
|
Total tax expense |
|
$ |
70,131 |
|
|
$ |
25,757 |
|
|
$ |
95,888 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31, 2013 |
|
|
|
|
|
|
|
|
|
|
|
|
Federal |
|
$ |
33,798 |
|
|
$ |
32,919 |
|
|
$ |
66,717 |
|
Foreign |
|
|
32,797 |
|
|
|
(14,410 |
) |
|
|
18,387 |
|
State and local |
|
|
1,377 |
|
|
|
(176 |
) |
|
|
1,201 |
|
Total tax expense |
|
$ |
67,972 |
|
|
$ |
18,333 |
|
|
$ |
86,305 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31, 2012 |
|
|
|
|
|
|
|
|
|
|
|
|
Federal |
|
$ |
51,032 |
|
|
$ |
24,517 |
|
|
$ |
75,549 |
|
Foreign |
|
|
26,836 |
|
|
|
(11,130 |
) |
|
|
15,706 |
|
State and local |
|
|
1,613 |
|
|
|
(55 |
) |
|
|
1,558 |
|
Total tax expense |
|
$ |
79,481 |
|
|
$ |
13,332 |
|
|
$ |
92,813 |
|
Total income tax expense from continuing operations is different from the amount determined by multiplying income from continuing operations before income taxes by the statutory federal tax rate of 35%. The reconciliation for such difference follows:
|
|
Year ended December 31, |
|
|||||||||||||||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|||||||||||||||
|
|
Amount |
|
|
Percentage |
|
|
Amount |
|
|
Percentage |
|
|
Amount |
|
|
Percentage |
|
||||||
|
|
(Dollars in thousands) |
|
|||||||||||||||||||||
Computed tax expense |
|
$ |
96,503 |
|
|
|
35.0 |
% |
|
$ |
85,752 |
|
|
|
35.0 |
% |
|
$ |
93,143 |
|
|
|
35.0 |
% |
Other |
|
|
(615 |
) |
|
|
(0.2 |
)% |
|
|
553 |
|
|
|
0.2 |
% |
|
|
(330 |
) |
|
|
(0.1 |
)% |
Total tax expense / effective rate |
|
$ |
95,888 |
|
|
|
34.8 |
% |
|
$ |
86,305 |
|
|
|
35.2 |
% |
|
$ |
92,813 |
|
|
|
34.9 |
% |
81
The main components of deferred income tax assets and liabilities were as follows:
|
|
December 31, |
|
|||||
|
|
2014 |
|
|
2013 |
|
||
|
|
(In thousands) |
|
|||||
Deferred tax assets: |
|
|
|
|
|
|
|
|
Policy benefit reserves and unpaid policy claims |
|
$ |
216,768 |
|
|
$ |
207,662 |
|
Intangibles and tax goodwill |
|
|
43,822 |
|
|
|
47,591 |
|
Future deductible liabilities |
|
|
22,972 |
|
|
|
27,606 |
|
Other |
|
|
19,764 |
|
|
|
15,759 |
|
Total deferred tax assets |
|
|
303,326 |
|
|
|
298,618 |
|
|
|
|
|
|
|
|
|
|
Deferred tax liabilities: |
|
|
|
|
|
|
|
|
Deferred policy acquisition costs |
|
|
(291,683 |
) |
|
|
(269,534 |
) |
Investments |
|
|
(28,909 |
) |
|
|
(26,010 |
) |
Unremitted earnings on foreign subsidiaries |
|
|
(2,602 |
) |
|
|
(2,848 |
) |
Reinsurance deposit asset |
|
|
(55,040 |
) |
|
|
(43,544 |
) |
Other |
|
|
(14,463 |
) |
|
|
(15,098 |
) |
Total deferred tax liabilities |
|
|
(392,697 |
) |
|
|
(357,034 |
) |
Net deferred tax liabilities |
|
$ |
(89,371 |
) |
|
$ |
(58,416 |
) |
The majority of total deferred tax assets are attributable to future policy benefit reserves and unpaid policy claims, which represents the difference between the financial statement carrying value and tax basis for liabilities for future policy benefits. The tax basis for future policy benefit reserves and unpaid policy claims is actuarially determined in accordance with guidelines set forth in the Internal Revenue Code. The majority of total deferred tax liabilities are attributable to DAC, which represents the difference between the policy acquisition costs capitalized for U.S. GAAP purposes and those capitalized for tax purposes, as well as the difference in the resulting amortization methods.
The Company has state net operating losses resulting in a deferred tax asset of approximately $7.3 million, which are available for use through 2034. The Company has no other material net operating loss or credit carryforwards.
In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, carryback and carryforward periods, and tax planning strategies in making this assessment. Management believes that it is more likely than not that the results of future operations will generate sufficient taxable income to realize the deferred tax assets. There was no deferred tax asset valuation allowance at December 31, 2014 and 2013.
The Company has direct and indirect ownership of a group of controlled foreign corporations in Canada. We have asserted a position of permanent reinvestment for the difference in share basis and certain operational earnings. Such operational earnings if not permanently reinvested would have generated a deferred tax liability of approximately $10.6 million as of December 31, 2014. For those operational earnings for which we have not made a permanent reinvestment assertion, we have established a deferred tax liability to account for the U.S. tax liability that will occur upon repatriation of such earnings. As of December 31, 2014, we had approximately $28.5 million in Canadian operational earnings available to be repatriated to the U.S. for which we have not made a permanent reinvestment assertion.
The total amount of unrecognized benefits on uncertain tax positions that, if recognized, would affect our effective tax rate was approximately $8.9 million and $8.3 million as of December 31, 2014 and 2013, respectively. We recognize interest expense related to unrecognized tax benefits in tax expense net of federal income tax. As of December 31, 2014 and 2013, the total amount of accrued interest and penalties in the consolidated balance sheets were approximately $2.6 million and $2.9 million, respectively. Additionally, we recognized interest related to unrecognized tax benefits in the consolidated statements of income of less than $0.1 million of expense in 2014 and 2013 and approximately $0.1 million of benefit in 2012.
A reconciliation of the change in the unrecognized income tax benefit for the years ended December 31, 2014 and 2013 is as follows:
|
|
December 31, |
|
|||||
|
|
2014 |
|
|
2013 |
|
||
|
|
(In thousands) |
|
|||||
Unrecognized tax benefits, beginning of period |
|
$ |
16,607 |
|
|
$ |
20,996 |
|
Change in prior period unrecognized tax benefits |
|
|
(16 |
) |
|
|
32 |
|
Change in current period unrecognized tax benefits |
|
|
2,102 |
|
|
|
2,108 |
|
Reductions as a result of a lapse in statute of limitations |
|
|
(2,679 |
) |
|
|
(6,529 |
) |
Unrecognized tax benefits, end of period |
|
$ |
16,014 |
|
|
$ |
16,607 |
|
We have no penalties included in calculating our provision for income taxes. There is no significant change that is reasonably possible to occur within twelve months of the reporting date.
82
In connection with our corporate reorganization, we entered into a tax separation agreement with Citigroup, whereby Citigroup agreed to indemnify the Company against any consolidated, combined, affiliated, unitary or similar federal, state or local income tax liability related to any taxable period ending on or before April 2010. As of December 31, 2014, the Company had a Citigroup tax indemnification asset of $4.8 million.
As a result of the separation from Citigroup, the Company is required to file two U.S. consolidated income tax returns at least through December 31, 2014. Our life insurance companies comprise one of the U.S. consolidated tax groups, while the Parent Company and the remaining U.S. subsidiaries comprise the second U.S. consolidated tax group. The method of allocation between companies is pursuant to a written agreement. Allocations generally are based upon separate return calculations with credit for net losses as utilized, and are calculated and settled quarterly.
The major tax jurisdictions in which we operate are the United States and Canada. We are currently open to tax audit by the Internal Revenue Service for the years ended December 31, 2009 and thereafter for federal tax purposes. We are currently open to audit in Canada for tax years ended December 31, 2008 and thereafter for federal and provincial tax purposes. For those periods prior to the IPO, we are fully indemnified by Citigroup.
(12) Stockholders’ Equity
A reconciliation of the number of shares of our common stock follows.
|
|
Year ended December 31, |
|
|||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|||
|
|
(In thousands) |
|
|||||||||
Common stock, beginning of period |
|
|
54,834 |
|
|
|
56,374 |
|
|
|
64,883 |
|
Shares of restricted common stock issued |
|
|
- |
|
|
|
280 |
|
|
|
438 |
|
Shares issued for stock options exercised |
|
|
4 |
|
|
|
- |
|
|
|
- |
|
Shares of common stock issued upon lapse of restricted stock units ("RSUs") |
|
|
502 |
|
|
|
1,122 |
|
|
|
998 |
|
Common stock retired |
|
|
(3,171 |
) |
|
|
(2,942 |
) |
|
|
(9,945 |
) |
Common stock, end of period |
|
|
52,169 |
|
|
|
54,834 |
|
|
|
56,374 |
|
The above reconciliation excludes RSUs, which do not have voting rights. As RSUs lapse, we issue common shares with voting rights. As of December 31, 2014, we had a total of approximately 1.2 million RSUs outstanding.
In 2012, we purchased approximately 7.8 million shares of our common stock owned by certain private equity funds managed by Warburg Pincus LLC (“Warburg Pincus”), which obtained shares of our common stock and warrants to purchase 4,103,110 additional shares of our common stock (the “warrants”) at a purchase price of $18.00 per underlying share in a private sale by Citigroup in connection with our IPO. The prices of the shares repurchased were based on the per share market value of our common stock at the time of the purchases. In addition, we repurchased approximately 1.7 million shares of our common stock in open market transactions during 2012.
In 2013, we repurchased the remaining equity interest in our Company held by Warburg Pincus, which included approximately 2.5 million shares of our common stock and all outstanding warrants. The per-share purchase price was determined based on the closing price of our common stock on May 28, 2013, which was the execution date of the agreement to repurchase the shares, and the purchase price per warrant was equal to the per-share purchase price less the warrant exercise price per underlying share as noted above.
In November 2013, our Board of Directors authorized a share repurchase program for up to $150.0 million of our outstanding common stock (the “share repurchase program”). Under the share repurchase program, we repurchased 3,016,615 shares of our common stock in open market transactions for an aggregate purchase price of approximately $147.9 million in 2014. As of December 31, 2014, there was approximately $2.1 million remaining for repurchases of our outstanding common stock under the share repurchase program.
In November 2014, our Board of Directors authorized a share repurchase program for up to $150.0 million of our outstanding common stock during 2015. Shares of our common stock have not been repurchased under this plan as of December 31, 2014.
(13) Earnings Per Share
The Company has outstanding common stock and equity awards that consist of restricted stock, RSUs and stock options. In addition, the warrants held by Warburg Pincus were outstanding until we repurchased and retired them in 2013. The restricted stock and RSUs maintain non-forfeitable dividend rights that result in dividend payment obligations on a one-to-one ratio with common shares for any future dividend declarations.
Unvested restricted stock and unvested RSUs are deemed participating securities for purposes of calculating EPS as they maintain dividend rights. We calculate EPS using the two-class method. Under the two-class method, we allocate earnings to common shares (excluding unvested restricted stock) and vested RSUs outstanding for the period. Earnings attributable to unvested participating securities, along with the corresponding share counts, are excluded from EPS as reflected in our consolidated statements of income.
83
In calculating basic EPS, we deduct any dividends and undistributed earnings allocated to unvested restricted stock and unvested RSUs from net income and then divide the result by the weighted-average number of common shares and vested RSUs outstanding for the period.
We determine the potential dilutive effect of warrants and stock options outstanding on EPS using the treasury-stock method. Under this method, we determine the proceeds that would be received from the exercise of the warrants and stock options outstanding, which includes cash received for the exercise price, the remaining unrecognized stock option compensation expense and the resulting effect on the income tax deduction from the exercise of stock options. We then use the average market price of our common shares during the period the warrants and stock options were outstanding to determine how many shares we could repurchase with the proceeds raised from the exercise of the warrants and stock options outstanding. The net incremental share count issued represents the potential dilutive securities. We then reallocate earnings to common shares and vested RSUs by incorporating the increased fully diluted share count to determine diluted EPS.
The calculation of basic and diluted EPS follows.
|
|
Year ended December 31, |
|
|||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|||
|
|
(In thousands, except per-share amounts) |
|
|||||||||
Basic EPS |
|
|
|
|
|
|
|
|
|
|
|
|
Numerator (continuing operations): |
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
$ |
179,834 |
|
|
$ |
158,701 |
|
|
$ |
173,309 |
|
Income attributable to unvested participating securities |
|
|
(2,038 |
) |
|
|
(2,605 |
) |
|
|
(4,637 |
) |
Income from continuing operations used in calculating basic EPS |
|
$ |
177,796 |
|
|
$ |
156,096 |
|
|
$ |
168,672 |
|
Numerator (discontinued operations): |
|
|
|
|
|
|
|
|
|
|
|
|
Income from discontinued operations |
|
$ |
1,578 |
|
|
$ |
4,024 |
|
|
$ |
497 |
|
Income attributable to unvested participating securities |
|
|
(18 |
) |
|
|
(66 |
) |
|
|
(13 |
) |
Income from discontinued operations used in calculating basic EPS |
|
$ |
1,560 |
|
|
$ |
3,958 |
|
|
$ |
484 |
|
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average vested shares |
|
|
54,567 |
|
|
|
55,834 |
|
|
|
61,059 |
|
Basic EPS from continuing operations |
|
$ |
3.26 |
|
|
$ |
2.80 |
|
|
$ |
2.76 |
|
Basic EPS from discontinued operations |
|
$ |
0.03 |
|
|
$ |
0.07 |
|
|
$ |
0.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted EPS |
|
|
|
|
|
|
|
|
|
|
|
|
Numerator (continuing operations): |
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
$ |
179,834 |
|
|
$ |
158,701 |
|
|
$ |
173,309 |
|
Income attributable to unvested participating securities |
|
|
(2,037 |
) |
|
|
(2,575 |
) |
|
|
(4,548 |
) |
Income from continuing operations used in calculating diluted EPS |
|
$ |
177,797 |
|
|
$ |
156,126 |
|
|
$ |
168,761 |
|
Numerator (discontinued operations): |
|
|
|
|
|
|
|
|
|
|
|
|
Income from discontinued operations |
|
$ |
1,578 |
|
|
$ |
4,024 |
|
|
$ |
497 |
|
Income attributable to unvested participating securities |
|
|
(18 |
) |
|
|
(65 |
) |
|
|
(13 |
) |
Income from discontinued operations used in calculating diluted EPS |
|
$ |
1,560 |
|
|
$ |
3,959 |
|
|
$ |
484 |
|
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average vested shares |
|
|
54,567 |
|
|
|
55,834 |
|
|
|
61,059 |
|
Dilutive effect of incremental shares if issued for warrants outstanding |
|
|
- |
|
|
|
787 |
|
|
|
1,342 |
|
Dilutive effect of incremental shares to be issued for equity awards |
|
|
31 |
|
|
|
4 |
|
|
|
- |
|
Weighted-average shares used in calculating diluted EPS |
|
|
54,598 |
|
|
|
56,625 |
|
|
|
62,401 |
|
Diluted EPS from continuing operations |
|
$ |
3.26 |
|
|
$ |
2.76 |
|
|
$ |
2.70 |
|
Diluted EPS from discontinued operations |
|
$ |
0.03 |
|
|
$ |
0.07 |
|
|
$ |
0.01 |
|
(14) Share-Based Transactions
The Company has outstanding equity awards under its Omnibus Incentive Plan (“OIP”). The OIP provides for the issuance of equity awards, including stock options, stock appreciation rights, restricted stock, deferred stock, RSUs, unrestricted stock, as well as cash-based awards. In addition to time-based vesting requirements, awards granted under the OIP also may be subject to specified performance criteria. Since 2010, the Company has issued equity awards to our management (officers and other key employees), non-employee directors, and sales force leaders under the OIP. As of December 31, 2014, we had approximately 2.1 million shares available for future grants under this plan.
Employee and Director Share-Based Compensation. As of December 31, 2014, the Company had outstanding restricted stock, RSUs, and stock options issued to our management (officers and other key employees), as well as restricted stock, RSUs, and deferred RSUs issued to our non-employee directors, under the OIP.
84
Restricted Stock and RSUs. The Company granted shares of restricted stock and RSUs to management (“management restricted stock and RSU awards”) as follows:
· |
Prior to 2014, management of the Company’s U.S. based subsidiaries received restricted stock and management of the Company’s Canadian subsidiaries received RSUs. These awards have time-based vesting requirements with equal and annual graded vesting over approximately three years subsequent to the grant date. |
· |
In 2014, management (regardless of geography) received RSUs that have time-based vesting requirements with equal and annual graded vesting over approximately three years subsequent to the grant date. During the third quarter of 2014, the Compensation Committee of the Board of Directors amended the equity awards granted to management in 2014 (the “modified awards”) to provide for such awards to vest upon the voluntary termination of employment by any employee who is “retirement eligible” as of his or her termination date. In order to be retirement eligible, an employee must be at least 55 years old and his or her age plus years of service with the Company must equal at least 75. |
The Company granted shares of restricted stock and RSUs to non-employee members of the Board of Directors (“director restricted stock and RSU awards”) as follows:
· |
Prior to 2013, non-employee directors received restricted stock that have time-based vesting requirements with equal and annual graded vesting over approximately three years subsequent to the grant date. |
· |
In 2013, non-employee directors received RSUs that have time-based vesting requirements that lapse approximately one year after the grant date. These awards also contain post-vesting sale restrictions until the non-employee director no longer serves on our Board. |
· |
In 2014, non-employee directors received RSUs that have time-based vesting requirements with equal and annual graded vesting over four quarters subsequent to the grant date. These awards also contain post-vesting sale restrictions until the non-employee director no longer serves on our Board. |
· |
In addition, certain directors elected to defer their cash and/or equity retainers into deferred RSUs, which vest immediately or on the dates the RSUs would have vested, respectively. |
All of our outstanding management and director restricted stock and RSU awards are eligible for dividends or dividend equivalents regardless of vesting status.
In connection with our granting of management and director restricted stock and RSU awards, we recognized expense and tax benefit offsets as follows:
|
|
Year ended December 31, |
|
|||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|||
|
|
(In thousands) |
|
|||||||||
Total management and director restricted stock and RSU awards |
|
$ |
15,726 |
|
|
$ |
13,101 |
|
|
$ |
18,944 |
|
Tax benefit associated with total management and director restricted stock and RSU award expense |
|
|
5,322 |
|
|
|
3,936 |
|
|
|
4,533 |
|
The following table summarizes management and director restricted stock and RSU activity during the years ended December 31, 2014, 2013, and 2012.
|
|
Shares |
|
|
Weighted-average measurement-date fair value per share |
|
||
|
|
(Shares in thousands) |
|
|||||
Unvested employee restricted stock and RSUs, December 31, 2011 |
|
|
2,064 |
|
|
$ |
16.88 |
|
Granted |
|
|
458 |
|
|
|
25.40 |
|
Forfeited |
|
|
(13 |
) |
|
|
22.70 |
|
Vested |
|
|
(1,002 |
) |
|
|
16.43 |
|
Unvested employee restricted stock and RSUs, December 31, 2012 |
|
|
1,507 |
|
|
|
19.72 |
|
Granted |
|
|
322 |
|
|
|
32.76 |
|
Forfeited |
|
|
(9 |
) |
|
|
28.72 |
|
Vested |
|
|
(1,098 |
) |
|
|
17.59 |
|
Unvested employee restricted stock and RSUs, December 31, 2013 |
|
|
722 |
|
|
|
28.67 |
|
Granted |
|
|
279 |
|
|
|
41.31 |
|
Forfeited |
|
|
(13 |
) |
|
|
30.49 |
|
Vested |
|
|
(408 |
) |
|
|
28.53 |
|
Unvested employee restricted stock and RSUs, December 31, 2014 |
|
|
580 |
|
|
|
34.67 |
|
As of December 31, 2014, total compensation cost not yet recognized in our financial statements related to management and director restricted stock and RSU awards with time-based vesting conditions yet to be reached was approximately $7.1 million, and the weighted-average period over which cost will be recognized was 0.8 years. Compensation costs related to management and director restricted stock and RSU awards were impacted by plan modifications, resulting in the accelerated recognition of expense for certain equity awards. Although the expense related to these modifications have been recognized, the respective equity awards are included in
85
the above table until such time as the retirement eligible employees elect to retire. See the modifications section below for more details.
Stock Options. Beginning in 2013, the Company issued stock options to certain of its executive officers under the OIP as part of their annual equity compensation. The remaining annual equity compensation for these executive officers was granted in the form of management restricted stock awards and RSUs discussed above. Stock options are generally granted with an exercise price equal to the fair market value of our common stock on the grant date, and they expire 10 years from the date of grant. These options have time-based restrictions with equal and annual graded vesting over a three-year period. Stock options issued in 2014 are included in the equity awards that were modified to provide for such awards to vest upon the voluntary termination of employment by any employee who is “retirement eligible” as of his or her termination date. Upon retirement, employees have the lesser of three years or the remaining option term to exercise any vested options.
Compensation expense and related tax benefits recognized for stock options awards were as follows:
|
|
Year ended December 31, |
|
|||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|||
|
|
(In thousands) |
|
|||||||||
Expense recognized for stock option awards |
|
$ |
1,803 |
|
|
$ |
323 |
|
|
$ |
- |
|
Tax benefit recognized for stock option awards |
|
|
631 |
|
|
|
113 |
|
|
|
- |
|
The fair value of each option was estimated on the date of grant using the Black-Scholes model. We derived expected volatility after considering our own historical volatility, as well as other public peer companies’ historical volatilities. The Company’s per share dividend yield as of the grant date was used as the input for the expected dividend payout on the underlying shares. The risk-free interest rate was based on the U.S. Treasury yield for a term approximating the expected life of the options at the time of grant. The Company used the simplified method to determine the expected life of options, as there was no historical exercise activity for the Company’s stock option awards as of the grant date. All inputs into the Black-Scholes model were estimates made at the time of grant. The actual realized value of each option grant could materially differ from these estimates, which would have no impact to future reported compensation expense.
The following assumptions were used to estimate the fair value of stock options granted:
|
|
Year ended December 31, |
||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
||
Expected volatility |
|
|
33.00 |
% |
|
|
30.00 |
% |
|
n/a |
Expected per share dividend yield |
|
|
1.17 |
% |
|
|
1.35 |
% |
|
n/a |
Risk-free interest rate |
|
|
1.81 |
% |
|
|
1.06 |
% |
|
n/a |
Expected term of options using simplified method |
|
6 years |
|
|
6 years |
|
|
n/a |
||
Fair value per option |
|
$ |
12.54 |
|
|
$ |
8.44 |
|
|
n/a |
The following table summarizes activity related to stock options outstanding and exercisable during the years ended December 31, 2014 and 2013.
|
|
Outstanding |
|
|
Exercisable |
|
||||||||||
|
|
Number of shares |
|
|
Weighted average exercise price |
|
|
Number of shares |
|
|
Weighted average exercise price |
|
||||
|
|
(Shares in thousands) |
|
|||||||||||||
Outstanding at December 31, 2012 |
|
— |
|
|
n/a |
|
|
— |
|
|
n/a |
|
||||
Granted |
|
|
134 |
|
|
$ |
32.63 |
|
|
|
|
|
|
|
|
|
Exercised |
|
— |
|
|
— |
|
|
|
|
|
|
n/a |
|
|||
Outstanding at December 31, 2013 |
|
|
134 |
|
|
|
32.63 |
|
|
— |
|
|
n/a |
|
||
Granted |
|
|
116 |
|
|
|
41.20 |
|
|
|
|
|
|
|
|
|
Exercised |
|
|
(4 |
) |
|
|
32.63 |
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2014 |
|
|
246 |
|
|
|
36.67 |
|
|
|
40 |
|
|
$ |
32.63 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Range of granted option exercise prices outstanding at December 31, 2014: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$32.63 (average term remaining - 8.2 years) |
|
|
130 |
|
|
$ |
32.63 |
|
|
|
40 |
|
|
$ |
32.63 |
|
$41.20 (average term remaining - 9.1 years) |
|
|
116 |
|
|
|
41.20 |
|
|
— |
|
|
n/a |
|
The aggregate intrinsic value represents the difference between the exercise price of our stock options and the quoted closing price of our common stock as of December 31, 2014. A summary of the intrinsic values of our stock options is as follows:
|
|
December 31, 2014 |
|
|
|
|
(In thousands) |
|
|
Aggregate intrinsic value of exercisable stock options |
|
$ |
873 |
|
Aggregate intrinsic value of stock options expected to vest |
|
|
3,451 |
|
Aggregate intrinsic value of stock options outstanding |
|
$ |
4,324 |
|
86
The intrinsic value of options exercised and the tax benefit realized from the options that were exercised during the year ended December 31, 2014 was approximately $53 thousand and $19 thousand, respectively. The value of issued shares that were withheld to satisfy the exercise price for stock options exercised during the year ended December 31, 2014 was approximately $142 thousand. As of December 31, 2014, there was approximately $0.5 million of total unrecognized compensation cost related to unvested options, and the weighted-average period over which cost will be recognized was approximately 0.9 years. Compensation costs related to stock option awards were impacted by plan modifications, resulting in the accelerated recognition of expense for certain equity awards. Although the expense related to these modifications have been recognized, the respective equity awards are included in the above table until such time as the retirement eligible employees elect to retire. See the modifications section below for more details.
Modification of Equity Awards Issued to Management in 2014. All unrecognized equity compensation expense for the modified awards granted to retirement eligible employees as of the date of the modification was recognized immediately during the third quarter of 2014 as there is no remaining substantive future requisite service period for these awards. The modification affects the timing of expense recognition for the modified awards and not the total amount of expense to be recognized given that the amount of awards expected to vest under the original service condition is not significantly different from the amount of awards now expected to vest after the modification. Almost one-third of our 2014 management equity award recipients were retirement eligible as of the date the modification was made. As a result of this modification, approximately $4.6 million of equity compensation expense for the modified awards was accelerated into 2014 rather than being recognized over the three-year vesting period of the award. This expense acceleration in 2014 will reduce the originally scheduled equity compensation expense for the modified awards in each subsequent period through the final vesting date in 2017. The retirement eligibility provision is expected to be included in equity awards granted to management in future periods.
Non-Employee Share-Based Compensation. Non-employee share-based transactions relate to the granting of RSUs to members of our sales force (“agent equity awards”). Agent equity awards are generally granted as a part of quarterly contests for successful life insurance policy acquisitions or renewals and, in the second half of 2014, for sales of investment and savings products for which the grant and the service period occur within the same calendar quarter.
The following table summarizes non-employee RSU activity during the years ended December 31, 2014, 2013, and 2012.
|
|
Shares |
|
|
Weighted-average measurement-date fair value per share |
|
||
|
|
(Shares in thousands) |
|
|||||
Unvested non-employee RSUs, December 31, 2011 |
|
|
117 |
|
|
$ |
17.55 |
|
Granted |
|
|
379 |
|
|
|
22.94 |
|
Vested |
|
|
(364 |
) |
|
|
20.38 |
|
Unvested non-employee RSUs, December 31, 2012 |
|
|
132 |
|
|
|
25.42 |
|
Granted |
|
|
504 |
|
|
|
32.14 |
|
Vested |
|
|
(532 |
) |
|
|
29.64 |
|
Unvested non-employee RSUs, December 31, 2013 |
|
|
104 |
|
|
|
36.44 |
|
Granted |
|
|
295 |
|
|
|
45.08 |
|
Vested |
|
|
(326 |
) |
|
|
41.23 |
|
Unvested non-employee RSUs, December 31, 2014 |
|
|
73 |
|
|
|
49.98 |
|
Agent equity awards vest and are measured using the fair market value at the conclusion of the quarterly contest; which is the time that performance is complete. However, agent equity awards are subject to long-term sales restrictions expiring over three years. Because the sale restrictions extend up to three years beyond the vesting period, the fair market value of the awards incorporates an illiquidity discount reflecting the risk associated with the post-vesting restrictions. To quantify this discount for each award, we use a series of put option models with one-, two- and three-year tenors to estimate a hypothetical cost of eliminating the downside risk associated with the sale restrictions.
The most significant assumptions in the Black-Scholes models are the volatility assumptions. We derive volatility assumptions primarily from the historical volatility of our common stock using terms comparable to the sale restriction terms.
The following table presents the assumptions used in valuing quarterly RSU grants to agents:
|
|
Year ended December 31, |
||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
||
Expected volatility |
|
17% to 31% |
|
|
20% to 35% |
|
|
20% to 50% |
||
Quarterly dividends expected |
|
$ |
0.12 |
|
|
$ |
0.11 |
|
|
$0.03 to $0.09 |
Risk-free interest rates |
|
Less than 2% |
|
|
Less than 2% |
|
|
Less than 1% |
To the extent that these awards are an incremental direct cost of successful acquisitions or renewals of life insurance policies that result directly from and are essential to the policy acquisition(s) and would not have been incurred had the policy acquisition(s) not occurred, we defer and amortize the fair value of the awards in the same manner as other deferred policy acquisition costs. All agent equity awards that are not directly related to the acquisition or renewal of life insurance policies are recognized as expense over the requisite vesting period.
87
Details on the granting and valuation of these awards follow:
|
|
Year ended December 31, |
|
|||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|||
|
|
(Dollars in thousands, except per-share amounts) |
|
|||||||||
Total quarterly non-employee RSUs granted |
|
|
294,985 |
|
|
|
503,737 |
|
|
|
378,505 |
|
Measurement date per-share fair value of awards |
|
$42.96 to $49.98 |
|
|
$26.39 to $36.44 |
|
|
$20.36 to $25.42 |
|
|||
Illiquidity discounts |
|
8% to 9% |
|
|
13% to 18% |
|
|
17% to 32% |
|
|||
Quarterly incentive awards expense recognized currently |
|
$ |
453 |
|
|
$ |
364 |
|
|
$ |
- |
|
Quarterly incentive awards expense deferred |
|
|
13,598 |
|
|
|
15,818 |
|
|
|
8,686 |
|
Concurrent tax benefit of deferred expense |
|
|
4,500 |
|
|
|
5,001 |
|
|
|
2,640 |
|
As of December 31, 2014, all agent equity awards were fully vested with the exception of approximately 73,000 shares that vested on January 1, 2015. As such, any related compensation cost not recognized as either expense or deferred acquisition costs in our financial statements through December 31, 2014 is immaterial.
(15) Statutory Accounting and Dividend Restrictions
U.S. Insurance Subsidiaries. Our U.S. insurance subsidiaries include Primerica Life, NBLIC, Peach Re, and Vidalia Re. Primerica Life, which wholly owns Peach Re and Vidalia Re, ceded to each in separate coinsurance arrangements certain level premium term life insurance policies.
Our U.S. insurance subsidiaries are required to report their results of operations and financial position to state authorities on the basis of statutory accounting practices prescribed or permitted by such authorities and the National Association of Insurance Commissioners (“NAIC”), which is a comprehensive basis of accounting other than U.S. GAAP. Prescribed statutory accounting practices include a variety of publications of the NAIC, as well as state laws, regulations and general administrative rules. Permitted statutory accounting practices encompass all accounting practices not so prescribed. The Company’s principal life insurance company, Primerica Life, prepares its statutory financial statements on the basis of accounting practices prescribed or permitted by the NAIC and the Massachusetts Division of Insurance (“Massachusetts DOI”) and includes the statutory financial statements of its wholly owned insurance subsidiaries, NBLIC, Peach Re, and Vidalia Re. NBLIC’s statutory financial statements are prepared on the basis of accounting practices prescribed or permitted by the NAIC and the New York State Department of Financial Services, while the statutory financial statements of Peach Re and Vidalia Re are prepared on the basis of accounting practices prescribed or permitted by the NAIC and the Vermont Department of Financial Regulation (“Vermont DOI”). Our U.S. insurance subsidiaries’ ability to pay dividends to their parent is subject to and limited by the various laws and regulations of their respective states. There are no regulatory restrictions on the ability of the Parent Company to pay dividends.
Primerica Life’s statutory ordinary dividend capacity is based on the greater of: (1) the previous year’s statutory net gain from operations (excluding pro rata distributions of any class of the insurer’s own securities) or (2) 10% of the previous year-end statutory surplus (net of capital stock), which may only be paid out of statutory unassigned surplus. Dividends that, together with the amount of other distributions or dividends made within the preceding 12 months, exceed this statutory limitation are referred to as extraordinary dividends. Extraordinary dividends require advance notice to the Massachusetts DOI, Primerica Life’s primary state insurance regulator, and are subject to potential disapproval. For dividends exceeding these thresholds, Primerica Life must provide notice to the Massachusetts DOI and receive notice that the Massachusetts DOI does not object to the payment of such dividends.
Primerica Life’s statutory capital and surplus and statutory unassigned surplus at December 31, 2014 and 2013 was as follows:
|
|
December 31, 2014 |
|
|
December 31, 2013 |
|
||
|
|
(In thousands) |
|
|||||
Statutory capital and surplus |
|
$ |
498,992 |
|
|
$ |
563,260 |
|
Statutory unassigned surplus |
|
|
9,773 |
|
|
|
99,707 |
|
Primerica Life’s statutory net gain from operations was approximately $267.4 million and $306.7 million in 2014 and 2013, respectively. Primerica Life made no pro rata distributions of any class of its own securities during 2014 or 2013. During 2014, Primerica Life paid ordinary dividends of $235.0 million to the Parent Company and had estimated ordinary dividend capacity of approximately $9.8 million as of January 1, 2015.
Primerica Life’s investment basis in NBLIC, Peach Re, and Vidalia Re reflect their statutory capital and surplus amounts recorded in accordance with statutory accounting practices prescribed or permitted by the NAIC and each subsidiary’s state of domicile; New York and Vermont, respectively. Peach Re was formed as a special purpose financial captive insurance company and, with the explicit permission of the Vermont DOI, has included the value of a letter of credit serving as collateral for its policy reserves as an admitted asset in its statutory capital and surplus. This permitted accounting practice was critical to the organization and operational plans of Peach Re and explicitly included in the licensing order issued by the Vermont DOI. The impact of this permitted practice as of December 31, 2014 was approximately $507.0 million on Peach Re’s statutory capital and surplus. As of December 31, 2014, if Peach Re had not been permitted to include the letter of credit as an admitted asset, Primerica Life would have been below the minimum statutory capital and surplus level of approximately $79.3 million that triggers a regulatory action event. However, if Peach Re was not permitted to include the letter of credit as an admitted asset in its statutory capital and surplus, Primerica Life would not have paid the ordinary dividends to the Parent Company that were paid in 2014.
88
Canadian Insurance Subsidiary. Primerica Life Canada is incorporated under the provisions of the Canada Business Corporations Act and is a domiciled Canadian Company subject to regulation under the Insurance Companies Act (Canada) by the Office of the Superintendent of Financial Institutions in Canada (“OSFI”) and by Provincial Superintendents of Financial Institutions/Insurance in those provinces in which Primerica Life Canada is licensed. The financial statements of Primerica Life Canada are prepared in accordance with International Financial Reporting Standards (“IFRS”).
Primerica Life Canada’s capacity to pay ordinary dividends to its parent is limited by OSFI regulations to the extent that its capital exceeds projected capital requirements. OSFI requires companies to set internal target levels of capital sufficient to provide for all the risks of the insurer, including risks specified in OSFI’s capital guidelines. As of December 31, 2014 and 2013, Primerica Life Canada’s statutory capital and surplus satisfied regulatory requirements and was approximately $290.1 million and $279.9 million, respectively.
In Canada, dividends can be paid subject to the paying insurance company continuing to have adequate capital and forms of liquidity as defined by OSFI following the dividend payment and upon 15 days minimum notice to OSFI. Primerica Life Canada’s dividend capacity at January 1, 2015 is estimated to be approximately $114.8 million, which is calculated based on its projection of maintaining internal target capital requirements under certain adverse capital scenarios during each year over the next five years. The actual amount of future dividends that Primerica Life Canada will declare and pay is also subject to the Company’s asserted position of permanent reinvestment of certain unremitted earnings discussed in Note 11 (Income Taxes).
(16) Commitments and Contingent Liabilities
Commitments. We lease office equipment and office and warehouse space under various noncancellable operating lease agreements that expire through June 2028. Total minimum rent expense was $7.7 million, $8.3 million, and $6.9 million for the years ended December 31, 2014, 2013, and 2012, respectively. We had no contingent rent expense during 2014, 2013, and 2012. In March 2013, our agreement to lease our new corporate headquarters in Duluth, Georgia, commenced, which replaced and consolidated substantially all of our prior executive and home office operations. The initial lease term is 15 years with estimated minimum annual rental payments ranging from approximately $4.5 million at inception to approximately $5.6 million in year 15.
As of December 31, 2014, the minimum aggregate rental commitments for operating leases were as follows:
|
|
|
|
December 31, 2014 |
|
|
|
|
|
|
(In thousands) |
|
|
|
2015 |
|
|
$ |
6,741 |
|
|
2016 |
|
|
|
6,689 |
|
|
2017 |
|
|
|
6,712 |
|
|
2018 |
|
|
|
6,052 |
|
|
2019 |
|
|
|
5,666 |
|
Thereafter |
|
|
|
45,714 |
|
|
Total minimum rental commitments for operating leases |
|
|
$ |
77,574 |
|
Letter of Credit. Effective March 31, 2012, Peach Re entered into a Credit Facility Agreement with Deutsche Bank (the “Credit Facility Agreement”) to support certain obligations for a portion of the reserves (commonly referred to as Regulation XXX reserves) related to level premium term life insurance policies ceded to Peach Re from Primerica Life under the Peach Re Coinsurance Agreement.
Under the Credit Facility Agreement, Deutsche Bank issued a letter of credit in the initial amount of $450.0 million with a term of approximately 14 years (the “LOC”) for the benefit of Primerica Life, the direct parent of Peach Re. At December 31, 2014, the amount of the LOC outstanding was approximately $507.0 million. This amount was also the maximum amount of the LOC, which will decline over the term of the LOC to correspond with declines in the Regulation XXX reserves. Pursuant to the terms of the Credit Facility Agreement, in the event amounts are drawn under the LOC by Primerica Life, Peach Re will be obligated, subject to certain limited conditions, to reimburse Deutsche Bank for the amount of any draws and interest thereon. Peach Re has collateralized its obligations to Deutsche Bank by granting it a security interest in all of its assets with the exception of amounts held in a special account established to meet minimum asset thresholds required by state regulatory authorities. As of December 31, 2014, the Company was in compliance with all financial covenants under the Credit Facility Agreement.
Contingent Liabilities. The Company is involved from time to time in legal disputes, regulatory inquiries and arbitration proceedings in the normal course of business. These disputes are subject to uncertainties, including the large and/or indeterminate amounts sought in certain of these matters and the inherent unpredictability of litigation. As such, the Company is unable to estimate the possible loss or range of loss that may result from these matters unless otherwise indicated.
The Company is currently undergoing targeted multi-state treasurer audits by 30 jurisdictions with respect to unclaimed property laws, and Primerica Life and NBLIC are currently subject to a targeted multi-state market conduct examination with respect to their claims-paying practices. The Treasurer of the State of West Virginia brought a suit against Primerica Life and other insurance companies alleging violations of the West Virginia unclaimed property act. The suit was dismissed, and the Treasurer has appealed. Other jurisdictions may pursue similar audits, examinations and litigation. The audits, examinations and litigation are expected to take
89
significant time to complete, and it is unclear whether the Company will be required to compare the Social Security Administration’s Death Master File to its records for periods prior to 2011, including with respect to policies which have lapsed, to determine whether benefits are owed in instances where an insured appears to have died but no claim for death benefits has been made. The potential outcome of such actions is difficult to predict but could subject the Company to adverse consequences, including, but not limited to, settlement payments, additional payments to beneficiaries and additional escheatment of funds deemed abandoned under state laws. At this time, the Company cannot reasonably estimate the likelihood or the impact of additional costs or liabilities that could result from the resolution of these matters. These actions may also result in changes to the Company’s procedures for the identification and escheatment of abandoned property and other financial liability.
(17) Benefit Plans
We established a defined contribution plan for the benefit of our employees in 2010. The expense associated with this plan was approximately $6.5 million, $6.5 million, and $6.4 million in 2014, 2013, and 2012, respectively.
Unaudited Quarterly Financial Data
In management’s opinion, the following quarterly consolidated financial information fairly presents the results of operations for such periods and is prepared on a basis consistent with our annual audited consolidated financial statements. Financial information for the quarters presented was prepared on a consolidated basis.
|
|
Quarter ended |
|
|
Quarter ended |
|
|
Quarter ended |
|
|
Quarter ended |
|
||||
|
|
March 31, 2014 |
|
|
June 30, 2014 |
|
|
September 30, 2014 |
|
|
December 31, 2014 |
|
||||
|
|
(In thousands, except per-share amounts) |
|
|||||||||||||
Direct premiums |
|
$ |
568,205 |
|
|
$ |
576,740 |
|
|
$ |
577,482 |
|
|
$ |
578,905 |
|
Ceded premiums |
|
|
(402,715 |
) |
|
|
(410,546 |
) |
|
|
(402,198 |
) |
|
|
(401,359 |
) |
Net premiums |
|
|
165,490 |
|
|
|
166,194 |
|
|
|
175,284 |
|
|
|
177,546 |
|
Commissions and fees |
|
|
126,933 |
|
|
|
132,039 |
|
|
|
132,928 |
|
|
|
135,267 |
|
Net investment income |
|
|
21,599 |
|
|
|
21,681 |
|
|
|
20,465 |
|
|
|
22,728 |
|
Realized investment gains (losses), including OTTI |
|
|
263 |
|
|
|
831 |
|
|
|
(281 |
) |
|
|
(1,074 |
) |
Other, net |
|
|
10,043 |
|
|
|
10,385 |
|
|
|
10,791 |
|
|
|
10,918 |
|
Total revenues |
|
|
324,328 |
|
|
|
331,130 |
|
|
|
339,187 |
|
|
|
345,385 |
|
Total benefits and expenses |
|
|
257,496 |
|
|
|
255,390 |
|
|
|
275,167 |
|
|
|
276,255 |
|
Income from continuing operations before income taxes |
|
|
66,832 |
|
|
|
75,740 |
|
|
|
64,020 |
|
|
|
69,130 |
|
Income taxes |
|
|
23,347 |
|
|
|
26,469 |
|
|
|
22,407 |
|
|
|
23,664 |
|
Income from continuing operations |
|
|
43,485 |
|
|
|
49,271 |
|
|
|
41,613 |
|
|
|
45,466 |
|
Income (loss) from discontinued operations, net of income taxes |
|
|
1,595 |
|
|
|
- |
|
|
|
(18 |
) |
|
|
- |
|
Net income |
|
$ |
45,080 |
|
|
$ |
49,271 |
|
|
$ |
41,595 |
|
|
$ |
45,466 |
|
Basic earnings per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
0.78 |
|
|
$ |
0.89 |
|
|
$ |
0.75 |
|
|
$ |
0.84 |
|
Discontinued operations |
|
|
0.03 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Basic earnings per share |
|
$ |
0.81 |
|
|
$ |
0.89 |
|
|
$ |
0.75 |
|
|
$ |
0.84 |
|
Diluted earnings per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
0.78 |
|
|
$ |
0.89 |
|
|
$ |
0.75 |
|
|
$ |
0.84 |
|
Discontinued operations |
|
|
0.03 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Diluted earnings per share |
|
$ |
0.81 |
|
|
$ |
0.89 |
|
|
$ |
0.75 |
|
|
$ |
0.84 |
|
90
|
|
Quarter ended |
|
|
Quarter ended |
|
|
Quarter ended |
|
|
Quarter ended |
|
||||
|
|
March 31, 2013 |
|
|
June 30, 2013 |
|
|
September 30, 2013 |
|
|
December 31, 2013 |
|
||||
|
|
(In thousands, except per-share amounts) |
|
|||||||||||||
Direct premiums |
|
$ |
560,904 |
|
|
$ |
568,391 |
|
|
$ |
567,047 |
|
|
$ |
568,848 |
|
Ceded premiums |
|
|
(410,604 |
) |
|
|
(417,450 |
) |
|
|
(407,488 |
) |
|
|
(408,615 |
) |
Net premiums |
|
|
150,300 |
|
|
|
150,941 |
|
|
|
159,559 |
|
|
|
160,233 |
|
Commissions and fees |
|
|
112,273 |
|
|
|
117,182 |
|
|
|
118,440 |
|
|
|
123,910 |
|
Net investment income |
|
|
23,216 |
|
|
|
21,027 |
|
|
|
22,103 |
|
|
|
22,407 |
|
Realized investment gains (losses), including OTTI |
|
|
2,286 |
|
|
|
3,468 |
|
|
|
(407 |
) |
|
|
899 |
|
Other, net |
|
|
10,375 |
|
|
|
10,872 |
|
|
|
10,714 |
|
|
|
10,773 |
|
Total revenues |
|
|
298,450 |
|
|
|
303,490 |
|
|
|
310,409 |
|
|
|
318,222 |
|
Total benefits and expenses |
|
|
239,310 |
|
|
|
236,540 |
|
|
|
247,637 |
|
|
|
262,078 |
|
Income from continuing operations before income taxes |
|
|
59,140 |
|
|
|
66,950 |
|
|
|
62,772 |
|
|
|
56,144 |
|
Income taxes |
|
|
21,005 |
|
|
|
23,782 |
|
|
|
22,040 |
|
|
|
19,477 |
|
Income from continuing operations |
|
|
38,135 |
|
|
|
43,168 |
|
|
|
40,732 |
|
|
|
36,667 |
|
Income (loss) from discontinued operations, net of income taxes |
|
|
710 |
|
|
|
322 |
|
|
|
2,458 |
|
|
|
534 |
|
Net income |
|
$ |
38,845 |
|
|
$ |
43,490 |
|
|
$ |
43,190 |
|
|
$ |
37,201 |
|
Basic earnings per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
0.66 |
|
|
$ |
0.75 |
|
|
$ |
0.74 |
|
|
$ |
0.66 |
|
Discontinued operations |
|
|
0.01 |
|
|
|
0.01 |
|
|
|
0.04 |
|
|
|
0.01 |
|
Basic earnings per share |
|
$ |
0.67 |
|
|
$ |
0.76 |
|
|
$ |
0.78 |
|
|
$ |
0.67 |
|
Diluted earnings per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
0.64 |
|
|
$ |
0.73 |
|
|
$ |
0.74 |
|
|
$ |
0.66 |
|
Discontinued operations |
|
|
0.01 |
|
|
|
0.01 |
|
|
|
0.04 |
|
|
|
0.01 |
|
Diluted earnings per share |
|
$ |
0.65 |
|
|
$ |
0.74 |
|
|
$ |
0.78 |
|
|
$ |
0.67 |
|
Quarterly amounts may not agree in total to the corresponding annual amounts due to rounding.
There have been no changes in, or disagreements with, accountants on accounting and financial disclosure matters during the years ended December 31, 2014 and 2013.
Disclosure Controls and Procedures
The Company’s management, with the participation of the Company’s Co-Chief Executive Officers and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report (the “Evaluation Date”). Based on such evaluation, the Company’s Co-Chief Executive Officers and Chief Financial Officer have concluded that, as of the Evaluation Date, the Company’s disclosure controls and procedures are effective.
Changes in Internal Control Over Financial Reporting
Changes that have materially affected, or are reasonably likely to materially affect the Company’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) were finalized during the fourth fiscal quarter of 2014 related to the reimplementation of our financial management (“FM”) software system. In 2014, we upgraded to the most current version of our FM software system in order to improve the efficiency of processing transactions in the general ledger and utilizing management financial reporting tools, which resulted in the elimination of certain manual processes and streamlining of certain key controls. These changes were undertaken to improve the efficiency of processes supporting our financial reporting and were not undertaken in response to any actual or perceived deficiencies or to remedy any gaps or weaknesses in the Company’s internal control over financial reporting.
Management’s Annual Report On Internal Control Over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting for our company. With the participation of the Co-Chief Executive Officers and the Chief Financial Officer, our management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework and criteria established in Internal Control—Integrated Framework (2013), issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based
91
on this evaluation, our management has concluded that our internal control over financial reporting was effective as of December 31, 2014.
Our independent auditor, KPMG LLP, an independent registered public accounting firm, has issued an attestation report on the effectiveness of our internal control over financial reporting. This attestation report appears below.
92
Report of Independent Registered Public Accounting Firm
The Board of Directors and Stockholders of Primerica, Inc.:
We have audited Primerica, Inc.’s (the Company) internal control over financial reporting as of December 31, 2014, based on criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit.
We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
In our opinion, Primerica, Inc. maintained, in all material respects, effective internal control over financial reporting as of December 31, 2014, based on criteria established in Internal Control—Integrated Framework (2013) issued by COSO.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of Primerica, Inc. and subsidiaries as of December 31, 2014 and 2013, and the related consolidated statements of income, comprehensive income, stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2014, and our report dated February 26, 2015 expressed an unqualified opinion on those consolidated financial statements.
/s/ KPMG LLP
Atlanta, Georgia
February 26, 2015
93
Not applicable.
94
Pursuant to General Instruction G to Form 10-K, and as described below portions of Items 10 through 14 of this report are incorporated by reference from the Company’s definitive Proxy Statement relating to the Company’s 2015 Annual Meeting of Stockholders (the “Proxy Statement”), which will be filed with the SEC within 120 days of December 31, 2014, pursuant to Regulation 14A under the Exchange Act. The Report of the Audit Committee of our Board of Directors and the Report of the Compensation Committee of our Board of Directors to be included in the Proxy Statement shall be deemed to be furnished in this report and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, as a result of such furnishing.
Our website address is www.primerica.com. You may obtain free electronic copies of our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and all amendments to those reports from the investors section of our website. These reports are available on our website as soon as reasonably practicable after we electronically file them with the SEC. These reports should also be available through the SEC’s website at www.sec.gov.
We have adopted corporate governance guidelines. The guidelines and the charters of our board committees are available in the corporate governance subsection of the investor relations section of our website, www.primerica.com, and are also available in print upon written request to the Corporate Secretary, Primerica, Inc., 1 Primerica Parkway, Duluth, GA 30099.
For a list of executive officers, see Part I Item X. Executive Officers of the Registrant herein.
We have adopted a written code of conduct that applies to all directors, officers and employees, including a separate code that applies to only our principal executive officers and senior financial officers in accordance with Section 406 of the Sarbanes-Oxley Act of 2002 and the rules of the SEC promulgated thereunder. Our Code of Conduct is available in the corporate governance subsection of the investor relations section of our website, www.primerica.com, and is available in print upon written request to the Corporate Secretary, Primerica, Inc., 1 Primerica Parkway, Duluth, GA 30099. In the event that we make changes in, or provide waivers from, the provisions of the Code of Conduct that the SEC requires us to disclose, we will disclose these events in the corporate governance section of our website.
Except for the information above and the information set forth in Part I, Item X. Executive Officers of the Registrant, the information required by this item will be contained under the following headings in the Proxy Statement and is incorporated herein by reference:
· |
Matters to be Voted on — Proposal 1: Election of Eleven Directors; |
· |
Governance — Director Independence; |
· |
Governance — Code of Conduct; |
· |
Board of Directors — Board Members; |
· |
Board of Directors — Board Committees; |
· |
Board of Directors — Director Legal Matters; |
· |
Share Ownership — Section 16(a) Beneficial Ownership Reporting Compliance; |
· |
Executive Compensation — Employment Agreements with Named Executive Officers; |
· |
Audit Committee Matters — Audit Committee Report; and |
· |
Related Party Transactions — Transactions with Citigroup. |
The information required by this item will be contained under the following headings in the Proxy Statement and is incorporated herein by reference:
· |
Board of Directors — Board Committees — Compensation Committee; |
· |
Board of Directors — Director Compensation; and |
· |
Executive Compensation. |
Except for the information set forth in Part II, Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities, the information required by this item will be contained under the following headings in the Proxy Statement and is incorporated herein by reference:
· |
Share Ownership — Ownership of our Common Stock. |
95
The information required by this item will be contained under the following headings in the Proxy Statement and is incorporated herein by reference:
· |
Introductory paragraph to Governance; |
· |
Governance — Director Independence; |
· |
Board of Directors — Board Committees; and |
· |
Related Party Transactions. |
The information required by this item will be contained under the following headings in the Proxy Statement and is incorporated herein by reference:
· |
Matters to be Voted on — Proposal 2: Ratification of the Appointment of KPMG LLP as Our Independent Registered Public Accounting Firm; |
· |
Board of Directors — Board Committees — Audit Committee; and |
· |
Audit Committee Matters — Fees and Services of Our Independent Registered Public Accounting Firm. |
96
(a) 1. FINANCIAL STATEMENTS
Included in Part II, Item 8, of this report:
Primerica, Inc.:
|
57 |
|
Consolidated Balance Sheets as of December 31, 2014 and 2013 |
|
58 |
|
59 |
|
|
60 |
|
|
61 |
|
|
62 |
|
|
63 |
|
|
90 |
2. FINANCIAL STATEMENT SCHEDULES
Included in Part IV of this report:
3. EXHIBIT INDEX
An “Exhibit Index” has been filed as part of this Report beginning on the following page and is incorporated herein by reference.
Schedules other than those listed above are omitted because they are not required, are not material, are not applicable, or the required information is shown in the financial statements or notes thereto.
(b) Exhibit Index.
The agreements included as exhibits to this report are included to provide information regarding the terms of these agreements and are not intended to provide any other factual or disclosure information about the Company or its subsidiaries, our business or the other parties to these agreements. These agreements may contain representations and warranties by each of the parties to the applicable agreement. These representations and warranties have been made solely for the benefit of the other parties to the applicable agreement and:
· |
should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate; |
· |
have been qualified by disclosures that were made to the other party in connection with the negotiation of the application agreement, which disclosures are not necessarily reflected in the agreement; |
· |
may apply standards of materiality in a way that is different from what may be viewed as material to our investors; and |
· |
were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement and are subject to more recent developments. |
97
Accordingly, these representations and warranties may not describe the actual state of affairs as of the date they were made or at any other time, and should not be relied upon by investors.
Exhibit Number |
|
Description |
|
Reference |
3.1 |
|
Amended and Restated Certificate of Incorporation of the Registrant. |
|
Incorporated by reference to Exhibit 3.1 to Primerica's Current Report on Form 8-K dated May 22, 2013 (Commission File No. 001-34680). |
3.2 |
|
Amended and Restated Bylaws of the Registrant. |
|
Incorporated by reference to Exhibit 3.2 to Primerica's Current Report on Form 8-K dated May 22, 2013 (Commission File No. 001-34680). |
4.1 |
|
Indenture, dated July 16, 2012, among the Registrant and Wells Fargo Bank, National Association, as trustee. |
|
Incorporated by reference to Exhibit 4.1 to Primerica's Current Report on Form 8-K dated July 11, 2012 (Commission File No. 001-34680). |
4.2 |
|
First Supplemental Indenture, dated July 16, 2012, among the Registrant and Wells Fargo Bank, National Association, as trustee. |
|
Incorporated by reference to Exhibit 4.2 to Primerica's Current Report on Form 8-K dated July 11, 2012 (Commission File No. 001-34680). |
4.3 |
|
Form of 4.750% Senior Notes due 2022. |
|
Incorporated by reference to Exhibit 4.3 (included in Exhibit 4.2 filed herewith) to Primerica's Current Report on Form 8-K dated July 11, 2012 (Commission File No. 001-34680). |
10.1 |
|
Tax Separation Agreement dated as of March 30, 2010 by and between the Registrant and Citigroup Inc. |
|
Incorporated by reference to Exhibit 10.3 to Primerica's Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 001-34680). |
10.2 |
|
80% Coinsurance Agreement dated March 31, 2010 by and between Primerica Life Insurance Company and Prime Reinsurance Company, Inc. |
|
Incorporated by reference to Exhibit 10.5 to Primerica's Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 001-34680). |
10.3 |
|
10% Coinsurance Agreement dated March 31, 2010 by and between Primerica Life Insurance Company and Prime Reinsurance Company, Inc. |
|
Incorporated by reference to Exhibit 10.6 to Primerica's Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 001-34680). |
10.4 |
|
80% Coinsurance Trust Agreement dated March 29, 2010 among Primerica Life Insurance Company, Prime Reinsurance Company, Inc. and The Bank of New York Mellon. |
|
Incorporated by reference to Exhibit 10.7 to Primerica's Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 001-34680). |
10.5 |
|
10% Coinsurance Economic Trust Agreement dated March 29, 2010 among Primerica Life Insurance Company, Prime Reinsurance Company, Inc. and The Bank of New York Mellon. |
|
Incorporated by reference to Exhibit 10.8 to Primerica's Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 001-34680). |
10.6 |
|
10% Coinsurance Excess Trust Agreement dated March 29, 2010 among Primerica Life Insurance Company, Prime Reinsurance Company, Inc. and The Bank of New York Mellon. |
|
Incorporated by reference to Exhibit 10.9 to Primerica's Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 001-34680). |
10.7 |
|
Capital Maintenance Agreement dated March 31, 2010 by and between Citigroup Inc. and Prime Reinsurance Company, Inc. |
|
Incorporated by reference to Exhibit 10.10 to Primerica's Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 001-34680). |
10.8 |
|
90% Coinsurance Agreement dated March 31, 2010 by and between National Benefit Life Insurance Company and American Health and Life Insurance Company. |
|
Incorporated by reference to Exhibit 10.11 to Primerica's Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 001-34680). |
10.9 |
|
Trust Agreement dated March 29, 2010 among National Benefit Life Insurance Company, American Health and Life Insurance Company and The Bank of New York Mellon. |
|
Incorporated by reference to Exhibit 10.12 to Primerica's Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 001-34680). |
10.10 |
|
Coinsurance Agreement dated March 31, 2010 by and between Primerica Life Insurance Company of Canada and Financial Reassurance Company 2010, Ltd. |
|
Incorporated by reference to Exhibit 10.13 to Primerica's Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 001-34680). |
10.11 |
|
Monitoring and Reporting Agreement dated as of March 31, 2010 by and among Primerica Life Insurance Company and Prime Reinsurance Company, Inc. |
|
Incorporated by reference to Exhibit 10.41 to Primerica's Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 001-34680). |
10.12 |
|
Monitoring and Reporting Agreement dated as of March 31, 2010 by and among National Benefit Life Insurance Company and American Health and Life Insurance Company. |
|
Incorporated by reference to Exhibit 10.42 to Primerica's Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 001-34680). |
10.13 |
|
Monitoring and Reporting Agreement dated as of March 31, 2010 by and among Primerica Life Insurance Company of Canada and Financial Reassurance Company 2010 Ltd. |
|
Incorporated by reference to Exhibit 10.43 to Primerica's Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 001-34680). |
10.14* |
|
Primerica, Inc. Stock Purchase Plan for Agents and Employees. |
|
Incorporated by reference to Exhibit 10.45 to Primerica's Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 001-34680). |
10.15* |
|
Primerica, Inc. Amended and Restated 2010 Omnibus Incentive Plan. |
|
Incorporated by reference to Exhibit 10.22 to Primerica's Annual Report on Form 10-K for the year ended December 31, 2011 (Commission File No. 001-34680). |
98
10.16* |
|
Form of Restricted Stock Award Agreement under the Primerica, Inc. 2010 Omnibus Incentive Plan (2012 and 2013 awards). |
|
Incorporated by reference to Exhibit 10.23 to Primerica's Annual Report on Form 10-K for the year ended December 31, 2011 (Commission File No. 001-34680). |
10.17* |
|
Form of U.S. Employee Restricted Stock Unit Restated Award Agreement under the Primerica, Inc. 2010 Omnibus Incentive Plan (2014 awards). |
|
Incorporated by reference to Exhibit 10.1 to Primerica's Quarterly Report on Form 10-Q for the quarter ended September 30, 2014 (Commission File No. 001-34680). |
10.18* |
|
Form of Restated Nonqualified Stock Option Award Agreement under the Primerica, Inc. 2010 Omnibus Incentive Plan (2013 awards). |
|
Incorporated by reference to Exhibit 10.2 to Primerica's Quarterly Report on Form 10-Q for the quarter ended September 30, 2014 (Commission File No. 001-34680). |
10.19* |
|
Form of Restated Nonqualified Stock Option Award Agreement under the Primerica, Inc. 2010 Omnibus Incentive Plan (2014 awards). |
|
Incorporated by reference to Exhibit 10.2 to Primerica's Quarterly Report on Form 10-Q for the quarter ended September 30, 2014 (Commission File No. 001-34680). |
10.20 |
|
Form of Director Restricted Stock Unit Award Agreement under the Primerica, Inc. 2010 Omnibus Incentive Plan. |
|
Incorporated by reference to Exhibit 10.19 to Primerica's Annual Report on Form 10-K for the year ended December 31, 2013 (Commission File No. 001-34680). |
10.21* |
|
Form of Indemnification Agreement for Directors and Officers. |
|
Incorporated by reference to Exhibit 10.48 to Primerica's Registration Statement on Form S-1 (File No. 333-162918). |
10.22* |
|
Transition Agreement, dated as of January 2, 2015, between the Registrant and Mr. D. Richard Williams. |
|
Incorporated by reference to Exhibit 99.2 to Primerica's Current Report on Form 8-K dated January 2, 2015 (Commission File No. 001-34680). |
10.23* |
|
Transition Agreement, dated as of January 2, 2015, between the Registrant and Mr. John A. Addison, Jr. |
|
Incorporated by reference to Exhibit 99.3 to Primerica's Current Report on Form 8-K dated January 2, 2015 (Commission File No. 001-34680). |
10.24* |
|
Amended and Restated Employment Agreement, dated as of January 2, 2015, between the Registrant and Mr. Peter W. Schneider. |
|
Incorporated by reference to Exhibit 99.5 to Primerica's Current Report on Form 8-K dated January 2, 2015 (Commission File No. 001-34680). |
10.25* |
|
Amended and Restated Employment Agreement, dated as of January 2, 2015, between the Registrant and Mr. Glenn J. Williams. |
|
Incorporated by reference to Exhibit 99.4 to Primerica's Current Report on Form 8-K dated January 2, 2015 (Commission File No. 001-34680). |
10.26* |
|
Amended and Restated Employment Agreement, dated as of January 2, 2015, between the Registrant and Ms. Alison S. Rand. |
|
Incorporated by reference to Exhibit 99.6 to Primerica's Current Report on Form 8-K dated January 2, 2015 (Commission File No. 001-34680). |
10.27* |
|
Amended and Restated Employment Agreement, dated as of January 2, 2015, between the Registrant and Mr. Gregory C. Pitts. |
|
Incorporated by reference to Exhibit 99.7 to Primerica's Current Report on Form 8-K dated January 2, 2015 (Commission File No. 001-34680). |
10.28 |
|
Nonemployee Directors' Deferred Compensation Plan, effective as of January 1, 2011, adopted on November 10, 2010. |
|
Incorporated by reference to Exhibit 10.31 to Annual Report on Form 10-K for the year ended December 31, 2010 (Commission File No. 001-34680). |
12.1 |
|
Statement re Computation of Ratios. |
|
Filed with the Securities and Exchange Commission as part of this Annual Report. |
21.1 |
|
Subsidiaries of the Registrant. |
|
Filed with the Securities and Exchange Commission as part of this Annual Report. |
23.1 |
|
Consent of KPMG LLP. |
|
Filed with the Securities and Exchange Commission as part of this Annual Report. |
31.1 |
|
Rule 13a-14(a)/15d-14(a) Certification, executed by D. Richard Williams, Chairman of the Board and Co-Chief Executive Officer. |
|
Filed with the Securities and Exchange Commission as part of this Annual Report. |
31.2 |
|
Rule 13a-14(a)/15d-14(a) Certification, executed by John A. Addison, Chairman of Primerica Distribution and Co-Chief Executive Officer. |
|
Filed with the Securities and Exchange Commission as part of this Annual Report. |
31.3 |
|
Rule 13a-14(a)/15d-14(a) Certification, executed by Alison S. Rand, Executive Vice President and Chief Financial Officer. |
|
Filed with the Securities and Exchange Commission as part of this Annual Report. |
32.1 |
|
Certifications required by Rule 13a-14(b) or Rule 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. 1350), executed by D. Richard Williams, Chairman of the Board and Co-Chief Executive Officer, John A. Addison, Chairman of Primerica Distribution and Co-Chief Executive Officer, and Alison S. Rand, Executive Vice President and Chief Financial Officer. |
|
Filed with the Securities and Exchange Commission as part of this Annual Report. |
101.INS |
|
XBRL Instance Document(1) |
|
Filed with the Securities and Exchange Commission as part of this Annual Report. |
101.SCH |
|
XBRL Taxonomy Extension Schema |
|
Filed with the Securities and Exchange Commission as part of this Annual Report. |
101.CAL |
|
XBRL Taxonomy Extension Calculation Linkbase |
|
Filed with the Securities and Exchange Commission as part of this Annual Report. |
99
101.DEF |
|
XBRL Taxonomy Extension Definition Linkbase |
|
Filed with the Securities and Exchange Commission as part of this Annual Report. |
101.LAB |
|
XBRL Taxonomy Extension Label Linkbase |
|
Filed with the Securities and Exchange Commission as part of this Annual Report. |
101.PRE |
|
XBRL Taxonomy Extension Presentation Linkbase |
|
Filed with the Securities and Exchange Commission as part of this Annual Report. |
* |
Identifies a management contract or compensatory plan or arrangement. |
(1) |
Includes the following materials contained in this Annual Report on Form 10-K for the year ended December 31, 2014, formatted in XBRL: (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Income, (iii) Consolidated Statements of Stockholders’ Equity, (iv) Consolidated Statements of Comprehensive Income, (v) Consolidated Statements of Cash Flows, and (vi) Notes to Consolidated Financial Statements. |
100
(c) Financial Statement Schedules.
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ON FINANCIAL
STATEMENT SCHEDULES
The Board of Directors and Stockholders of Primerica, Inc.:
Under date of February 26, 2015, we reported on the consolidated balance sheets of Primerica, Inc. and subsidiaries (the Company) as of December 31, 2014 and 2013, and the related consolidated statements of income, comprehensive income, stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2014. In connection with our audits of the aforementioned consolidated financial statements, we also audited the related financial statement schedules included herein. These financial statement schedules are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statement schedules based on our audits.
In our opinion, such financial statement schedules, when considered in relation to the basic consolidated financial statements taken as a whole, present fairly, in all material respects, the information set forth therein.
/s/ KPMG LLP
Atlanta, Georgia
February 26, 2015
101
Consolidated Summary of Investments — Other Than Investments in Related Parties
PRIMERICA, INC.
|
|
December 31, 2014 |
|
|||||||||
Type of Investment |
|
Amortized cost or cost |
|
|
Fair value |
|
|
Amount at which shown in the balance sheet |
|
|||
|
|
(In thousands) |
|
|||||||||
Fixed maturities: |
|
|
|
|
|
|
|
|
|
|
|
|
Bonds: |
|
|
|
|
|
|
|
|
|
|
|
|
United States Government and government agencies and authorities |
|
$ |
15,145 |
|
|
$ |
15,647 |
|
|
$ |
15,647 |
|
States, municipalities and political subdivisions |
|
|
38,763 |
|
|
|
41,333 |
|
|
|
41,333 |
|
Foreign governments |
|
|
122,396 |
|
|
|
124,030 |
|
|
|
124,030 |
|
Public utilities |
|
|
- |
|
|
|
- |
|
|
|
- |
|
Convertibles and bonds with warrants attached |
|
|
2,553 |
|
|
|
2,912 |
|
|
|
2,912 |
|
All other corporate bonds(1) |
|
|
1,713,509 |
|
|
|
1,809,024 |
|
|
|
1,800,215 |
|
Certificates of deposit |
|
|
- |
|
|
|
- |
|
|
|
- |
|
Redeemable preferred stocks |
|
|
2,844 |
|
|
|
2,694 |
|
|
|
2,694 |
|
Total fixed maturities |
|
|
1,895,210 |
|
|
|
1,995,640 |
|
|
|
1,986,831 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities: |
|
|
|
|
|
|
|
|
|
|
|
|
Common stocks: |
|
|
|
|
|
|
|
|
|
|
|
|
Public utilities |
|
|
8,811 |
|
|
|
12,097 |
|
|
|
12,097 |
|
Banks, trusts and insurance companies |
|
|
9,238 |
|
|
|
12,969 |
|
|
|
12,969 |
|
Industrial, miscellaneous and all other |
|
|
10,637 |
|
|
|
12,331 |
|
|
|
12,331 |
|
Nonredeemable preferred stocks |
|
|
15,052 |
|
|
|
15,993 |
|
|
|
15,993 |
|
Total equity securities |
|
|
43,738 |
|
|
|
53,390 |
|
|
|
53,390 |
|
Mortgage loans on real estate |
|
|
- |
|
|
|
- |
|
|
|
- |
|
Real estate |
|
|
- |
|
|
|
- |
|
|
|
- |
|
Policy loans |
|
|
28,095 |
|
|
|
28,095 |
|
|
|
28,095 |
|
Other long-term investments |
|
|
- |
|
|
|
- |
|
|
|
- |
|
Short-term investments |
|
|
- |
|
|
|
- |
|
|
|
- |
|
Total investments |
|
$ |
1,967,043 |
|
|
$ |
2,077,125 |
|
|
$ |
2,068,316 |
|
(1) |
The amount shown on the balance sheet does not match the amortized cost or cost or fair value for “All other corporate bonds” due to our held-to-maturity security, which is carried at cost on the balance sheet and all other fixed maturities are carried at fair value. |
See the accompanying report of independent registered public accounting firm.
102
Condensed Financial Information of Registrant
PRIMERICA, INC. (Parent Only)
Condensed Balance Sheets
|
|
December 31, |
|
|||||
|
|
2014 |
|
|
2013 |
|
||
|
|
(In thousands) |
|
|||||
Assets |
|
|
|
|
|
|
|
|
Investments: |
|
|
|
|
|
|
|
|
Fixed-maturity securities available-for-sale, at fair value (amortized cost: $160,839 in 2014 and $62,216 in 2013) |
|
$ |
161,840 |
|
|
$ |
62,420 |
|
Total investments |
|
|
161,840 |
|
|
|
62,420 |
|
Cash and cash equivalents |
|
|
32,634 |
|
|
|
11,361 |
|
Due from affiliates* |
|
|
92 |
|
|
|
76 |
|
Other receivables |
|
|
1,318 |
|
|
|
364 |
|
Deferred income taxes |
|
|
7,311 |
|
|
|
5,762 |
|
Investment in subsidiaries* |
|
|
1,430,484 |
|
|
|
1,528,360 |
|
Other assets |
|
|
2,442 |
|
|
|
2,801 |
|
Total assets |
|
|
1,636,121 |
|
|
|
1,611,144 |
|
Liabilities and Stockholders’ Equity |
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
Notes payable |
|
|
374,532 |
|
|
|
374,481 |
|
Current income tax payable |
|
|
3,287 |
|
|
|
2,185 |
|
Deferred income taxes |
|
|
3,489 |
|
|
|
3,797 |
|
Due to affiliates* |
|
|
1,182 |
|
|
|
168 |
|
Interest payable |
|
|
8,214 |
|
|
|
8,214 |
|
Other liabilities |
|
|
291 |
|
|
|
272 |
|
Commitments and contingent liabilities (see Note E) |
|
|
|
|
|
|
|
|
Total liabilities |
|
|
390,995 |
|
|
|
389,117 |
|
Stockholders’ equity: |
|
|
|
|
|
|
|
|
Common stock ($0.01 par value; authorized 500,000 in 2014 and 2013; issued and outstanding 52,169 shares in 2014 and 54,834 shares in 2013) |
|
|
522 |
|
|
|
548 |
|
Paid-in capital |
|
|
353,337 |
|
|
|
472,633 |
|
Retained earnings |
|
|
795,740 |
|
|
|
640,840 |
|
Accumulated other comprehensive income, net of income tax |
|
|
95,527 |
|
|
|
108,006 |
|
Total stockholders’ equity |
|
|
1,245,126 |
|
|
|
1,222,027 |
|
Total liabilities and stockholders’ equity |
|
$ |
1,636,121 |
|
|
$ |
1,611,144 |
|
* |
Eliminated in consolidation. |
See the accompanying notes to condensed financial statements.
See the accompanying report of independent registered public accounting firm.
103
Schedule II
Condensed Financial Information of Registrant
PRIMERICA, INC. (Parent Only)
Condensed Statements of Income
|
|
Year ended December 31, |
|
|||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|||
|
|
(In thousands) |
|
|||||||||
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
Dividends from subsidiaries* |
|
$ |
319,740 |
|
|
$ |
228,319 |
|
|
$ |
238,747 |
|
Net investment income |
|
|
1,010 |
|
|
|
762 |
|
|
|
1,074 |
|
Realized investment losses, including other-than-temporary impairment losses |
|
|
(1,574 |
) |
|
|
11 |
|
|
|
545 |
|
Total revenues |
|
|
319,176 |
|
|
|
229,092 |
|
|
|
240,366 |
|
Expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
18,174 |
|
|
|
18,172 |
|
|
|
17,266 |
|
Other operating expenses |
|
|
8,667 |
|
|
|
7,882 |
|
|
|
8,222 |
|
Total expenses |
|
|
26,841 |
|
|
|
26,054 |
|
|
|
25,488 |
|
Income (loss) before income taxes |
|
|
292,335 |
|
|
|
203,038 |
|
|
|
214,878 |
|
Income taxes |
|
|
(7,540 |
) |
|
|
(7,043 |
) |
|
|
(5,998 |
) |
Income (loss) before equity in undistributed earnings of subsidiaries |
|
|
299,875 |
|
|
|
210,081 |
|
|
|
220,876 |
|
Equity in undistributed earnings of subsidiaries* |
|
|
(118,463 |
) |
|
|
(47,356 |
) |
|
|
(47,070 |
) |
Net income |
|
$ |
181,412 |
|
|
$ |
162,725 |
|
|
$ |
173,806 |
|
* |
Eliminated in consolidation. |
See the accompanying notes to condensed financial statements.
See the accompanying report of independent registered public accounting firm.
104
Schedule II
Condensed Financial Information of Registrant
PRIMERICA, INC. (Parent Only)
Condensed Statements of Comprehensive Income
|
|
Year ended December 31, |
|
|||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|||
|
|
(In thousands) |
|
|||||||||
Net income |
|
$ |
181,412 |
|
|
$ |
162,725 |
|
|
$ |
173,806 |
|
Other comprehensive income (loss) before income taxes: |
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized investment gains (losses): |
|
|
|
|
|
|
|
|
|
|
|
|
Equity in unrealized holding gains (losses) on investment securities held by subsidiaries |
|
|
7,296 |
|
|
|
(47,651 |
) |
|
|
18,127 |
|
Change in unrealized holding gains/(losses) on investment securities |
|
|
(778 |
) |
|
|
(358 |
) |
|
|
1,127 |
|
Reclassification adjustment for realized investment (gains) losses included in net income |
|
|
1,574 |
|
|
|
(11 |
) |
|
|
(545 |
) |
Foreign currency translation adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
Equity in unrealized foreign currency translation gains of subsidiaries |
|
|
(20,527 |
) |
|
|
(13,695 |
) |
|
|
4,221 |
|
Total other comprehensive income (loss) before income taxes |
|
|
(12,435 |
) |
|
|
(61,715 |
) |
|
|
22,930 |
|
Income tax expense (benefit) related to items of other comprehensive income (loss) |
|
|
44 |
|
|
|
(311 |
) |
|
|
185 |
|
Other comprehensive income (loss), net of income taxes |
|
|
(12,479 |
) |
|
|
(61,404 |
) |
|
|
22,745 |
|
Total comprehensive income |
|
$ |
168,933 |
|
|
$ |
101,321 |
|
|
$ |
196,551 |
|
See the accompanying notes to condensed financial statements.
See the accompanying report of independent registered public accounting firm.
105
Schedule II
Condensed Financial Information of Registrant
PRIMERICA, INC. (Parent Only)
Condensed Statements of Cash Flows
|
|
Year ended December 31, |
|
|
|||||||||
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|
|||
|
|
(In thousands) |
|
|
|||||||||
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
181,412 |
|
|
$ |
162,725 |
|
|
$ |
173,806 |
|
|
Adjustments to reconcile net income to cash provided by (used in) operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity in undistributed earnings of subsidiaries* (1) |
|
|
(70,472 |
) |
|
|
47,356 |
|
|
|
8,535 |
|
|
Deferred tax provision |
|
|
(1,778 |
) |
|
|
(227 |
) |
|
|
(1,139 |
) |
|
Change in income taxes |
|
|
979 |
|
|
|
(4,912 |
) |
|
|
2,451 |
|
|
Realized investment (gains) losses, including other-than-temporary impairments |
|
|
1,574 |
|
|
|
(11 |
) |
|
|
(545 |
) |
|
Accretion and amortization of investments |
|
|
203 |
|
|
|
60 |
|
|
|
400 |
|
|
Depreciation and amortization |
|
|
23 |
|
|
|
23 |
|
|
|
183 |
|
|
Share-based compensation |
|
|
998 |
|
|
|
718 |
|
|
|
215 |
|
|
Change in due to/from affiliates* |
|
|
998 |
|
|
|
(336 |
) |
|
|
438 |
|
|
Change in other operating assets and liabilities, net |
|
|
(550 |
) |
|
|
290 |
|
|
|
(109 |
) |
|
Net cash provided by (used in) operating activities |
|
|
113,387 |
|
|
|
205,686 |
|
|
|
184,235 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Available-for-sale investments sold, matured or called: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities — sold |
|
|
45,312 |
|
|
|
2,679 |
|
|
|
67,267 |
|
|
Fixed-maturity securities — matured or called |
|
|
53,512 |
|
|
|
20,269 |
|
|
|
24,503 |
|
|
Available-for-sale investments acquired: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed-maturity securities(1) |
|
|
(10,290 |
) |
|
|
(33,118 |
) |
|
|
(82,107 |
) |
|
Other, net |
|
|
- |
|
|
|
- |
|
|
|
(70 |
) |
|
Net cash provided by (used in) investing activities |
|
|
88,534 |
|
|
|
(10,170 |
) |
|
|
9,593 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends paid |
|
|
(26,512 |
) |
|
|
(25,058 |
) |
|
|
(14,737 |
) |
|
Common stock repurchased |
|
|
(147,922 |
) |
|
|
(86,280 |
) |
|
|
(257,584 |
) |
|
Warrants repurchased |
|
|
- |
|
|
|
(68,399 |
) |
|
|
- |
|
|
Excess tax benefit on share-based compensation |
|
|
163 |
|
|
|
79 |
|
|
|
22 |
|
|
Tax withholdings on share-based compensation |
|
|
(6,377 |
) |
|
|
(14,793 |
) |
|
|
(10,628 |
) |
|
Proceeds from issuance of Senior Notes, net of discount |
|
|
- |
|
|
|
- |
|
|
|
374,411 |
|
|
Payments of note issued to Citigroup |
|
|
- |
|
|
|
- |
|
|
|
(300,000 |
) |
|
Payments of deferred financing costs |
|
|
- |
|
|
|
- |
|
|
|
(3,109 |
) |
|
Net cash provided by (used) in financing activities |
|
|
(180,648 |
) |
|
|
(194,451 |
) |
|
|
(211,625 |
) |
|
Change in cash and cash equivalents |
|
|
21,273 |
|
|
|
1,065 |
|
|
|
(17,797 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, beginning of period |
|
|
11,361 |
|
|
|
10,296 |
|
|
|
28,093 |
|
|
Cash and cash equivalents, end of period |
|
$ |
32,634 |
|
|
$ |
11,361 |
|
|
$ |
10,296 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental disclosures of cash flow information: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest paid |
|
$ |
17,813 |
|
|
$ |
17,070 |
|
|
$ |
15,858 |
|
|
* |
Eliminated in consolidation. |
(1) |
Does not include $188,935 and $38,535 of fixed-maturity securities transferred from subsidiaries in the form of noncash dividends for the years ended December 31, 2014 and 2012, respectively. |
See the accompanying notes to condensed financial statements.
See the accompanying report of independent registered public accounting firm.
106
Schedule II
Condensed Financial Information of Registrant
PRIMERICA, INC. (Parent Only)
Notes to Condensed Financial Statements
(A) Corporate Reorganization
Primerica, Inc. (“we”, “us” or the “Company”) is a holding company with our primary asset being the capital stock of our operating subsidiaries, and our primary liability being $375.0 million in principal amount of senior unsecured notes issued in a public offering in 2012 (the “Senior Notes”). We were incorporated in Delaware on October 29, 2009 by Citigroup, Inc. (“Citigroup”), to serve as a holding company for the life insurance and financial product distribution businesses that we have operated for more than 30 years. In April 2010, these indirect subsidiaries of Citigroup were transferred to us through multiple transactions (the “corporate reorganization”), which culminated in the sale of a portion of our common stock owned by Citigroup in an initial public offering (the “IPO”). Prior to our corporate reorganization, we had no material assets or liabilities.
(B) Basis of Presentation
These condensed financial statements reflect the results of operations, financial position and cash flows for the Company. We prepare our financial statements in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). These principles are established primarily by the Financial Accounting Standards Board (“FASB”). The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect financial statement balances, revenues and expenses and cash flows, as well as the disclosure of contingent assets and liabilities. Management considers available facts and knowledge of existing circumstances when establishing the estimates included in our financial statements.
The most significant item that involves a greater degree of accounting estimates subject to change in the future is determination of our investments in subsidiaries. Estimates for this and other items are subject to change and are reassessed by management in accordance with U.S. GAAP. Actual results could differ from those estimates.
The accompanying condensed financial statements should be read in conjunction with the consolidated financial statements and notes thereto of Primerica, Inc. and subsidiaries included in Part II, Item 8 of this report.
Certain reclassifications have been made to prior-period amounts to conform to current-period reporting classifications. These reclassifications had no impact on net income or total stockholders’ equity.
(C) Note Payable
In July 2012, we issued the Senior Notes in a public offering at a price of 99.843% of the principal amount with an annual interest rate of 4.75%, payable semi-annually in arrears on January 15 and July 15. The Senior Notes mature on July 15, 2022.
As unsecured senior obligations, the Senior Notes rank equally in right of payment with all existing and future unsubordinated indebtedness and senior to all existing and future subordinated indebtedness of the Company. The Senior Notes are structurally subordinated in right of payment to all existing and future liabilities of our subsidiaries. In addition, the Senior Notes contain covenants that restrict our ability to, among other things, create or incur any indebtedness that is secured by a lien on the capital stock of certain of our subsidiaries, and merge, consolidate or sell all or substantially all of our properties and assets.
We were in compliance with the covenants of the Senior Notes at December 31, 2014. No events of default(s) occurred on the Senior Notes during the year ended December 31, 2014.
(D) Dividends
For the years ended December 31, 2014, 2013, and 2012, the Company received dividends from our non-life insurance subsidiaries of approximately $71.3 million, $63.9 million, and $73.6 million, respectively. For the years ended December 31, 2014, 2013, and 2012, the Company received dividends from our life insurance subsidiaries of approximately $248.4 million, $164.4 million, and $165.1 million, respectively.
(E) Commitments and Contingent Liabilities
We have capital maintenance agreements with Peach Re, Inc. (“Peach Re”) and Vidalia Re, Inc., (“Vidalia Re”), special purpose financial captive insurance companies and indirect wholly owned subsidiaries of the Company. Each of the capital maintenance agreement requires us at times to make capital contributions to Peach Re and Vidalia Re to insure that their regulatory accounts as defined in the coinsurance agreements with Primerica Life Insurance Company (“Primerica Life”), a life insurance company and wholly owned subsidiary of the Company, will not be less than $20.0 million for each financial captive insurance company. For Peach Re, the regulatory account will only be used to satisfy obligations under its coinsurance agreement after all other available assets have been used, including a letter of credit (“LOC”) issued by Deutsche Bank for the benefit of Primerica Life. The LOC was issued in
107
2012 with a term of approximately 14 years. At December 31, 2014, the amount of the LOC outstanding was approximately $507.0 million. For Vidalia Re, the regulatory account will only be used to satisfy obligations under its coinsurance agreement after all other available assets have been used including its held-to-maturity security guaranteed by Hannover Re.
The Company is involved from time to time in legal disputes, regulatory inquiries and arbitration proceedings in the normal course of business. These disputes are subject to uncertainties, including large and/or indeterminate amounts sought in certain of these matters and the inherent unpredictability of litigation. As such, the Company is unable to estimate the possible loss or range of loss that may result from these matters.
108
Supplementary Insurance Information
PRIMERICA, INC.
|
|
Deferred policy acquisition costs |
|
|
Future policy benefits |
|
|
Unearned premiums |
|
|
Other policy benefits and claims payable |
|
|
Separate account liabilities |
|
|||||
|
|
(In thousands) |
|
|||||||||||||||||
December 31, 2014 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Term Life Insurance |
|
$ |
1,264,152 |
|
|
$ |
5,052,661 |
|
|
$ |
- |
|
|
$ |
252,525 |
|
|
$ |
- |
|
Investment and Savings Products |
|
|
58,156 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
2,439,863 |
|
Corporate and Other Distributed Products |
|
|
28,872 |
|
|
|
211,947 |
|
|
|
912 |
|
|
|
12,307 |
|
|
|
440 |
|
Total |
|
$ |
1,351,180 |
|
|
$ |
5,264,608 |
|
|
$ |
912 |
|
|
$ |
264,832 |
|
|
$ |
2,440,303 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2013 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Term Life Insurance |
|
$ |
1,115,286 |
|
|
$ |
4,843,176 |
|
|
$ |
- |
|
|
$ |
237,197 |
|
|
$ |
- |
|
Investment and Savings Products |
|
|
63,607 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
2,503,197 |
|
Corporate and Other Distributed Products |
|
|
29,573 |
|
|
|
219,927 |
|
|
|
1,802 |
|
|
|
16,107 |
|
|
|
632 |
|
Total |
|
$ |
1,208,466 |
|
|
$ |
5,063,103 |
|
|
$ |
1,802 |
|
|
$ |
253,304 |
|
|
$ |
2,503,829 |
|
|
|
Premium revenue |
|
|
Net investment income |
|
|
Benefits and claims |
|
|
Amortization of deferred policy acquisition costs |
|
|
Other operating expenses |
|
|
Premiums written |
|
||||||
|
|
(In thousands) |
|
|||||||||||||||||||||
Year ended December 31, 2014 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Term Life Insurance |
|
$ |
660,684 |
|
|
$ |
69,772 |
|
|
$ |
295,332 |
|
|
$ |
133,331 |
|
|
$ |
129,598 |
|
|
$ |
- |
|
Investment and Savings Products |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
8,734 |
|
|
|
357,322 |
|
|
|
- |
|
Corporate and Other Distributed Products |
|
|
23,831 |
|
|
|
16,701 |
|
|
|
16,085 |
|
|
|
2,313 |
|
|
|
121,593 |
|
|
|
934 |
|
Total |
|
$ |
684,515 |
|
|
$ |
86,473 |
|
|
$ |
311,417 |
|
|
$ |
144,378 |
|
|
$ |
608,513 |
|
|
$ |
934 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31, 2013 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Term Life Insurance |
|
$ |
597,162 |
|
|
$ |
68,796 |
|
|
$ |
262,357 |
|
|
$ |
115,891 |
|
|
$ |
119,526 |
|
|
$ |
- |
|
Investment and Savings Products |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
11,195 |
|
|
|
340,794 |
|
|
|
- |
|
Corporate and Other Distributed Products |
|
|
23,871 |
|
|
|
19,956 |
|
|
|
17,574 |
|
|
|
2,097 |
|
|
|
116,130 |
|
|
|
905 |
|
Total |
|
$ |
621,033 |
|
|
$ |
88,752 |
|
|
$ |
279,931 |
|
|
$ |
129,183 |
|
|
$ |
576,450 |
|
|
$ |
905 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31, 2012 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Term Life Insurance |
|
$ |
543,658 |
|
|
$ |
66,119 |
|
|
$ |
239,346 |
|
|
$ |
104,272 |
|
|
$ |
110,590 |
|
|
$ |
- |
|
Investment and Savings Products |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
10,956 |
|
|
|
281,893 |
|
|
|
- |
|
Corporate and Other Distributed Products |
|
|
23,621 |
|
|
|
34,685 |
|
|
|
14,702 |
|
|
|
3,370 |
|
|
|
122,521 |
|
|
|
1,165 |
|
Total |
|
$ |
567,279 |
|
|
$ |
100,804 |
|
|
$ |
254,048 |
|
|
$ |
118,598 |
|
|
$ |
515,004 |
|
|
$ |
1,165 |
|
See the accompanying report of independent registered public accounting firm.
109
Reinsurance
PRIMERICA, INC.
|
|
Year ended December 31, 2014 |
|
|||||||||||||||||
|
|
Gross amount |
|
|
Ceded to other companies |
|
|
Assumed from other companies |
|
|
Net amount |
|
|
Percentage of amount assumed to net |
|
|||||
|
|
(Dollars in thousands) |
|
|||||||||||||||||
Life insurance in force |
|
$ |
685,998,013 |
|
|
$ |
607,218,906 |
|
|
$ |
- |
|
|
$ |
78,779,107 |
|
|
|
— |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life insurance |
|
$ |
2,299,355 |
|
|
$ |
1,615,847 |
|
|
$ |
- |
|
|
$ |
683,508 |
|
|
|
— |
% |
Accident and health insurance |
|
|
1,977 |
|
|
|
970 |
|
|
|
- |
|
|
|
1,007 |
|
|
|
— |
% |
Total premiums |
|
$ |
2,301,332 |
|
|
$ |
1,616,817 |
|
|
$ |
- |
|
|
$ |
684,515 |
|
|
|
— |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31, 2013 |
|
|||||||||||||||||
|
|
Gross amount |
|
|
Ceded to other companies |
|
|
Assumed from other companies |
|
|
Net amount |
|
|
Percentage of amount assumed to net |
|
|||||
|
|
(Dollars in thousands) |
|
|||||||||||||||||
Life insurance in force |
|
$ |
679,337,825 |
|
|
$ |
601,309,340 |
|
|
$ |
- |
|
|
$ |
78,028,485 |
|
|
|
— |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life insurance |
|
$ |
2,262,721 |
|
|
$ |
1,642,775 |
|
|
$ |
- |
|
|
$ |
619,946 |
|
|
|
— |
% |
Accident and health insurance |
|
|
2,470 |
|
|
|
1,383 |
|
|
|
- |
|
|
|
1,087 |
|
|
|
— |
% |
Total premiums |
|
$ |
2,265,191 |
|
|
$ |
1,644,158 |
|
|
$ |
- |
|
|
$ |
621,033 |
|
|
|
— |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31, 2012 |
|
|||||||||||||||||
|
|
Gross amount |
|
|
Ceded to other companies |
|
|
Assumed from other companies |
|
|
Net amount |
|
|
Percentage of amount assumed to net |
|
|||||
|
|
(Dollars in thousands) |
|
|||||||||||||||||
Life insurance in force |
|
$ |
675,164,992 |
|
|
$ |
599,133,626 |
|
|
$ |
- |
|
|
$ |
76,031,366 |
|
|
|
— |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life insurance |
|
$ |
2,227,821 |
|
|
$ |
1,661,822 |
|
|
$ |
- |
|
|
$ |
565,999 |
|
|
|
— |
% |
Accident and health insurance |
|
|
3,211 |
|
|
|
1,931 |
|
|
|
- |
|
|
|
1,280 |
|
|
|
— |
% |
Total premiums |
|
$ |
2,231,032 |
|
|
$ |
1,663,753 |
|
|
$ |
- |
|
|
$ |
567,279 |
|
|
|
— |
% |
See the accompanying report of independent registered public accounting firm.
110
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Primerica, Inc.
By: |
|
/s/ Alison S. Rand |
|
February 26, 2015 |
|
|
Alison S. Rand |
|
|
|
|
Executive Vice President and |
|
|
|
|
Chief Financial Officer |
|
|
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
/s/ D. Richard Williams |
|
Chairman of the Board and Co-Chief Executive Officer (Principal Executive Officer) |
|
February 26, 2015 |
D. Richard Williams |
|
|
||
|
|
|
||
/s/ John A. Addison, Jr. |
|
Chairman of Primerica Distribution and Co-Chief Executive Officer (Principal Executive Officer) |
|
February 26, 2015 |
John A. Addison, Jr. |
|
|
||
|
|
|
||
/s/ Alison S. Rand |
|
Executive Vice President and Chief Financial Officer (Principal Financial and Accounting Officer) |
|
February 26, 2015 |
Alison S. Rand |
|
|
||
|
|
|
||
/s/ Joel M. Babbit |
|
Director |
|
February 26, 2015 |
Joel M. Babbit |
|
|
||
|
|
|
||
/s/ P. George Benson |
|
Director |
|
February 26, 2015 |
P. George Benson |
|
|
||
|
|
|
||
/s/ Gary L. Crittenden |
|
Director |
|
February 26, 2015 |
Gary L. Crittenden |
|
|
||
|
|
|
||
/s/ Cynthia N. Day |
|
Director |
|
February 26, 2015 |
Cynthia N. Day |
|
|
||
|
|
|
||
/s/ Mark Mason |
|
Director |
|
February 26, 2015 |
Mark Mason |
|
|
||
|
|
|
||
/s/ Robert F. McCullough |
|
Director |
|
February 26, 2015 |
Robert F. McCullough |
|
|
||
|
|
|
||
/s/ Beatriz R. Perez |
|
Director |
|
February 26, 2015 |
Beatriz R. Perez |
|
|
||
|
|
|
||
/s/ Barbara A. Yastine |
|
Director |
|
February 26, 2015 |
Barbara A. Yastine |
|
|
111